diff --git "a/data/example-predictions-cv.csv" "b/data/example-predictions-cv.csv"
--- "a/data/example-predictions-cv.csv"
+++ "b/data/example-predictions-cv.csv"
@@ -1,247 +1,247 @@
-antibody_id,antibody_name,Titer,Purity,SEC %Monomer,SMAC,HIC,HAC,PR_CHO,PR_Ova,AC-SINS_pH6.0,AC-SINS_pH7.4,Tonset,Tm1,Tm2,hc_subtype,lc_subtype,highest_clinical_trial_asof_feb2025,est_status_asof_feb2025,vh_protein_sequence,hc_protein_sequence,hc_dna_sequence,vl_protein_sequence,lc_protein_sequence,lc_dna_sequence,hierarchical_cluster_fold,random_fold,hierarchical_cluster_IgG_isotype_stratified_fold,light_aligned_aho,heavy_aligned_aho
-GDPa1-001,abagovomab,140.25,98.53,97.00999999999999,2.7300000000000004,2.59,,0.4,0.26,-0.63,2.5,62.144999999999996,69.535,83.08,IgG1,Kappa,Phase-III,Discontinued,QVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGAAGCTGCAGGAATCCGGCGCTGAGTTGGCCAGACCCGGCGCCTCTGTGAAACTGTCTTGCAAGGCCTCTGGGTATACATTCACCAACTACTGGATGCAGTGGGTAAAACAGCGCCCAGGACAGGGACTGGATTGGATTGGAGCCATCTACCCTGGTGATGGCAATACTAGGTACACACACAAATTCAAGGGCAAGGCAACCCTCACCGCTGACAAGAGCAGCTCCACGGCGTACATGCAACTCAGTTCCCTTGCATCAGAGGACAGTGGGGTTTATTACTGTGCTCGGGGCGAAGGTAACTATGCCTGGTTTGCATATTGGGGGCAGGGGACTACCGTCACAGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIK,MRAWIFFLLCLAGRALADIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCGAGCTGACCCAGTCTCCAGCGTCACTTTCCGCTAGCGTTGGGGAAACCGTGACCATCACATGCCAGGCTAGCGAGAACATTTACAGCTATCTGGCCTGGCACCAACAGAAACAGGGGAAATCTCCTCAGTTGCTTGTGTATAATGCAAAAACTCTCGCCGGAGGCGTCAGCTCTCGGTTTTCCGGATCAGGAAGTGGTACGCATTTCTCCCTGAAGATTAAGAGTCTCCAACCGGAAGACTTTGGCATTTACTATTGTCAGCATCACTACGGCATCCTGCCCACTTTCGGTGGGGGCACAAAGTTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,2,DIELTQSPASLSASVGETVTITCQAS--ENIY------SYLAWHQQKQGKSPQLLVYN--------AKTLAGGVSSRFSGSGSG--THFSLKIKSLQPEDFGIYYCQHHYG-----------------------ILPTFGGGTKLEIK-,QVKLQES-GAELARPGASVKLSCKASG-YTFTN-----YWMQWVKQRPGQGLDWIGAIYPG---DGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNY--------------------AWFAYWGQGTTVTVSS
-GDPa1-002,abituzumab,193.31,99.825,97.62,2.745,2.545,3.69,0.21,0.1,1.12,2.125,60.629999999999995,69.93,80.33,IgG2,Kappa,Phase-II,Active,QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAACTTCAGCAGTCCGGCGGCGAACTCGCAAAACCTGGTGCTTCTGTAAAAGTGAGCTGCAAGGCCTCCGGGTATACGTTCTCATCCTTTTGGATGCACTGGGTGCGACAGGCCCCCGGTCAAGGACTGGAGTGGATCGGGTACATAAATCCACGGAGCGGGTACACCGAATATAACGAGATTTTTCGCGACAAGGCGACAATGACCACAGACACCTCTACCAGTACAGCTTACATGGAGCTGAGTTCCCTGAGGTCTGAAGATACAGCCGTCTATTATTGTGCAAGCTTCTTGGGCAGAGGCGCCATGGATTACTGGGGACAGGGAACTACTGTTACTGTGTCAAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAGTCCCCCAGCTCCCTGAGTGCCAGCGTGGGTGATAGGGTGACAATAACTTGTAGAGCGTCCCAGGATATTTCCAATTACTTGGCATGGTACCAGCAGAAGCCTGGCAAAGCCCCAAAGCTTCTCATCTATTATACATCTAAAATCCACTCTGGAGTTCCCAGCCGGTTTTCAGGGAGTGGGAGCGGTACCGACTACACCTTCACGATTTCATCTCTGCAACCTGAAGACATTGCTACTTATTATTGCCAGCAAGGCAACACATTCCCATACACTTTTGGCCAGGGAACCAAAGTCGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,0,DIQMTQSPSSLSASVGDRVTITCRAS--QDIS------NYLAWYQQKPGKAPKLLIYY--------TSKIHSGVPSRFSGSGSG--TDYTFTISSLQPEDIATYYCQQGNT-----------------------FPYTFGQGTKVEIK-,QVQLQQS-GGELAKPGASVKVSCKASG-YTFSS-----FWMHWVRQAPGQGLEWIGYINPR---SGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGR---------------------GAMDYWGQGTTVTVSS
-GDPa1-003,abrezekimab,114.75,98.35,89.055,2.74,2.705,,0.14,0.1,0.6200000000000001,1.625,57.36,68.765,85.03,IgG4,Kappa,Phase-I,Discontinued,QVTLKESGPVLVKPTETLTLTCTVSGFSLTNYHVQWIRQPPGKALEWLGVMWSDGDTSFNSVLKSRLTISRDTSKSQVVLTMTNMDPVDTATYYCARDGTIAAMDYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVTLKESGPVLVKPTETLTLTCTVSGFSLTNYHVQWIRQPPGKALEWLGVMWSDGDTSFNSVLKSRLTISRDTSKSQVVLTMTNMDPVDTATYYCARDGTIAAMDYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTACACTGAAAGAGTCCGGGCCTGTGCTGGTGAAGCCGACCGAGACACTGACCTTGACGTGCACAGTCTCCGGCTTCAGCCTGACCAATTATCACGTGCAATGGATAAGACAGCCCCCAGGGAAAGCCCTCGAATGGCTCGGAGTGATGTGGTCTGACGGCGACACGAGCTTTAACAGTGTGCTTAAGTCTCGGCTGACCATTTCACGCGATACCAGTAAGTCCCAGGTGGTCTTGACCATGACAAACATGGATCCCGTCGATACTGCGACTTACTACTGTGCTAGGGACGGAACTATCGCAGCCATGGATTATTTCGACTACTGGGGCCAGGGTACACTTGTTACTGTATCAAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCLASEDISNYLAWYQQKPGKAPKLLIYHTSRLQDGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYRFPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCLASEDISNYLAWYQQKPGKAPKLLIYHTSRLQDGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYRFPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACGCAGTCCCCCAGCTCTCTCTCCGCCTCTGTTGGGGATCGCGTGACCATCACCTGCTTGGCGTCAGAGGATATATCAAACTATCTGGCCTGGTACCAGCAGAAGCCAGGCAAAGCTCCTAAGCTGCTGATCTACCACACATCTAGACTGCAGGACGGGGTCCCAAGTCGGTTTAGCGGTTCCGGCAGCGGCACCGACTTCACACTTACTATCAGCAGTCTCCAGCCTGAAGACTTCGCAACCTATTACTGTCAACAAGGATATAGGTTTCCCCTTACATTCGGGGGTGGAACTAAGGTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,2,DIQMTQSPSSLSASVGDRVTITCLAS--EDIS------NYLAWYQQKPGKAPKLLIYH--------TSRLQDGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQGYR-----------------------FPLTFGGGTKVEIK-,QVTLKES-GPVLVKPTETLTLTCTVSG-FSLTN-----YHVQWIRQPPGKALEWLGVMWS----DGDTSFNSVLKSRLTISRDTSKSQVVLTMTNMDPVDTATYYCARDGTIAA------------------MDYFDYWGQGTLVTVSS
-GDPa1-004,abrilumab,327.32,98.57499999999999,98.60499999999999,2.715,2.565,1.005,0.02,0.08,0.8700000000000001,-0.625,64.175,72.38,75.93,IgG2,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTCGTGCAGTCCGGGGCGGAAGTCAAAAAGCCTGGCGCCTCTGTGAAGGTGTCCTGTAAAGTATCAGGCTATACTTTGTCCGACCTCTCCATCCACTGGGTCAGGCAAGCTCCAGGCAAAGGTCTGGAGTGGATGGGCGGATTCGATCCCCAGGACGGTGAGACCATTTACGCACAGAAGTTCCAGGGGAGAGTTACGATGACCGAGGATACAAGTACAGACACAGCCTACATGGAACTTAGCTCACTGAAGAGCGAAGACACCGCTGTCTATTACTGCGCCACCGGGTCATCTTCTAGCTGGTTTGATCCGTGGGGACAGGGAACTCTGGTTACTGTGAGCAGTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAGAGCCCCTCCTCTGTATCAGCCTCCGTCGGCGATAGAGTGACCATTACCTGCAGGGCTTCCCAGGGGATATCAAGCTGGCTGGCTTGGTATCAACAGAAGCCAGGTAAGGCGCCTAAGCTGTTGATCTACGGAGCAAGCAATCTTGAATCTGGCGTGCCTTCCCGCTTCAGTGGCTCAGGAAGTGGGACTGATTTCACACTGACAATCAGTAGCCTCCAACCAGAGGACTTTGCCAACTACTATTGTCAGCAGGCCAACTCTTTTCCCTGGACGTTCGGTCAGGGGACTAAAGTTGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,3,0,DIQMTQSPSSVSASVGDRVTITCRAS--QGIS------SWLAWYQQKPGKAPKLLIYG--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFANYYCQQANS-----------------------FPWTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKVSG-YTLSD-----LSIHWVRQAPGKGLEWMGGFDPQ---DGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSS---------------------SWFDPWGQGTLVTVSS
-GDPa1-005,adalimumab,313.39,99.3,96.12,2.705,2.495,,0.18,0.1,2.0,3.875,62.35,72.0,84.84,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCGTCGAATCCGGCGGTGGGCTGGTGCAGCCCGGCAGGAGCCTCAGATTGAGTTGTGCAGCGTCTGGCTTCACGTTTGATGACTATGCTATGCACTGGGTTAGGCAGGCTCCTGGCAAGGGGCTTGAGTGGGTTTCCGCTATAACTTGGAACTCAGGACATATCGATTACGCAGACTCAGTGGAGGGTCGATTCACCATTAGCCGCGATAATGCCAAGAACTCCCTGTATTTGCAAATGAATAGCCTGCGGGCCGAGGACACCGCCGTATATTACTGCGCCAAAGTGTCTTACCTTAGTACTGCATCATCCCTGGACTACTGGGGACAGGGGACACTGGTGACAGTCTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACTCAGTCTCCAAGCAGCCTCAGCGCGTCAGTCGGGGATAGAGTGACAATTACCTGCAGGGCCTCTCAGGGCATCCGGAACTACCTGGCTTGGTATCAGCAGAAACCCGGGAAGGCACCTAAGCTGCTGATTTATGCCGCAAGTACGTTGCAGAGTGGCGTGCCTTCCCGATTCTCAGGCTCCGGTTCTGGAACCGATTTTACCCTCACAATCTCCAGCCTTCAACCCGAGGACGTAGCTACCTATTACTGTCAGCGCTACAATAGGGCCCCATACACTTTCGGACAAGGTACAAAAGTTGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,DIQMTQSPSSLSASVGDRVTITCRAS--QGIR------NYLAWYQQKPGKAPKLLIYA--------ASTLQSGVPSRFSGSGSG--TDFTLTISSLQPEDVATYYCQRYNR-----------------------APYTFGQGTKVEIK-,EVQLVES-GGGLVQPGRSLRLSCAASG-FTFDD-----YAMHWVRQAPGKGLEWVSAITWN---SGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLST------------------ASSLDYWGQGTLVTVSS
-GDPa1-006,aducanumab,367.3,91.565,99.84,2.725,2.46,,0.38,0.31,1.5,26.625,61.605000000000004,70.505,85.88,IgG1,Kappa,Approved,NFD,QVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTCGAGTCAGGAGGGGGCGTTGTACAACCCGGACGGTCTCTGCGCCTCTCATGTGCCGCCTCCGGCTTTGCATTCAGCAGTTATGGCATGCACTGGGTGAGGCAGGCCCCTGGTAAGGGCCTTGAATGGGTCGCAGTGATTTGGTTTGACGGAACGAAAAAGTACTATACTGACAGTGTGAAAGGGCGCTTCACCATCAGCAGAGATAACAGCAAAAACACACTCTACCTGCAGATGAATACCTTGCGAGCGGAGGATACAGCTGTGTATTACTGCGCCCGGGATAGAGGTATAGGGGCTAGGCGAGGCCCATACTATATGGACGTCTGGGGCAAGGGAACCACTGTGACAGTGTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGTCACCAAGTTCCTTGTCTGCCTCTGTCGGCGACAGAGTGACCATTACTTGTAGGGCATCTCAGAGCATATCATCCTACCTCAACTGGTACCAGCAAAAACCCGGGAAGGCTCCTAAGCTGCTGATCTATGCGGCTTCCAGCCTGCAAAGTGGTGTTCCCAGCCGCTTCAGTGGCTCCGGCAGCGGAACGGACTTCACCCTCACAATCTCATCTCTGCAGCCTGAAGATTTTGCCACCTATTACTGCCAGCAGAGCTATTCCACACCACTTACTTTTGGGGGTGGAACCAAGGTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCRAS--QSIS------SYLNWYQQKPGKAPKLLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSYS-----------------------TPLTFGGGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FAFSS-----YGMHWVRQAPGKGLEWVAVIWFD---GTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGAR---------------RGPYYMDVWGKGTTVTVSS
-GDPa1-007,alemtuzumab,190.23,90.86500000000001,96.055,2.7,2.45,,0.16,0.13,0.0,0.0,57.92,71.63,80.75,IgG1,Kappa,Approved,Active,QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTCCAAGAGTCCGGGCCTGGGCTTGTCCGGCCAAGCCAGACCCTGTCCCTGACCTGTACTGTCTCTGGATTCACGTTTACAGACTTTTACATGAATTGGGTGAGACAGCCCCCAGGAAGAGGGCTTGAGTGGATTGGTTTCATCCGCGATAAGGCTAAGGGCTACACAACAGAATATAACCCTTCAGTAAAAGGTAGGGTTACAATGTTGGTGGATACTAGTAAAAACCAGTTTTCACTGAGGCTCAGTAGCGTTACCGCCGCCGACACCGCAGTCTATTACTGCGCGCGAGAAGGACACACCGCCGCTCCCTTCGACTATTGGGGCCAAGGCTCTCTGGTGACTGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAGTCTCCCAGTTCACTGAGTGCTTCCGTGGGGGACAGGGTTACTATTACGTGCAAGGCCTCCCAGAACATCGACAAGTACCTCAACTGGTACCAGCAGAAACCAGGCAAGGCACCTAAACTCCTGATTTATAATACAAACAATTTGCAGACCGGCGTGCCATCTCGCTTTTCAGGAAGCGGCTCTGGTACTGATTTCACATTCACCATTAGCTCCCTTCAACCTGAAGATATCGCCACTTATTACTGTCTGCAGCACATAAGCCGGCCCAGAACATTTGGACAAGGGACCAAGGTCGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,DIQMTQSPSSLSASVGDRVTITCKAS--QNID------KYLNWYQQKPGKAPKLLIYN--------TNNLQTGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCLQHIS-----------------------RPRTFGQGTKVEIK-,QVQLQES-GPGLVRPSQTLSLTCTVSG-FTFTD-----FYMNWVRQPPGRGLEWIGFIRDKA-KGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTA--------------------APFDYWGQGSLVTVSS
-GDPa1-008,alirocumab,89.39,100.0,96.72,2.71,2.535,,,,1.37,2.625,62.510000000000005,74.15,77.64,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAACTGGTAGAATCAGGGGGTGGCCTCGTGCAGCCCGGGGGAAGCCTTAGACTGTCTTGCGCGGCATCCGGTTTTACCTTCAACAACTATGCTATGAATTGGGTGCGCCAGGCCCCTGGCAAAGGATTGGACTGGGTTTCTACGATAAGTGGCTCCGGCGGGACAACCAACTACGCAGATAGCGTCAAGGGGAGGTTTATCATTAGCCGGGACTCCAGCAAGCACACACTCTACTTGCAGATGAATAGTCTGCGAGCCGAGGATACTGCCGTGTACTATTGTGCTAAAGATTCTAATTGGGGCAACTTCGACCTTTGGGGAAGGGGCACTCTGGTTACCGTGTCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATAGTGATGACTCAGTCTCCTGATTCCTTGGCTGTGTCCCTTGGAGAAAGGGCCACCATTAACTGTAAATCTTCTCAGAGCGTGCTGTACCGAAGCAATAATCGCAACTTCCTCGGATGGTACCAACAGAAGCCTGGTCAGCCCCCAAACCTGCTGATCTACTGGGCCAGTACCCGGGAGTCAGGCGTCCCAGACAGATTTAGCGGGAGTGGGTCCGGTACAGACTTTACGCTGACAATTAGCTCACTTCAGGCGGAGGACGTAGCAGTTTACTATTGCCAACAGTATTATACCACACCCTATACTTTCGGCCAGGGCACCAAGCTCGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,2,DIVMTQSPDSLAVSLGERATINCKSS--QSVLYRSNNRNFLGWYQQKPGQPPNLLIYW--------ASTRESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQQYYT-----------------------TPYTFGQGTKLEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFNN-----YAMNWVRQAPGKGLDWVSTISGS---GGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNW---------------------GNFDLWGRGTLVTVSS
-GDPa1-009,amatuximab,224.95,99.65,97.44,2.7350000000000003,2.67,4.07,0.66,0.82,3.5,18.5,,,,IgG1,Kappa,Phase-II,Discontinued,QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAATTGCAGCAGTCAGGCCCTGAACTGGAGAAACCAGGGGCATCTGTGAAAATTTCTTGTAAGGCCAGCGGTTATAGCTTCACGGGCTATACTATGAATTGGGTAAAGCAGTCCCACGGGAAGTCCCTGGAATGGATCGGGCTGATAACTCCGTATAACGGTGCCTCATCATACAACCAGAAGTTTCGGGGAAAAGCCACACTCACAGTGGACAAGTCTTCCAGTACCGCTTACATGGATCTGCTTAGCCTCACCAGTGAGGACAGCGCTGTTTATTTCTGCGCGAGAGGCGGGTACGACGGAAGGGGCTTTGATTACTGGGGCTCTGGAACACCCGTCACCGTGTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIK,MRAWIFFLLCLAGRALADIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGAGCTGACTCAGTCCCCCGCCATAATGAGCGCGTCCCCCGGGGAGAAAGTGACAATGACCTGTTCAGCTTCTAGCTCCGTCAGTTATATGCATTGGTATCAGCAGAAGTCCGGCACAAGCCCTAAGAGATGGATCTACGATACATCTAAGTTGGCATCAGGTGTACCAGGGAGGTTCTCAGGCTCCGGATCAGGAAACAGTTACAGCCTCACCATCAGCTCTGTGGAGGCCGAAGACGACGCTACTTACTATTGCCAGCAATGGAGTAAACACCCGCTGACCTTTGGTTCTGGCACGAAGGTTGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,3,2,DIELTQSPAIMSASPGEKVTMTCSAS--SSVS-------YMHWYQQKSGTSPKRWIYD--------TSKLASGVPGRFSGSGSG--NSYSLTISSVEAEDDATYYCQQWSK-----------------------HPLTFGSGTKVEIK-,QVQLQQS-GPELEKPGASVKISCKASG-YSFTG-----YTMNWVKQSHGKSLEWIGLITPY---NGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDG--------------------RGFDYWGSGTPVTVSS
-GDPa1-010,andecaliximab,291.17,99.33500000000001,98.875,3.455,3.1550000000000002,,0.18,0.15,-0.63,-0.375,62.57,70.2,81.515,IgG1,Kappa,Phase-III,Discontinued,QVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAGCTGCAGGAGTCAGGACCCGGGTTGGTCAAACCGAGCGAAACCCTTAGCCTCACATGTACCGTTAGTGGCTTCTCTCTGTTGTCTTATGGCGTGCACTGGGTAAGACAGCCTCCAGGCAAGGGTCTCGAATGGCTCGGGGTGATATGGACTGGGGGTACAACGAATTATAACTCCGCACTTATGTCAAGGTTTACTATCTCCAAGGACGACTCTAAAAACACAGTCTATCTGAAAATGAATAGTCTGAAGACCGAGGATACTGCTATTTACTATTGCGCCCGGTACTACTACGGCATGGATTACTGGGGACAGGGAACACTGGTGACCGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACCCAGAGCCCGAGCTCCCTGAGCGCTTCTGTGGGCGACAGAGTGACCATTACGTGTAAGGCTTCTCAGGATGTCAGGAATACTGTCGCCTGGTATCAACAGAAACCCGGGAAAGCGCCAAAGCTTTTGATCTACTCAAGTTCATACCGCAACACAGGAGTTCCCGACCGGTTCAGTGGCAGCGGTTCTGGGACTGATTTCACCCTGACAATCTCCTCCCTCCAAGCAGAAGACGTGGCCGTGTATTATTGCCAGCAGCACTACATCACACCTTACACTTTTGGTGGCGGAACCAAGGTAGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,DIQMTQSPSSLSASVGDRVTITCKAS--QDVR------NTVAWYQQKPGKAPKLLIYS--------SSYRNTGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQQHYI-----------------------TPYTFGGGTKVEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-FSLLS-----YGVHWVRQPPGKGLEWLGVIWT----GGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYY-----------------------GMDYWGQGTLVTVSS
-GDPa1-011,anetumab,261.98,98.75,98.47,2.775,2.8099999999999996,,0.17,0.1,18.0,17.375,62.31,72.355,82.96,IgG1,Lambda,Phase-II,Discontinued,QVELVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVELVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCGAGCTCGTGCAGTCCGGCGCCGAAGTGAAGAAACCTGGAGAATCACTGAAGATTAGCTGCAAAGGTTCCGGATATAGCTTTACTTCTTACTGGATCGGTTGGGTTAGACAGGCTCCAGGCAAGGGTCTGGAGTGGATGGGAATAATCGATCCGGGAGACAGTCGCACCAGGTACAGTCCCTCATTCCAAGGGCAGGTAACCATTTCTGCCGACAAATCAATCTCTACGGCTTATCTTCAGTGGTCCAGTCTCAAGGCGAGCGACACTGCCATGTATTATTGTGCACGGGGGCAGTTGTACGGGGGCACATACATGGATGGCTGGGGGCAGGGCACCCTGGTGACAGTCAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIALTQPASVSGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYDIESATPVFGGGTKLTVL,MRAWIFFLLCLAGRALADIALTQPASVSGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYDIESATPVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGCTCTGACGCAGCCTGCGAGTGTGAGTGGATCCCCCGGCCAGTCTATAACTATCAGCTGTACCGGCACCTCTAGCGATATTGGGGGTTACAACAGTGTGAGCTGGTATCAACAGCACCCTGGAAAGGCTCCAAAGCTTATGATCTATGGCGTCAATAATAGGCCCTCTGGAGTAAGCAACAGATTTTCCGGGTCCAAAAGCGGTAACACCGCCTCCTTGACAATTTCAGGGCTGCAGGCAGAGGACGAGGCCGACTACTATTGCTCATCATACGATATTGAATCTGCCACTCCAGTGTTCGGCGGGGGCACAAAACTCACAGTTCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,4,DIALTQP-ASVSGSPGQSITISCTGTS-SDIGG----YNSVSWYQQHPGKAPKLMIYG--------VNNRPSGVSNRFSGSKSG--NTASLTISGLQAEDEADYYCSSYDIE---------------------SATPVFGGGTKLTVL-,QVELVQS-GAEVKKPGESLKISCKGSG-YSFTS-----YWIGWVRQAPGKGLEWMGIIDPG---DSRTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGQLYG-------------------GTYMDGWGQGTLVTVSS
-GDPa1-012,anifrolumab,92.11,100.0,97.33,2.6900000000000004,2.4800000000000004,,,,1.87,-0.125,60.295,69.545,83.41499999999999,IgG1,Kappa,Approved,Active,EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGCTGGTGCAATCCGGCGCCGAGGTGAAGAAGCCCGGGGAGAGCTTGAAGATTTCATGTAAAGGGTCAGGTTACATCTTCACTAACTACTGGATTGCCTGGGTAAGACAGATGCCAGGCAAAGGACTCGAATCTATGGGCATCATTTACCCTGGTGACTCCGATATCCGCTATTCTCCGTCCTTCCAGGGCCAAGTCACAATAAGCGCAGATAAATCTATCACCACGGCTTATCTTCAGTGGAGCAGTCTGAAGGCGAGTGACACTGCTATGTATTACTGCGCCCGGCACGACATAGAGGGGTTTGATTATTGGGGAAGGGGAACCCTGGTGACAGTTAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTTCTGACACAGTCCCCTGGTACCCTGTCTTTGAGCCCAGGCGAGCGGGCCACTCTCAGTTGCCGCGCTTCCCAGAGCGTCAGCTCTTCCTTTTTCGCCTGGTATCAGCAGAAACCTGGACAGGCTCCACGACTCCTTATTTACGGTGCATCATCAAGGGCAACCGGAATTCCCGATCGCCTTAGCGGCTCCGGGTCAGGGACTGACTTTACATTGACGATCACCAGACTGGAACCCGAAGATTTCGCGGTGTATTACTGTCAACAGTACGACAGTTCTGCCATCACATTCGGCCAAGGGACCAGGCTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,3,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----SFFAWYQQKPGQAPRLLIYG--------ASSRATGIPDRLSGSGSG--TDFTLTITRLEPEDFAVYYCQQYDS-----------------------SAITFGQGTRLEIK-,EVQLVQS-GAEVKKPGESLKISCKGSG-YIFTN-----YWIAWVRQMPGKGLESMGIIYPG---DSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIE----------------------GFDYWGRGTLVTVSS
-GDPa1-013,anrukinzumab,301.96,98.36500000000001,98.04499999999999,2.76,2.7350000000000003,,0.0,0.0,2.25,2.125,64.23,72.44,,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFISYAMSWVRQAPGKGLEWVASISSGGNTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLDGYYFGFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFISYAMSWVRQAPGKGLEWVASISSGGNTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLDGYYFGFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAACTGGTGGAGTCAGGGGGTGGACTGGTTCAGCCCGGAGGGTCCCTCCGATTGAGCTGCGCAGCATCCGGCTTTACCTTCATCAGTTACGCTATGTCATGGGTTAGACAGGCCCCTGGTAAGGGCCTTGAATGGGTGGCTAGCATTTCTAGTGGCGGGAATACATACTACCCAGATTCTGTCAAAGGCAGGTTCACTATAAGCCGGGATAACGCTAAGAATAGCCTCTATCTGCAGATGAACTCCTTGCGCGCGGAGGACACCGCCGTATACTATTGTGCCAGGCTGGACGGATATTACTTCGGGTTTGCCTATTGGGGCCAGGGAACACTTGTGACGGTGTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASESVDNYGKSLMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPWTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASESVDNYGKSLMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPWTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACCCAATCTCCATCCTCCCTCTCTGCTTCCGTAGGTGACAGAGTGACTATCACATGTAAAGCGAGTGAATCAGTCGATAACTACGGCAAGTCTCTCATGCACTGGTACCAGCAGAAGCCCGGGAAAGCCCCTAAACTGTTGATTTATAGGGCCAGTAATCTGGAGAGTGGCGTTCCAAGCCGGTTCTCCGGAAGCGGCAGCGGGACTGATTTTACCCTGACAATCTCAAGCCTTCAACCTGAAGACTTCGCAACGTATTACTGCCAGCAGTCAAACGAGGATCCCTGGACCTTTGGGGGTGGAACAAAGGTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCKAS--ESVDNY--GKSLMHWYQQKPGKAPKLLIYR--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSNE-----------------------DPWTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFIS-----YAMSWVRQAPGKGLEWVASISS----GGNTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLDGYY--------------------FGFAYWGQGTLVTVSS
-GDPa1-014,atezolizumab,319.37,98.265,99.14,4.08,3.755,,0.0,0.0,2.87,8.0,60.82,70.525,85.575,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGCTGGTGGAGTCCGGAGGCGGGCTCGTGCAACCCGGTGGAAGCCTGAGACTGTCTTGTGCAGCCAGCGGGTTCACTTTTAGTGACAGTTGGATACATTGGGTCCGCCAGGCTCCTGGCAAGGGACTCGAGTGGGTGGCATGGATCTCCCCATACGGCGGAAGCACCTATTATGCGGATTCCGTAAAAGGGCGATTCACAATTTCTGCCGATACATCAAAGAATACCGCTTATTTGCAGATGAACTCACTTAGGGCTGAAGACACTGCCGTTTACTACTGCGCCCGGAGACACTGGCCGGGTGGCTTTGACTACTGGGGCCAGGGGACGCTGGTGACCGTTAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGTCCCCCTCCTCCTTGAGTGCGAGCGTGGGCGACAGAGTCACAATAACATGCAGGGCTTCTCAAGATGTGAGCACGGCCGTGGCCTGGTATCAGCAGAAGCCCGGTAAAGCTCCTAAGCTTCTCATTTACAGTGCATCTTTCCTCTATTCAGGAGTACCTTCCCGGTTCAGCGGCTCTGGGTCAGGGACCGACTTTACCCTGACTATCTCAAGCCTGCAACCAGAGGACTTCGCAACCTACTATTGTCAGCAGTACCTGTACCACCCAGCCACCTTTGGCCAGGGAACTAAAGTTGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQMTQSPSSLSASVGDRVTITCRAS--QDVS------TAVAWYQQKPGKAPKLLIYS--------ASFLYSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYLY-----------------------HPATFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSD-----SWIHWVRQAPGKGLEWVAWISPY---GGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWP---------------------GGFDYWGQGTLVTVSS
-GDPa1-015,avelumab,359.69,85.61500000000001,97.03,2.975,3.115,3.7800000000000002,0.1,0.1,-0.38,2.625,61.12,71.57,83.34,IgG1,Lambda,Approved,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGCTCGAGAGTGGCGGCGGATTGGTACAACCCGGAGGGTCACTGAGACTTAGCTGTGCTGCCTCTGGTTTCACATTTTCCTCTTACATCATGATGTGGGTTAGGCAGGCCCCAGGCAAAGGACTGGAATGGGTGTCAAGTATATATCCTAGCGGCGGAATTACATTCTACGCTGATACAGTCAAGGGGCGATTTACCATCAGCCGCGACAACTCCAAAAACACTTTGTATCTTCAGATGAATTCTCTGCGGGCAGAAGACACCGCCGTGTACTACTGCGCGAGGATTAAGCTGGGTACTGTTACCACCGTGGATTATTGGGGGCAGGGCACTCTCGTCACGGTGAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,MRAWIFFLLCLAGRALAQSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCTGCCCTTACTCAGCCCGCTTCAGTGAGTGGCTCCCCAGGACAGTCTATCACCATTTCTTGTACTGGGACCAGTTCCGACGTTGGGGGATACAACTACGTCTCATGGTATCAGCAACACCCGGGCAAAGCACCCAAGCTGATGATCTACGACGTGTCAAATAGGCCTAGCGGGGTGAGTAATAGATTCAGCGGATCCAAATCTGGTAACACAGCTTCCCTGACCATAAGTGGCCTCCAAGCCGAAGATGAGGCGGATTATTATTGCAGCTCCTACACAAGCAGCTCAACTCGGGTATTTGGTACCGGCACAAAGGTCACGGTGTTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,4,4,QSALTQP-ASVSGSPGQSITISCTGTS-SDVGG----YNYVSWYQQHPGKAPKLMIYD--------VSNRPSGVSNRFSGSKSG--NTASLTISGLQAEDEADYYCSSYTSS----------------------STRVFGTGTKVTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----YIMMWVRQAPGKGLEWVSSIYPS---GGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGT-------------------VTTVDYWGQGTLVTVSS
-GDPa1-016,bapineuzumab,168.63,99.60499999999999,96.055,2.7,2.46,4.71,,,1.37,-0.875,62.14,72.69,85.13,IgG1,Kappa,Phase-II,Discontinued,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASIRSGGGRTYYSDNVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHYSGSSDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASIRSGGGRTYYSDNVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHYSGSSDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTCTTGAGTCAGGCGGGGGCTTGGTACAACCCGGGGGCAGCTTGCGGCTGTCTTGCGCGGCTTCCGGTTTCACCTTTAGTAACTACGGCATGTCCTGGGTGAGACAGGCCCCTGGCAAGGGGCTGGAATGGGTTGCTTCCATTAGGAGCGGGGGAGGACGGACATATTACTCTGACAATGTCAAGGGCCGATTCACTATCAGCAGGGATAATTCTAAAAACACGCTGTACCTCCAGATGAACAGTCTGAGAGCCGAAGACACAGCAGTGTATTATTGTGTGCGCTATGATCACTACTCAGGAAGCTCCGACTACTGGGGTCAGGGAACCCTCGTCACTGTTAGTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTPGEPASISCKSSQSLLDSDGKTYLNWLLQKPGQSPQRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTPGEPASISCKSSQSLLDSDGKTYLNWLLQKPGQSPQRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTTGTTATGACACAAAGCCCGTTGTCCCTGCCCGTCACCCCAGGCGAACCTGCTAGCATCTCTTGTAAGTCAAGTCAGTCTCTGCTGGATTCCGACGGGAAAACATACCTCAACTGGCTGCTGCAAAAACCAGGACAGTCTCCCCAGAGGCTCATCTACCTTGTGAGTAAGTTGGATAGCGGGGTGCCCGACCGCTTCTCCGGATCAGGATCCGGGACTGACTTTACTCTTAAGATTAGCAGAGTGGAGGCCGAAGACGTAGGTGTCTATTATTGCTGGCAGGGCACCCACTTCCCTCGGACCTTTGGCCAGGGTACGAAAGTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,1,DVVMTQSPLSLPVTPGEPASISCKSS--QSLLDSD-GKTYLNWLLQKPGQSPQRLIYL--------VSKLDSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCWQGTH-----------------------FPRTFGQGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSN-----YGMSWVRQAPGKGLEWVASIRSG---GGRTYYSDNVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHYS--------------------GSSDYWGQGTLVTVSS
-GDPa1-017,basiliximab,126.74,98.34,85.225,2.6900000000000004,2.635,4.58,,,4.0,22.0,55.55,64.18,81.96,IgG1,Kappa,Approved,NFD,QVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS,MRAWIFFLLCLAGRALAQVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTCCAGCAGTCTGGTACCGTCTTGGCCAGGCCCGGGGCATCCGTGAAAATGTCCTGCAAGGCCAGCGGATATAGCTTTACTCGGTACTGGATGCATTGGATTAAACAGCGCCCTGGGCAGGGCCTCGAATGGATCGGCGCAATATATCCAGGAAATAGCGATACGAGTTACAACCAAAAGTTCGAGGGAAAGGCTAAACTGACAGCCGTAACCAGCGCTTCTACCGCCTACATGGAACTGTCCTCCCTGACACACGAGGACTCTGCGGTTTACTACTGTAGTAGAGATTATGGGTATTACTTCGACTTTTGGGGTCAGGGCACCACACTTACTGTGTCATCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK,MRAWIFFLLCLAGRALAQIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATTGTTTCAACACAGAGTCCCGCGATTATGTCCGCCTCTCCGGGCGAGAAGGTCACCATGACTTGCTCTGCTAGCTCCTCTCGGTCTTATATGCAATGGTACCAGCAAAAACCTGGGACCAGCCCAAAGCGCTGGATCTATGATACATCCAAACTTGCATCAGGTGTGCCCGCCAGGTTCTCAGGAAGCGGCAGTGGGACCAGCTACTCCCTCACCATAAGTTCAATGGAAGCTGAAGACGCAGCCACATATTACTGTCACCAGAGATCCAGCTACACGTTTGGCGGAGGTACTAAACTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,2,QIVSTQSPAIMSASPGEKVTMTCSAS--SSRS-------YMQWYQQKPGTSPKRWIYD--------TSKLASGVPARFSGSGSG--TSYSLTISSMEAEDAATYYCHQRS-------------------------SYTFGGGTKLEIK-,QVQLQQS-GTVLARPGASVKMSCKASG-YSFTR-----YWMHWIKQRPGQGLEWIGAIYPG---NSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGY----------------------YFDFWGQGTTLTVSS
-GDPa1-018,bavituximab,108.15,99.63,97.16499999999999,3.8899999999999997,3.085,,,,4.37,29.5,57.355000000000004,65.82,82.83,IgG1,Kappa,Phase-III,Active,EVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSS,MRAWIFFLLCLAGRALAEVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTTCAGCAATCAGGCCCAGAGCTGGAGAAACCCGGAGCCTCTGTGAAGTTGAGCTGCAAGGCGAGCGGCTACTCCTTCACCGGCTATAACATGAATTGGGTAAAGCAGTCCCATGGGAAATCCCTCGAATGGATTGGCCACATCGACCCTTACTACGGTGACACATCCTATAACCAAAAGTTTAGGGGAAAAGCTACTCTCACGGTTGATAAGAGTTCTTCTACCGCATATATGCAGCTGAAGAGTCTGACATCAGAAGATAGCGCCGTGTACTATTGTGTGAAAGGTGGCTACTATGGGCACTGGTACTTCGACGTCTGGGGAGCTGGGACAACCGTGACTGTCTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAAATGACTCAATCACCGTCTTCTCTGAGCGCCTCCCTTGGCGAACGGGTTTCCCTGACTTGCAGAGCTTCTCAGGATATCGGGAGCAGCTTGAACTGGCTGCAGCAGGGTCCCGACGGCACCATCAAACGACTCATTTATGCCACAAGTTCACTGGACAGCGGAGTGCCTAAGCGCTTTTCAGGCAGTAGGAGTGGGTCCGACTACAGCCTGACAATTTCTTCCCTTGAAAGTGAGGACTTCGTCGATTACTACTGTCTCCAGTATGTGTCCTCACCACCCACGTTCGGTGCAGGAACCAAACTCGAGTTGAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,3,2,DIQMTQSPSSLSASLGERVSLTCRAS--QDIG------SSLNWLQQGPDGTIKRLIYA--------TSSLDSGVPKRFSGSRSG--SDYSLTISSLESEDFVDYYCLQYVS-----------------------SPPTFGAGTKLELK-,EVQLQQS-GPELEKPGASVKLSCKASG-YSFTG-----YNMNWVKQSHGKSLEWIGHIDPY---YGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYG-------------------HWYFDVWGAGTTVTVSS
-GDPa1-019,belantamab,345.31,99.72,98.33500000000001,2.7199999999999998,2.79,,0.51,0.22,2.37,2.875,62.005,70.33500000000001,84.515,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYWMHWVRQAPGQGLEWMGATYRGHSDTYYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGAIYDGYDVLDNWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYWMHWVRQAPGQGLEWMGATYRGHSDTYYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGAIYDGYDVLDNWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTCCAGAGCGGGGCCGAGGTGAAAAAACCCGGATCCAGTGTAAAGGTCTCTTGCAAGGCTAGCGGCGGAACTTTTTCAAACTACTGGATGCACTGGGTTCGGCAAGCGCCTGGGCAAGGGCTGGAGTGGATGGGCGCAACCTATAGAGGTCATTCTGATACCTACTACAACCAGAAGTTCAAGGGCAGGGTGACAATTACGGCAGACAAATCAACATCTACCGCTTACATGGAACTGAGCAGCTTGCGCTCCGAAGATACTGCCGTGTACTATTGTGCCCGAGGCGCCATCTATGACGGCTATGACGTCCTCGATAATTGGGGTCAGGGAACCCTTGTGACAGTGTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKLLIYYTSNLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYRKLPWTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKLLIYYTSNLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYRKLPWTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAGAGTCCCTCTTCACTTTCTGCCTCAGTGGGAGACAGGGTTACAATTACCTGTTCCGCAAGCCAGGATATTTCCAATTATCTGAACTGGTACCAACAGAAACCTGGAAAAGCCCCAAAGCTCCTGATCTATTACACATCCAACTTGCACAGCGGCGTCCCATCTCGGTTTAGTGGCAGCGGGAGCGGCACCGACTTCACTCTTACAATCTCCTCACTGCAGCCCGAAGATTTCGCTACCTATTACTGCCAACAGTACAGAAAGCTGCCTTGGACGTTTGGTCAGGGGACTAAGCTCGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,1,DIQMTQSPSSLSASVGDRVTITCSAS--QDIS------NYLNWYQQKPGKAPKLLIYY--------TSNLHSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYRK-----------------------LPWTFGQGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSN-----YWMHWVRQAPGQGLEWMGATYRG---HSDTYYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGAIYDG------------------YDVLDNWGQGTLVTVSS
-GDPa1-020,belimumab,301.96,99.25999999999999,97.745,2.8,2.91,,0.21,0.1,2.25,1.0,55.815,65.12,79.255,IgG1,Lambda,Approved,Active,QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGCAGCAGTCAGGAGCCGAGGTGAAAAAGCCAGGATCCAGTGTGCGAGTTTCCTGCAAAGCAAGCGGAGGTACCTTCAATAACAACGCAATAAACTGGGTTAGACAGGCTCCCGGGCAAGGGCTGGAATGGATGGGCGGGATCATTCCGATGTTTGGCACAGCTAAGTACTCTCAGAATTTCCAGGGCCGGGTCGCTATCACAGCCGACGAGTCCACGGGTACTGCGAGTATGGAACTGTCTAGCCTTCGCTCCGAGGACACCGCAGTCTACTATTGTGCCAGAAGCAGGGATCTCTTGCTGTTTCCTCACCATGCCCTCTCACCCTGGGGCAGGGGCACTATGGTAACCGTGAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVL,MRAWIFFLLCLAGRALASSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCTCCTCTGAGCTGACCCAAGACCCCGCTGTTAGCGTGGCGCTCGGGCAGACAGTCCGCGTAACTTGCCAAGGGGACAGCTTGCGATCTTACTACGCCTCATGGTATCAGCAGAAACCTGGACAGGCACCCGTGCTCGTGATATATGGCAAGAACAATAGACCGAGTGGGATTCCAGACCGGTTCAGCGGATCATCAAGTGGCAACACTGCCTCCCTGACAATCACCGGTGCACAGGCCGAAGATGAAGCTGATTACTATTGTTCCTCTAGGGATAGCTCCGGTAATCACTGGGTGTTTGGCGGCGGAACGGAGCTGACCGTCCTTGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,4,SSELTQD-PAVSVALGQTVRVTCQGD---SLRS-----YYASWYQQKPGQAPVLVIYG--------KNNRPSGIPDRFSGSSSG--NTASLTITGAQAEDEADYYCSSRDSS---------------------GNHWVFGGGTELTVL-,QVQLQQS-GAEVKKPGSSVRVSCKASG-GTFNN-----NAINWVRQAPGQGLEWMGGIIPM---FGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLF----------------PHHALSPWGRGTMVTVSS
-GDPa1-021,bemarituzumab,257.51,98.93,98.63,2.7199999999999998,2.7350000000000003,3.8449999999999998,0.0,0.0,-0.5,-0.125,60.995000000000005,69.94999999999999,86.50999999999999,IgG1,Kappa,Phase-III,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYIFTTYNVHWVRQAPGQGLEWIGSIYPDNGDTSYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYCARGDFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYIFTTYNVHWVRQAPGQGLEWIGSIYPDNGDTSYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYCARGDFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTACAGTCCGGCGCCGAGGTGAAAAAGCCAGGTAGCAGTGTCAAAGTGAGTTGTAAGGCCTCAGGATACATCTTTACCACATATAACGTTCACTGGGTTCGGCAAGCGCCCGGGCAGGGACTCGAGTGGATAGGCAGCATCTATCCTGACAATGGAGACACCTCCTACAATCAGAACTTCAAGGGCCGCGCCACAATTACAGCTGATAAAAGCACGTCTACCGCATACATGGAATTGTCTTCTCTGAGGAGCGAAGACACTGCTGTCTACTATTGCGCCAGAGGGGATTTCGCATATTGGGGGCAAGGTACCCTTGTGACTGTGTCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQGVSNDVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHSTTPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQGVSNDVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHSTTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACGCAGTCTCCATCCAGTCTTTCCGCATCTGTAGGCGATAGGGTTACCATCACCTGCAAGGCTTCTCAGGGCGTGAGTAACGACGTGGCCTGGTACCAGCAGAAGCCAGGCAAAGCGCCTAAGTTGCTGATCTACTCCGCTTCATACAGATATACAGGGGTCCCTTCACGGTTTAGCGGAAGCGGAAGCGGGACTGATTTCACCTTCACTATAAGCTCACTCCAACCCGAAGACATCGCCACATATTATTGTCAACAGCACTCCACAACCCCCTACACTTTTGGTCAGGGCACAAAACTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQMTQSPSSLSASVGDRVTITCKAS--QGVS------NDVAWYQQKPGKAPKLLIYS--------ASYRYTGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCQQHST-----------------------TPYTFGQGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YIFTT-----YNVHWVRQAPGQGLEWIGSIYPD---NGDTSYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYCARGD-------------------------FAYWGQGTLVTVSS
-GDPa1-022,benralizumab,291.17,91.305,98.41499999999999,2.8499999999999996,2.7199999999999998,4.154999999999999,0.38,0.27,4.37,13.5,61.38,70.65,82.03,IgG1,Kappa,Approved,Active,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTACAGCTCGTCCAGTCTGGAGCTGAAGTGAAAAAACCCGGCGCCTCCGTCAAGGTTTCATGTAAGGCGTCCGGCTACACATTCACTAGCTACGTGATCCACTGGGTGCGCCAGCGGCCTGGACAGGGCCTGGCCTGGATGGGGTATATCAACCCATATAATGATGGGACCAAATACAACGAGAGGTTTAAGGGAAAGGTTACTATAACCAGTGACCGAAGCACATCTACCGTCTACATGGAGCTGAGTTCCCTGAGATCTGAAGATACCGCAGTGTATCTCTGCGGCAGGGAGGGTATTAGATACTATGGGCTGTTGGGGGACTACTGGGGCCAAGGTACGCTTGTGACAGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACACAGTCTCCATCTAGTCTGAGCGCTTCCGTGGGCGACAGGGTGACTATAACATGTGGAACCTCAGAGGATATCATTAATTATCTCAACTGGTACCAACAGAAGCCTGGGAAAGCCCCCAAGCTGCTGATCTATCACACCAGCAGATTGCAGTCCGGGGTCCCAAGCCGGTTTAGTGGCTCTGGTTCCGGGACTGATTTTACCCTTACAATTTCAAGCCTCCAGCCCGAGGACTTCGCAACTTACTATTGCCAACAGGGATACACACTGCCTTACACCTTCGGCCAGGGTACGAAGGTTGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQMTQSPSSLSASVGDRVTITCGTS--EDII------NYLNWYQQKPGKAPKLLIYH--------TSRLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQGYT-----------------------LPYTFGQGTKVEIK-,EVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----YVIHWVRQRPGQGLAWMGYINPY---NDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYY------------------GLLGDYWGQGTLVTVSS
-GDPa1-023,bevacizumab,89.39,93.785,96.61,3.17,3.1950000000000003,,,,0.25,0.125,62.86,71.50999999999999,85.245,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGGTTGAGAGCGGCGGGGGATTGGTGCAGCCTGGTGGCTCACTCCGCCTGAGCTGTGCTGCCTCTGGGTATACCTTTACAAATTACGGCATGAATTGGGTCAGACAAGCCCCAGGAAAGGGCCTGGAATGGGTGGGGTGGATCAACACGTATACTGGAGAGCCGACATATGCTGCCGACTTCAAACGGAGGTTCACCTTCTCACTCGATACCAGCAAATCCACTGCGTATTTGCAGATGAACAGTCTGCGAGCAGAAGACACCGCAGTTTATTACTGCGCCAAGTACCCCCATTACTACGGTTCCTCTCACTGGTACTTTGATGTATGGGGGCAGGGCACTCTTGTGACAGTCAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACCCAGTCTCCCAGCTCCCTTTCCGCCAGCGTGGGTGACAGGGTGACTATAACCTGTTCAGCTTCTCAGGACATCTCCAACTACCTGAATTGGTATCAACAGAAACCTGGAAAGGCCCCAAAGGTACTGATCTATTTCACAAGCAGTCTCCACTCAGGCGTGCCCTCCAGATTTAGCGGGTCAGGAAGTGGCACAGATTTTACACTGACGATTTCTTCTTTGCAACCAGAAGATTTCGCAACTTACTACTGCCAGCAGTATAGTACCGTTCCTTGGACTTTCGGCCAGGGGACCAAAGTCGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCSAS--QDIS------NYLNWYQQKPGKAPKVLIYF--------TSSLHSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYST-----------------------VPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YTFTN-----YGMNWVRQAPGKGLEWVGWINTY---TGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGS----------------SHWYFDVWGQGTLVTVSS
-GDPa1-024,bezlotoxumab,151.33,99.61,97.5,2.6950000000000003,2.4450000000000003,,0.48,0.71,1.5,15.875,62.5,71.08,84.93,IgG1,Kappa,Approved,NFD,EVQLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIFYPGDSSTRYSPSFQGQVTISADKSVNTAYLQWSSLKASDTAMYYCARRRNWGNAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIFYPGDSSTRYSPSFQGQVTISADKSVNTAYLQWSSLKASDTAMYYCARRRNWGNAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGTTGGTGCAGTCTGGAGCTGAAGTGAAGAAAAGCGGGGAGTCCCTTAAAATTAGTTGTAAGGGTTCCGGATACAGCTTCACGTCTTATTGGATCGGCTGGGTCCGACAGATGCCTGGCAAGGGCCTCGAGTGGATGGGTATCTTTTACCCAGGCGATTCATCAACACGCTACTCACCCAGTTTCCAAGGGCAGGTGACCATTAGCGCTGACAAGTCCGTGAACACTGCATACCTGCAGTGGTCCTCTCTGAAAGCCAGCGACACAGCCATGTATTATTGCGCGAGACGGAGGAATTGGGGCAACGCCTTTGATATATGGGGACAAGGGACTATGGTCACCGTATCTAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSTWTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSTWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTTCTCACCCAATCCCCCGGTACCCTGAGCCTGTCTCCTGGCGAGAGGGCAACGTTGAGTTGTAGGGCGAGTCAGTCTGTGAGCTCCTCCTATCTGGCCTGGTACCAGCAGAAGCCCGGGCAAGCCCCACGACTCTTGATCTACGGCGCCTCATCACGGGCTACTGGAATACCTGACCGCTTTTCCGGGAGTGGAAGCGGCACTGACTTCACACTTACAATTAGCAGACTGGAACCAGAAGATTTTGCTGTGTATTACTGCCAGCAGTATGGTTCTTCAACATGGACCTTCGGCCAGGGGACCAAGGTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,3,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----SYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------STWTFGQGTKVEIK-,EVQLVQS-GAEVKKSGESLKISCKGSG-YSFTS-----YWIGWVRQMPGKGLEWMGIFYPG---DSSTRYSPSFQGQVTISADKSVNTAYLQWSSLKASDTAMYYCARRRNWG--------------------NAFDIWGQGTMVTVSS
-GDPa1-025,bimagrumab,393.89,86.045,98.83500000000001,2.7649999999999997,2.83,,0.84,0.77,12.0,24.875,63.435,74.93,,IgG1,Lambda,Phase-II,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSSYINWVRQAPGQGLEWMGTINPVSGSTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGWFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSSYINWVRQAPGQGLEWMGTINPVSGSTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGWFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTTGTACAGTCCGGGGCAGAAGTCAAAAAACCAGGCGCGTCCGTGAAGGTCAGTTGTAAGGCCTCAGGCTATACTTTCACATCAAGCTACATCAATTGGGTGCGCCAGGCCCCCGGGCAGGGTTTGGAGTGGATGGGGACCATTAACCCTGTCAGCGGATCCACTAGCTATGCTCAGAAGTTTCAAGGAAGGGTTACTATGACAAGAGACACATCTATAAGTACCGCATACATGGAGCTGAGCAGGCTGCGGTCTGACGATACGGCTGTTTACTACTGCGCCCGAGGTGGCTGGTTCGATTATTGGGGACAAGGCACCCTCGTGACCGTGTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVNWYQQHPGKAPKLMIYGVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCGTFAGGSYYGVFGGGTKLTVL,MRAWIFFLLCLAGRALAQSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVNWYQQHPGKAPKLMIYGVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCGTFAGGSYYGVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCCGCTTTGACTCAACCCGCAAGCGTGTCTGGTAGTCCAGGGCAGTCTATTACTATCTCATGTACAGGGACCAGCTCAGACGTCGGCTCCTACAATTACGTTAACTGGTATCAACAGCACCCGGGCAAGGCGCCCAAGCTGATGATATATGGGGTGTCCAAGAGGCCTAGTGGCGTGTCTAATAGATTCTCTGGCAGTAAAAGCGGGAACACCGCCAGCCTTACAATCTCAGGCCTCCAGGCCGAGGACGAAGCTGATTACTACTGCGGTACCTTCGCCGGTGGCTCCTATTATGGAGTCTTTGGAGGAGGAACAAAACTGACGGTACTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,4,QSALTQP-ASVSGSPGQSITISCTGTS-SDVGS----YNYVNWYQQHPGKAPKLMIYG--------VSKRPSGVSNRFSGSKSG--NTASLTISGLQAEDEADYYCGTFAGG---------------------SYYGVFGGGTKLTVL-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----SYINWVRQAPGQGLEWMGTINPV---SGSTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGW------------------------FDYWGQGTLVTVSS
-GDPa1-026,bimekizumab,116.1,88.905,97.7,2.715,2.83,,,,0.8700000000000001,2.625,70.16,76.24,,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMAWVRQAPGKGLEWVATITYEGRNTYYRDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGSIYRLWFAHWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMAWVRQAPGKGLEWVATITYEGRNTYYRDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGSIYRLWFAHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGCTGGTTGAGTCTGGTGGGGGACTTGTGCAGCCGGGAGGATCCCTGAGGTTGTCTTGTGCTGCCAGTGGCTTCACGTTCAGCGATTACAACATGGCTTGGGTCAGACAAGCCCCCGGCAAAGGCCTGGAGTGGGTCGCCACTATTACTTATGAAGGCAGAAACACATATTACCGAGATTCAGTGAAGGGCAGGTTTACCATATCCCGGGACAACGCAAAGAATTCTCTCTACTTGCAGATGAATAGCCTCCGGGCCGAGGACACCGCAGTGTATTACTGCGCTTCCCCTCCACAATATTACGAAGGGAGTATCTACCGCCTTTGGTTTGCGCACTGGGGTCAGGGGACACTGGTGACCGTATCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK,MRAWIFFLLCLAGRALAAIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCCATTCAACTGACACAGAGTCCCTCCAGTTTGAGCGCATCCGTCGGGGATCGCGTGACCATAACCTGTCGGGCTGACGAGAGCGTGAGAACCCTGATGCACTGGTACCAGCAGAAGCCTGGCAAAGCGCCTAAGCTTCTCATTTACCTCGTATCAAACTCTGAAATCGGAGTGCCAGATAGGTTCAGCGGCTCAGGTTCTGGCACGGACTTCCGACTGACAATCTCCTCTCTGCAACCAGAAGACTTTGCCACCTATTATTGCCAGCAGACATGGAGCGATCCCTGGACTTTTGGACAGGGGACTAAGGTTGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,AIQLTQSPSSLSASVGDRVTITCRAD--ESVR------TLMHWYQQKPGKAPKLLIYL--------VSNSEIGVPDRFSGSGSG--TDFRLTISSLQPEDFATYYCQQTWS-----------------------DPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSD-----YNMAWVRQAPGKGLEWVATITYE---GRNTYYRDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGS--------------IYRLWFAHWGQGTLVTVSS
-GDPa1-027,bleselumab,212.57,99.33,87.9,2.7300000000000004,2.5999999999999996,4.16,0.68,0.47,4.87,19.625,55.2,70.77000000000001,81.66499999999999,IgG4,Kappa,Phase-II,Discontinued,QLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAQLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAACTGCAACTTCAGGAATCAGGGCCCGGTCTGCTTAAACCGTCTGAGACCCTCTCTCTGACTTGTACAGTGTCTGGCGGATCTATTTCATCCCCAGGATACTACGGCGGGTGGATCAGGCAGCCACCTGGCAAAGGCTTGGAGTGGATAGGGAGCATTTACAAGTCCGGCAGCACTTATCACAACCCCAGTCTGAAAAGTCGGGTCACGATCAGTGTAGACACATCAAAGAATCAGTTCAGCTTGAAGCTCAGCTCCGTGACCGCTGCCGATACCGCAGTGTATTACTGCACTCGCCCTGTGGTTAGATATTTTGGATGGTTCGACCCCTGGGGGCAGGGTACCCTGGTCACAGTTAGCTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIK,MRAWIFFLLCLAGRALAAIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCTATTCAGCTGACACAGAGCCCTTCATCCCTTAGTGCGTCCGTCGGAGATAGGGTTACAATAACATGTAGAGCATCCCAAGGTATCTCATCTGCTCTCGCATGGTATCAGCAGAAGCCCGGAAAAGCCCCAAAGCTGTTGATTTACGACGCCTCCAATCTCGAGAGCGGCGTGCCATCTCGGTTCAGTGGCAGCGGGTCAGGGACGGATTTTACTCTGACCATCTCTAGCCTGCAGCCTGAGGACTTCGCCACTTACTATTGCCAGCAGTTTAACAGTTACCCCACCTTCGGCCAAGGTACCAAGGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,2,AIQLTQSPSSLSASVGDRVTITCRAS--QGIS------SALAWYQQKPGKAPKLLIYD--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQFNS------------------------YPTFGQGTKVEIK-,QLQLQES-GPGLLKPSETLSLTCTVSG-GSISSP---GYYGGWIRQPPGKGLEWIGSIYK----SGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRY-------------------FGWFDPWGQGTLVTVSS
-GDPa1-028,blosozumab,,,,,,,,,,,,,,IgG4,Kappa,Phase-II,Active,QVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTGCAGAGTGGCGCCGAGGTCAAGAAGCCCGGGGCTTCCGTAAAAGTGAGTTGCAAGGTGTCAGGATTCCCAATTAAGGACACGTTCCAACACTGGGTTCGGCAGGCCCCGGGCAAAGGACTCGAGTGGATGGGCTGGTCCGATCCTGAAATCGGTGACACTGAGTATGCCTCTAAATTTCAGGGGAGAGTCACCATGACAGAAGATACAAGCACTGATACCGCTTATATGGAGCTTAGCTCACTGAGGAGCGAAGACACCGCAGTGTACTACTGTGCGACCGGGGATACGACTTACAAGTTTGACTTCTGGGGACAGGGTACCACAGTCACAGTTTCTTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAGATGACTCAATCTCCCTCCTCACTGAGTGCGAGCGTGGGCGATAGGGTAACAATCACATGCAAGGCTTCTCAGGATGTGCACACTGCAGTGGCCTGGTACCAGCAGAAACCTGGCAAAGCCCCAAAGCTCTTGATTTACTGGGCCAGCACAAGATGGACGGGGGTTCCTTCTCGGTTCAGCGGTAGTGGATCCGGAACCGACTTCACCCTGACTATCTCAAGCCTTCAGCCCGAAGACTTTGCTACCTATTATTGTCAACAGTACTCCGACTATCCATGGACATTTGGTGGGGGCACCAAAGTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,0,DIQMTQSPSSLSASVGDRVTITCKAS--QDVH------TAVAWYQQKPGKAPKLLIYW--------ASTRWTGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYSD-----------------------YPWTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKVSG-FPIKD-----TFQHWVRQAPGKGLEWMGWSDPE---IGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTT---------------------YKFDFWGQGTTVTVSS
-GDPa1-029,bococizumab,167.77,99.815,98.20500000000001,3.605,2.76,,0.86,0.8,17.0,21.875,62.03,70.22,77.46000000000001,IgG2,Kappa,Phase-III,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTGGTGCAATCTGGCGCCGAGGTGAAAAAACCCGGGGCTAGCGTGAAAGTCTCATGCAAGGCCAGCGGGTATACTTTCACTTCCTATTATATGCACTGGGTTCGCCAAGCCCCGGGACAGGGCCTGGAGTGGATGGGAGAAATCTCCCCTTTTGGGGGTAGAACAAACTACAATGAAAAGTTCAAGTCCAGAGTCACAATGACAAGGGATACGAGTACTTCTACCGTATATATGGAGCTCTCATCTCTTCGAAGCGAAGACACAGCTGTGTACTACTGTGCGAGGGAGCGGCCATTGTACGCAAGTGACCTGTGGGGCCAGGGTACCACCGTTACCGTGAGCTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACCCAGTCTCCTTCATCCCTGAGTGCCAGCGTTGGAGACAGGGTCACTATCACCTGTCGCGCTAGTCAGGGCATCTCTAGTGCTCTCGCCTGGTACCAGCAGAAACCAGGGAAGGCCCCCAAACTGTTGATTTATTCCGCATCTTATAGATACACAGGAGTGCCCAGCCGATTCTCAGGGAGCGGCAGCGGCACGGATTTTACCTTCACCATATCCTCACTCCAGCCGGAAGACATTGCGACATACTATTGCCAACAGAGGTACTCCCTGTGGCGGACATTTGGTCAAGGTACTAAGCTTGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSLSASVGDRVTITCRAS--QGIS------SALAWYQQKPGKAPKLLIYS--------ASYRYTGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCQQRYS-----------------------LWRTFGQGTKLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----YYMHWVRQAPGQGLEWMGEISPF---GGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPL---------------------YASDLWGQGTTVTVSS
-GDPa1-030,brazikumab,320.38,99.5,98.455,6.585,4.5,1.525,0.23,0.02,2.5,0.625,60.459999999999994,70.52000000000001,80.685,IgG1,Lambda,Phase-III,Discontinued,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTGGAGTCCGGTGGCGGTGTCGTGCAACCTGGAAGATCCCTGCGCCTTAGTTGTGCCGCCAGCGGGTTTACCTTTTCTTCATACGGCATGCACTGGGTAAGGCAAGCACCCGGCAAAGGGCTCGAGTGGGTGGCCGTCATCTGGTACGACGGCAGCAATGAATATTACGCCGACTCCGTGAAGGGCCGATTCACTATATCTCGGGATAACTCTAAGAACACCCTGTATCTCCAGATGAATAGCTTGAGAGCGGAAGATACAGCTGTTTATTATTGCGCTCGGGACAGGGGATACACTTCCAGCTGGTACCCAGATGCATTCGACATTTGGGGGCAGGGAACAATGGTCACGGTGAGTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCCGTGTTGACACAGCCCCCTAGCGTTTCTGGGGCGCCCGGCCAAAGAGTGACAATTTCCTGTACCGGATCATCAAGTAATACCGGTGCTGGCTACGACGTACACTGGTATCAGCAAGTGCCAGGGACTGCCCCTAAGCTCCTGATATATGGGTCCGGAAACAGGCCATCTGGTGTGCCGGATCGGTTTTCTGGCAGTAAAAGCGGTACAAGCGCTAGTCTCGCCATCACTGGCCTTCAGGCCGAGGATGAAGCAGACTACTACTGCCAGTCATATGACAGCTCTCTGTCCGGCTGGGTCTTCGGAGGAGGGACCCGCCTGACGGTCCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,1,4,QSVLTQP-PSVSGAPGQRVTISCTGSS-SNTGA----GYDVHWYQQVPGTAPKLLIYG--------SGNRPSGVPDRFSGSKSG--TSASLAITGLQAEDEADYYCQSYDSS---------------------LSGWVFGGGTRLTVL-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YGMHWVRQAPGKGLEWVAVIWYD---GSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSS---------------WYPDAFDIWGQGTMVTVSS
-GDPa1-031,brentuximab,244.68,99.49000000000001,99.45,2.6799999999999997,3.025,1.545,0.14,0.03,0.37,-0.5,61.46,69.81,85.93,IgG1,Kappa,Approved,Active,QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSA,MRAWIFFLLCLAGRALAQIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATCCAGCTCCAGCAGAGCGGACCTGAAGTGGTCAAACCGGGGGCATCTGTCAAAATAAGCTGCAAAGCTTCCGGGTACACGTTCACCGACTATTATATTACCTGGGTAAAGCAGAAGCCAGGGCAAGGATTGGAATGGATCGGTTGGATTTACCCCGGATCAGGCAACACTAAGTATAATGAGAAGTTTAAAGGCAAGGCCACCCTGACTGTGGACACCTCAAGTAGCACAGCCTTCATGCAGCTTTCCTCTCTGACAAGTGAGGATACTGCGGTGTACTTTTGTGCTAACTACGGCAATTACTGGTTCGCATATTGGGGCCAGGGTACACAAGTGACAGTTTCCGCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIK,MRAWIFFLLCLAGRALADIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGCTGACTCAGAGTCCGGCTAGCCTGGCCGTGTCCCTCGGGCAGAGGGCGACCATAAGTTGTAAGGCCTCTCAAAGCGTCGATTTTGACGGCGATTCTTATATGAATTGGTACCAACAGAAACCTGGGCAGCCTCCCAAGGTTCTGATTTACGCTGCCTCAAATCTCGAGTCCGGAATCCCCGCAAGATTCTCTGGCAGCGGATCAGGTACAGATTTTACTCTTAACATTCACCCAGTCGAAGAAGAAGACGCCGCAACATACTATTGCCAGCAGTCCAACGAGGACCCATGGACCTTCGGTGGCGGGACGAAATTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,0,4,DIVLTQSPASLAVSLGQRATISCKAS--QSVDFD--GDSYMNWYQQKPGQPPKVLIYA--------ASNLESGIPARFSGSGSG--TDFTLNIHPVEEEDAATYYCQQSNE-----------------------DPWTFGGGTKLEIK-,QIQLQQS-GPEVVKPGASVKISCKASG-YTFTD-----YYITWVKQKPGQGLEWIGWIYPG---SGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNY----------------------WFAYWGQGTQVTVSA
-GDPa1-032,briakinumab,451.1,99.595,99.58,2.745,2.58,,0.4,0.28,18.5,28.0,61.480000000000004,73.44,,IgG1,Lambda,Preregistration (w),Discontinued,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIRYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHGSHDNWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIRYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHGSHDNWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAACTCGTCGAGTCCGGTGGCGGCGTGGTACAGCCCGGGAGATCACTCAGACTGAGCTGCGCAGCCTCCGGTTTCACATTTTCCAGCTATGGCATGCACTGGGTGCGACAGGCCCCTGGCAAGGGGTTGGAATGGGTGGCTTTTATCCGGTACGATGGAAGTAACAAGTACTACGCGGACTCTGTTAAGGGGAGGTTCACAATTTCAAGGGATAACAGTAAAAACACCCTGTATCTGCAGATGAATTCTCTTCGCGCTGAGGACACTGCCGTCTATTACTGTAAAACCCACGGATCTCATGACAATTGGGGACAGGGCACGATGGTGACTGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSVLTQPPSVSGAPGQRVTISCSGSRSNIGSNTVKWYQQLPGTAPKLLIYYNDQRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDRYTHPALLFGTGTKVTVL,MRAWIFFLLCLAGRALAQSVLTQPPSVSGAPGQRVTISCSGSRSNIGSNTVKWYQQLPGTAPKLLIYYNDQRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDRYTHPALLFGTGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCTGTGTTGACCCAGCCACCTTCCGTAAGCGGAGCACCCGGACAAAGGGTTACTATCTCTTGCTCCGGTTCACGGTCCAATATTGGCAGCAACACCGTCAAATGGTACCAGCAGCTCCCTGGTACCGCCCCGAAGCTGCTGATCTATTATAACGATCAGAGACCAAGCGGCGTGCCCGACCGATTTAGTGGGTCCAAGTCTGGGACAAGTGCTTCACTGGCGATAACGGGACTGCAAGCCGAGGACGAAGCTGATTACTATTGTCAGAGCTACGACCGCTACACTCACCCCGCCTTGCTCTTCGGCACAGGGACAAAAGTGACCGTCCTTGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,1,4,QSVLTQP-PSVSGAPGQRVTISCSGSR-SNIGS-----NTVKWYQQLPGTAPKLLIYY--------NDQRPSGVPDRFSGSKSG--TSASLAITGLQAEDEADYYCQSYDRYT--------------------HPALLFGTGTKVTVL-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YGMHWVRQAPGKGLEWVAFIRYD---GSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHGS------------------------HDNWGQGTMVTVSS
-GDPa1-033,brodalumab,281.07,98.48,97.1,2.755,2.5,,0.82,0.84,4.87,12.875,60.825,70.565,78.91,IgG2,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTGGTTCAATCAGGCGCTGAAGTGAAAAAGCCTGGAGCAAGCGTAAAAGTGTCTTGCAAGGCCAGTGGGTACACATTTACTAGGTATGGTATCAGCTGGGTGCGACAGGCCCCCGGCCAGGGGCTGGAGTGGATGGGATGGATTTCTACCTATAGCGGGAATACCAACTATGCCCAGAAGCTTCAGGGCAGAGTTACTATGACAACCGATACTTCAACCTCCACCGCGTACATGGAGCTCAGATCTCTGAGGTCCGATGACACAGCTGTCTACTACTGTGCACGCCGGCAATTGTACTTCGACTATTGGGGACAGGGTACGCTCGTGACAGTGAGTTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTTATGACGCAGTCACCTGCCACACTGTCTGTGTCACCAGGTGAGAGAGCCACTTTGTCCTGTCGGGCCTCCCAGAGCGTATCTTCTAATCTCGCGTGGTTCCAGCAGAAGCCGGGGCAAGCACCCCGACCACTTATTTATGACGCCAGTACTAGGGCTACAGGGGTGCCTGCACGCTTCTCCGGCAGTGGAAGCGGCACCGATTTTACCCTGACAATCAGCTCCCTCCAAAGCGAAGACTTTGCTGTCTATTACTGCCAGCAGTACGATAACTGGCCCCTGACCTTCGGTGGCGGAACCAAGGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,2,EIVMTQSPATLSVSPGERATLSCRAS--QSVS------SNLAWFQQKPGQAPRPLIYD--------ASTRATGVPARFSGSGSG--TDFTLTISSLQSEDFAVYYCQQYDN-----------------------WPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTR-----YGISWVRQAPGQGLEWMGWISTY---SGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQL-----------------------YFDYWGQGTLVTVSS
-GDPa1-034,brontictuzumab,363.39,96.48,97.19999999999999,2.9000000000000004,2.87,3.7649999999999997,0.11,0.11,3.75,12.875,59.57,74.38,77.17500000000001,IgG2,Lambda,Phase-I,Discontinued,QVQLVQSGAEVKKPGASVKISCKVSGYTLRGYWIEWVRQAPGKGLEWIGQILPGTGRTNYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYCARFDGNYGYYAMDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKISCKVSGYTLRGYWIEWVRQAPGKGLEWIGQILPGTGRTNYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYCARFDGNYGYYAMDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAACTTGTTCAATCCGGGGCCGAGGTGAAAAAGCCCGGTGCTTCCGTGAAAATTTCATGTAAGGTGAGCGGCTATACTCTGAGGGGCTACTGGATAGAGTGGGTTCGCCAGGCCCCTGGCAAGGGACTCGAGTGGATCGGTCAGATCCTGCCAGGCACCGGAAGGACAAACTATAACGAAAAATTTAAGGGGCGAGTGACGATGACCGCGGATACATCTACAGACACTGCTTACATGGAACTGAGTTCATTGCGGAGCGAAGATACAGCAGTGTACTACTGCGCCAGATTCGACGGAAATTATGGCTACTACGCAATGGACTATTGGGGGCAGGGGACCACTGTAACCGTCTCTAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWFQQKPGQAPRTLIGGTNNRAPGVPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNHWVFGGGTKLTVL,MRAWIFFLLCLAGRALAQAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWFQQKPGQAPRTLIGGTNNRAPGVPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNHWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGCTGTGGTAACCCAAGAACCATCTCTGACCGTCTCCCCAGGCGGGACAGTGACACTTACATGCAGGAGCTCTACAGGGGCCGTGACTACTTCAAACTACGCTAATTGGTTTCAGCAGAAGCCTGGCCAGGCACCCCGCACCCTTATCGGGGGTACGAACAATAGAGCCCCCGGCGTGCCGGCTCGGTTCAGTGGCTCCCTCTTGGGCGGTAAGGCAGCGCTGACCTTGTCAGGAGCACAGCCTGAGGACGAGGCCGAATATTATTGTGCCCTCTGGTACAGCAACCACTGGGTTTTCGGAGGGGGAACCAAACTGACTGTCCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,1,0,4,QAVVTQE-PSLTVSPGGTVTLTCRSST-GAVTT----SNYANWFQQKPGQAPRTLIGG--------TNNRAPGVPARFSGSLLG--GKAALTLSGAQPEDEAEYYCALWYS-----------------------NHWVFGGGTKLTVL-,QVQLVQS-GAEVKKPGASVKISCKVSG-YTLRG-----YWIEWVRQAPGKGLEWIGQILPG---TGRTNYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYCARFDGNYG------------------YYAMDYWGQGTTVTVSS
-GDPa1-035,budigalimab,110.8,99.78999999999999,96.8,2.74,2.62,,,,0.0,-1.375,59.605,67.64500000000001,82.35499999999999,IgG1,Kappa,Phase-II/III,Active,EIQLVQSGAEVKKPGSSVKVSCKASGYTFTHYGMNWVRQAPGQGLEWVGWVNTYTGEPTYADDFKGRLTFTLDTSTSTAYMELSSLRSEDTAVYYCTREGEGLGFGDWGQGTTVTVSS,MRAWIFFLLCLAGRALAEIQLVQSGAEVKKPGSSVKVSCKASGYTFTHYGMNWVRQAPGQGLEWVGWVNTYTGEPTYADDFKGRLTFTLDTSTSTAYMELSSLRSEDTAVYYCTREGEGLGFGDWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCCAGCTGGTGCAGTCTGGCGCTGAGGTGAAGAAACCTGGCAGTTCCGTTAAGGTCAGCTGTAAGGCATCAGGCTACACATTTACCCACTATGGAATGAACTGGGTAAGACAGGCCCCAGGGCAGGGGCTGGAATGGGTCGGCTGGGTTAATACCTACACCGGGGAGCCCACATATGCCGACGACTTTAAAGGTAGGTTGACTTTCACTCTCGACACCTCCACATCTACGGCGTACATGGAGCTGAGCAGCCTCCGCTCAGAAGATACAGCTGTGTATTACTGCACCCGGGAGGGAGAAGGACTTGGGTTCGGTGATTGGGGCCAAGGAACTACGGTGACTGTGAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTPGEPASISCRSSQSIVHSHGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHIPVTFGQGTKLEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTPGEPASISCRSSQSIVHSHGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHIPVTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTCGTGATGACCCAGAGCCCCCTTTCCTTGCCGGTCACACCCGGTGAGCCTGCCAGCATCTCATGCCGGAGTAGTCAGAGCATCGTTCATTCACACGGAGACACATACCTCGAGTGGTACCTGCAAAAGCCAGGACAATCACCACAGCTGCTGATATACAAAGTTTCTAACAGATTCAGCGGCGTACCTGACCGCTTCTCCGGCTCCGGGTCCGGGACGGACTTCACTCTCAAAATCTCTAGGGTGGAGGCTGAAGATGTGGGCGTGTATTATTGTTTTCAGGGTTCTCACATTCCCGTGACCTTTGGACAGGGGACTAAGCTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DVVMTQSPLSLPVTPGEPASISCRSS--QSIVHSH-GDTYLEWYLQKPGQSPQLLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCFQGSH-----------------------IPVTFGQGTKLEIK-,EIQLVQS-GAEVKKPGSSVKVSCKASG-YTFTH-----YGMNWVRQAPGQGLEWVGWVNTY---TGEPTYADDFKGRLTFTLDTSTSTAYMELSSLRSEDTAVYYCTREGEG---------------------LGFGDWGQGTTVTVSS
-GDPa1-036,burosumab,203.48,99.41999999999999,98.14,2.725,2.565,3.71,0.21,0.0,0.0,0.375,58.724999999999994,67.51,82.435,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTGCAGTCTGGAGCCGAGGTGAAGAAGCCTGGGGCTAGCGTGAAAGTGAGCTGTAAAGCAAGTGGTTACACGTTTACCAATCATTATATGCACTGGGTCCGACAAGCGCCAGGCCAGGGGCTCGAATGGATGGGCATAATTAACCCCATCTCTGGCTCAACAAGCAACGCCCAGAAGTTCCAGGGGAGGGTAACAATGACTAGAGACACATCCACCAGTACTGTCTACATGGAACTTAGCTCTCTGCGGTCCGAGGATACTGCAGTGTATTACTGCGCTCGCGACATCGTTGACGCCTTCGATTTTTGGGGACAAGGTACCATGGTTACCGTCTCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,AIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIK,MRAWIFFLLCLAGRALAAIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCTATCCAGCTTACCCAGTCTCCCTCCTCACTCTCCGCGAGCGTTGGAGACAGGGTCACCATCACATGTAGAGCCAGTCAGGGAATCAGTTCAGCCCTGGTGTGGTATCAGCAAAAGCCTGGTAAGGCCCCTAAATTGCTCATTTATGATGCTAGCAGCCTGGAAAGTGGGGTACCATCACGGTTTTCCGGCTCTGGCAGCGGGACGGATTTCACTCTGACAATTTCCTCTCTGCAACCAGAGGACTTCGCAACATACTACTGCCAGCAGTTCAACGATTACTTTACCTTTGGCCCCGGTACTAAAGTGGACATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,1,AIQLTQSPSSLSASVGDRVTITCRAS--QGIS------SALVWYQQKPGKAPKLLIYD--------ASSLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQFND------------------------YFTFGPGTKVDIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTN-----HYMHWVRQAPGQGLEWMGIINPI---SGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVD----------------------AFDFWGQGTMVTVSS
-GDPa1-037,cabiralizumab,57.13,100.0,87.14,2.6950000000000003,2.7199999999999998,,,,-0.13,-0.5,58.45,68.935,86.08,IgG4,Kappa,Phase-II,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDNYMIWVRQAPGQGLEWMGDINPYNGGTTFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARESPYFSNLYVMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFTDNYMIWVRQAPGQGLEWMGDINPYNGGTTFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARESPYFSNLYVMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAACTTGTTCAGAGTGGAGCGGAAGTCAAAAAACCAGGGTCATCCGTCAAAGTATCTTGCAAGGCTAGTGGTTACACCTTTACTGACAATTACATGATTTGGGTGAGGCAGGCACCCGGACAGGGCCTCGAGTGGATGGGCGATATCAACCCTTACAATGGTGGAACAACCTTTAACCAGAAGTTCAAGGGGCGGGTCACGATAACCGCCGACAAGAGCACAAGCACCGCCTATATGGAGCTGAGCTCTCTGCGCTCCGAGGACACTGCTGTGTACTATTGTGCCAGAGAAAGCCCGTATTTCTCCAACTTGTATGTGATGGATTACTGGGGGCAGGGCACTCTGGTGACAGTGTCATCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCKASQSVDYDGDNYMNWYQQKPGQAPRLLIYAASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHLSNEDLSTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCKASQSVDYDGDNYMNWYQQKPGQAPRLLIYAASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHLSNEDLSTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTGACGCAGAGCCCCGCCACATTGTCACTGAGCCCCGGTGAGCGGGCTACACTCTCTTGTAAAGCAAGTCAGTCTGTGGATTATGACGGCGATAACTACATGAATTGGTACCAGCAAAAGCCTGGACAGGCGCCAAGACTTCTGATTTATGCAGCCTCCAATTTGGAGAGCGGCATCCCTGCTAGGTTTTCCGGATCCGGGAGTGGCACCGATTTTACCCTTACTATCTCAAGCCTGGAGCCAGAGGACTTCGCCGTTTATTACTGCCACCTGTCTAACGAAGACCTCTCCACTTTCGGGGGTGGGACCAAGGTCGAAATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,3,EIVLTQSPATLSLSPGERATLSCKAS--QSVDYD--GDNYMNWYQQKPGQAPRLLIYA--------ASNLESGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCHLSNE-----------------------DLSTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFTD-----NYMIWVRQAPGQGLEWMGDINPY---NGGTTFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARESPYFS-----------------NLYVMDYWGQGTLVTVSS
-GDPa1-038,camidanlumab,352.37,99.38499999999999,98.23,2.75,2.66,4.885,0.61,0.61,1.5,15.5,60.19499999999999,72.75,77.89,IgG1,Kappa,Phase-II,Active,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYIINWVRQAPGQGLEWMGRIIPILGVENYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARKDWFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYIINWVRQAPGQGLEWMGRIIPILGVENYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARKDWFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTGGTGCAGTCCGGTGCCGAGGTTAAGAAACCCGGCTCTTCCGTTAAGGTCAGCTGTAAGGCTTCTGGAGGGACCTTCTCCCGGTACATTATCAACTGGGTCAGGCAAGCTCCAGGACAGGGGCTCGAGTGGATGGGACGCATCATCCCTATACTTGGTGTAGAGAATTACGCACAGAAATTTCAGGGGAGAGTGACGATTACAGCAGATAAAAGCACTTCAACCGCCTATATGGAACTGAGTTCATTGAGGAGCGAAGACACAGCCGTGTACTATTGCGCGCGAAAGGATTGGTTCGACTATTGGGGCCAAGGCACTCTGGTGACCGTGTCTAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATCGTGCTCACACAATCCCCCGGTACCTTGAGTCTGTCACCCGGCGAACGGGCGACTCTCTCCTGTCGAGCTTCACAGTCTGTCTCTTCATACTTGGCATGGTACCAGCAGAAACCTGGCCAAGCCCCGCGCCTTCTGATTTATGGCGCCTCCAGTAGGGCCACCGGGATTCCAGACAGATTTAGCGGCTCCGGTAGCGGGACCGATTTTACACTTACGATATCTAGGCTGGAGCCAGAGGACTTCGCTGTTTATTATTGCCAGCAGTACGGAAGCAGCCCTCTGACTTTCGGAGGGGGAACAAAGGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,3,EIVLTQSPGTLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------SPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSR-----YIINWVRQAPGQGLEWMGRIIPI---LGVENYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARKDW------------------------FDYWGQGTLVTVSS
-GDPa1-039,camrelizumab,265.64,98.8,89.9,3.13,3.0999999999999996,,0.05,0.1,5.0,14.0,58.455,68.77,,IgG4,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYMMSWVRQAPGKGLEWVATISGGGANTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLYYFDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYMMSWVRQAPGKGLEWVATISGGGANTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLYYFDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAATTGGTGGAGAGTGGAGGAGGGCTGGTTCAGCCAGGGGGCAGCCTTAGGCTGTCCTGTGCAGCCAGCGGATTTACCTTCAGCTCTTATATGATGTCTTGGGTTCGACAGGCGCCCGGAAAGGGTCTCGAATGGGTGGCTACAATTAGTGGCGGGGGCGCCAACACTTACTACCCTGACTCAGTCAAAGGCAGGTTCACCATCTCTCGCGACAATGCAAAGAACTCCTTGTACCTCCAGATGAATTCCCTGCGGGCCGAGGATACCGCCGTATACTATTGCGCTAGACAACTGTATTACTTTGATTATTGGGGTCAGGGCACGACTGTCACAGTGAGCTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCLASQTIGTWLTWYQQKPGKAPKLLIYTATSLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQVYSIPWTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCLASQTIGTWLTWYQQKPGKAPKLLIYTATSLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQVYSIPWTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAAATGACCCAATCTCCATCCTCCCTGTCAGCAAGTGTAGGCGACAGGGTGACCATTACCTGCCTGGCCAGCCAGACGATTGGTACATGGCTCACATGGTACCAGCAGAAGCCCGGGAAAGCGCCTAAGCTCCTTATTTACACGGCCACATCCTTGGCTGATGGGGTTCCTTCTCGGTTCAGCGGGAGCGGAAGTGGAACAGACTTCACTCTGACCATCAGCTCACTGCAGCCAGAAGATTTTGCTACTTACTATTGTCAGCAGGTCTATTCTATCCCCTGGACTTTTGGCGGTGGCACCAAGGTGGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,1,DIQMTQSPSSLSASVGDRVTITCLAS--QTIG------TWLTWYQQKPGKAPKLLIYT--------ATSLADGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQVYS-----------------------IPWTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YMMSWVRQAPGKGLEWVATISGG---GANTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLY-----------------------YFDYWGQGTTVTVSS
-GDPa1-040,carlumab,257.51,99.245,89.845,2.76,3.13,,0.42,0.1,-0.38,0.375,62.54,74.83,,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGIYGELDFWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGIYGELDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGTTGGTTCAGTCCGGGGCTGAAGTGAAGAAGCCAGGCAGCAGCGTTAAAGTGAGTTGCAAAGCCAGCGGGGGAACGTTCTCATCTTACGGGATCTCTTGGGTGAGGCAGGCCCCTGGCCAAGGTCTTGAATGGATGGGAGGAATCATCCCCATTTTTGGGACAGCAAACTATGCTCAGAAGTTTCAGGGAAGAGTGACCATTACTGCGGATGAATCTACCAGCACCGCATACATGGAGCTCAGTTCCCTGCGGTCCGAGGATACAGCCGTGTATTACTGTGCCCGCTACGACGGCATATATGGCGAGCTGGACTTCTGGGGCCAAGGTACTCTGGTAACAGTCTCATCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSDAYLAWYQQKPGQAPRLLIYDASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYIQLHSFTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSDAYLAWYQQKPGQAPRLLIYDASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYIQLHSFTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTCACCCAGTCTCCAGCTACGTTGTCCCTGTCCCCTGGTGAGAGGGCAACATTGAGCTGCCGGGCCAGTCAAAGTGTTTCCGATGCCTACCTTGCGTGGTACCAGCAGAAACCCGGCCAAGCCCCACGCCTGCTTATATATGACGCAAGCTCTCGAGCTACAGGGGTACCTGCCAGATTCTCTGGATCAGGGTCAGGAACTGATTTTACACTCACCATCTCCAGCCTGGAGCCCGAGGACTTCGCTGTGTATTATTGTCACCAGTACATCCAGCTGCATAGCTTCACCTTTGGCCAGGGCACTAAGGTCGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,3,EIVLTQSPATLSLSPGERATLSCRAS--QSVSD-----AYLAWYQQKPGQAPRLLIYD--------ASSRATGVPARFSGSGSG--TDFTLTISSLEPEDFAVYYCHQYIQL----------------------HSFTFGQGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSS-----YGISWVRQAPGQGLEWMGGIIPI---FGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGIY--------------------GELDFWGQGTLVTVSS
-GDPa1-041,cemiplimab,72.14,98.07499999999999,84.655,2.73,2.7300000000000004,,,,3.0,2.625,,,,IgG4,Kappa,Approved,Active,EVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGTTGGAGAGCGGTGGAGTGCTGGTGCAGCCCGGTGGCTCCTTGAGACTGTCATGTGCTGCCAGCGGGTTTACCTTCAGTAATTTTGGTATGACATGGGTGCGGCAGGCACCTGGCAAAGGCCTTGAATGGGTCAGTGGGATCTCCGGAGGCGGACGAGACACATACTTCGCGGATAGCGTTAAGGGCAGGTTTACTATTTCACGCGATAATTCTAAGAACACTCTGTATCTCCAGATGAACTCTCTCAAAGGCGAAGACACGGCCGTGTACTACTGCGTTAAGTGGGGGAACATATATTTCGACTATTGGGGACAAGGGACCCTTGTCACCGTATCCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFR,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGTCCCCTTCAAGCCTGTCTGCATCAGTCGGGGACTCCATCACTATCACCTGCAGGGCTTCCCTGAGCATTAACACTTTTCTCAACTGGTATCAACAGAAGCCAGGCAAAGCTCCGAATCTTCTGATTTACGCCGCCTCATCTTTGCACGGTGGGGTGCCTAGTCGCTTCAGCGGCTCTGGATCCGGTACAGACTTCACACTGACAATAAGAACCCTCCAGCCAGAGGATTTCGCGACGTACTATTGTCAACAGAGCAGTAATACCCCCTTTACTTTCGGACCCGGCACCGTTGTGGACTTTCGGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,1,DIQMTQSPSSLSASVGDSITITCRAS--LSIN------TFLNWYQQKPGKAPNLLIYA--------ASSLHGGVPSRFSGSGSG--TDFTLTIRTLQPEDFATYYCQQSSN-----------------------TPFTFGPGTVVDFR-,EVQLLES-GGVLVQPGGSLRLSCAASG-FTFSN-----FGMTWVRQAPGKGLEWVSGISGG---GRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNI----------------------YFDYWGQGTLVTVSS
-GDPa1-042,certolizumab,313.39,99.305,96.935,3.0599999999999996,3.1799999999999997,,0.0,0.0,1.37,2.0,60.805,70.56,86.035,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGCTGGTCGAGAGTGGTGGGGGCCTCGTGCAGCCAGGCGGGTCCTTGCGACTGAGTTGCGCCGCTTCCGGATACGTTTTCACCGACTATGGGATGAACTGGGTACGCCAAGCCCCTGGCAAAGGACTGGAGTGGATGGGCTGGATAAACACTTACATCGGGGAGCCCATTTATGCAGATAGCGTTAAGGGACGGTTTACATTCAGCCTGGACACGTCTAAGTCTACTGCATATCTCCAGATGAATTCACTTAGGGCCGAAGACACCGCCGTGTACTATTGTGCTAGAGGCTACAGGTCCTACGCGATGGATTACTGGGGCCAGGGTACACTTGTGACCGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAAAGCCCATCATCTCTGAGTGCGTCCGTCGGAGACAGGGTAACGATCACCTGCAAGGCCAGTCAGAACGTGGGGACAAATGTTGCATGGTATCAGCAGAAGCCAGGAAAGGCTCCTAAAGCCTTGATTTATTCCGCCAGCTTTCTGTACTCAGGCGTGCCCTATAGATTCAGCGGTTCTGGCTCTGGCACCGATTTCACTCTCACCATTTCCAGCCTTCAGCCCGAGGACTTCGCTACATACTACTGTCAGCAGTATAACATATACCCTCTGACCTTTGGTCAAGGGACTAAAGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCKAS--QNVG------TNVAWYQQKPGKAPKALIYS--------ASFLYSGVPYRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYNI-----------------------YPLTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YVFTD-----YGMNWVRQAPGKGLEWMGWINTY---IGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRS---------------------YAMDYWGQGTLVTVSS
-GDPa1-043,cetrelimab,69.28,100.0,95.64,3.15,3.4,,,,14.75,15.375,60.25,71.42,,IgG4,Kappa,Phase-III,Active,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARPGLAAAYDTGSLDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARPGLAAAYDTGSLDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTGCAAAGTGGCGCTGAGGTGAAGAAACCGGGGTCTTCAGTTAAGGTGTCTTGTAAAGCATCCGGGGGAACTTTCTCCTCATACGCAATTAGCTGGGTCAGGCAAGCACCTGGCCAGGGGCTTGAGTGGATGGGCGGCATCATACCAATTTTCGACACAGCCAACTATGCCCAGAAGTTTCAGGGACGAGTAACCATCACAGCTGACGAATCCACCTCTACGGCTTACATGGAGCTGAGCTCCCTGAGAAGTGAAGATACCGCTGTCTACTATTGCGCGCGGCCCGGATTGGCCGCCGCCTATGATACAGGCAGCCTCGACTACTGGGGTCAGGGTACCCTCGTGACTGTTTCAAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNYWPLTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNYWPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTTCTGACCCAGTCTCCAGCTACTCTCTCACTGAGCCCAGGCGAGAGGGCCACACTTTCCTGCCGGGCGAGCCAGTCTGTGCGATCCTATTTGGCCTGGTATCAGCAGAAGCCCGGACAAGCCCCTCGCCTCTTGATATATGATGCCTCCAACAGAGCAACGGGGATTCCCGCTAGGTTCAGCGGTTCTGGCAGTGGGACAGACTTCACACTTACCATTAGTTCACTGGAACCGGAGGACTTTGCAGTGTACTACTGTCAACAGCGGAATTACTGGCCTCTGACTTTTGGACAGGGCACCAAGGTCGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,3,EIVLTQSPATLSLSPGERATLSCRAS--QSVR------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRNY-----------------------WPLTFGQGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSS-----YAISWVRQAPGQGLEWMGGIIPI---FDTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARPGLAAAY----------------DTGSLDYWGQGTLVTVSS
-GDPa1-044,cetuximab,78.27,98.695,95.65,2.745,2.815,,,,0.5,3.625,63.155,72.66,84.92,IgG1,Kappa,Approved,Active,QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA,MRAWIFFLLCLAGRALAQVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAACTGAAACAATCTGGGCCTGGTTTGGTTCAGCCATCACAGTCTCTCAGTATAACTTGTACAGTGAGCGGGTTCTCCCTTACCAATTATGGCGTGCACTGGGTCAGACAGTCCCCCGGTAAGGGACTGGAGTGGCTCGGGGTCATCTGGAGCGGAGGCAACACCGACTATAATACGCCGTTTACAAGCCGGCTGTCAATCAATAAGGACAACTCCAAGAGTCAGGTGTTCTTCAAAATGAACAGCCTGCAGTCCAACGATACAGCGATTTACTATTGCGCAAGGGCTCTTACTTACTATGATTACGAATTTGCCTACTGGGGCCAGGGAACCTTGGTGACCGTATCTGCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK,MRAWIFFLLCLAGRALADILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCTGCTGACACAGAGCCCCGTGATCCTCAGCGTCTCCCCAGGCGAGAGGGTGTCATTCAGCTGCCGCGCCAGTCAATCTATCGGGACCAATATTCACTGGTACCAGCAGAGAACTAATGGAAGTCCCCGGCTCTTGATCAAGTATGCAAGTGAATCCATATCCGGAATTCCTTCTCGATTTTCCGGCAGCGGTTCTGGGACCGACTTCACTCTGTCTATAAACTCAGTTGAGTCAGAGGACATTGCTGATTACTATTGTCAACAGAACAACAATTGGCCGACGACATTTGGCGCCGGTACCAAACTTGAACTGAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,1,DILLTQSPVILSVSPGERVSFSCRAS--QSIG------TNIHWYQQRTNGSPRLLIKY--------ASESISGIPSRFSGSGSG--TDFTLSINSVESEDIADYYCQQNNN-----------------------WPTTFGAGTKLELK-,QVQLKQS-GPGLVQPSQSLSITCTVSG-FSLTN-----YGVHWVRQSPGKGLEWLGVIWS----GGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYY-------------------DYEFAYWGQGTLVTVSA
-GDPa1-045,cixutumumab,417.22,99.225,97.56,3.025,3.2649999999999997,,0.3,0.16,9.75,16.0,65.285,73.36,83.41,IgG1,Lambda,Phase-II,Discontinued,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWSTQDHYYYYYMDVWGKGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWSTQDHYYYYYMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGTTGGTGCAGTCTGGCGCTGAAGTGAAAAAGCCTGGCTCATCAGTCAAGGTCAGCTGTAAGGCTAGCGGAGGTACTTTTTCTTCCTACGCCATCTCCTGGGTGAGACAGGCACCCGGGCAAGGACTTGAATGGATGGGTGGGATTATTCCAATCTTCGGGACAGCAAACTATGCCCAAAAGTTCCAGGGCCGGGTTACAATAACTGCCGACAAATCCACCAGTACTGCGTACATGGAGCTGTCAAGTCTGCGCAGCGAGGATACCGCAGTATACTACTGCGCTAGGGCCCCGCTCCGATTTCTGGAGTGGTCTACACAGGACCACTATTATTATTACTACATGGATGTTTGGGGCAAAGGAACGACCGTGACCGTGAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,SSELTQDPAVSVALGQTVRITCQGDSLRSYYATWYQQKPGQAPILVIYGENKRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCKSRDGSGQHLVFGGGTKLTVL,MRAWIFFLLCLAGRALASSELTQDPAVSVALGQTVRITCQGDSLRSYYATWYQQKPGQAPILVIYGENKRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCKSRDGSGQHLVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCTCTAGTGAACTGACCCAGGATCCTGCAGTGTCTGTTGCCCTGGGGCAAACTGTGAGGATAACCTGCCAGGGCGACTCCCTGCGATCCTACTACGCAACCTGGTATCAGCAGAAACCGGGACAAGCCCCAATCCTCGTCATCTACGGCGAGAATAAGCGGCCCAGCGGTATTCCCGACAGATTCTCAGGCAGCTCTAGTGGCAACACAGCTTCCTTGACAATTACTGGCGCTCAGGCGGAAGATGAGGCCGACTATTATTGTAAAAGCCGCGATGGATCAGGGCAGCACCTGGTATTTGGAGGTGGGACGAAGCTCACAGTGCTTGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,4,SSELTQD-PAVSVALGQTVRITCQGD---SLRS-----YYATWYQQKPGQAPILVIYG--------ENKRPSGIPDRFSGSSSG--NTASLTITGAQAEDEADYYCKSRDGS---------------------GQHLVFGGGTKLTVL-,EVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSS-----YAISWVRQAPGQGLEWMGGIIPI---FGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWST---------QDHYYYYYMDVWGKGTTVTVSS
-GDPa1-046,clazakizumab,236.56,99.245,98.33,2.7350000000000003,2.685,,0.1,0.0,1.37,1.375,64.14,73.095,85.11,IgG1,Kappa,Phase-III,Active,EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAACTCGTGGAAAGTGGTGGGGGACTGGTACAGCCTGGTGGCTCACTGCGACTCAGCTGCGCGGCATCCGGGTTTAGCCTGTCTAATTACTACGTCACTTGGGTTCGGCAGGCCCCCGGAAAGGGCTTGGAGTGGGTGGGCATAATCTATGGAAGCGACGAGACCGCCTATGCTACGAGCGCTATCGGCAGATTCACAATTTCTAGGGACAACAGTAAAAACACCTTGTACCTTCAGATGAACTCTCTGCGCGCCGAGGATACAGCCGTCTACTATTGTGCAAGGGATGACTCCTCCGATTGGGACGCTAAGTTCAATCTGTGGGGCCAGGGGACTCTTGTGACCGTTTCATCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK,MRAWIFFLLCLAGRALAAIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCTATACAGATGACCCAGTCCCCTTCTTCTCTCTCCGCCTCAGTGGGCGACAGAGTCACAATTACCTGTCAGGCCAGCCAGAGTATCAACAACGAACTGAGCTGGTACCAGCAGAAGCCCGGTAAGGCCCCCAAGCTGCTGATCTATCGCGCATCAACCCTTGCTTCAGGAGTTCCGAGCCGGTTCAGCGGGTCCGGGTCCGGCACTGACTTCACATTGACGATTAGTAGTCTCCAACCAGATGATTTTGCGACATACTATTGCCAACAGGGTTACTCTCTGAGGAATATTGACAATGCATTTGGAGGGGGCACTAAAGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,AIQMTQSPSSLSASVGDRVTITCQAS--QSIN------NELSWYQQKPGKAPKLLIYR--------ASTLASGVPSRFSGSGSG--TDFTLTISSLQPDDFATYYCQQGYSLR--------------------NIDNAFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FSLSN-----YYVTWVRQAPGKGLEWVGIIYG----SDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDW------------------DAKFNLWGQGTLVTVSS
-GDPa1-047,codrituzumab,296.49,98.33500000000001,97.515,2.68,2.465,3.875,0.48,0.28,1.12,2.375,63.644999999999996,70.81,76.515,IgG1,Kappa,Phase-II,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPGQGLEWMGALDPKTGDTAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCTRFYSYTYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPGQGLEWMGALDPKTGDTAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCTRFYSYTYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTCGTCCAATCCGGAGCGGAAGTTAAGAAGCCTGGCGCTAGCGTGAAGGTGTCCTGTAAGGCCTCTGGCTACACCTTCACCGACTATGAAATGCACTGGGTACGGCAGGCACCAGGTCAGGGGCTCGAGTGGATGGGTGCTCTTGATCCCAAGACAGGCGACACCGCCTACTCTCAGAAATTCAAAGGAAGGGTTACTCTGACCGCCGATAAATCAACAAGCACCGCCTATATGGAGCTGAGCTCCCTGACTAGTGAGGACACTGCAGTGTATTATTGCACAAGATTTTACAGTTACACGTACTGGGGGCAAGGGACATTGGTGACGGTGTCTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSNRNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQNTHVPPTFGQGTKLEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTPGEPASISCRSSQSLVHSNRNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQNTHVPPTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTCGTAATGACACAGTCACCTCTCAGCCTGCCCGTGACCCCCGGGGAGCCAGCTAGCATCTCTTGTCGATCCTCCCAATCATTGGTTCACTCCAACAGAAACACTTATCTCCATTGGTACCTGCAGAAACCAGGCCAGTCTCCCCAGCTTCTGATATACAAGGTCTCTAATAGGTTCAGCGGCGTGCCGGATCGGTTTTCCGGTAGCGGGAGTGGAACCGATTTTACGTTGAAGATCAGTCGCGTGGAAGCCGAGGACGTGGGTGTTTATTACTGCTCACAAAATACCCACGTGCCTCCTACTTTCGGCCAGGGAACAAAACTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DVVMTQSPLSLPVTPGEPASISCRSS--QSLVHSN-RNTYLHWYLQKPGQSPQLLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCSQNTH-----------------------VPPTFGQGTKLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTD-----YEMHWVRQAPGQGLEWMGALDPK---TGDTAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCTRFYS------------------------YTYWGQGTLVTVSS
-GDPa1-048,coltuximab,213.95,99.075,97.705,2.715,2.51,3.445,0.0,0.0,2.0,1.625,64.11,70.055,83.63,IgG1,Kappa,Phase-II,Active,QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS,MRAWIFFLLCLAGRALAQVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTGCAGCCGGGCGCCGAGGTCGTTAAGCCTGGGGCGAGCGTCAAGTTGTCCTGCAAGACCAGTGGCTACACATTCACATCAAATTGGATGCACTGGGTAAAACAGGCCCCAGGTCAGGGACTTGAATGGATTGGCGAGATCGATCCCAGCGACTCCTACACTAACTACAACCAGAATTTTCAAGGGAAGGCCAAACTCACCGTGGACAAAAGCACTTCAACGGCATATATGGAAGTGTCTTCTCTGAGGTCTGATGATACCGCTGTGTACTATTGTGCAAGAGGTTCCAACCCCTACTATTACGCTATGGACTATTGGGGGCAGGGAACCAGTGTTACAGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK,MRAWIFFLLCLAGRALAEIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTCACGCAGAGCCCTGCTATCATGAGTGCGAGCCCCGGGGAGCGGGTTACCATGACCTGCTCAGCATCTAGTGGAGTGAACTACATGCACTGGTACCAGCAGAAACCAGGAACAAGCCCTCGCCGATGGATCTATGACACTTCTAAACTGGCTTCCGGCGTCCCAGCCAGGTTTTCAGGATCCGGGTCTGGGACAGATTATTCCCTGACCATAAGCTCCATGGAGCCCGAGGACGCCGCCACCTACTATTGTCATCAAAGAGGCTCATACACTTTCGGTGGCGGTACAAAGCTTGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,2,EIVLTQSPAIMSASPGERVTMTCSAS--SGVN-------YMHWYQQKPGTSPRRWIYD--------TSKLASGVPARFSGSGSG--TDYSLTISSMEPEDAATYYCHQRG-------------------------SYTFGGGTKLEIK-,QVQLVQP-GAEVVKPGASVKLSCKTSG-YTFTS-----NWMHWVKQAPGQGLEWIGEIDPS---DSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPY-------------------YYAMDYWGQGTSVTVSS
-GDPa1-049,concizumab,139.45,99.475,88.325,2.74,2.865,,,,3.37,1.625,56.260000000000005,68.89,,IgG4,Kappa,Approved,Active,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTGGTGGAGAGCGGAGGCGGGCTTGTTAAGCCCGGGGGCAGCCTTAGGTTGTCCTGCGCCGCCAGCGGATTTACTTTTTCCAACTACGCTATGTCTTGGGTGAGACAAACCCCAGAGAAACGCCTCGAGTGGGTGGCCACCATCTCTCGATCAGGCTCTTACAGTTACTTCCCTGACAGCGTTCAGGGCAGATTCACAATTTCCAGGGACAATGCAAAGAACAGTCTGTATCTCCAGATGAATAGTCTGCGGGCCGAAGATACAGCGGTATATTACTGTGCTCGGCTGGGAGGTTATGACGAAGGGGATGCAATGGATTCATGGGGCCAGGGTACTACGGTCACCGTCTCCTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIK,MRAWIFFLLCLAGRALADIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGATGACCCAGACACCATTGTCCCTCTCTGTTACCCCCGGGCAGCCTGCCTCCATCAGCTGTAAGTCCAGCCAGTCCCTTCTGGAAAGTGACGGGAAAACTTATCTGAACTGGTATTTGCAGAAGCCGGGTCAGTCTCCTCAGCTGCTTATTTACCTGGTGTCTATTCTCGATAGCGGGGTCCCCGATAGATTCTCAGGTAGTGGCTCAGGAACGGATTTCACCCTCAAAATCAGCAGGGTAGAGGCAGAGGACGTCGGCGTGTACTACTGCCTGCAAGCTACTCACTTTCCACAAACATTTGGAGGCGGAACAAAAGTGGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,4,DIVMTQTPLSLSVTPGQPASISCKSS--QSLLESD-GKTYLNWYLQKPGQSPQLLIYL--------VSILDSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCLQATH-----------------------FPQTFGGGTKVEIK-,EVQLVES-GGGLVKPGGSLRLSCAASG-FTFSN-----YAMSWVRQTPEKRLEWVATISRS---GSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDE------------------GDAMDSWGQGTTVTVSS
-GDPa1-050,crenezumab,151.23,99.83,92.715,2.74,2.89,1.35,,,4.37,18.625,66.89,74.57,84.71,IgG4,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGTTGGTGGAGTCTGGAGGCGGGCTGGTCCAGCCAGGCGGGTCCCTGAGACTTTCATGCGCCGCGTCCGGCTTCACCTTCTCATCTTACGGGATGAGTTGGGTTCGGCAGGCTCCTGGTAAGGGGTTGGAACTGGTGGCATCCATCAACAGTAATGGTGGATCTACTTACTACCCCGATAGTGTCAAGGGCCGATTTACGATTAGCCGCGACAACGCTAAAAACAGCCTCTATCTGCAGATGAATAGCCTCAGGGCCGAAGACACAGCCGTGTATTATTGTGCATCAGGCGATTACTGGGGACAAGGAACAACCGTGACTGTAAGCTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATAGTGATGACCCAGAGTCCACTTTCCCTGCCCGTTACACCCGGAGAGCCCGCCTCTATCAGTTGCCGATCCTCCCAGTCTCTGGTGTATTCAAACGGAGACACCTACTTGCATTGGTATCTGCAAAAACCTGGGCAAAGCCCTCAGCTCCTGATCTATAAGGTGAGCAATAGGTTTTCAGGCGTACCGGATCGGTTTAGTGGGAGCGGTAGCGGGACGGACTTCACACTCAAGATTTCTAGAGTTGAAGCTGAGGACGTCGGCGTGTACTACTGTTCACAGTCCACCCACGTCCCATGGACTTTCGGCCAGGGTACTAAGGTGGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,4,DIVMTQSPLSLPVTPGEPASISCRSS--QSLVYSN-GDTYLHWYLQKPGQSPQLLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCSQSTH-----------------------VPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YGMSWVRQAPGKGLELVASINSN---GGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASG---------------------------DYWGQGTTVTVSS
-GDPa1-051,crizanlizumab,303.51,99.545,98.445,2.705,2.4450000000000003,,0.09,0.06,-0.38,-0.875,62.57,73.94,,IgG2,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTCCAGAGTGGTGCGGAGGTCAAAAAACCTGGTGCCTCAGTAAAGGTTAGCTGTAAGGTCTCCGGGTATACGTTCACATCCTACGATATCAACTGGGTTAGACAAGCCCCAGGGAAAGGCCTGGAGTGGATGGGATGGATATATCCCGGCGATGGCAGCATTAAGTACAACGAAAAGTTTAAAGGAAGGGTGACTATGACCGTGGACAAGTCAACCGACACCGCTTACATGGAACTTTCTTCTCTCCGCTCCGAGGACACAGCCGTGTACTACTGCGCTCGACGGGGCGAGTATGGGAATTATGAAGGAGCAATGGATTACTGGGGCCAGGGGACATTGGTGACTGTGAGCAGTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAAATGACACAGAGTCCATCCTCACTGTCTGCTTCCGTTGGTGACAGGGTGACGATTACCTGTAAAGCGAGCCAGAGTGTGGACTACGACGGACACTCATACATGAACTGGTATCAGCAAAAGCCCGGGAAAGCTCCAAAGCTCCTTATCTATGCCGCAAGCAATCTCGAAAGTGGCGTACCTTCCAGATTCAGCGGGTCTGGATCAGGCACAGACTTTACCCTGACAATCTCTAGCCTGCAGCCCGAAGATTTTGCCACTTATTACTGCCAGCAGTCCGATGAGAACCCTTTGACTTTCGGCGGTGGGACCAAAGTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,0,DIQMTQSPSSLSASVGDRVTITCKAS--QSVDYD--GHSYMNWYQQKPGKAPKLLIYA--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSDE-----------------------NPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKVSG-YTFTS-----YDINWVRQAPGKGLEWMGWIYPG---DGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGN-----------------YEGAMDYWGQGTLVTVSS
-GDPa1-052,cusatuzumab,164.3,96.815,95.98,2.725,2.59,1.45,0.0,0.01,-0.38,-1.0,66.905,72.005,81.7,IgG1,Lambda,Phase-II,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSVYYMNWVRQAPGKGLEWVSDINNEGGTTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYCARDAGYSNHVPIFDSWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSVYYMNWVRQAPGKGLEWVSDINNEGGTTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYCARDAGYSNHVPIFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGTTGGTGGAGTCCGGCGGCGGGCTGGTTCAGCCCGGGGGATCCCTGAGACTGTCCTGTGCTGCCTCAGGCTTCACCTTCAGCGTGTATTATATGAATTGGGTTCGACAGGCCCCAGGGAAGGGGCTTGAGTGGGTGAGTGACATTAATAACGAAGGAGGCACTACCTACTACGCGGACAGCGTCAAGGGACGCTTTACTATCTCCCGGGATAACTCAAAAAATAGTCTGTACCTCCAGATGAACAGCCTCAGGGCCGAGGATACAGCTGTATATTATTGCGCAAGGGATGCAGGTTACTCTAACCACGTGCCTATATTTGACTCTTGGGGCCAAGGTACGCTTGTCACAGTGAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QAVVTQEPSLTVSPGGTVTLTCGLKSGSVTSDNFPTWYQQTPGQAPRLLIYNTNTRHSGVPDRFSGSILGNKAALTITGAQADDEAEYFCALFISNPSVEFGGGTQLTVL,MRAWIFFLLCLAGRALAQAVVTQEPSLTVSPGGTVTLTCGLKSGSVTSDNFPTWYQQTPGQAPRLLIYNTNTRHSGVPDRFSGSILGNKAALTITGAQADDEAEYFCALFISNPSVEFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGCCGTAGTGACCCAGGAACCTTCCCTTACTGTCAGTCCCGGGGGCACAGTGACCCTGACGTGTGGGCTGAAAAGTGGCAGCGTCACGAGCGATAACTTTCCAACCTGGTACCAGCAAACACCGGGACAGGCCCCAAGGCTGTTGATCTACAACACCAACACACGGCACTCCGGTGTTCCTGACAGATTCTCTGGCTCAATATTGGGCAATAAGGCAGCTCTTACTATCACCGGTGCTCAGGCAGACGATGAGGCGGAGTATTTTTGCGCCCTCTTCATTTCTAATCCCTCAGTGGAATTCGGGGGAGGAACTCAGCTCACAGTGCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,4,4,QAVVTQE-PSLTVSPGGTVTLTCGLKS-GSVTS----DNFPTWYQQTPGQAPRLLIYN--------TNTRHSGVPDRFSGSILG--NKAALTITGAQADDEAEYFCALFISN----------------------PSVEFGGGTQLTVL-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSV-----YYMNWVRQAPGKGLEWVSDINNE---GGTTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYCARDAGYSN-----------------HVPIFDSWGQGTLVTVSS
-GDPa1-053,dacetuzumab,34.26,99.48,92.02,2.72,2.48,,,,-0.25,0.375,63.82,71.24,76.42,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGTTGGTGGAGAGCGGAGGGGGCCTGGTTCAACCTGGCGGGAGCCTTCGACTCTCCTGCGCTGCCAGCGGATACTCCTTCACTGGATATTACATACACTGGGTAAGGCAAGCCCCCGGTAAAGGCCTCGAGTGGGTGGCTAGGGTGATTCCAAACGCAGGTGGGACGTCATATAATCAGAAGTTTAAGGGGCGCTTCACCCTTTCAGTTGACAACAGTAAAAATACAGCCTACCTGCAGATGAACAGTCTGAGAGCCGAAGATACCGCGGTGTATTACTGTGCACGGGAAGGAATCTATTGGTGGGGCCAGGGCACACTGGTCACTGTCTCTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACTCAGAGTCCTTCCTCCCTTTCTGCTTCAGTCGGGGATCGGGTCACAATTACCTGCAGGAGCAGCCAAAGCCTGGTTCACTCTAACGGTAACACCTTTCTCCACTGGTACCAGCAGAAACCCGGCAAGGCCCCAAAGCTGCTGATATATACAGTATCAAATAGATTTAGTGGCGTGCCTAGTCGCTTCAGCGGATCCGGTTCTGGAACTGATTTCACCTTGACAATCTCCTCTCTCCAACCAGAAGACTTCGCAACGTACTTTTGTTCACAGACCACACATGTGCCCTGGACTTTCGGCCAGGGGACCAAAGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQMTQSPSSLSASVGDRVTITCRSS--QSLVHSN-GNTFLHWYQQKPGKAPKLLIYT--------VSNRFSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYFCSQTTH-----------------------VPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YSFTG-----YYIHWVRQAPGKGLEWVARVIPN---AGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREG-------------------------IYWWGQGTLVTVSS
-GDPa1-054,daclizumab,261.98,99.1,98.545,2.715,2.58,,0.12,0.07,0.0,0.125,63.6,71.55000000000001,77.715,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTGCAAAGCGGTGCCGAGGTGAAAAAACCCGGTTCTAGCGTCAAGGTTAGTTGTAAGGCTTCAGGATACACGTTCACATCCTACCGGATGCACTGGGTTAGGCAGGCCCCAGGCCAGGGCTTGGAATGGATAGGCTATATTAACCCTTCTACCGGGTATACTGAATATAATCAAAAGTTTAAGGACAAAGCAACAATCACAGCGGACGAGAGTACCAACACCGCTTACATGGAACTGTCATCCCTCCGCTCCGAGGATACTGCAGTCTACTACTGCGCCAGAGGAGGCGGGGTGTTCGATTATTGGGGGCAGGGAACTCTTGTGACCGTAAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK,MRAWIFFLLCLAGRALADIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGTCACCAAGTACTCTCTCAGCTAGCGTCGGGGACAGGGTGACCATCACCTGCTCCGCGTCCAGCTCTATCTCCTATATGCATTGGTATCAGCAGAAGCCTGGTAAAGCCCCTAAGCTGCTTATTTACACAACGAGTAACCTCGCATCCGGGGTACCAGCCAGATTCAGTGGCAGCGGATCTGGAACTGAATTCACCTTGACTATAAGCTCACTGCAACCCGACGATTTTGCTACCTATTACTGTCACCAACGGTCTACATACCCCCTGACATTTGGCCAGGGCACCAAGGTTGAGGTGAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQMTQSPSTLSASVGDRVTITCSAS--SSIS-------YMHWYQQKPGKAPKLLIYT--------TSNLASGVPARFSGSGSG--TEFTLTISSLQPDDFATYYCHQRST-----------------------YPLTFGQGTKVEVK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFTS-----YRMHWVRQAPGQGLEWIGYINPS---TGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGG-----------------------VFDYWGQGTLVTVSS
-GDPa1-055,dalotuzumab,464.78,98.755,98.36,2.73,2.7300000000000004,,0.53,0.39,1.75,4.375,62.845,70.43,82.61,IgG1,Kappa,Phase-II,Discontinued,QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTCCAAGAGAGTGGGCCTGGTCTGGTGAAGCCAAGCGAAACCCTGTCCCTCACATGCACAGTATCTGGCTACAGCATTACGGGAGGGTATCTTTGGAATTGGATCCGCCAGCCGCCCGGCAAGGGACTTGAGTGGATTGGATATATCTCCTACGACGGCACCAACAATTACAAACCCTCACTGAAAGACAGGGTTACTATAAGCCGGGATACCTCTAAAAACCAGTTCTCATTGAAGCTGTCTAGCGTGACTGCTGCAGACACTGCCGTTTACTACTGTGCCCGATATGGTAGAGTGTTCTTTGATTATTGGGGCCAGGGGACATTGGTCACCGTGAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGATGACCCAGAGTCCCCTCTCTCTGCCAGTTACACCTGGAGAGCCTGCTAGTATCTCCTGTCGCTCATCTCAATCAATAGTCCACTCTAACGGTAACACGTACCTCCAGTGGTATCTGCAGAAACCCGGACAGTCCCCGCAGCTGCTTATCTACAAGGTAAGCAATAGACTGTACGGGGTGCCCGATAGGTTTAGCGGAAGCGGCTCCGGCACCGACTTTACTTTGAAGATTTCCCGGGTGGAAGCCGAAGATGTGGGTGTGTATTATTGCTTCCAGGGGAGCCATGTTCCATGGACTTTCGGCCAAGGGACAAAAGTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,DIVMTQSPLSLPVTPGEPASISCRSS--QSIVHSN-GNTYLQWYLQKPGQSPQLLIYK--------VSNRLYGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCFQGSH-----------------------VPWTFGQGTKVEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-YSITG----GYLWNWIRQPPGKGLEWIGYISY----DGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRV----------------------FFDYWGQGTLVTVSS
-GDPa1-056,daratumumab,228.75,99.295,97.595,2.775,2.67,3.69,0.0,0.0,1.75,-0.5,63.31,72.935,85.065,IgG1,Kappa,Approved,Active,EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTCTGGAATCAGGCGGTGGGTTGGTTCAACCAGGGGGATCTCTGAGGCTGAGTTGTGCAGTCTCCGGGTTCACATTCAATAGCTTCGCCATGTCATGGGTGCGACAGGCTCCCGGTAAAGGACTCGAGTGGGTCAGCGCCATATCTGGGTCCGGCGGAGGCACTTACTACGCAGACTCCGTGAAGGGCAGATTTACTATTTCCCGGGACAACTCTAAGAATACACTCTATTTGCAGATGAACAGTCTGCGCGCCGAGGATACCGCGGTGTACTTCTGCGCTAAGGATAAAATCCTTTGGTTTGGTGAACCTGTGTTTGACTATTGGGGCCAGGGAACGCTGGTAACCGTTAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATAGTTCTCACCCAAAGCCCTGCTACTCTCTCCCTGAGCCCAGGCGAGAGGGCAACACTTTCTTGTCGAGCAAGCCAGTCTGTGTCATCTTACCTGGCTTGGTATCAGCAGAAACCCGGGCAGGCGCCCAGGCTGCTGATCTACGACGCCTCCAATAGAGCCACCGGAATCCCTGCCCGGTTCTCAGGAAGTGGCTCCGGTACCGATTTTACACTTACTATTAGTAGCTTGGAGCCCGAGGACTTCGCCGTCTATTACTGCCAGCAACGCTCCAACTGGCCACCGACATTTGGGCAGGGCACGAAGGTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSN-----------------------WPPTFGQGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAVSG-FTFNS-----FAMSWVRQAPGKGLEWVSAISGS---GGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWF-----------------GEPVFDYWGQGTLVTVSS
-GDPa1-057,denosumab,259.84,99.11,99.3,2.73,2.4299999999999997,4.43,0.0,0.07,2.87,12.125,62.41,73.36,,IgG2,Kappa,Approved,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGTTGCTTGAAAGCGGGGGTGGCCTTGTCCAACCCGGGGGCAGTCTCCGATTGTCCTGTGCGGCCTCAGGATTCACGTTCTCTAGCTATGCCATGTCATGGGTCCGCCAGGCACCAGGCAAGGGACTGGAGTGGGTGTCTGGGATCACAGGTAGTGGCGGATCTACCTACTACGCAGACAGCGTAAAGGGAAGATTTACTATTAGCCGGGATAACAGTAAAAATACCCTGTACCTGCAGATGAACTCACTCAGGGCTGAAGACACCGCCGTGTATTATTGCGCTAAAGATCCTGGTACTACAGTTATAATGTCCTGGTTTGACCCGTGGGGCCAGGGGACACTGGTGACCGTGTCCTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,EIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATAGTCCTGACGCAAAGCCCAGGTACCCTGAGCCTCTCTCCCGGCGAGAGAGCCACTTTGTCTTGCAGAGCTTCCCAGTCAGTGCGCGGAAGGTATCTGGCTTGGTATCAGCAGAAGCCTGGCCAAGCGCCGCGGCTGCTTATCTACGGGGCAAGCTCTCGAGCCACAGGGATTCCCGATAGGTTCTCCGGTTCCGGAAGTGGAACCGACTTTACACTCACAATTAGTCGCTTGGAACCAGAGGACTTCGCCGTTTTTTACTGTCAGCAGTACGGCAGCTCACCTCGGACCTTCGGGCAGGGCACTAAGGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,4,4,EIVLTQSPGTLSLSPGERATLSCRAS--QSVRG-----RYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVFYCQQYGS-----------------------SPRTFGQGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----YAMSWVRQAPGKGLEWVSGITGS---GGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTV-----------------IMSWFDPWGQGTLVTVSS
-GDPa1-058,depatuxizumab,307.59,99.37,98.25,2.715,2.535,,0.21,0.12,-0.13,1.0,60.084999999999994,70.1,82.33,IgG1,Kappa,Phase-III,Discontinued,QVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGCAAGAATCTGGCCCTGGGCTGGTTAAGCCATCCCAGACTCTGTCCCTCACATGCACCGTGTCTGGCTACAGTATTTCAAGCGACTTCGCGTGGAATTGGATAAGGCAGCCTCCCGGAAAGGGACTGGAGTGGATGGGATATATCTCTTATTCCGGTAATACTAGATACCAGCCAAGCCTTAAGAGCCGAATCACAATTAGTCGGGACACGTCCAAAAACCAGTTTTTTCTTAAACTCAACAGCGTCACCGCTGCAGATACAGCCACATACTACTGTGTAACCGCCGGGCGCGGTTTCCCCTATTGGGGGCAGGGCACTTTGGTCACCGTGTCATCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGAGCCCCTCTTCCATGTCAGTGTCTGTCGGAGACAGAGTGACCATTACTTGCCACAGCAGCCAAGACATTAACTCCAATATCGGCTGGCTGCAGCAGAAGCCAGGTAAATCCTTCAAGGGACTGATCTACCATGGGACAAACCTCGATGACGGCGTTCCGAGCAGGTTCTCCGGTTCAGGGAGTGGCACGGATTACACCTTGACCATTTCTAGTCTTCAACCCGAAGACTTCGCTACTTACTATTGTGTACAGTATGCCCAGTTTCCTTGGACCTTTGGAGGGGGCACAAAGCTGGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,3,DIQMTQSPSSMSVSVGDRVTITCHSS--QDIN------SNIGWLQQKPGKSFKGLIYH--------GTNLDDGVPSRFSGSGSG--TDYTLTISSLQPEDFATYYCVQYAQ-----------------------FPWTFGGGTKLEIK-,QVQLQES-GPGLVKPSQTLSLTCTVSG-YSISS----DFAWNWIRQPPGKGLEWMGYISY----SGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGR-----------------------GFPYWGQGTLVTVSS
-GDPa1-059,dinutuximab,228.75,98.56,98.14,2.795,2.745,,0.42,0.67,2.62,18.125,62.485,69.315,84.345,IgG1,Kappa,Approved,Active,EVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSS,MRAWIFFLLCLAGRALAEVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGTTGCTGCAGTCCGGCCCAGAACTGGAGAAGCCCGGTGCGTCTGTTATGATAAGCTGCAAAGCTTCTGGGAGTTCCTTCACTGGCTACAATATGAATTGGGTGAGGCAGAACATCGGGAAGTCCCTTGAGTGGATCGGAGCTATTGACCCTTACTATGGAGGCACAAGTTACAACCAGAAGTTTAAAGGCAGAGCCACCCTCACAGTCGACAAATCATCTTCAACTGCATACATGCACCTGAAGTCTCTCACCAGCGAGGATAGTGCCGTGTATTATTGTGTAAGCGGGATGGAATATTGGGGCCAAGGAACCTCCGTCACGGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK,MRAWIFFLLCLAGRALAEIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTGATGACTCAGTCCCCCGCCACCCTGTCCGTCAGCCCTGGAGAACGCGCTACACTCAGCTGCCGATCAAGTCAGTCACTGGTCCACAGAAACGGTAACACTTATCTGCATTGGTACTTGCAGAAGCCAGGCCAGAGCCCCAAACTGTTGATCCACAAGGTGTCTAATCGGTTTAGCGGCGTGCCAGACAGGTTCTCCGGTTCAGGCTCTGGGACAGATTTCACCCTCAAGATTTCCAGGGTGGAGGCAGAAGACCTTGGAGTATACTTTTGTAGTCAATCTACACATGTTCCGCCTCTTACGTTCGGGGCCGGGACCAAACTCGAGCTGAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,EIVMTQSPATLSVSPGERATLSCRSS--QSLVHRN-GNTYLHWYLQKPGQSPKLLIHK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDLGVYFCSQSTHV----------------------PPLTFGAGTKLELK-,EVQLLQS-GPELEKPGASVMISCKASG-SSFTG-----YNMNWVRQNIGKSLEWIGAIDPY---YGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGM--------------------------EYWGQGTSVTVSS
-GDPa1-060,domagrozumab,345.31,98.9,97.985,2.75,2.71,,0.0,0.0,2.25,2.0,64.7,70.37,80.83,IgG1,Kappa,Phase-II,Discontinued,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAACTGTTGGAAAGTGGGGGCGGCCTCGTGCAGCCAGGAGGATCTCTGAGGCTCTCCTGCGCCGCATCAGGATTCACCTTTAGCTCCTATGCCATGTCTTGGGTCCGGCAGGCTCCTGGCAAGGGCCTTGAGTGGGTGTCTACTATCAGCTCCGGGGGTTCCTACACTTCATACCCCGACAGCGTAAAAGGTCGATTCACAATTTCACGCGATAATAGCAAAAACACACTGTACCTGCAAATGAATAGTCTTAGAGCCGAAGATACGGCGGTGTATTATTGTGCTAAGCAGGACTATGCAATGAACTACTGGGGGCAGGGCACCTTGGTTACCGTCAGTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGTCCCCATCCAGCTTGAGCGCTAGTGTGGGCGATAGGGTTACCATCACCTGCAAGGCGTCTCAGGACGTGTCAACGGCCGTCGCCTGGTATCAGCAAAAACCCGGTAAGGCTCCTAAGCTTCTGATTTACAGTGCCTCTTACCGGTACACTGGCGTGCCCTCTAGATTCTCCGGAAGCGGGTCAGGGACAGACTTCACACTCACCATATCCTCACTGCAGCCTGAAGACTTTGCAACCTATTATTGTCAACAGCACTACAGCACACCATGGACTTTTGGTGGCGGAACTAAAGTAGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,DIQMTQSPSSLSASVGDRVTITCKAS--QDVS------TAVAWYQQKPGKAPKLLIYS--------ASYRYTGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQHYS-----------------------TPWTFGGGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----YAMSWVRQAPGKGLEWVSTISSG---GSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDY-----------------------AMNYWGQGTLVTVSS
-GDPa1-061,dostarlimab,241.97,99.30000000000001,91.38499999999999,2.9050000000000002,2.96,,0.0,0.05,3.0,8.625,56.735,67.71000000000001,75.815,IgG4,Kappa,Approved,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSTISGGGSYTYYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASPYYAMDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSTISGGGSYTYYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASPYYAMDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGCTGCTGGAATCCGGCGGCGGGTTGGTGCAACCTGGCGGATCTCTTCGCCTGAGTTGTGCCGCTTCTGGGTTCACATTCAGCAGCTACGATATGAGTTGGGTGAGGCAGGCTCCCGGAAAAGGCCTCGAATGGGTTTCCACAATTTCAGGTGGGGGCTCATACACTTATTACCAGGACTCCGTGAAGGGGCGGTTTACTATCTCCAGAGACAATAGCAAGAACACCTTGTACCTCCAGATGAACAGTCTGCGAGCCGAGGACACCGCCGTATATTATTGCGCGTCTCCATACTATGCAATGGATTACTGGGGTCAAGGAACAACGGTCACCGTGAGCTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQLTQSPSFLSAYVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTLHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHYSSYPWTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQLTQSPSFLSAYVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTLHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHYSSYPWTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGCTGACTCAGAGCCCTAGTTTCTTGTCTGCGTATGTTGGAGACAGGGTCACCATCACATGTAAGGCTTCTCAAGATGTGGGTACCGCCGTGGCCTGGTACCAGCAGAAACCCGGGAAGGCCCCTAAGCTCCTCATATACTGGGCATCCACACTGCACACCGGCGTACCATCTAGATTCTCAGGCAGTGGCTCCGGTACGGAGTTTACCCTTACAATTTCCTCACTGCAACCCGAAGACTTCGCTACTTATTACTGCCAGCATTACAGCAGCTATCCATGGACATTTGGGCAGGGAACTAAACTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,1,DIQLTQSPSFLSAYVGDRVTITCKAS--QDVG------TAVAWYQQKPGKAPKLLIYW--------ASTLHTGVPSRFSGSGSG--TEFTLTISSLQPEDFATYYCQHYSS-----------------------YPWTFGQGTKLEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----YDMSWVRQAPGKGLEWVSTISGG---GSYTYYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASPYY-----------------------AMDYWGQGTTVTVSS
-GDPa1-062,duligotuzumab,206.92,99.08,97.385,2.745,2.79,,0.23,0.0,1.87,9.375,61.58,74.13499999999999,,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTGGTGGAGAGCGGCGGCGGACTGGTGCAGCCCGGCGGAAGTTTGAGACTCAGTTGCGCTGCTTCTGGATTTACCCTTTCCGGGGACTGGATCCACTGGGTGCGACAAGCTCCTGGCAAGGGTCTCGAGTGGGTTGGCGAAATATCCGCCGCAGGGGGCTATACAGATTATGCCGATTCAGTCAAAGGGAGGTTCACCATTAGCGCCGACACTTCCAAGAATACGGCGTACCTGCAGATGAACTCTCTTCGGGCCGAGGATACCGCTGTCTATTACTGTGCCAGGGAAAGCCGCGTTTCTTTCGAGGCAGCAATGGACTACTGGGGTCAGGGGACACTGGTAACTGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACCCAGAGCCCATCCTCCCTCTCTGCCTCTGTGGGTGACAGGGTAACAATCACTTGCAGAGCAAGTCAGAACATTGCTACGGACGTCGCCTGGTATCAGCAGAAGCCTGGCAAGGCCCCCAAATTGCTGATATACAGCGCTTCCTTTCTTTACTCCGGCGTTCCGAGCCGGTTCAGCGGATCAGGGTCAGGCACCGATTTCACCCTGACAATTTCATCTCTGCAACCTGAGGACTTCGCGACCTATTACTGTCAACAGAGTGAACCCGAGCCATATACATTTGGGCAGGGAACTAAGGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,0,DIQMTQSPSSLSASVGDRVTITCRAS--QNIA------TDVAWYQQKPGKAPKLLIYS--------ASFLYSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSEP-----------------------EPYTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTLSG-----DWIHWVRQAPGKGLEWVGEISAA---GGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSF------------------EAAMDYWGQGTLVTVSS
-GDPa1-063,dupilumab,109.47,99.58000000000001,75.3,2.91,2.915,3.835,0.16,0.13,3.62,13.875,54.379999999999995,69.9,79.99000000000001,IgG4,Kappa,Approved,Active,EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCGTGGAGTCCGGAGGCGGGCTGGAGCAACCTGGTGGTTCACTGAGGCTCAGTTGTGCAGGATCTGGGTTCACATTTAGGGATTACGCGATGACTTGGGTTCGGCAGGCCCCAGGCAAAGGGTTGGAATGGGTGTCCTCTATCAGCGGAAGCGGCGGTAATACATACTACGCTGATAGCGTCAAGGGCCGCTTCACCATAAGTCGGGACAATTCCAAGAACACCCTGTATCTTCAGATGAACTCTCTTCGCGCTGAGGACACAGCCGTTTATTATTGCGCCAAAGACAGACTGTCCATTACCATCAGACCCCGATATTACGGATTGGATGTGTGGGGGCAGGGCACCACGGTCACTGTAAGCTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGTTATGACACAGAGCCCTCTGTCTCTCCCCGTAACCCCCGGTGAACCGGCCTCAATAAGTTGCCGATCCAGCCAGAGTCTTCTCTACTCTATCGGATACAATTATCTCGACTGGTATCTGCAGAAGTCCGGGCAAAGCCCTCAGTTGCTGATTTATCTGGGCTCCAACCGGGCTAGCGGCGTCCCAGATAGATTTTCCGGCTCAGGGTCTGGGACCGACTTCACTTTGAAAATCTCAAGGGTGGAGGCAGAGGACGTGGGTTTCTACTACTGTATGCAGGCCCTTCAGACTCCATATACATTTGGACAAGGAACGAAACTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,4,DIVMTQSPLSLPVTPGEPASISCRSS--QSLLYSI-GYNYLDWYLQKSGQSPQLLIYL--------GSNRASGVPDRFSGSGSG--TDFTLKISRVEAEDVGFYYCMQALQ-----------------------TPYTFGQGTKLEIK-,EVQLVES-GGGLEQPGGSLRLSCAGSG-FTFRD-----YAMTWVRQAPGKGLEWVSSISGS---GGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIR--------------PRYYGLDVWGQGTTVTVSS
-GDPa1-064,durvalumab,196.76,99.405,97.565,2.7300000000000004,2.63,3.83,0.0,0.0,0.37000000000000005,3.875,62.715,70.66,84.78,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFGELAFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFGELAFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTCGTGGAAAGCGGCGGGGGACTTGTGCAGCCCGGAGGGAGCCTGAGGCTGTCCTGTGCTGCAAGCGGTTTCACCTTCTCTCGCTACTGGATGTCCTGGGTTCGGCAGGCCCCTGGCAAGGGTCTTGAGTGGGTAGCCAACATCAAGCAGGACGGCTCAGAAAAATACTACGTGGACTCAGTCAAGGGCAGATTTACCATATCTAGAGACAATGCCAAAAACTCTCTCTATCTGCAAATGAATAGTTTGAGGGCTGAGGATACGGCGGTGTACTATTGCGCCCGAGAAGGGGGCTGGTTCGGAGAGCTGGCATTTGATTATTGGGGCCAAGGAACTTTGGTCACAGTCTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTCTTGACCCAGAGTCCAGGGACACTGTCCCTGTCACCTGGTGAAAGAGCGACCTTGAGCTGTAGGGCCTCCCAAAGGGTTTCTAGTAGCTATCTGGCCTGGTACCAGCAGAAACCGGGTCAAGCTCCACGCCTTCTTATCTACGACGCTTCCAGCCGGGCCACGGGCATCCCTGATCGATTCTCTGGCTCAGGAAGCGGCACAGATTTCACTCTGACAATATCTAGACTCGAGCCCGAAGACTTTGCAGTGTATTATTGCCAGCAGTACGGGTCCCTCCCCTGGACTTTTGGACAGGGGACCAAGGTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPGTLSLSPGERATLSCRAS--QRVSS-----SYLAWYQQKPGQAPRLLIYD--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------LPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSR-----YWMSWVRQAPGKGLEWVANIKQD---GSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFG------------------ELAFDYWGQGTLVTVSS
-GDPa1-065,eculizumab,327.32,99.57,97.745,2.84,2.865,,0.0,0.05,0.8700000000000001,0.625,63.010000000000005,73.88499999999999,,IgG2,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAATTGGTTCAGTCAGGGGCAGAAGTGAAAAAGCCGGGAGCGAGTGTGAAGGTGTCCTGTAAGGCTTCTGGTTATATCTTTAGTAACTATTGGATTCAGTGGGTACGGCAGGCCCCTGGCCAGGGTCTGGAATGGATGGGCGAGATACTTCCCGGAAGCGGGTCCACCGAATACACCGAGAATTTCAAAGACAGAGTGACAATGACTCGAGATACCAGCACCTCAACAGTTTACATGGAGCTCTCCTCCCTGCGCTCAGAGGACACAGCCGTCTATTACTGCGCTAGGTACTTCTTTGGGTCTTCTCCAAACTGGTATTTCGATGTCTGGGGCCAAGGAACTCTGGTCACGGTGAGCAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACACAATCTCCCAGTTCACTCTCCGCTAGCGTGGGTGACAGGGTCACCATTACGTGTGGCGCCTCTGAGAACATCTACGGGGCTCTGAACTGGTATCAGCAGAAACCAGGAAAGGCGCCCAAGTTGCTTATCTACGGGGCAACTAATCTGGCCGACGGCGTTCCTTCCCGGTTTAGCGGCAGTGGGTCAGGAACAGATTTCACTCTCACCATTTCCAGCCTGCAGCCTGAGGATTTTGCCACCTATTACTGCCAAAACGTACTGAATACCCCACTTACTTTCGGACAGGGTACAAAAGTGGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSLSASVGDRVTITCGAS--ENIY------GALNWYQQKPGKAPKLLIYG--------ATNLADGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQNVLN-----------------------TPLTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YIFSN-----YWIQWVRQAPGQGLEWMGEILPG---SGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSS-----------------PNWYFDVWGQGTLVTVSS
-GDPa1-066,efalizumab,244.68,98.775,95.245,2.71,2.505,3.9299999999999997,0.11,0.09,0.8700000000000001,0.125,60.59,70.46000000000001,86.945,IgG1,Kappa,Approved,NFD,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTTGTGGAATCTGGCGGCGGGCTTGTACAACCCGGCGGTAGCCTCCGCCTGAGTTGCGCCGCATCCGGTTATAGCTTCACTGGACACTGGATGAATTGGGTGAGGCAGGCGCCAGGCAAAGGGCTGGAGTGGGTGGGAATGATTCATCCTTCTGATTCAGAGACGCGGTATAACCAAAAGTTTAAGGACAGGTTCACAATCAGTGTCGATAAATCCAAGAACACCCTGTACCTGCAGATGAATTCACTCCGAGCTGAAGACACAGCCGTGTATTACTGTGCTAGAGGGATATACTTTTACGGCACCACATACTTCGACTATTGGGGACAGGGGACCTTGGTCACTGTTAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACTCAGAGCCCATCTTCACTGTCCGCTTCCGTGGGTGACAGGGTGACCATCACTTGTAGAGCCAGTAAGACAATCTCTAAGTACCTGGCCTGGTACCAGCAAAAGCCCGGCAAAGCGCCTAAGCTGCTCATTTATTCTGGCTCCACCTTGCAGTCAGGCGTTCCCAGCCGGTTTAGCGGGAGCGGATCAGGTACAGATTTCACCCTTACTATAAGTTCCCTCCAACCAGAGGACTTTGCAACATACTATTGCCAGCAGCACAACGAATATCCTCTGACGTTCGGGCAGGGAACCAAAGTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,DIQMTQSPSSLSASVGDRVTITCRAS--KTIS------KYLAWYQQKPGKAPKLLIYS--------GSTLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQHNE-----------------------YPLTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YSFTG-----HWMNWVRQAPGKGLEWVGMIHPS---DSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYG------------------TTYFDYWGQGTLVTVSS
-GDPa1-067,eldelumab,151.33,99.375,94.265,6.775,3.4400000000000004,3.615,0.0,0.01,0.8700000000000001,-0.375,56.215,66.025,82.875,IgG1,Kappa,Phase-II,Discontinued,QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAATGCAGCTGGTCGAGTCCGGCGGGGGCGTCGTGCAGCCTGGCAGAAGTCTGCGCCTCTCTTGCACTGCGTCAGGTTTTACCTTTTCAAATAACGGAATGCACTGGGTGAGGCAGGCACCCGGTAAAGGCCTGGAATGGGTTGCCGTGATTTGGTTCGACGGGATGAACAAGTTCTATGTAGATTCCGTGAAAGGGAGATTCACAATAAGCAGGGATAACTCTAAGAATACGTTGTATCTTGAGATGAATAGCCTCCGGGCTGAGGATACTGCCATCTATTACTGTGCTCGAGAAGGAGACGGGAGCGGAATCTACTACTACTATGGCATGGACGTCTGGGGACAGGGTACCACAGTTACCGTGAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTCTTGACTCAGAGCCCTGGGACCCTCAGTCTGTCCCCAGGCGAAAGGGCTACATTGTCCTGCCGCGCCTCTCAGTCCGTGTCATCAAGCTACCTCGCCTGGTATCAGCAAAAGCCCGGTCAGGCCCCCAGACTTCTGATCTACGGGGCAAGTTCACGGGCGACGGGGATTCCGGACCGATTCAGCGGCTCCGGCTCTGGTACTGATTTCACCCTGACCATCAGTAGGCTGGAACCCGAGGACTTCGCTGTTTATTATTGTCAACAGTACGGAAGCTCTCCTATCTTTACATTTGGACCAGGCACAAAAGTGGATATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,2,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----SYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGSS----------------------PIFTFGPGTKVDIK-,QMQLVES-GGGVVQPGRSLRLSCTASG-FTFSN-----NGMHWVRQAPGKGLEWVAVIWFD---GMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGI---------------YYYYGMDVWGQGTTVTVSS
-GDPa1-068,elezanumab,276.0,96.34,96.12,2.755,2.615,,0.0,0.01,2.5,0.125,61.055,72.15,77.25,IgG1,Lambda,Phase-II,Active,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSHGISWVRQAPGQGLDWMGWISPYSGNTNYAQKLQGRVTMTTDTSTSTAYMELSSLRSEDTAVYYCARVGSGPYYYMDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGASVKVSCKASGYTFTSHGISWVRQAPGQGLDWMGWISPYSGNTNYAQKLQGRVTMTTDTSTSTAYMELSSLRSEDTAVYYCARVGSGPYYYMDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGTTGGTACAGTCAGGCGCCGAAGTTAAGAAACCTGGAGCAAGCGTGAAGGTGTCTTGTAAGGCAAGTGGCTACACATTCACTAGCCACGGGATTAGTTGGGTGAGACAGGCTCCGGGTCAAGGACTTGATTGGATGGGATGGATCAGCCCCTATTCCGGCAACACGAATTACGCCCAGAAACTCCAAGGCCGCGTCACCATGACTACTGATACCTCCACATCTACCGCGTACATGGAGCTGTCCTCACTGCGGTCAGAGGACACCGCCGTGTATTACTGCGCTAGGGTCGGGTCTGGCCCATACTATTATATGGACGTTTGGGGGCAGGGTACACTGGTCACAGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSALTQPRSVSGSPGQSVTISCTGTSSSVGDSIYVSWYQQHPGKAPKLMLYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGTDTLFGGGTKVTVL,MRAWIFFLLCLAGRALAQSALTQPRSVSGSPGQSVTISCTGTSSSVGDSIYVSWYQQHPGKAPKLMLYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGTDTLFGGGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGAGTGCCCTGACGCAGCCTAGGTCAGTATCCGGGAGCCCCGGTCAATCTGTGACCATAAGCTGCACAGGCACTTCTTCCTCCGTTGGGGATTCTATTTACGTGAGCTGGTATCAACAGCACCCCGGAAAGGCTCCTAAATTGATGCTCTATGATGTGACCAAACGGCCATCCGGTGTGCCAGACAGATTCTCTGGATCAAAGTCAGGCAACACAGCGAGTCTCACAATCAGCGGGCTTCAGGCAGAAGACGAGGCCGACTACTACTGTTATAGTTACGCTGGAACCGATACTCTGTTTGGCGGCGGCACCAAGGTCACTGTCCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,4,QSALTQP-RSVSGSPGQSVTISCTGTS-SSVGD----SIYVSWYQQHPGKAPKLMLYD--------VTKRPSGVPDRFSGSKSG--NTASLTISGLQAEDEADYYCYSYAG-----------------------TDTLFGGGTKVTVL-,EVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----HGISWVRQAPGQGLDWMGWISPY---SGNTNYAQKLQGRVTMTTDTSTSTAYMELSSLRSEDTAVYYCARVGSGP-------------------YYYMDVWGQGTLVTVSS
-GDPa1-069,elotuzumab,203.48,61.54,98.125,2.815,2.915,,0.0,0.03,0.8700000000000001,0.0,60.28,69.82,85.655,IgG1,Kappa,Approved,NFD,EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAATTGGTGGAATCCGGGGGAGGACTGGTGCAGCCTGGTGGGAGCTTGAGACTTAGCTGTGCGGCCAGCGGGTTTGACTTTTCTAGGTATTGGATGAGTTGGGTGCGACAGGCCCCAGGCAAGGGCCTGGAGTGGATAGGCGAAATTAATCCCGATAGTTCCACCATCAACTATGCACCCTCCCTCAAAGACAAATTCATTATCTCAAGGGATAACGCTAAGAATTCACTGTACCTGCAGATGAACTCTCTTCGGGCTGAGGACACGGCCGTCTACTATTGCGCACGCCCGGACGGTAATTACTGGTACTTCGATGTATGGGGCCAGGGAACACTCGTGACTGTCAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACGCAGAGCCCTTCCTCTCTGAGCGCGTCCGTGGGCGATAGAGTTACCATCACATGCAAAGCCTCACAGGACGTGGGAATCGCAGTCGCTTGGTACCAACAGAAACCTGGTAAGGTGCCCAAGTTGCTTATTTACTGGGCCAGTACTAGGCACACTGGCGTACCAGACCGGTTCAGTGGGTCAGGATCTGGGACAGACTTTACTCTCACAATATCCAGCCTGCAACCAGAAGATGTCGCTACCTATTATTGTCAGCAGTACTCTAGCTACCCCTATACCTTCGGCCAGGGTACCAAAGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,DIQMTQSPSSLSASVGDRVTITCKAS--QDVG------IAVAWYQQKPGKVPKLLIYW--------ASTRHTGVPDRFSGSGSG--TDFTLTISSLQPEDVATYYCQQYSS-----------------------YPYTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FDFSR-----YWMSWVRQAPGKGLEWIGEINPD---SSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNY--------------------WYFDVWGQGTLVTVSS
-GDPa1-070,emactuzumab,177.67,97.44,97.33500000000001,2.7199999999999998,2.8449999999999998,3.825,0.1,0.0,1.12,1.125,60.815,70.28,84.13499999999999,IgG1,Kappa,Phase-III,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGVIWTDGGTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQRLYFDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGVIWTDGGTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQRLYFDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTCCAGAGCGGGGCCGAGGTCAAAAAACCTGGGGCCAGCGTGAAGGTGTCTTGCAAGGCATCCGGTTACACGTTCACTTCATACGACATTAGTTGGGTACGACAGGCTCCCGGACAGGGTTTGGAGTGGATGGGCGTCATCTGGACAGATGGGGGAACCAACTATGCACAGAAGCTTCAGGGCCGGGTGACTATGACAACGGACACCAGTACATCTACCGCTTACATGGAACTGAGGAGCCTGAGGTCCGACGATACAGCGGTTTATTATTGTGCCCGCGATCAGAGACTCTACTTTGACGTGTGGGGCCAAGGAACTACCGTGACCGTTTCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASEDVNTYVSWYQQKPGKAPKLLIYAASNRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSYPTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASEDVNTYVSWYQQKPGKAPKLLIYAASNRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSYPTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACCCAGAGCCCTTCTTCTCTCTCTGCCTCCGTGGGCGACCGGGTAACCATCACCTGTAGGGCATCCGAGGATGTGAACACTTATGTCTCATGGTATCAGCAGAAACCTGGCAAGGCCCCAAAGCTTCTGATATACGCGGCTAGTAATAGATACACTGGCGTTCCAAGTCGATTTTCCGGATCCGGTTCAGGAACAGATTTTACGCTGACAATTAGCTCATTGCAACCCGAAGACTTCGCTACTTACTACTGCCAGCAGAGCTTCAGCTATCCCACCTTCGGGCAAGGGACAAAGCTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQMTQSPSSLSASVGDRVTITCRAS--EDVN------TYVSWYQQKPGKAPKLLIYA--------ASNRYTGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSFS------------------------YPTFGQGTKLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----YDISWVRQAPGQGLEWMGVIWT----DGGTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQRL----------------------YFDVWGQGTTVTVSS
-GDPa1-071,emapalumab,202.74,99.455,94.63,2.935,2.795,1.81,0.0,0.0,0.12,2.0,60.055,69.09,81.59,IgG1,Lambda,Approved,NFD,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAACTTCTGGAATCTGGGGGCGGGCTCGTTCAGCCTGGCGGATCACTGCGCTTGTCCTGCGCCGCCTCCGGATTTACATTCTCCAGCTATGCGATGAGCTGGGTCCGGCAGGCCCCAGGCAAGGGTCTGGAGTGGGTAAGTGCCATCTCTGGAAGCGGCGGGAGTACTTACTACGCTGATTCAGTGAAGGGGAGATTCACGATTTCCCGAGACAATTCAAAAAACACCCTCTATCTTCAGATGAACAGCTTGAGGGCAGAGGACACTGCTGTGTACTATTGTGCAAAAGATGGCTCTTCTGGCTGGTACGTTCCGCACTGGTTTGACCCCTGGGGTCAGGGAACCCTGGTCACAGTGAGCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVL,MRAWIFFLLCLAGRALANFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCAATTTCATGCTCACACAACCACACTCTGTGTCCGAGTCACCAGGTAAGACTGTAACCATCTCATGCACCCGAAGCTCCGGGAGCATAGCCTCCAATTATGTTCAATGGTACCAGCAGCGGCCTGGGTCTAGCCCCACCACAGTGATTTATGAAGATAACCAGAGGCCTTCAGGCGTCCCCGACCGCTTTTCCGGGTCTATCGACAGCAGTAGTAACAGCGCATCCCTGACAATTTCTGGCTTGAAAACTGAGGACGAAGCTGATTACTATTGTCAGTCATACGATGGCAGTAACAGATGGATGTTCGGTGGAGGAACGAAGCTTACCGTGCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,3,4,NFMLTQP-HSVSESPGKTVTISCTRSS-GSIAS-----NYVQWYQQRPGSSPTTVIYE--------DNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGS----------------------NRWMFGGGTKLTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----YAMSWVRQAPGKGLEWVSAISGS---GGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWY----------------VPHWFDPWGQGTLVTVSS
-GDPa1-072,emibetuzumab,781.93,99.275,91.58,2.7300000000000004,2.785,,0.83,0.86,12.12,22.875,57.29,67.555,75.805,IgG4,Kappa,Phase-II,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGTTGGTGCAATCCGGTGCAGAAGTGAAGAAGCCTGGGGCCTCCGTGAAAGTCAGCTGCAAGGCTTCTGGGTATACCTTCACCGACTACTACATGCACTGGGTTCGACAGGCCCCAGGACAGGGCCTTGAGTGGATGGGGCGGGTCAATCCCAATAGGCGGGGCACTACTTATAACCAAAAATTTGAGGGCAGAGTGACGATGACAACAGATACCTCTACATCAACAGCCTACATGGAACTGAGAAGTCTCAGGTCAGATGACACCGCAGTATACTATTGTGCTCGCGCGAACTGGCTGGACTATTGGGGACAGGGTACTACGGTTACCGTCAGCAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACTCAGAGCCCATCCTCACTTTCCGCATCCGTGGGTGATAGGGTAACCATTACCTGTTCAGTCTCTAGTTCTGTCTCCAGTATTTACCTGCACTGGTACCAGCAGAAACCTGGCAAGGCCCCAAAGTTGCTGATCTATAGCACCAGCAACCTCGCTTCTGGCGTTCCCAGTCGCTTCAGCGGCTCAGGGTCCGGAACAGATTTCACACTCACTATATCTAGCCTGCAACCCGAGGACTTTGCCACGTACTATTGCCAAGTGTACTCAGGGTATCCTCTGACATTTGGAGGTGGGACCAAGGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSLSASVGDRVTITCSVS--SSVSS-----IYLHWYQQKPGKAPKLLIYS--------TSNLASGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQVYSG-----------------------YPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTD-----YYMHWVRQAPGQGLEWMGRVNPN---RRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANW------------------------LDYWGQGTTVTVSS
-GDPa1-073,enavatuzumab,257.51,98.83,96.765,2.74,2.79,3.26,0.0,0.0,-0.25,-0.5,61.3,71.22,83.71000000000001,IgG1,Kappa,Phase-I,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTGTTGAAAGCGGCGGGGGCCTGGTCCAGCCCGGAGGAAGCTTGCGACTTTCTTGCGCGGCATCCGGCTTCACGTTCAGTTCCTACTGGATGTCTTGGGTGAGACAGGCACCTGGTAAAGGACTGGAGTGGGTGGCTGAAATTAGGCTCAAGTCAGACAACTATGCCACCCACTACGCCGAGAGCGTCAAAGGTCGGTTTACAATCTCACGCGATGATTCCAAGAACTCTTTGTACCTCCAAATGAATTCCCTGAGAGCCGAAGATACTGCTGTATACTATTGTACAGGGTATTACGCTGACGCCATGGACTATTGGGGCCAGGGGACCCTGGTTACTGTGAGTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGAGCCCCAGTTCCCTCAGCGCATCTGTAGGCGATAGGGTTACGATCACCTGCAGAGCTAGCCAGAGTGTCAGCACCTCTTCATATTCCTACATGCACTGGTATCAGCAAAAACCTGGAAAAGCCCCTAAGTTGCTGATCAAGTACGCCTCTAACCTGGAATCCGGCGTGCCAAGCCGGTTTAGTGGGTCAGGTTCAGGCACTGACTTTACTCTTACCATCTCCTCTCTGCAACCAGAAGACTTCGCGACATATTACTGTCAGCATTCCTGGGAGATACCCTACACCTTCGGAGGGGGTACAAAAGTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,0,DIQMTQSPSSLSASVGDRVTITCRAS--QSVSTS--SYSYMHWYQQKPGKAPKLLIKY--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQHSWE-----------------------IPYTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YWMSWVRQAPGKGLEWVAEIRLKS-DNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYAD----------------------AMDYWGQGTLVTVSS
-GDPa1-074,enokizumab,180.76,99.87,98.59,2.995,3.5700000000000003,,0.33,0.03,0.8700000000000001,1.625,60.015,71.675,80.655,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGGTTCAATCCGGGGCCGAGGTGAAAAAGCCCGGGTCCAGTGTCAAGGTGTCCTGCAAAGCGAGCGGTGGAACGTTTAGCTACTATTGGATTGAGTGGGTGAGACAGGCACCGGGCCAGGGATTGGAGTGGATGGGTGAGATACTCCCTGGCTCAGGAACCACTAATCCAAACGAAAAATTCAAGGGCAGGGTTACAATCACAGCCGACGAGAGCACCAGCACCGCTTATATGGAACTGAGTTCTCTTCGCTCAGAAGACACCGCTGTCTACTACTGTGCCCGGGCAGATTATTACGGCTCTGACTACGTAAAGTTCGATTATTGGGGCCAGGGGACACTGGTGACTGTCTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAAATGACCCAGTCACCAAGCAGTCTGTCCGCTAGTGTAGGCGACAGAGTTACCATCACTTGCAAAGCCTCCCAGCATGTCATTACACACGTGACTTGGTATCAGCAGAAGCCAGGAAAGGCCCCCAAGCTCCTTATTTACGGGACTTCCTATTCTTATAGCGGTGTGCCCTCCAGGTTCTCTGGATCAGGCAGCGGGACAGACTTTACACTGACAATCTCTAGCTTGCAACCTGAAGATTTCGCAACCTACTACTGTCAGCAGTTTTATGAGTACCCTCTGACGTTCGGCGGTGGGACCAAAGTGGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,1,DIQMTQSPSSLSASVGDRVTITCKAS--QHVI------THVTWYQQKPGKAPKLLIYG--------TSYSYSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQFYE-----------------------YPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSY-----YWIEWVRQAPGQGLEWMGEILPG---SGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGS-----------------DYVKFDYWGQGTLVTVSS
-GDPa1-075,epratuzumab,491.08,94.52,97.045,2.6950000000000003,2.545,4.01,0.55,0.29,0.5,7.875,60.26,68.545,83.705,IgG1,Kappa,Phase-III,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTTGTGCAGAGCGGCGCCGAGGTGAAGAAACCAGGCTCCAGCGTAAAAGTGAGTTGCAAGGCCTCAGGCTATACATTCACAAGTTATTGGCTGCACTGGGTCAGGCAGGCCCCCGGGCAAGGACTCGAATGGATCGGGTACATTAACCCTAGAAATGACTATACCGAGTACAACCAGAATTTCAAGGATAAAGCAACTATCACAGCGGACGAATCCACTAACACCGCTTACATGGAGTTGTCATCCCTGCGGTCTGAAGATACAGCATTCTACTTTTGTGCTCGACGCGACATAACCACCTTTTATTGGGGACAGGGTACTACGGTGACCGTTTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIK,MRAWIFFLLCLAGRALADIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGCTGACTCAAAGTCCTAGCTCTCTGTCAGCTTCCGTGGGGGATCGGGTCACCATGAGCTGCAAGTCCAGCCAGTCTGTGCTCTATTCCGCCAACCATAAGAATTACCTGGCGTGGTACCAGCAGAAACCAGGCAAGGCACCCAAATTGCTGATTTATTGGGCCAGTACAAGGGAATCTGGCGTTCCCTCAAGATTTTCCGGAAGCGGGAGCGGTACAGACTTTACTTTCACCATCTCCAGTCTCCAGCCGGAGGACATAGCTACATATTACTGTCACCAATACCTTTCATCTTGGACGTTCGGCGGTGGAACCAAACTTGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,1,DIQLTQSPSSLSASVGDRVTMSCKSS--QSVLYSANHKNYLAWYQQKPGKAPKLLIYW--------ASTRESGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCHQYLS------------------------SWTFGGGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFTS-----YWLHWVRQAPGQGLEWIGYINPR---NDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDI-----------------------TTFYWGQGTTVTVSS
-GDPa1-076,eptinezumab,642.34,99.655,99.675,2.755,3.6799999999999997,,0.1,0.03,0.37,3.625,60.135000000000005,70.33500000000001,83.045,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAVSGIDLSGYYMNWVRQAPGKGLEWVGVIGINGATYYASWAKGRFTISRDNSKTTVYLQMNSLRAEDTAVYFCARGDIWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAVSGIDLSGYYMNWVRQAPGKGLEWVGVIGINGATYYASWAKGRFTISRDNSKTTVYLQMNSLRAEDTAVYFCARGDIWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAACTTGTGGAAAGCGGCGGAGGTCTGGTACAGCCCGGAGGTAGTCTGAGGTTGTCATGCGCCGTTTCTGGGATTGATCTGTCCGGATACTATATGAATTGGGTGCGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTTGGCGTGATTGGGATAAACGGGGCCACTTACTATGCGAGCTGGGCTAAAGGCAGATTCACCATCTCTCGGGACAATTCAAAGACAACGGTGTATTTGCAGATGAACAGCCTCAGGGCTGAGGATACTGCAGTCTACTTTTGTGCACGCGGAGACATCTGGGGTCAGGGGACACTGGTGACCGTCTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QVLTQSPSSLSASVGDRVTINCQASQSVYHNTYLAWYQQKPGKVPKQLIYDASTLASGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLGSYDCTNGDCFVFGGGTKVEIK,MRAWIFFLLCLAGRALAQVLTQSPSSLSASVGDRVTINCQASQSVYHNTYLAWYQQKPGKVPKQLIYDASTLASGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLGSYDCTNGDCFVFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCTGACCCAGAGCCCCAGCTCCCTCAGTGCTTCCGTTGGAGACAGGGTCACGATAAACTGCCAAGCCAGTCAGAGCGTATATCACAACACCTACCTGGCATGGTACCAGCAGAAACCAGGAAAGGTGCCCAAACAGCTGATCTACGATGCTTCTACCCTGGCGTCAGGGGTTCCGTCCCGGTTCTCAGGGAGTGGATCTGGCACTGATTTTACACTCACTATTTCCTCTTTGCAACCTGAGGACGTGGCCACCTACTATTGTCTTGGCAGCTATGACTGCACAAATGGGGATTGTTTCGTGTTTGGTGGCGGTACAAAGGTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,-QVLTQSPSSLSASVGDRVTINCQAS--QSVYH----NTYLAWYQQKPGKVPKQLIYD--------ASTLASGVPSRFSGSGSG--TDFTLTISSLQPEDVATYYCLGSYDCT-------------------NGDCFVFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAVSG-IDLSG-----YYMNWVRQAPGKGLEWVGVIGI----NGATYYASWAKGRFTISRDNSKTTVYLQMNSLRAEDTAVYFCARG---------------------------DIWGQGTLVTVSS
-GDPa1-077,erenumab,376.03,99.75,97.96000000000001,3.2300000000000004,2.825,4.19,0.24,0.12,4.87,14.875,59.91,70.29,75.045,IgG2,Lambda,Approved,NFD,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTCGTCGAGAGCGGCGGCGGTGTGGTGCAACCTGGACGGTCACTGCGCCTTAGTTGCGCCGCTTCCGGGTTTACATTCTCATCCTTTGGAATGCATTGGGTAAGGCAGGCACCCGGGAAAGGGCTGGAATGGGTAGCCGTGATAAGTTTCGATGGCAGTATCAAGTATTCTGTGGATTCCGTCAAAGGCAGGTTTACTATTAGCCGGGACAATTCAAAGAACACGCTGTTCTTGCAGATGAACAGCCTGAGAGCGGAGGACACAGCAGTTTACTACTGTGCTAGAGACCGACTCAATTATTATGATTCCAGCGGGTACTACCACTACAAGTATTACGGCATGGCCGTTTGGGGTCAGGGAACCACCGTCACTGTGTCTTCTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCAGTCTTGACTCAGCCCCCTAGCGTATCTGCCGCCCCAGGCCAAAAGGTGACAATCTCATGCTCCGGCTCCTCCAGCAACATTGGGAATAACTATGTTAGTTGGTACCAACAGTTGCCAGGTACCGCTCCGAAGCTTCTCATTTACGACAATAACAAAAGACCTTCTGGAATACCCGACAGGTTTTCCGGCTCAAAGAGTGGGACCAGCACGACACTCGGCATCACTGGGCTGCAGACAGGCGACGAGGCGGATTATTACTGTGGTACCTGGGATAGCCGGCTGTCTGCAGTCGTGTTCGGGGGAGGAACTAAACTGACCGTGCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,2,3,QSVLTQP-PSVSAAPGQKVTISCSGSS-SNIGN-----NYVSWYQQLPGTAPKLLIYD--------NNKRPSGIPDRFSGSKSG--TSTTLGITGLQTGDEADYYCGTWDSR---------------------LSAVVFGGGTKLTVL-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----FGMHWVRQAPGKGLEWVAVISFD---GSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSG---------YYHYKYYGMAVWGQGTTVTVSS
-GDPa1-078,etaracizumab,213.95,96.975,97.03,2.715,2.4850000000000003,,0.14,0.11,4.87,20.0,60.53,71.36,84.14,IgG1,Kappa,Phase-II,Discontinued,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTACAGCTGGTGGAATCTGGGGGCGGGGTCGTTCAGCCTGGAAGATCACTGCGGCTGTCCTGTGCTGCCAGTGGCTTTACTTTTAGCTCCTATGATATGTCCTGGGTCCGACAGGCTCCCGGGAAGGGTTTGGAGTGGGTCGCAAAAGTGTCTTCTGGCGGCGGGAGTACTTACTATCTGGATACCGTGCAGGGACGCTTCACGATCAGTAGGGACAATAGCAAGAACACACTTTATCTTCAAATGAACTCACTCAGGGCGGAGGACACCGCCGTGTACTACTGCGCAAGACACCTCCATGGAAGCTTCGCCTCATGGGGTCAGGGCACAACCGTTACAGTGAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGTTGACTCAGTCTCCTGCCACGCTTTCCCTCTCACCGGGCGAAAGGGCTACCCTTTCTTGTCAGGCAAGCCAGAGCATCAGCAACTTCCTGCACTGGTATCAACAGAGACCCGGTCAGGCGCCACGGCTCTTGATTCGCTACCGATCCCAATCAATCTCAGGGATTCCAGCCAGGTTCAGTGGATCCGGGTCCGGGACCGATTTCACCCTGACAATAAGTTCTCTGGAGCCTGAGGACTTTGCTGTTTATTACTGCCAGCAGAGCGGTAGTTGGCCCCTGACTTTTGGCGGCGGAACAAAAGTCGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPATLSLSPGERATLSCQAS--QSIS------NFLHWYQQRPGQAPRLLIRY--------RSQSISGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQSGS-----------------------WPLTFGGGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YDMSWVRQAPGKGLEWVAKVSSG---GGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHG----------------------SFASWGQGTTVTVSS
-GDPa1-079,etrolizumab,296.49,94.315,98.85,2.725,2.585,3.7649999999999997,0.27,0.01,0.62,1.375,59.9,71.07,82.06,IgG1,Kappa,Phase-III,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAACTCGTAGAAAGTGGAGGGGGCCTGGTCCAGCCAGGTGGCTCCCTGCGACTGAGTTGCGCAGCCTCAGGCTTCTTTATAACAAACAACTATTGGGGGTGGGTGCGCCAGGCCCCTGGCAAGGGCTTGGAGTGGGTGGGGTATATCAGCTACTCTGGTAGCACCTCATATAATCCCTCCCTTAAGAGTAGGTTCACTATTTCAAGAGACACCAGCAAAAACACTTTTTACCTCCAGATGAATTCCCTTCGGGCGGAAGACACAGCTGTGTACTACTGTGCTAGAACGGGGAGCTCTGGATATTTCGATTTTTGGGGACAGGGCACCCTGGTCACAGTGTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACCCAGTCCCCAAGCTCACTGTCCGCGAGTGTCGGCGACAGAGTTACCATTACCTGCAGGGCTTCCGAAAGCGTGGATGACCTGCTGCACTGGTACCAGCAAAAGCCCGGAAAAGCCCCAAAGCTCCTGATCAAATACGCCTCACAGAGCATATCCGGCGTACCTTCTCGGTTCTCTGGGAGCGGAAGTGGGACAGATTTTACTCTTACAATCAGTTCATTGCAACCCGAGGATTTTGCAACGTATTATTGTCAGCAGGGCAATTCTCTCCCTAACACTTTCGGTCAGGGTACAAAGGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQMTQSPSSLSASVGDRVTITCRAS--ESVD------DLLHWYQQKPGKAPKLLIKY--------ASQSISGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQGNS-----------------------LPNTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FFITN-----NYWGWVRQAPGKGLEWVGYISY----SGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSS---------------------GYFDFWGQGTLVTVSS
-GDPa1-080,evinacumab,212.57,99.805,93.15,2.76,2.6900000000000004,,0.01,0.1,3.0,1.5,59.33,70.19,,IgG4,Kappa,Approved,Active,EVQLVESGGGVIQPGGSLRLSCAASGFTFDDYAMNWVRQGPGKGLEWVSAISGDGGSTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAFFYCAKDLRNTIFGVVIPDAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGVIQPGGSLRLSCAASGFTFDDYAMNWVRQGPGKGLEWVSAISGDGGSTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAFFYCAKDLRNTIFGVVIPDAFDIWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGTTGGTGGAGTCCGGGGGTGGTGTGATCCAGCCCGGCGGCTCACTGAGACTGTCTTGCGCCGCCTCCGGTTTCACGTTCGACGATTACGCTATGAACTGGGTGAGGCAGGGGCCAGGAAAGGGACTCGAATGGGTCTCTGCTATCAGTGGAGATGGCGGGAGCACTTATTATGCCGACTCTGTCAAAGGAAGGTTCACCATATCCCGAGACAATAGCAAGAACAGCCTTTACCTCCAAATGAACAGTCTGCGGGCAGAAGATACAGCGTTTTTCTACTGTGCCAAAGACCTGCGCAATACTATTTTTGGGGTGGTGATCCCTGACGCATTTGATATTTGGGGCCAGGGCACAATGGTTACCGTATCAAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACCCAGTCACCCTCAACACTCTCAGCGTCCGTCGGTGACAGGGTTACCATCACTTGCCGCGCCTCCCAGTCTATTAGAAGCTGGCTGGCATGGTATCAGCAAAAACCTGGCAAAGCTCCCAAGCTGCTTATCTATAAGGCTTCCTCTTTGGAGAGTGGGGTGCCGTCTCGGTTTTCTGGAAGCGGCAGCGGAACTGAGTTTACACTGACAATTAGTAGTCTCCAACCAGATGATTTCGCCACCTACTACTGTCAGCAGTACAACTCCTACAGCTATACGTTCGGCCAGGGGACCAAGCTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,1,DIQMTQSPSTLSASVGDRVTITCRAS--QSIR------SWLAWYQQKPGKAPKLLIYK--------ASSLESGVPSRFSGSGSG--TEFTLTISSLQPDDFATYYCQQYNS-----------------------YSYTFGQGTKLEIK-,EVQLVES-GGGVIQPGGSLRLSCAASG-FTFDD-----YAMNWVRQGPGKGLEWVSAISGD---GGSTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAFFYCAKDLRNTIFG-------------VVIPDAFDIWGQGTMVTVSS
-GDPa1-081,evolocumab,395.76,98.455,97.88499999999999,2.815,2.8600000000000003,,0.1,0.1,2.0,1.625,58.155,67.485,79.845,IgG2,Lambda,Approved,Active,EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGCTGGTCCAATCCGGAGCCGAGGTTAAGAAACCTGGGGCCTCAGTAAAGGTGTCATGCAAGGCCAGTGGTTACACTCTGACATCCTATGGCATCTCTTGGGTGCGCCAGGCTCCCGGCCAAGGTCTTGAATGGATGGGATGGGTGTCTTTCTACAACGGAAATACCAACTATGCACAGAAACTGCAGGGCAGAGGGACAATGACTACAGACCCATCCACTAGCACCGCATATATGGAACTCCGGAGTTTGCGAAGCGATGACACCGCGGTGTACTACTGTGCTAGGGGCTATGGCATGGATGTGTGGGGGCAGGGGACGACCGTCACAGTTTCTAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL,MRAWIFFLLCLAGRALAESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGTCTGCCCTCACCCAGCCAGCTAGCGTGAGTGGGTCACCCGGTCAGTCCATCACAATAAGTTGTACCGGCACATCCTCAGACGTTGGCGGTTATAATTCCGTGTCCTGGTATCAACAGCACCCCGGCAAGGCACCTAAACTTATGATCTACGAGGTCTCTAACAGGCCGTCCGGGGTGAGCAATAGATTCTCTGGAAGCAAGTCTGGCAACACAGCGAGTTTGACCATTTCAGGCCTGCAGGCCGAAGATGAAGCTGACTATTACTGCAACTCATACACTAGCACCAGCATGGTATTTGGAGGGGGAACGAAACTGACTGTCCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,3,3,ESALTQP-ASVSGSPGQSITISCTGTS-SDVGG----YNSVSWYQQHPGKAPKLMIYE--------VSNRPSGVSNRFSGSKSG--NTASLTISGLQAEDEADYYCNSYTS-----------------------TSMVFGGGTKLTVL-,EVQLVQS-GAEVKKPGASVKVSCKASG-YTLTS-----YGISWVRQAPGQGLEWMGWVSFY---NGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYG------------------------MDVWGQGTTVTVSS
-GDPa1-082,farletuzumab,464.78,98.195,98.17500000000001,2.8099999999999996,2.66,3.65,0.0,0.0,1.12,-0.875,59.405,71.255,79.97,IgG1,Kappa,Phase-III,Discontinued,EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGCTCGTGGAAAGCGGCGGTGGTGTGGTTCAGCCTGGAAGATCACTCCGACTGAGCTGCTCTGCTTCCGGCTTCACATTCTCTGGGTACGGATTGAGTTGGGTGAGGCAGGCACCGGGAAAAGGGCTGGAGTGGGTCGCCATGATCTCCAGTGGCGGCTCCTATACTTATTACGCCGATAGCGTCAAGGGTAGATTTGCTATTTCCCGGGATAACGCCAAGAATACCCTGTTTCTTCAAATGGATTCACTGAGGCCCGAGGACACGGGCGTATATTTTTGTGCCCGCCACGGAGACGACCCCGCATGGTTCGCGTACTGGGGGCAGGGGACACCAGTGACCGTGAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGTTGACGCAATCTCCGTCATCTCTTTCCGCTTCTGTGGGCGATAGAGTGACTATCACTTGCTCCGTCAGCTCCTCTATTAGCAGCAACAACCTCCACTGGTACCAGCAAAAACCCGGAAAGGCACCAAAACCATGGATTTATGGGACAAGTAATCTGGCCAGTGGTGTACCCTCAAGGTTCTCCGGGTCAGGCAGCGGTACAGATTATACCTTCACCATATCCTCACTGCAGCCTGAAGACATTGCCACATATTACTGTCAGCAGTGGAGTAGCTACCCTTACATGTATACCTTTGGACAGGGCACCAAGGTTGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,1,DIQLTQSPSSLSASVGDRVTITCSVS--SSISS-----NNLHWYQQKPGKAPKPWIYG--------TSNLASGVPSRFSGSGSG--TDYTFTISSLQPEDIATYYCQQWSSY---------------------PYMYTFGQGTKVEIK-,EVQLVES-GGGVVQPGRSLRLSCSASG-FTFSG-----YGLSWVRQAPGKGLEWVAMISSG---GSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDP--------------------AWFAYWGQGTPVTVSS
-GDPa1-083,fasinumab,88.48,98.075,88.34,2.715,2.7699999999999996,1.505,,,0.37000000000000005,0.125,55.25,69.44,76.83,IgG4,Kappa,Phase-III,Discontinued,QVQLVQSGAEVKKPGASVKVSCKVSGFTLTELSIHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCSTIFGVVTNFDNWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKVSGFTLTELSIHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCSTIFGVVTNFDNWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTCGTGCAGAGTGGTGCCGAGGTAAAGAAACCCGGAGCCTCCGTCAAGGTCAGTTGTAAAGTCTCTGGCTTCACTTTGACAGAGCTGTCAATACACTGGGTTAGACAAGCGCCAGGCAAGGGTCTCGAGTGGATGGGCGGATTCGATCCTGAGGACGGCGAAACCATTTACGCACAGAAATTTCAGGGGAGGGTGACAATGACGGAAGACACTAGCACAGATACCGCTTATATGGAGCTGACTTCCCTTCGGAGCGAAGACACCGCTGTGTATTACTGCTCAACCATCTTTGGGGTGGTAACGAACTTCGATAATTGGGGACAGGGGACACTGGTGACCGTTTCTAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASAGDRVTITCRASQAIRNDLGWYQQKPGKAPKRLIYAAFNLQSGVPSRFSGSGSGTEFTLTISSLQPEDLASYYCQQYNRYPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASAGDRVTITCRASQAIRNDLGWYQQKPGKAPKRLIYAAFNLQSGVPSRFSGSGSGTEFTLTISSLQPEDLASYYCQQYNRYPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAAATGACCCAGTCACCCAGCTCCCTCAGCGCTTCTGCCGGCGACAGGGTCACAATCACATGCCGAGCATCTCAGGCCATTAGAAATGATCTCGGATGGTACCAGCAGAAACCTGGAAAGGCACCTAAGCGGTTGATCTATGCCGCTTTTAACCTGCAATCTGGCGTTCCAAGCCGCTTCAGTGGGTCCGGGAGTGGCACCGAATTTACGCTTACCATCAGCTCCCTGCAACCAGAGGATCTGGCGTCATATTACTGTCAGCAGTACAACAGGTATCCCTGGACTTTCGGTCAGGGTACTAAGGTGGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,0,DIQMTQSPSSLSASAGDRVTITCRAS--QAIR------NDLGWYQQKPGKAPKRLIYA--------AFNLQSGVPSRFSGSGSG--TEFTLTISSLQPEDLASYYCQQYNR-----------------------YPWTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKVSG-FTLTE-----LSIHWVRQAPGKGLEWMGGFDPE---DGETIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCSTIFGVV--------------------TNFDNWGQGTLVTVSS
-GDPa1-084,fezakinumab,251.19,99.88,96.035,3.6500000000000004,3.3049999999999997,,0.3,0.11,1.75,6.0,61.58,69.595,80.33,IgG1,Lambda,Phase-I,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWVGWINPYTGSAFYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREPEKFDSDDSDVWGRGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWVGWINPYTGSAFYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREPEKFDSDDSDVWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTGCAGTCTGGCGCGGAGGTGAAGAAACCGGGAGCCAGCGTCAAGGTGTCATGTAAGGCTAGCGGGTACACATTCACCAACTATTACATGCACTGGGTGCGACAGGCCCCCGGGCAGGGCCTGGAATGGGTTGGATGGATCAATCCTTACACTGGTTCTGCCTTTTATGCTCAAAAATTTAGGGGCCGGGTTACAATGACCAGGGACACCTCCATTAGCACGGCATATATGGAGTTGTCACGCCTTCGGTCTGATGACACCGCAGTCTATTACTGCGCCAGAGAGCCAGAAAAATTCGACAGTGACGATTCCGATGTATGGGGGAGAGGTACACTCGTGACTGTGTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QAVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGDSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDNSLSGYVFGGGTQLTVL,MRAWIFFLLCLAGRALAQAVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGDSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDNSLSGYVFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGCCGTGCTTACTCAGCCACCAAGCGTGAGCGGGGCACCCGGCCAGAGAGTCACCATTTCTTGTACAGGAAGCTCAAGCAATATAGGAGCCGGCTACGGTGTTCACTGGTACCAGCAGCTGCCCGGTACTGCGCCTAAACTGCTGATCTATGGGGACAGTAACCGGCCTTCAGGGGTGCCGGACAGGTTCAGTGGGTCCAAGTCTGGTACGTCCGCATCCTTGGCTATCACCGGACTCCAAGCCGAGGACGAAGCTGATTACTATTGCCAGTCTTACGATAACTCACTCTCCGGATATGTCTTTGGCGGCGGCACACAGTTGACCGTACTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,1,4,QAVLTQP-PSVSGAPGQRVTISCTGSS-SNIGA----GYGVHWYQQLPGTAPKLLIYG--------DSNRPSGVPDRFSGSKSG--TSASLAITGLQAEDEADYYCQSYDNS---------------------LSGYVFGGGTQLTVL-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTN-----YYMHWVRQAPGQGLEWVGWINPY---TGSAFYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREPEKFD------------------SDDSDVWGRGTLVTVSS
-GDPa1-085,ficlatuzumab,313.39,99.495,97.73500000000001,2.755,2.62,3.7,0.0,0.0,2.0,0.625,61.260000000000005,70.63,82.16,IgG1,Kappa,Phase-III,Active,QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS,MRAWIFFLLCLAGRALAQVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTGCAGCCTGGGGCTGAAGTCAAGAAACCGGGCACCTCCGTTAAACTGAGCTGTAAAGCTAGTGGCTACACATTCACAACATATTGGATGCACTGGGTCAGACAGGCGCCCGGCCAGGGGCTCGAGTGGATAGGTGAGATTAACCCAACAAATGGGCATACCAACTACAACCAGAAGTTCCAGGGTCGCGCAACCCTGACCGTGGACAAGAGTACTAGCACGGCCTACATGGAGCTTTCTTCACTGCGGAGCGAAGATACTGCCGTTTATTACTGCGCCAGGAATTATGTAGGATCTATCTTTGACTATTGGGGACAAGGAACCTTGCTCACTGTGTCATCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTGTAATGACACAATCCCCGGATAGCCTGGCTATGAGCCTGGGCGAGAGAGTTACCCTTAACTGCAAAGCCTCCGAAAATGTGGTCTCTTACGTCTCATGGTACCAGCAGAAGCCTGGGCAGTCTCCAAAGTTGCTCATCTATGGCGCGTCAAATAGGGAGAGTGGCGTGCCCGATCGGTTCAGTGGATCCGGATCTGCCACAGACTTTACCCTGACGATCTCCAGCGTGCAGGCAGAAGATGTGGCTGACTACCACTGTGGCCAGAGCTATAACTATCCCTACACTTTCGGTCAAGGGACTAAACTCGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,4,DIVMTQSPDSLAMSLGERVTLNCKAS--ENVV------SYVSWYQQKPGQSPKLLIYG--------ASNRESGVPDRFSGSGSA--TDFTLTISSVQAEDVADYHCGQSYN-----------------------YPYTFGQGTKLEIK-,QVQLVQP-GAEVKKPGTSVKLSCKASG-YTFTT-----YWMHWVRQAPGQGLEWIGEINPT---NGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVG---------------------SIFDYWGQGTLLTVSS
-GDPa1-086,figitumumab,571.63,74.145,99.52000000000001,3.0700000000000003,2.99,,0.0,0.01,14.75,20.375,61.120000000000005,70.21000000000001,80.62,IgG2,Kappa,Phase-I,Discontinued,EVQLLESGGGLVQPGGSLRLSCTASGFTFSSYAMNWVRQAPGKGLEWVSAISGSGGTTFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSYYYYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCTASGFTFSSYAMNWVRQAPGKGLEWVSAISGSGGTTFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSYYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTCTGGAGTCCGGCGGCGGACTTGTTCAGCCCGGAGGGTCACTGAGGCTCTCCTGTACCGCCTCTGGGTTTACATTTAGTAGCTATGCAATGAACTGGGTAAGACAGGCTCCTGGCAAAGGGCTGGAATGGGTTAGCGCCATTTCCGGATCAGGTGGCACTACCTTCTACGCGGACAGCGTCAAGGGTAGGTTCACCATCTCTCGAGATAATTCTCGCACTACTTTGTACCTGCAAATGAACAGTTTGCGGGCCGAAGACACCGCTGTGTATTACTGCGCAAAGGATCTCGGGTGGAGCGACTCCTATTATTACTACTACGGAATGGATGTGTGGGGTCAGGGCACAACAGTGACGGTCAGTTCAGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQFPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASRLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPCSFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQFPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASRLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPCSFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACGCAGTTCCCCTCCTCACTGAGTGCATCCGTTGGCGACCGAGTCACTATAACCTGCAGGGCTTCTCAGGGGATCCGCAACGATCTGGGATGGTACCAGCAAAAGCCAGGCAAAGCTCCTAAAAGACTTATTTATGCGGCCTCTAGGCTGCATCGGGGTGTGCCTAGTCGGTTTTCAGGCAGCGGGTCAGGAACAGAGTTTACTCTCACCATTTCTAGCTTGCAACCCGAGGATTTCGCCACCTACTACTGCCTCCAGCACAATAGCTATCCATGTTCCTTCGGTCAGGGGACAAAGCTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,2,DIQMTQFPSSLSASVGDRVTITCRAS--QGIR------NDLGWYQQKPGKAPKRLIYA--------ASRLHRGVPSRFSGSGSG--TEFTLTISSLQPEDFATYYCLQHNS-----------------------YPCSFGQGTKLEIK-,EVQLLES-GGGLVQPGGSLRLSCTASG-FTFSS-----YAMNWVRQAPGKGLEWVSAISGS---GGTTFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSY--------------YYYYGMDVWGQGTTVTVSS
-GDPa1-087,fletikumab,154.29,99.275,91.785,2.785,3.05,,0.1,0.1,3.0,0.5,56.35,71.33500000000001,,IgG4,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAACTCGTTCAGAGCGGCGCAGAAGTGAAGAGACCTGGAGCCAGCGTCAAGGTGTCCTGCAAAGCCTCCGGATATACTTTCACAAACGACATTATACATTGGGTCCGGCAGGCCCCAGGCCAGCGACTGGAGTGGATGGGGTGGATTAATGCCGGCTATGGTAACACCCAATACAGTCAGAATTTCCAGGATAGAGTGTCTATCACAAGGGATACCTCAGCTTCTACTGCATACATGGAGTTGATCAGCCTTCGCTCAGAAGACACGGCGGTTTATTACTGTGCTAGGGAGCCGCTGTGGTTTGGTGAATCAAGTCCCCACGATTATTACGGAATGGACGTGTGGGGGCAGGGGACCACAGTGACCGTCTCTTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAAIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCGATACAGCTGACACAAAGCCCTTCTTCACTTTCCGCCAGCGTGGGTGATCGGGTTACAATCACTTGTAGGGCATCCCAGGGCATTAGCTCTGCCCTGGCTTGGTACCAGCAGAAGCCTGGCAAGGCCCCCAAATTGCTGATCTACGACGCAAGTAGTCTGGAGTCCGGGGTGCCATCAAGATTCTCAGGATCTGGTAGCGGAACCGATTTTACTCTCACCATTAGTTCTCTCCAACCAGAGGACTTCGCTACATATTATTGCCAGCAGTTCAACTCCTACCCCCTTACGTTTGGGGGCGGGACCAAAGTCGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,3,0,AIQLTQSPSSLSASVGDRVTITCRAS--QGIS------SALAWYQQKPGKAPKLLIYD--------ASSLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQFNS-----------------------YPLTFGGGTKVEIK-,QVQLVQS-GAEVKRPGASVKVSCKASG-YTFTN-----DIIHWVRQAPGQRLEWMGWINAG---YGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESS------------PHDYYGMDVWGQGTTVTVSS
-GDPa1-088,foralumab,253.14,99.27000000000001,98.51,2.7199999999999998,2.5549999999999997,,,,2.0,20.5,60.595,70.32,83.695,IgG1,Kappa,Phase-II,Active,QVQLVESGGGVVQPGRSLRLSCAASGFKFSGYGMHWVRQAPGKGLEWVAVIWYDGSKKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGYWHFDLWGRGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFKFSGYGMHWVRQAPGKGLEWVAVIWYDGSKKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGYWHFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTCGAGAGCGGTGGGGGCGTCGTACAGCCCGGCAGGTCCCTGCGACTTTCTTGTGCCGCCTCAGGCTTTAAGTTCAGCGGTTACGGAATGCATTGGGTGAGACAAGCTCCTGGCAAAGGATTGGAATGGGTGGCAGTGATCTGGTATGATGGAAGCAAAAAATATTATGTGGACTCCGTTAAGGGGCGGTTTACCATTAGTAGAGACAATTCTAAGAACACGCTCTATCTGCAGATGAACTCCCTGCGCGCCGAGGATACAGCGGTGTACTACTGCGCTAGGCAAATGGGCTACTGGCACTTCGACCTCTGGGGGCGGGGGACCTTGGTCACTGTTTCAAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTCCTTACACAATCACCTGCCACGTTGTCTTTGTCCCCCGGGGAACGAGCCACTCTTTCTTGCCGCGCTAGTCAGTCAGTTTCCAGTTACCTGGCTTGGTATCAGCAGAAGCCTGGACAGGCGCCCAGACTCCTGATTTATGATGCCTCTAACCGGGCCACCGGCATCCCCGCAAGGTTCAGCGGTAGCGGAAGCGGGACTGACTTTACACTGACAATCTCCAGCCTCGAGCCAGAGGACTTTGCAGTGTACTACTGTCAGCAAAGGTCCAATTGGCCGCCACTGACCTTCGGTGGCGGCACCAAAGTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,2,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSNW----------------------PPLTFGGGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FKFSG-----YGMHWVRQAPGKGLEWVAVIWYD---GSKKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGY---------------------WHFDLWGRGTLVTVSS
-GDPa1-089,fremanezumab,83.83,99.53,99.86500000000001,2.87,3.585,4.375,,,1.62,1.625,59.980000000000004,70.67,79.5,IgG2,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTGGTGGAGAGTGGAGGTGGCCTCGTCCAACCTGGCGGATCACTGAGACTGAGCTGTGCAGCATCTGGGTTTACCTTCAGTAACTATTGGATATCCTGGGTGAGGCAGGCCCCCGGCAAGGGGCTGGAATGGGTGGCTGAAATCAGATCTGAGTCCGATGCCAGCGCCACACACTACGCCGAGGCGGTAAAAGGTCGGTTTACTATCTCTCGCGATAATGCTAAGAATTCACTTTACCTGCAGATGAACAGCCTCCGAGCTGAGGACACAGCTGTCTATTACTGCTTGGCCTACTTCGACTATGGACTTGCAATTCAGAACTATTGGGGGCAAGGCACCTTGGTTACGGTTTCCAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGTTGACACAGAGCCCCGCCACACTCTCCCTGAGCCCCGGAGAGCGCGCTACCCTGTCTTGTAAAGCTAGCAAACGGGTGACCACTTACGTTAGCTGGTATCAACAGAAGCCTGGTCAGGCGCCTCGATTGCTTATCTACGGCGCAAGTAATAGGTATCTGGGAATACCAGCCAGATTCTCCGGCTCAGGCAGTGGTACAGATTTTACCCTTACGATTTCTTCCCTCGAACCGGAGGACTTCGCCGTCTATTACTGCTCTCAGTCATATAACTACCCATACACCTTTGGGCAAGGGACTAAGCTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,3,4,EIVLTQSPATLSLSPGERATLSCKAS--KRVT------TYVSWYQQKPGQAPRLLIYG--------ASNRYLGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCSQSYN-----------------------YPYTFGQGTKLEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSN-----YWISWVRQAPGKGLEWVAEIRSES-DASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYG-------------------LAIQNYWGQGTLVTVSS
-GDPa1-090,fresolimumab,139.45,99.25999999999999,89.735,2.77,3.0700000000000003,1.045,0.1,0.1,1.0,0.5,55.445,68.77,76.32,IgG4,Kappa,Phase-I,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGYTFSSNVISWVRQAPGQGLEWMGGVIPIVDIANYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLVLDAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFSSNVISWVRQAPGQGLEWMGGVIPIVDIANYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLVLDAMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTACAGTCTGGGGCCGAGGTGAAGAAGCCTGGAAGCTCAGTCAAAGTGTCATGCAAGGCATCCGGATATACATTTAGTTCCAATGTGATCAGTTGGGTACGCCAAGCCCCCGGACAGGGGCTTGAGTGGATGGGTGGCGTGATTCCAATTGTGGACATAGCGAACTATGCCCAGAGGTTCAAAGGCAGAGTTACAATCACAGCCGACGAGTCTACCAGCACTACTTATATGGAACTGAGCTCACTCCGGTCCGAAGATACCGCTGTTTACTACTGTGCTAGCACCCTGGGTCTGGTGTTGGACGCAATGGATTACTGGGGGCAGGGCACCCTCGTTACGGTCTCCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,ETVLTQSPGTLSLSPGERATLSCRASQSLGSSYLAWYQQKPGQAPRLLIYGASSRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYADSPITFGQGTRLEIK,MRAWIFFLLCLAGRALAETVLTQSPGTLSLSPGERATLSCRASQSLGSSYLAWYQQKPGQAPRLLIYGASSRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYADSPITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGACCGTGCTGACACAGTCACCCGGAACATTGAGCCTTAGTCCGGGCGAGCGGGCCACCTTGAGTTGTAGGGCCTCTCAGTCCCTGGGGAGCTCATATCTCGCTTGGTATCAGCAAAAGCCAGGTCAGGCCCCAAGACTGCTGATATACGGGGCGTCTTCTCGCGCACCCGGAATCCCTGACAGGTTCTCCGGCTCCGGTTCCGGAACTGATTTCACACTTACGATTAGCAGACTCGAACCTGAAGATTTTGCAGTCTACTATTGCCAGCAATACGCTGACAGCCCCATCACTTTTGGGCAGGGCACCCGACTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,3,ETVLTQSPGTLSLSPGERATLSCRAS--QSLGS-----SYLAWYQQKPGQAPRLLIYG--------ASSRAPGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYAD-----------------------SPITFGQGTRLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFSS-----NVISWVRQAPGQGLEWMGGVIPI---VDIANYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLV-------------------LDAMDYWGQGTLVTVSS
-GDPa1-091,fulranumab,249.63,99.4,97.34,3.0,2.5700000000000003,,0.76,0.27,3.5,12.875,63.235,73.045,,IgG2,Kappa,Phase-III,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAACTGGTCGAAAGTGGCGGAGGGCTGGTGCAGCCCGGGGGCTCTTTGAGGCTCTCTTGCGCGGCCTCAGGATTTACATTGCGCAGTTATTCTATGAATTGGGTGCGGCAGGCCCCTGGCAAAGGCCTCGAATGGGTGTCCTATATCTCCCGAAGCAGCCATACCATCTTTTACGCTGACAGCGTCAAGGGAAGATTCACTATTTCCAGGGACAACGCCAAGAACAGTCTTTACCTGCAGATGGACTCCCTTAGAGATGAGGATACCGCAATGTATTACTGTGCTCGGGTATATTCATCTGGGTGGCACGTGTCAGACTACTTCGATTACTGGGGTCAGGGCATACTGGTTACGGTTAGCAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAAIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCTATTCAGTTGACACAGTCACCCAGCAGCCTGTCAGCCAGTGTGGGCGATAGGGTGACGATTACTTGCAGAGCTTCCCAGGGTATATCTTCTGCATTGGCCTGGTACCAGCAGAAGCCCGGAAAGGCGCCTAAACTGCTCATCTACGACGCCTCCTCACTTGAGTCTGGCGTCCCATCTCGGTTTTCCGGGAGTGGCTCCGGAACAGATTTCACCCTGACCATCAGCAGCCTCCAACCTGAAGACTTCGCAACCTACTATTGTCAGCAATTTAACAGTTATCCACTGACTTTCGGAGGGGGTACAAAGGTTGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,2,AIQLTQSPSSLSASVGDRVTITCRAS--QGIS------SALAWYQQKPGKAPKLLIYD--------ASSLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQFNS-----------------------YPLTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTLRS-----YSMNWVRQAPGKGLEWVSYISRS---SHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWH----------------VSDYFDYWGQGILVTVSS
-GDPa1-092,galcanezumab,236.63,99.48,88.81,2.75,2.975,,0.95,0.88,4.87,3.5,58.465,71.275,75.95,IgG4,Kappa,Approved,NFD,QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGTTGGTACAGAGTGGAGCAGAAGTGAAAAAACCCGGCTCTTCCGTGAAGGTTAGCTGCAAGGCCTCAGGATACACTTTTGGGAACTATTGGATGCAATGGGTGCGCCAGGCACCTGGCCAGGGCCTGGAGTGGATGGGGGCCATCTACGAGGGTACCGGTAAGACAGTGTATATACAGAAGTTCGCCGATAGGGTGACCATTACCGCTGACAAATCTACATCCACCGCCTATATGGAACTGTCAAGCCTCCGGTCAGAGGATACGGCGGTGTACTACTGTGCTAGACTTTCTGACTACGTTAGCGGGTTCGGATATTGGGGCCAAGGCACAACTGTCACTGTCTCCAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACACAGAGCCCATCATCCCTCAGTGCGAGCGTTGGGGACAGAGTGACTATCACATGTAGGGCCTCTAAGGATATATCCAAGTATCTGAACTGGTACCAGCAGAAACCGGGGAAGGCACCAAAGTTGCTTATTTACTACACCAGCGGGTATCACAGCGGAGTCCCTTCTCGGTTTTCCGGATCAGGAAGTGGCACCGATTTCACTCTCACCATTTCTTCCCTGCAACCCGAAGACTTTGCTACGTACTATTGCCAGCAAGGCGATGCCCTGCCCCCTACATTCGGTGGCGGTACCAAAGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,3,0,DIQMTQSPSSLSASVGDRVTITCRAS--KDIS------KYLNWYQQKPGKAPKLLIYY--------TSGYHSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQGDA-----------------------LPPTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFGN-----YWMQWVRQAPGQGLEWMGAIYEG---TGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYV--------------------SGFGYWGQGTTVTVSS
-GDPa1-093,galiximab,179.14,98.78,98.41,3.505,3.4000000000000004,,0.19,0.06,-0.63,-0.125,62.395,72.44,,IgG1,Lambda,Phase-II,Discontinued,QVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTCCAAGAAAGCGGGCCTGGCCTGGTGAAACCATCAGAGACATTGTCTCTTACATGTGCAGTTTCCGGCGGGAGTATCTCAGGAGGATACGGATGGGGCTGGATAAGGCAACCCCCTGGCAAGGGCCTGGAGTGGATTGGTTCTTTCTACTCAAGCAGCGGGAACACTTATTACAATCCCTCCCTGAAGAGCCAGGTCACCATCTCTACTGACACCTCTAAGAACCAGTTCAGCTTGAAACTCAACAGTATGACAGCCGCTGACACCGCCGTGTACTATTGCGTTAGAGATCGGCTTTTTAGTGTGGTAGGAATGGTATATAATAATTGGTTTGATGTGTGGGGGCCAGGTGTGCTGGTCACGGTCTCCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,ESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVL,MRAWIFFLLCLAGRALAESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAATCCGCACTTACACAGCCTCCAAGCGTTAGTGGAGCTCCCGGGCAGAAAGTGACCATTTCCTGTACTGGTTCTACTAGCAATATTGGCGGTTATGATCTGCACTGGTACCAACAGCTGCCAGGCACCGCACCCAAACTCCTCATATACGATATCAACAAGCGGCCTTCTGGCATCTCCGACAGATTCAGCGGGTCAAAGTCCGGAACCGCGGCCTCTTTGGCTATCACAGGGCTGCAGACGGAGGACGAGGCCGATTACTATTGCCAGAGTTATGACAGCTCACTGAACGCCCAAGTGTTTGGAGGCGGCACAAGGCTTACCGTCTTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,2,4,ESALTQP-PSVSGAPGQKVTISCTGST-SNIGG-----YDLHWYQQLPGTAPKLLIYD--------INKRPSGISDRFSGSKSG--TAASLAITGLQTEDEADYYCQSYDSS---------------------LNAQVFGGGTRLTVL-,QVQLQES-GPGLVKPSETLSLTCAVSG-GSISG----GYGWGWIRQPPGKGLEWIGSFYSS---SGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVG-------------MVYNNWFDVWGPGVLVTVSS
-GDPa1-094,ganitumab,203.48,99.31,98.82,2.74,2.585,4.220000000000001,0.75,0.39,0.37000000000000005,4.5,61.165,70.6,85.775,IgG1,Kappa,Phase-III,Discontinued,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGRTDAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGRTDAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGCAAGAGTCCGGGCCCGGATTGGTGAAACCGAGTGGCACACTCAGCCTTACCTGTGCCGTTTCTGGCGGGAGTATCAGCAGCAGCAATTGGTGGTCCTGGGTCCGGCAGCCACCTGGCAAAGGCCTGGAGTGGATCGGAGAAATTTACCACTCAGGTAGTACAAATTATAACCCCTCCCTGAAGTCTAGGGTGACCATAAGCGTGGACAAATCTAAGAACCAGTTTTCCCTCAAGCTGTCATCCGTGACAGCTGCAGATACTGCTGTCTACTATTGCGCGCGCTGGACGGGCAGAACCGACGCCTTCGATATTTGGGGGCAAGGAACTATGGTGACCGTATCATCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTGGTGATGACACAGAGCCCACTCTCCCTTCCCGTCACTCCAGGCGAGCCGGCTAGCATATCTTGTCGCTCCTCCCAAAGCTTGCTGCACTCAAACGGCTACAACTATCTGGATTGGTATCTTCAGAAGCCTGGTCAGTCTCCCCAGCTGCTGATCTATTTGGGCAGCAATAGGGCCTCTGGAGTACCCGATAGATTCTCCGGAAGTGGGAGTGGGACCGACTTCACCCTCAAAATTTCACGGGTCGAGGCAGAAGACGTGGGAGTTTACTACTGCATGCAGGGGACGCATTGGCCTCTGACATTTGGTCAAGGCACTAAAGTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,DVVMTQSPLSLPVTPGEPASISCRSS--QSLLHSN-GYNYLDWYLQKPGQSPQLLIYL--------GSNRASGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCMQGTH-----------------------WPLTFGQGTKVEIK-,QVQLQES-GPGLVKPSGTLSLTCAVSG-GSISS----SNWWSWVRQPPGKGLEWIGEIYH----SGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGRT--------------------DAFDIWGQGTMVTVSS
-GDPa1-095,gantenerumab,313.39,70.425,99.475,2.685,2.465,5.48,0.26,0.13,0.8700000000000001,2.0,60.515,70.655,82.995,IgG1,Kappa,Phase-III,Discontinued,QVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTGAACTCGTGGAATCCGGCGGAGGGCTGGTCCAGCCAGGGGGATCCTTGAGACTTAGTTGCGCCGCTAGTGGCTTCACCTTTAGCTCCTACGCCATGTCATGGGTGCGACAGGCTCCCGGTAAGGGTTTGGAGTGGGTGTCCGCGATTAATGCAAGCGGCACCCGGACCTATTATGCTGACTCTGTCAAAGGGCGGTTTACTATCAGCCGCGACAACTCTAAGAATACGCTGTATCTGCAAATGAACAGCCTCAGGGCCGAGGATACTGCAGTGTATTACTGTGCCAGAGGAAAAGGCAACACACACAAGCCTTACGGCTACGTCAGGTACTTCGATGTGTGGGGGCAGGGAACACTGGTTACAGTATCATCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIK,MRAWIFFLLCLAGRALADIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGTTGACCCAGTCACCTGCCACACTGTCTCTGTCCCCGGGCGAGAGGGCAACACTGTCCTGCCGGGCTTCCCAATCAGTTAGCAGCTCCTATCTCGCGTGGTATCAGCAAAAGCCCGGACAGGCCCCAAGATTGCTTATTTATGGGGCCTCAAGCCGCGCAACTGGTGTGCCAGCCCGATTTAGTGGGAGTGGAAGCGGTACGGATTTCACTCTGACAATCTCTTCTCTTGAACCTGAGGACTTTGCTACCTACTACTGTCTCCAGATTTACAACATGCCCATCACCTTCGGCCAGGGCACCAAAGTCGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,2,DIVLTQSPATLSLSPGERATLSCRAS--QSVSS-----SYLAWYQQKPGQAPRLLIYG--------ASSRATGVPARFSGSGSG--TDFTLTISSLEPEDFATYYCLQIYN-----------------------MPITFGQGTKVEIK-,QVELVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YAMSWVRQAPGKGLEWVSAINAS---GTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKP-------------YGYVRYFDVWGQGTLVTVSS
-GDPa1-096,gatipotuzumab,134.81,86.91499999999999,97.00999999999999,2.615,2.54,3.69,0.0,0.03,0.0,-1.375,60.05,70.595,82.015,IgG1,Kappa,Phase-II,Active,EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGGTTGAATCCGGAGGAGGTCTGGTACAGCCTGGCGGGTCTATGAGATTGAGCTGTGTGGCTAGCGGATTCCCCTTCTCAAACTATTGGATGAATTGGGTGCGGCAAGCCCCAGGCAAAGGGCTTGAGTGGGTGGGCGAAATCCGACTTAAAAGTAACAACTACACCACACATTACGCAGAATCAGTTAAGGGCCGCTTTACTATTAGCAGGGACGATTCCAAGAATAGTCTCTACCTGCAGATGAATTCTCTCAAGACAGAGGACACGGCCGTCTATTATTGCACCAGGCACTATTACTTTGATTACTGGGGGCAGGGTACCCTGGTGACTGTCTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGTCATGACTCAGTCTCCACTCTCCAACCCCGTGACTCCTGGGGAACCCGCAAGTATCTCTTGCCGCAGCTCTAAAAGTCTGCTCCACTCCAACGGGATCACATACTTTTTCTGGTATTTGCAGAAGCCTGGCCAGTCCCCACAGCTTCTGATATACCAAATGAGCAATCTGGCCTCAGGAGTCCCTGACAGGTTCTCAGGTAGCGGAAGCGGCACCGACTTCACGCTGCGGATTTCCAGAGTTGAGGCTGAAGATGTGGGTGTATATTACTGTGCCCAAAATCTTGAGTTGCCCCCGACATTTGGCCAGGGGACCAAAGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,1,DIVMTQSPLSNPVTPGEPASISCRSS--KSLLHSN-GITYFFWYLQKPGQSPQLLIYQ--------MSNLASGVPDRFSGSGSG--TDFTLRISRVEAEDVGVYYCAQNLE-----------------------LPPTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSMRLSCVASG-FPFSN-----YWMNWVRQAPGKGLEWVGEIRLKS-NNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYY------------------------FDYWGQGTLVTVSS
-GDPa1-097,gemtuzumab,294.08,99.56,88.72999999999999,3.335,3.395,1.54,0.1,0.1,1.87,0.375,58.01,66.66499999999999,75.19,IgG4,Kappa,Approved,NFD,EVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGCTGGTTCAATCAGGTGCAGAGGTTAAAAAGCCTGGCTCCTCAGTGAAAGTCAGCTGCAAGGCCTCTGGGTACACAATCACTGATTCCAACATTCACTGGGTGAGACAGGCTCCCGGACAGTCCCTGGAGTGGATAGGGTATATCTATCCATACAACGGCGGGACTGACTATAACCAAAAATTCAAGAACAGGGCCACACTGACAGTAGATAATCCGACCAATACCGCTTACATGGAGCTTTCTAGCCTCCGGAGTGAAGACACCGCGTTTTACTACTGTGTGAATGGAAATCCCTGGCTCGCCTATTGGGGTCAGGGCACCTTGGTGACGGTGAGCAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVK,MRAWIFFLLCLAGRALADIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGCTGACTCAGAGCCCTAGCACGCTGAGCGCTTCCGTGGGTGATAGAGTCACAATCACATGTAGGGCCTCCGAATCTCTGGACAACTATGGAATTCGCTTCCTTACCTGGTTTCAACAGAAGCCCGGCAAGGCACCCAAATTGCTCATGTACGCCGCTAGCAATCAGGGCTCAGGTGTTCCTTCTCGGTTCAGTGGAAGTGGGTCCGGCACTGAGTTTACCCTCACCATATCTTCACTGCAACCAGACGACTTTGCGACCTATTACTGCCAGCAGACAAAAGAAGTGCCATGGTCCTTCGGGCAGGGGACTAAGGTAGAGGTGAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,0,DIQLTQSPSTLSASVGDRVTITCRAS--ESLDNY--GIRFLTWFQQKPGKAPKLLMYA--------ASNQGSGVPSRFSGSGSG--TEFTLTISSLQPDDFATYYCQQTKE-----------------------VPWSFGQGTKVEVK-,EVQLVQS-GAEVKKPGSSVKVSCKASG-YTITD-----SNIHWVRQAPGQSLEWIGYIYPY---NGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNP-----------------------WLAYWGQGTLVTVSS
-GDPa1-098,gevokizumab,151.52,97.83500000000001,97.81,2.715,2.4800000000000004,3.745,0.25,0.02,0.8700000000000001,1.0,,,,IgG2,Kappa,Phase-III,Active,QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTTCAGGAGAGTGGCCCAGGTCTGGTGAAGCCCTCCCAGACGCTGTCTTTGACCTGCTCATTCTCCGGGTTTAGCCTGTCTACTAGTGGAATGGGGGTGGGCTGGATTAGACAGCCATCAGGTAAAGGACTCGAATGGCTTGCACACATCTGGTGGGACGGAGACGAGAGCTACAACCCCAGCCTGAAATCTAGGCTCACCATCTCCAAAGACACAAGCAAGAATCAAGTGAGTTTGAAGATAACTTCAGTCACAGCTGCCGATACCGCCGTTTACTTCTGTGCGCGGAACCGCTATGATCCTCCTTGGTTTGTTGATTGGGGGCAGGGCACACTGGTAACCGTCTCCTCTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACCCAGTCTACCTCCTCATTGTCCGCCTCTGTTGGGGATAGAGTCACTATTACATGCAGGGCATCACAGGATATCTCTAACTACCTGAGCTGGTATCAGCAGAAACCCGGTAAGGCTGTGAAGCTTCTCATCTATTATACAAGTAAACTGCACTCCGGAGTACCAAGCCGGTTTAGCGGTTCAGGCAGTGGCACTGACTACACGTTGACCATTTCCAGCCTGCAACAGGAAGACTTCGCCACATACTTTTGTCTGCAAGGCAAAATGCTCCCTTGGACCTTCGGACAGGGGACTAAGCTTGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,1,DIQMTQSTSSLSASVGDRVTITCRAS--QDIS------NYLSWYQQKPGKAVKLLIYY--------TSKLHSGVPSRFSGSGSG--TDYTLTISSLQQEDFATYFCLQGKM-----------------------LPWTFGQGTKLEIK-,QVQLQES-GPGLVKPSQTLSLTCSFSG-FSLSTS---GMGVGWIRQPSGKGLEWLAHIWW----DGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDP--------------------PWFVDWGQGTLVTVSS
-GDPa1-099,gimsilumab,301.96,99.82,98.825,2.7199999999999998,2.545,,0.33,0.12,1.37,2.5,62.75,70.185,83.57,IgG1,Kappa,Phase-I,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMHWLRQVPGKGPVWVSRINGAGTSITYADSVRGRFTISRDNANNTLFLQMNSLRADDTALYFCARANSVWFRGLFDYWGQGTPVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMHWLRQVPGKGPVWVSRINGAGTSITYADSVRGRFTISRDNANNTLFLQMNSLRADDTALYFCARANSVWFRGLFDYWGQGTPVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGCTCGTGGAAAGTGGGGGAGGCTTGGTGCAGCCTGGCGGGTCCCTGAGGCTTTCCTGTGCCGCTAGCGGGTTCACATTCAGCAGACATTGGATGCACTGGCTTCGGCAGGTTCCCGGCAAGGGGCCGGTCTGGGTGTCACGAATTAATGGAGCCGGTACCTCTATAACTTACGCCGATAGTGTTCGCGGCCGGTTTACAATCTCACGCGACAACGCAAACAACACGTTGTTCCTGCAAATGAATTCTCTGAGAGCTGACGACACCGCGCTGTATTTTTGCGCCAGGGCAAATTCTGTGTGGTTCCGAGGTCTCTTTGATTACTGGGGACAGGGCACTCCAGTGACCGTATCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPVTLSVSPGERVTLSCRASQSVSTNLAWYQQKLGQGPRLLIYGASTRATDIPARFSGSGSETEFTLTISSLQSEDFAVYYCQQYDKWPDTFGQGTKLEIK,MRAWIFFLLCLAGRALAEIVLTQSPVTLSVSPGERVTLSCRASQSVSTNLAWYQQKLGQGPRLLIYGASTRATDIPARFSGSGSETEFTLTISSLQSEDFAVYYCQQYDKWPDTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTTACGCAGTCCCCAGTAACTCTGTCTGTGTCACCCGGCGAAAGAGTCACCTTGAGTTGCCGGGCTTCTCAGTCAGTGTCCACAAACCTCGCGTGGTACCAGCAGAAGTTGGGACAGGGCCCGCGACTCCTGATATACGGCGCCTCTACTAGGGCTACAGACATCCCCGCACGCTTCAGTGGAAGCGGGAGCGAAACCGAGTTTACACTGACCATCTCCAGCCTGCAAAGCGAGGATTTTGCCGTTTATTATTGTCAGCAGTACGACAAGTGGCCTGATACCTTCGGGCAAGGTACTAAACTTGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPVTLSVSPGERVTLSCRAS--QSVS------TNLAWYQQKLGQGPRLLIYG--------ASTRATDIPARFSGSGSE--TEFTLTISSLQSEDFAVYYCQQYDK-----------------------WPDTFGQGTKLEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSR-----HWMHWLRQVPGKGPVWVSRINGA---GTSITYADSVRGRFTISRDNANNTLFLQMNSLRADDTALYFCARANSVWF------------------RGLFDYWGQGTPVTVSS
-GDPa1-100,girentuximab,78.27,86.185,96.845,2.705,2.525,,,,-0.38,-0.5,59.370000000000005,68.65,82.82,IgG1,Kappa,Phase-III,Discontinued,DVKLVESGGGLVKLGGSLKLSCAASGFTFSNYYMSWVRQTPEKRLELVAAINSDGGITYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSGYFSMDYWGQGTSVTVSS,MRAWIFFLLCLAGRALADVKLVESGGGLVKLGGSLKLSCAASGFTFSNYYMSWVRQTPEKRLELVAAINSDGGITYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSGYFSMDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTTAAGCTCGTGGAGTCCGGGGGCGGGCTGGTGAAACTCGGCGGTAGCCTCAAACTGAGCTGTGCTGCGAGTGGTTTTACGTTCTCAAACTATTATATGTCCTGGGTGAGACAGACCCCCGAAAAGCGGTTGGAACTGGTAGCTGCCATTAATTCTGATGGAGGAATCACTTACTACCTTGATACTGTCAAAGGACGATTTACAATAAGCCGCGACAACGCCAAGAATACCTTGTATCTTCAGATGTCTAGCCTGAAGTCAGAGGACACCGCCCTGTTCTACTGCGCAAGGCACAGAAGTGGGTACTTCTCCATGGACTATTGGGGCCAAGGCACATCCGTCACAGTGTCTAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGTCATGACTCAAAGCCAGAGGTTCATGTCCACAACAGTTGGCGACCGGGTCTCAATCACCTGCAAGGCATCCCAGAATGTGGTGTCTGCCGTAGCTTGGTATCAGCAGAAGCCTGGGCAGAGTCCCAAACTGTTGATTTATAGCGCGTCAAACAGATACACCGGCGTGCCAGATCGCTTTACAGGTTCTGGATCTGGTACCGACTTCACGCTCACTATCAGCAATATGCAATCCGAGGACCTTGCCGATTTTTTCTGTCAGCAGTACAGTAACTACCCGTGGACCTTTGGCGGAGGGACTAAACTGGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,4,3,DIVMTQSQRFMSTTVGDRVSITCKAS--QNVV------SAVAWYQQKPGQSPKLLIYS--------ASNRYTGVPDRFTGSGSG--TDFTLTISNMQSEDLADFFCQQYSN-----------------------YPWTFGGGTKLEIK-,DVKLVES-GGGLVKLGGSLKLSCAASG-FTFSN-----YYMSWVRQTPEKRLELVAAINSD---GGITYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSGY--------------------FSMDYWGQGTSVTVSS
-GDPa1-101,glembatumumab,339.78,99.22,96.1,9.14,3.8,,0.18,0.1,16.87,18.375,61.120000000000005,74.015,,IgG2,Kappa,Phase-III,Discontinued,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTACAGCTGCAAGAGTCCGGCCCAGGTTTGGTCAAACCCTCACAGACTTTGAGCCTCACATGTACCGTGTCTGGGGGCAGCATCAGTAGTTTCAATTATTATTGGTCTTGGATCAGACATCACCCTGGCAAGGGTCTTGAATGGATTGGATATATATATTATAGCGGGTCCACTTACTCCAACCCGTCCCTGAAGTCAAGGGTGACTATTTCTGTGGATACCAGCAAAAATCAGTTTTCACTCACACTGTCTAGCGTTACGGCAGCTGACACAGCCGTGTACTACTGCGCCCGGGGATACAACTGGAACTACTTCGACTACTGGGGGCAGGGAACCCTGGTCACCGTTTCCAGTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTGATGACACAGAGCCCCGCTACTCTCTCAGTATCTCCAGGAGAAAGGGCCACACTGTCCTGTCGCGCCAGTCAGAGTGTCGATAATAACCTTGTGTGGTATCAGCAGAAGCCGGGCCAGGCACCACGGCTGTTGATCTACGGCGCGTCCACCAGAGCTACCGGTATTCCTGCCCGATTCTCCGGATCAGGGAGCGGTACCGAGTTTACCCTGACTATTAGCTCTCTCCAATCTGAAGACTTCGCAGTGTACTATTGCCAGCAATACAATAACTGGCCTCCCTGGACATTTGGGCAGGGCACGAAGGTTGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,1,EIVMTQSPATLSVSPGERATLSCRAS--QSVD------NNLVWYQQKPGQAPRLLIYG--------ASTRATGIPARFSGSGSG--TEFTLTISSLQSEDFAVYYCQQYNNW----------------------PPWTFGQGTKVEIK-,QVQLQES-GPGLVKPSQTLSLTCTVSG-GSISSF---NYYWSWIRHHPGKGLEWIGYIYY----SGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNW---------------------NYFDYWGQGTLVTVSS
-GDPa1-102,golimumab,296.49,96.41499999999999,99.08500000000001,3.455,3.175,,0.11,0.11,0.75,7.875,59.849999999999994,73.41,,IgG1,Kappa,Approved,Active,QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAATTGGTTGAGTCTGGTGGAGGGGTCGTGCAGCCCGGAAGAAGTCTCAGACTCTCCTGTGCCGCGAGCGGCTTCATCTTTTCTTCATATGCAATGCACTGGGTCCGCCAAGCCCCTGGGAATGGTCTGGAATGGGTCGCCTTCATGTCTTACGACGGCTCAAATAAGAAGTACGCTGATTCAGTTAAAGGAAGGTTTACCATATCCCGGGATAACTCCAAAAATACACTGTATCTGCAGATGAACAGCCTTCGGGCTGAGGACACAGCTGTGTATTACTGCGCACGAGATAGGGGCATTGCAGCCGGGGGCAACTATTACTACTACGGCATGGACGTGTGGGGGCAGGGAACGACTGTAACCGTGAGCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTTCTTACCCAGAGTCCTGCGACCCTGTCCCTGTCCCCTGGCGAGAGAGCCACTTTGTCTTGCAGGGCCTCACAATCTGTCTACTCCTACCTGGCCTGGTACCAGCAAAAACCCGGGCAGGCCCCACGGCTTCTGATCTATGATGCAAGTAACCGCGCTACCGGAATCCCGGCACGATTCAGCGGATCTGGGAGCGGCACGGATTTTACTCTCACAATTAGCAGCCTCGAGCCCGAAGACTTCGCTGTGTATTATTGTCAGCAGAGGTCAAATTGGCCACCTTTCACATTTGGTCCCGGCACAAAGGTGGACATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVY------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSNW----------------------PPFTFGPGTKVDIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FIFSS-----YAMHWVRQAPGNGLEWVAFMSYD---GSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGG-------------NYYYYGMDVWGQGTTVTVSS
-GDPa1-103,guselkumab,291.91,98.87,98.24000000000001,2.795,3.17,,0.78,0.83,4.87,13.0,62.275,72.0,83.935,IgG1,Lambda,Approved,Active,EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGGTGCAGAGCGGAGCTGAAGTGAAAAAGCCAGGAGAATCATTGAAGATCTCTTGTAAGGGTAGTGGCTACTCCTTCTCTAATTATTGGATCGGGTGGGTTAGACAAATGCCTGGCAAAGGTCTCGAGTGGATGGGGATAATTGACCCCTCCAACTCCTACACCCGGTATTCTCCGTCATTCCAGGGACAGGTCACTATCAGCGCCGATAAGAGCATTTCTACAGCTTACCTGCAGTGGAGTAGTCTGAAGGCCTCCGATACGGCAATGTATTACTGCGCGAGGTGGTACTATAAACCCTTTGACGTATGGGGGCAAGGCACCCTTGTCACAGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGAGCGTGCTGACACAGCCCCCTTCCGTGTCCGGGGCCCCAGGACAGCGGGTCACAATTTCATGCACTGGAAGCTCTAGTAATATCGGCAGCGGTTACGATGTGCACTGGTACCAACAGCTGCCTGGGACCGCACCAAAGCTTCTTATATATGGCAACTCTAAAAGGCCGTCCGGCGTGCCCGACAGATTTTCAGGGTCCAAATCTGGCACTAGCGCCAGCCTGGCTATCACCGGACTGCAATCAGAAGATGAGGCTGACTACTATTGTGCGAGTTGGACGGACGGCCTCAGTTTGGTTGTATTCGGTGGGGGAACAAAGCTCACCGTCTTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,3,4,QSVLTQP-PSVSGAPGQRVTISCTGSS-SNIGS----GYDVHWYQQLPGTAPKLLIYG--------NSKRPSGVPDRFSGSKSG--TSASLAITGLQSEDEADYYCASWTDG---------------------LSLVVFGGGTKLTVL-,EVQLVQS-GAEVKKPGESLKISCKGSG-YSFSN-----YWIGWVRQMPGKGLEWMGIIDPS---NSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYK----------------------PFDVWGQGTLVTVSS
-GDPa1-104,ianalumab,110.8,98.36,98.725,2.77,3.17,4.355,,,15.870000000000001,25.875,63.53,72.66,77.09,IgG1,Kappa,Phase-III,Active,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWGWIRQSPGRGLEWLGRIYYRSKWYNSYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARYQWVPKIGVFDSWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWGWIRQSPGRGLEWLGRIYYRSKWYNSYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARYQWVPKIGVFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTACAGCTGCAGCAGAGCGGACCCGGACTTGTCAAACCAAGTCAGACTCTTTCTCTCACATGCGCTATCTCCGGGGACTCAGTGTCCTCAAATTCCGCCGCATGGGGGTGGATTCGACAGAGTCCTGGCAGGGGTTTGGAGTGGCTGGGGCGCATCTATTACAGATCTAAGTGGTATAACAGCTACGCGGTGAGCGTGAAGTCACGGATCACCATTAATCCTGATACAAGTAAGAACCAGTTCTCTCTGCAACTCAACTCTGTCACCCCCGAAGACACCGCCGTGTACTATTGTGCTAGATACCAATGGGTTCCAAAAATAGGTGTTTTTGATAGCTGGGGCCAGGGCACTCTGGTGACGGTCTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVLTQSPATLSLSPGERATLSCRASQFILPEYLSWYQQKPGQAPRLLIYGSSSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQFYSSPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADIVLTQSPATLSLSPGERATLSCRASQFILPEYLSWYQQKPGQAPRLLIYGSSSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQFYSSPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATAGTCCTGACGCAGTCACCCGCTACCCTTTCTCTCTCTCCCGGAGAACGCGCGACACTGAGCTGTCGGGCCTCCCAGTTCATCCTGCCAGAATATCTCTCCTGGTATCAGCAAAAACCTGGTCAGGCCCCTAGACTGTTGATTTACGGATCCTCAAGTCGAGCTACAGGGGTGCCAGCAAGGTTCAGTGGCAGCGGGTCCGGTACCGACTTTACTCTGACCATTAGCTCTCTTGAGCCGGAGGACTTTGCCGTTTATTACTGCCAGCAATTCTACAGCTCACCCTTGACATTTGGCCAGGGCACTAAGGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,3,DIVLTQSPATLSLSPGERATLSCRAS--QFILP-----EYLSWYQQKPGQAPRLLIYG--------SSSRATGVPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQFYS-----------------------SPLTFGQGTKVEIK-,QVQLQQS-GPGLVKPSQTLSLTCAISG-DSVSSN---SAAWGWIRQSPGRGLEWLGRIYYR--SKWYNSYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARYQWVPK------------------IGVFDSWGQGTLVTVSS
-GDPa1-105,ibalizumab,120.09,99.63,87.49000000000001,2.925,3.01,,0.1,0.1,1.0,0.0,55.58,70.245,77.58,IgG4,Kappa,Approved,NFD,QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGCAACAGAGCGGACCCGAAGTGGTGAAACCAGGCGCCTCAGTGAAGATGTCTTGCAAGGCGTCAGGATACACATTCACAAGCTACGTCATACACTGGGTGAGACAGAAGCCGGGGCAAGGCCTGGATTGGATTGGCTATATCAACCCTTACAACGACGGTACCGATTATGACGAGAAGTTTAAGGGGAAAGCTACCCTGACCAGTGACACTTCCACATCTACCGCCTACATGGAATTGTCCTCCCTTCGGAGTGAGGATACTGCCGTATACTACTGTGCTCGCGAGAAAGACAATTATGCAACGGGTGCCTGGTTCGCATATTGGGGACAGGGGACACTCGTCACTGTTAGCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCGTGATGACCCAGTCTCCAGACAGCCTTGCTGTCTCTCTCGGGGAGAGAGTCACAATGAACTGCAAGAGCTCTCAGAGCCTGCTGTATAGTACAAATCAAAAAAACTACCTGGCATGGTATCAGCAGAAACCCGGGCAGAGCCCTAAATTGCTGATATATTGGGCCTCCACAAGGGAATCCGGTGTACCGGACCGCTTTTCAGGATCAGGTTCCGGCACCGATTTCACGCTTACTATTTCCAGTGTGCAGGCCGAGGACGTTGCGGTGTATTACTGTCAGCAATACTACTCATACCGGACCTTCGGCGGAGGCACTAAGCTCGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,4,DIVMTQSPDSLAVSLGERVTMNCKSS--QSLLYSTNQKNYLAWYQQKPGQSPKLLIYW--------ASTRESGVPDRFSGSGSG--TDFTLTISSVQAEDVAVYYCQQYYS------------------------YRTFGGGTKLEIK-,QVQLQQS-GPEVVKPGASVKMSCKASG-YTFTS-----YVIHWVRQKPGQGLDWIGYINPY---NDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYA-----------------TGAWFAYWGQGTLVTVSS
-GDPa1-106,icrucumab,46.59,99.68,95.98,6.13,3.28,,,,3.75,3.375,58.71,68.33,81.52,IgG1,Kappa,Phase-II,Discontinued,QAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGCTCAGGTAGTTGAGAGCGGCGGGGGAGTGGTACAGTCCGGGAGGAGCTTGCGACTTTCATGTGCTGCCTCTGGTTTTGCTTTCAGCTCCTACGGCATGCACTGGGTGCGCCAGGCCCCCGGCAAAGGACTCGAATGGGTGGCCGTCATCTGGTACGACGGATCTAATAAGTATTATGCCGATTCCGTGCGGGGGCGGTTCACGATTAGCAGGGATAACTCTGAAAACACTCTCTATCTGCAGATGAATAGTCTGAGAGCAGAGGATACCGCAGTCTATTACTGCGCGAGAGACCATTACGGCTCAGGGGTGCATCACTACTTTTATTACGGTCTGGACGTCTGGGGACAAGGCACAACAGTGACCGTTTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGTTGACTCAGAGCCCTGGAACGCTGTCTCTTTCCCCGGGCGAGAGGGCCACTTTGAGTTGTCGCGCATCTCAGTCCGTGTCCTCATCTTATCTGGCTTGGTACCAGCAGAAACCAGGCCAAGCGCCCAGGCTGCTTATATATGGCGCCTCAAGTCGAGCTACCGGGATTCCAGACAGATTTAGTGGCAGCGGGAGCGGCACAGATTTTACACTCACAATTTCCCGGCTCGAACCTGAGGACTTCGCCGTCTATTACTGCCAACAGTACGGAAGCTCACCCCTGACCTTCGGAGGTGGGACCAAGGTTGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,2,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----SYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------SPLTFGGGTKVEIK-,QAQVVES-GGGVVQSGRSLRLSCAASG-FAFSS-----YGMHWVRQAPGKGLEWVAVIWYD---GSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVH-------------HYFYYGLDVWGQGTTVTVSS
-GDPa1-107,imgatuzumab,301.96,98.125,93.295,2.79,2.795,3.9800000000000004,0.22,0.18,1.0,0.375,62.37,71.78,84.3,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGFTFTDYKIHWVRQAPGQGLEWMGYFNPNSGYSTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGGYYVMDAWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGFTFTDYKIHWVRQAPGQGLEWMGYFNPNSGYSTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGGYYVMDAWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAGCTCGTCCAGTCAGGCGCTGAAGTGAAGAAACCCGGGTCATCCGTGAAAGTAAGCTGCAAGGCCTCTGGTTTTACATTTACGGACTACAAAATTCACTGGGTCCGCCAGGCCCCAGGTCAGGGCCTTGAGTGGATGGGGTACTTCAATCCTAACAGTGGATATTCCACCTATGCACAAAAGTTCCAGGGCAGAGTTACCATCACTGCCGACAAGTCCACATCTACCGCCTACATGGAGCTGAGCAGTCTGAGGTCCGAAGATACAGCAGTGTATTACTGTGCTCGGTTGAGCCCGGGAGGGTACTATGTGATGGATGCGTGGGGACAGGGCACTACCGTCACTGTGTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQGINNYLNWYQQKPGKAPKRLIYNTNNLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSFPTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGINNYLNWYQQKPGKAPKRLIYNTNNLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSFPTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAAATGACCCAGTCCCCTAGCTCTCTGTCAGCCAGTGTGGGCGACAGGGTCACCATTACTTGTCGGGCATCCCAGGGAATCAATAACTACCTTAATTGGTACCAGCAGAAGCCTGGTAAGGCCCCCAAGAGACTCATTTATAATACAAACAACTTGCAGACTGGCGTTCCATCTCGCTTCAGCGGCAGTGGCTCTGGGACGGAGTTTACACTGACCATCTCCAGCCTGCAACCCGAAGACTTCGCTACCTACTATTGCCTGCAGCACAACTCATTTCCAACTTTCGGGCAGGGAACAAAACTCGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,1,DIQMTQSPSSLSASVGDRVTITCRAS--QGIN------NYLNWYQQKPGKAPKRLIYN--------TNNLQTGVPSRFSGSGSG--TEFTLTISSLQPEDFATYYCLQHNS------------------------FPTFGQGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-FTFTD-----YKIHWVRQAPGQGLEWMGYFNPN---SGYSTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGG-------------------YYVMDAWGQGTTVTVSS
-GDPa1-108,inclacumab,294.08,98.83500000000001,86.52000000000001,2.7350000000000003,2.635,,0.1,0.1,1.5,1.5,59.72,70.745,88.57,IgG4,Kappa,Phase-II,Discontinued,EVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTGGTCGAGAGTGGCGGAGGTCTGGTTCGGCCTGGCGGGAGCCTCAGGCTTTCATGCGCCGCCTCCGGCTTCACGTTTAGCAACTATGATATGCACTGGGTGCGACAGGCAACCGGCAAGGGATTGGAATGGGTGAGCGCCATCACCGCCGCTGGGGACATATACTACCCCGGTTCAGTCAAGGGAAGATTTACTATTTCTCGCGAAAATGCTAAAAACAGCCTGTATCTGCAGATGAACTCTCTTCGGGCGGGGGACACAGCAGTGTACTATTGTGCTAGGGGCAGATATTCCGGCAGTGGATCTTACTACAATGATTGGTTCGACCCATGGGGGCAAGGTACACTCGTGACTGTATCCTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGCTCACCCAGTCCCCCGCAACGCTGTCTCTGTCCCCCGGGGAGCGAGCAACTTTGTCATGCAGAGCTAGCCAGAGTGTCAGCAGCTATTTGGCCTGGTACCAACAGAAGCCAGGCCAGGCGCCTCGGCTGCTCATATACGACGCCTCCAACAGGGCCACAGGAATTCCTGCCAGGTTTTCTGGAAGTGGCTCCGGTACTGACTTCACCCTGACCATTAGCTCTCTTGAACCGGAGGATTTCGCTGTGTACTATTGTCAACAGCGCTCAAATTGGCCACTTACATTTGGTGGCGGGACAAAAGTTGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,3,3,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSN-----------------------WPLTFGGGTKVEIK-,EVQLVES-GGGLVRPGGSLRLSCAASG-FTFSN-----YDMHWVRQATGKGLEWVSAITA----AGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGS--------------YYNDWFDPWGQGTLVTVSS
-GDPa1-109,inebilizumab,110.8,97.785,84.83500000000001,2.775,2.94,,0.0,0.0,0.12,-0.625,62.58,72.225,84.31,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSWMNWVRQAPGKGLEWVGRIYPGDGDTNYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITTVRDFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSSWMNWVRQAPGKGLEWVGRIYPGDGDTNYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITTVRDFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTGGTGGAATCCGGTGGCGGACTTGTGCAGCCTGGTGGATCTTTGAGGCTGTCTTGTGCGGCATCCGGGTTTACTTTTAGTTCTTCCTGGATGAACTGGGTGAGGCAGGCTCCCGGCAAAGGGCTGGAATGGGTTGGGAGAATCTACCCAGGGGACGGAGACACAAACTACAATGTCAAGTTCAAAGGCCGCTTCACTATAAGCCGAGATGATAGCAAGAACTCATTGTATCTCCAGATGAATAGTCTCAAGACAGAGGATACCGCCGTGTATTACTGCGCCCGGAGCGGATTCATTACGACCGTGAGAGACTTTGACTATTGGGGCCAAGGCACCCTGGTAACAGTCTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPDFQSVTPKEKVTITCRASESVDTFGISFMNWFQQKPDQSPKLLIHEASNQGSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQSKEVPFTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPDFQSVTPKEKVTITCRASESVDTFGISFMNWFQQKPDQSPKLLIHEASNQGSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQSKEVPFTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATCGTGCTGACTCAGTCTCCAGATTTTCAGTCAGTGACCCCAAAGGAGAAAGTCACCATAACATGCAGGGCCTCCGAGAGTGTTGACACATTCGGGATCAGTTTCATGAACTGGTTTCAGCAGAAACCCGACCAGAGCCCCAAGCTCCTTATCCACGAAGCTTCCAACCAGGGATCTGGCGTACCTTCTCGGTTCAGCGGTTCAGGCAGCGGTACCGACTTTACTTTGACTATTAATTCCCTGGAGGCGGAAGATGCAGCCACGTACTATTGTCAACAATCAAAAGAGGTGCCTTTCACATTTGGAGGGGGCACCAAGGTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,3,EIVLTQSPDFQSVTPKEKVTITCRAS--ESVDTF--GISFMNWFQQKPDQSPKLLIHE--------ASNQGSGVPSRFSGSGSG--TDFTLTINSLEAEDAATYYCQQSKE-----------------------VPFTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----SWMNWVRQAPGKGLEWVGRIYPG---DGDTNYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITT------------------VRDFDYWGQGTLVTVSS
-GDPa1-110,infliximab,,,,,,,,,,,,,,IgG1,Kappa,Approved,NFD,EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS,MRAWIFFLLCLAGRALAEVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCAAGCTGGAGGAGTCTGGCGGGGGACTGGTCCAACCTGGAGGTTCCATGAAACTTAGTTGTGTAGCTTCCGGCTTCATCTTCAGCAATCACTGGATGAATTGGGTGAGGCAGTCCCCCGAAAAGGGACTCGAATGGGTGGCCGAGATCAGGAGTAAGTCTATTAACTCCGCAACACATTATGCGGAGAGTGTTAAAGGCCGATTTACCATATCACGGGATGACTCAAAAAGCGCCGTGTATCTCCAGATGACTGATTTGAGAACTGAGGACACCGGGGTGTACTATTGCAGCCGCAACTACTACGGGTCAACGTATGACTACTGGGGCCAGGGCACAACACTGACCGTTTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK,MRAWIFFLLCLAGRALADILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACTCCTGACACAGAGCCCTGCTATTCTGTCCGTTAGCCCCGGAGAGCGCGTGTCTTTTTCATGCCGAGCATCACAGTTCGTAGGGAGCAGCATTCACTGGTATCAACAGAGAACCAACGGCTCCCCCAGGCTTCTCATCAAATACGCCTCCGAGTCTATGTCCGGTATTCCGTCACGGTTTAGCGGGAGTGGATCAGGCACGGACTTCACCCTGAGTATCAATACAGTCGAATCCGAGGATATCGCCGACTACTATTGTCAGCAAAGTCATTCTTGGCCATTCACTTTTGGTTCTGGCACTAACTTGGAAGTGAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,1,DILLTQSPAILSVSPGERVSFSCRAS--QFVG------SSIHWYQQRTNGSPRLLIKY--------ASESMSGIPSRFSGSGSG--TDFTLSINTVESEDIADYYCQQSHS-----------------------WPFTFGSGTNLEVK-,EVKLEES-GGGLVQPGGSMKLSCVASG-FIFSN-----HWMNWVRQSPEKGLEWVAEIRSKS-INSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYG---------------------STYDYWGQGTTLTVSS
-GDPa1-111,inotuzumab,637.93,99.465,85.305,2.835,2.76,4.785,0.71,0.32,4.37,21.0,57.495000000000005,68.16,78.41,IgG4,Kappa,Approved,Active,EVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGTTGGTGCAGAGCGGTGCTGAGGTGAAAAAGCCCGGAGCCTCTGTAAAAGTCTCTTGCAAGGCCAGCGGCTACAGATTCACCAACTATTGGATTCACTGGGTGAGGCAAGCCCCAGGACAAGGTCTGGAATGGATCGGGGGAATAAATCCTGGGAACAATTACGCAACATATAGGCGCAAGTTCCAGGGGCGGGTCACCATGACAGCCGATACTTCCACTAGTACAGTGTATATGGAGCTCAGCAGTCTTCGATCCGAAGACACTGCGGTTTACTACTGTACCCGGGAGGGGTACGGCAACTACGGCGCATGGTTTGCTTATTGGGGCCAGGGCACGCTGGTCACCGTTTCATCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTGCAGGTTACCCAGAGCCCTTCCTCCTTGAGTGCTTCAGTGGGGGACAGGGTGACCATAACATGTAGATCCAGTCAGTCACTGGCCAACTCATACGGTAACACTTTTTTGAGCTGGTATCTGCATAAGCCAGGAAAAGCACCACAGCTCCTGATCTACGGAATCTCTAATCGCTTTTCTGGAGTACCTGACCGGTTCAGCGGCTCTGGGAGTGGCACAGATTTTACACTTACGATTTCCAGCCTCCAACCCGAAGACTTCGCCACTTACTATTGCCTGCAAGGCACCCACCAGCCCTATACTTTCGGTCAGGGGACCAAGGTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,0,DVQVTQSPSSLSASVGDRVTITCRSS--QSLANSY-GNTFLSWYLHKPGKAPQLLIYG--------ISNRFSGVPDRFSGSGSG--TDFTLTISSLQPEDFATYYCLQGTH-----------------------QPYTFGQGTKVEIK-,EVQLVQS-GAEVKKPGASVKVSCKASG-YRFTN-----YWIHWVRQAPGQGLEWIGGINPG---NNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNY------------------GAWFAYWGQGTLVTVSS
-GDPa1-112,intetumumab,217.56,99.35499999999999,97.34,2.7350000000000003,2.63,4.654999999999999,0.14,0.1,2.37,3.125,62.379999999999995,72.74000000000001,85.035,IgG1,Kappa,Phase-II,Discontinued,QVQLVESGGGVVQPGRSRRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAVISFDGSNKYYVDSVKGRFTISRDNSENTLYLQVNILRAEDTAVYYCAREARGSYAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSRRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAVISFDGSNKYYVDSVKGRFTISRDNSENTLYLQVNILRAEDTAVYYCAREARGSYAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTGGAAAGCGGCGGAGGGGTAGTTCAGCCCGGTCGCTCTAGAAGGTTGTCATGCGCCGCTTCTGGATTTACATTCTCCCGCTATACCATGCACTGGGTGCGACAGGCCCCTGGCAAAGGACTGGAGTGGGTGGCAGTCATAAGTTTTGATGGGTCAAACAAGTATTACGTGGACAGTGTCAAGGGCAGGTTCACAATCAGCCGGGACAATTCCGAAAATACGCTGTACCTTCAAGTAAACATCCTCCGAGCGGAGGATACTGCCGTGTACTACTGTGCTAGAGAGGCCCGGGGCAGCTATGCATTCGACATTTGGGGGCAGGGCACCATGGTTACTGTGTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTGCTGACACAGAGCCCGGCCACCCTTTCTCTCTCTCCTGGCGAACGGGCCACTCTCAGTTGTCGAGCATCACAAAGCGTCAGTTCCTACCTTGCGTGGTATCAGCAGAAGCCTGGCCAAGCTCCCAGGCTGCTGATCTATGATGCCTCTAACAGGGCCACTGGCATTCCCGCTCGCTTCAGCGGATCCGGATCAGGGACCGATTTTACATTGACCATAAGCTCCCTGGAACCAGAGGACTTCGCAGTGTACTACTGCCAGCAGAGATCCAATTGGCCACCCTTCACGTTTGGTCCAGGGACAAAGGTTGACATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSNW----------------------PPFTFGPGTKVDIK-,QVQLVES-GGGVVQPGRSRRLSCAASG-FTFSR-----YTMHWVRQAPGKGLEWVAVISFD---GSNKYYVDSVKGRFTISRDNSENTLYLQVNILRAEDTAVYYCAREARGS--------------------YAFDIWGQGTMVTVSS
-GDPa1-113,ipilimumab,296.49,99.35,98.82499999999999,3.4699999999999998,3.2199999999999998,,0.1,0.1,0.0,7.5,60.775,72.24000000000001,77.59,IgG1,Kappa,Approved,Active,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTTGAGTCAGGGGGAGGGGTCGTTCAGCCTGGCAGAAGCCTTCGGCTCTCTTGTGCGGCATCCGGTTTCACATTTTCTTCCTACACGATGCACTGGGTGCGCCAGGCCCCCGGCAAAGGCCTCGAATGGGTAACCTTCATTTCCTACGATGGTAATAACAAATATTATGCCGACTCAGTCAAGGGCAGGTTCACCATAAGTCGAGACAACAGCAAGAATACATTGTACTTGCAGATGAACAGTCTGAGAGCTGAGGACACTGCCATCTATTACTGCGCTAGGACCGGGTGGCTGGGACCATTTGATTATTGGGGCCAAGGAACTCTGGTGACAGTGTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGCTCACTCAGAGCCCAGGTACGCTCTCCCTGTCCCCTGGCGAGAGAGCTACCCTTTCATGTCGAGCCAGCCAAAGCGTTGGGAGCTCTTACCTTGCATGGTACCAGCAGAAGCCAGGCCAGGCCCCGAGGCTGCTGATTTATGGAGCTTTCTCTCGGGCCACTGGTATCCCCGACAGATTCAGTGGATCCGGCTCAGGAACAGACTTTACATTGACCATTTCCCGCCTGGAGCCTGAAGATTTCGCGGTGTACTATTGCCAGCAATATGGCTCTAGTCCCTGGACCTTTGGGCAGGGGACAAAAGTCGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPGTLSLSPGERATLSCRAS--QSVGS-----SYLAWYQQKPGQAPRLLIYG--------AFSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------SPWTFGQGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YTMHWVRQAPGKGLEWVTFISYD---GNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWL---------------------GPFDYWGQGTLVTVSS
-GDPa1-114,isatuximab,42.75,99.75,94.725,2.955,3.185,,,,2.25,0.0,61.72,71.64500000000001,84.245,IgG1,Kappa,Approved,Active,QVQLVQSGAEVAKPGTSVKLSCKASGYTFTDYWMQWVKQRPGQGLEWIGTIYPGDGDTGYAQKFQGKATLTADKSSKTVYMHLSSLASEDSAVYYCARGDYYGSNSLDYWGQGTSVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVAKPGTSVKLSCKASGYTFTDYWMQWVKQRPGQGLEWIGTIYPGDGDTGYAQKFQGKATLTADKSSKTVYMHLSSLASEDSAVYYCARGDYYGSNSLDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTCGTGCAGTCTGGTGCCGAGGTTGCCAAACCGGGCACTTCTGTGAAACTGTCCTGCAAGGCTTCCGGATATACTTTTACAGACTATTGGATGCAGTGGGTCAAGCAGAGACCCGGCCAGGGTTTGGAATGGATCGGCACCATTTACCCTGGGGATGGAGATACGGGGTACGCCCAAAAGTTCCAGGGGAAAGCCACACTTACCGCGGACAAGTCATCCAAGACCGTGTACATGCACCTGAGTAGCCTGGCAAGCGAGGATAGTGCTGTGTACTACTGTGCAAGGGGCGACTATTACGGAAGCAACTCCCTCGACTATTGGGGGCAAGGCACATCTGTCACCGTAAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSHLSMSTSLGDPVSITCKASQDVSTVVAWYQQKPGQSPRRLIYSASYRYIGVPDRFTGSGAGTDFTFTISSVQAEDLAVYYCQQHYSPPYTFGGGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSHLSMSTSLGDPVSITCKASQDVSTVVAWYQQKPGQSPRRLIYSASYRYIGVPDRFTGSGAGTDFTFTISSVQAEDLAVYYCQQHYSPPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCGTGATGACACAGAGCCATCTGAGCATGTCAACTTCACTGGGCGACCCCGTCTCCATTACATGCAAAGCTAGCCAAGACGTGTCCACAGTAGTGGCCTGGTACCAGCAGAAGCCTGGTCAGAGCCCAAGAAGGCTCATCTATTCCGCCAGTTACCGCTACATTGGTGTGCCTGATCGGTTTACCGGGTCTGGCGCTGGAACCGATTTCACTTTTACGATATCTTCTGTTCAGGCGGAAGACTTGGCAGTCTATTATTGTCAACAGCACTACAGTCCCCCATATACCTTCGGAGGCGGGACCAAACTTGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,4,2,DIVMTQSHLSMSTSLGDPVSITCKAS--QDVS------TVVAWYQQKPGQSPRRLIYS--------ASYRYIGVPDRFTGSGAG--TDFTFTISSVQAEDLAVYYCQQHYS-----------------------PPYTFGGGTKLEIK-,QVQLVQS-GAEVAKPGTSVKLSCKASG-YTFTD-----YWMQWVKQRPGQGLEWIGTIYPG---DGDTGYAQKFQGKATLTADKSSKTVYMHLSSLASEDSAVYYCARGDYYG-------------------SNSLDYWGQGTSVTVSS
-GDPa1-115,iscalimab,157.0,87.77,97.51,2.875,2.975,3.745,0.0,0.01,0.5,-0.125,62.875,71.225,83.61,IgG1,Kappa,Phase-II,Active,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAACTCGTCGAAAGCGGCGGGGGTGTGGTACAGCCAGGGCGCTCTCTGAGGTTGTCATGTGCAGCATCTGGGTTCACATTTAGCAGTTACGGGATGCACTGGGTGCGGCAGGCGCCCGGAAAAGGTCTGGAATGGGTTGCCGTTATTTCATATGAGGAGAGTAACAGATATCATGCCGATTCCGTCAAGGGAAGATTCACAATATCCCGAGACAACAGCAAGATCACTCTTTACCTCCAAATGAATAGCCTGAGGACGGAGGACACCGCCGTGTACTATTGCGCTCGGGATGGAGGCATCGCCGCTCCTGGCCCGGACTACTGGGGCCAGGGCACTCTGGTGACCGTGTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR,MRAWIFFLLCLAGRALADIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATAGTCATGACACAAAGCCCCCTTTCTCTCACGGTTACCCCCGGAGAGCCCGCCTCAATTTCCTGCCGATCAAGTCAGAGCCTTCTGTATTCAAACGGGTATAACTACCTCGATTGGTATCTGCAGAAGCCTGGTCAGTCCCCACAGGTCCTGATCTCCTTGGGCAGCAATCGGGCCTCTGGGGTGCCAGACAGGTTCTCTGGCTCCGGTAGCGGCACAGACTTTACCCTGAAGATTAGTAGGGTGGAAGCTGAGGACGTAGGGGTGTACTACTGTATGCAAGCACGCCAGACTCCTTTTACTTTCGGACCGGGAACCAAAGTGGATATCAGAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,1,DIVMTQSPLSLTVTPGEPASISCRSS--QSLLYSN-GYNYLDWYLQKPGQSPQVLISL--------GSNRASGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCMQARQ-----------------------TPFTFGPGTKVDIR-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YGMHWVRQAPGKGLEWVAVISYE---ESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIA-------------------APGPDYWGQGTLVTVSS
-GDPa1-116,itolizumab,313.39,99.265,98.08500000000001,2.705,2.46,4.465,0.21,0.11,1.0,2.125,62.64,72.985,84.31,IgG1,Kappa,Approved,Active,EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTTGTGGAGTCCGGTGGAGGGCTGGTAAAGCCAGGGGGCTCCCTCAAGTTGTCCTGTGCCGCGAGTGGATTCAAGTTTAGCAGGTACGCTATGAGCTGGGTCAGGCAAGCCCCCGGTAAACGACTTGAGTGGGTGGCCACAATCTCATCCGGAGGCTCTTATATTTACTATCCTGACTCTGTCAAAGGCAGATTCACAATATCACGGGACAATGTTAAAAACACCCTGTACTTGCAGATGAGCAGTCTGCGCAGCGAAGATACCGCAATGTATTACTGCGCTAGACGGGACTATGATCTGGATTACTTTGACAGTTGGGGCCAGGGGACTCTCGTTACGGTGTCATCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAGATGACCCAGTCACCCAGCTCACTGAGCGCTTCTGTTGGCGATCGGGTGACAATCACTTGTAAGGCATCTAGGGACATTAGAAGTTACCTGACTTGGTATCAGCAGAAACCTGGTAAGGCCCCGAAAACCCTCATCTATTACGCTACATCCCTGGCGGACGGAGTCCCATCTCGCTTCAGCGGCTCTGGAAGCGGCCAAGATTACTCACTTACCATCTCCTCCCTGGAGTCCGACGACACAGCCACGTATTACTGCTTGCAACACGGGGAAAGTCCCTTTACCCTCGGGAGTGGTACTAAACTTGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,3,DIQMTQSPSSLSASVGDRVTITCKAS--RDIR------SYLTWYQQKPGKAPKTLIYY--------ATSLADGVPSRFSGSGSG--QDYSLTISSLESDDTATYYCLQHGE-----------------------SPFTLGSGTKLEIK-,EVQLVES-GGGLVKPGGSLKLSCAASG-FKFSR-----YAMSWVRQAPGKRLEWVATISSG---GSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDL--------------------DYFDSWGQGTLVTVSS
-GDPa1-117,ixekizumab,,99.485,87.15,2.8099999999999996,3.08,,0.95,0.96,24.75,28.375,54.995,68.435,81.53,IgG4,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGGTCCAGAGCGGAGCTGAGGTGAAGAAACCAGGCAGCTCTGTTAAAGTAAGTTGCAAGGCATCCGGTTATTCATTTACGGATTACCACATCCATTGGGTGCGGCAGGCCCCTGGACAAGGCCTCGAGTGGATGGGGGTCATAAATCCCATGTACGGGACAACCGACTATAACCAGAGGTTCAAGGGCAGAGTGACTATTACCGCTGATGAGTCTACTAGTACAGCCTACATGGAATTGAGCTCACTTCGATCCGAAGACACAGCCGTTTATTACTGTGCGCGCTATGACTACTTCACAGGTACCGGCGTGTACTGGGGGCAGGGAACCCTGGTCACTGTGTCCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCGTGATGACCCAGACACCCCTGTCACTTTCCGTTACCCCTGGGCAGCCAGCCTCCATCTCTTGCCGATCTAGTCGCTCACTCGTACACAGCAGGGGCAACACATACCTGCACTGGTACCTGCAGAAACCCGGACAGTCCCCTCAACTCCTTATTTATAAGGTGTCAAATAGATTCATTGGTGTGCCAGACCGGTTCAGTGGATCTGGCTCCGGCACCGATTTTACATTGAAGATCAGCAGGGTCGAGGCTGAGGACGTCGGTGTGTACTATTGTAGCCAGAGCACTCATCTGCCGTTCACGTTTGGGCAAGGGACTAAATTGGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,1,4,DIVMTQTPLSLSVTPGQPASISCRSS--RSLVHSR-GNTYLHWYLQKPGQSPQLLIYK--------VSNRFIGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCSQSTH-----------------------LPFTFGQGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YSFTD-----YHIHWVRQAPGQGLEWMGVINPM---YGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFT--------------------GTGVYWGQGTLVTVSS
-GDPa1-118,ladiratuzumab,162.76,98.225,97.33500000000001,2.6950000000000003,2.615,,0.12,0.0,0.5,-0.875,60.80500000000001,70.31,82.52,IgG1,Kappa,Phase-II,Active,QVQLVQSGAEVKKPGASVKVSCKASGLTIEDYYMHWVRQAPGQGLEWMGWIDPENGDTEYGPKFQGRVTMTRDTSINTAYMELSRLRSDDTAVYYCAVHNAHYGTWFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGLTIEDYYMHWVRQAPGQGLEWMGWIDPENGDTEYGPKFQGRVTMTRDTSINTAYMELSRLRSDDTAVYYCAVHNAHYGTWFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAACTGGTGCAGTCAGGGGCTGAAGTGAAGAAGCCGGGAGCCAGCGTGAAAGTGAGTTGCAAAGCCTCAGGCCTCACCATAGAGGACTATTACATGCACTGGGTCCGGCAGGCGCCAGGCCAGGGTTTGGAATGGATGGGATGGATCGATCCTGAAAACGGCGATACTGAGTACGGCCCCAAGTTTCAGGGTAGGGTGACCATGACCAGAGACACGTCTATTAATACCGCCTACATGGAGCTGTCCCGCCTGCGAAGCGATGACACAGCAGTCTACTATTGTGCAGTTCATAACGCCCACTATGGAACTTGGTTCGCTTATTGGGGGCAAGGGACACTTGTCACAGTTTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTLGQPASISCRSSQSLLHSSGNTYLEWYQQRPGQSPRPLIYKISTRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPYTFGGGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCRSSQSLLHSSGNTYLEWYQQRPGQSPRPLIYKISTRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTGGTTATGACCCAAAGCCCACTCAGTCTGCCTGTGACCCTTGGGCAGCCTGCCTCCATTAGTTGCCGATCCTCACAATCATTGCTGCATTCATCTGGAAACACATATCTGGAGTGGTACCAGCAGCGGCCCGGTCAGTCTCCAAGGCCGCTCATTTACAAGATCAGCACCCGCTTCAGCGGAGTCCCCGACAGATTTAGTGGGTCCGGCTCCGGAACGGATTTCACTCTGAAAATCTCTAGGGTAGAGGCTGAAGATGTGGGCGTGTATTACTGTTTCCAGGGGAGCCACGTCCCCTATACTTTTGGCGGTGGCACAAAAGTTGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,0,4,DVVMTQSPLSLPVTLGQPASISCRSS--QSLLHSS-GNTYLEWYQQRPGQSPRPLIYK--------ISTRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCFQGSH-----------------------VPYTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-LTIED-----YYMHWVRQAPGQGLEWMGWIDPE---NGDTEYGPKFQGRVTMTRDTSINTAYMELSRLRSDDTAVYYCAVHNAHY-------------------GTWFAYWGQGTLVTVSS
-GDPa1-119,lampalizumab,126.74,99.03999999999999,95.14,2.715,2.575,,,,3.0,0.375,62.375,69.775,83.14500000000001,IgG1,Kappa,Phase-III,Discontinued,EVQLVQSGPELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREGGVNNWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGPELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREGGVNNWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGCTTGTCCAATCTGGCCCAGAACTGAAAAAACCCGGTGCCAGTGTGAAAGTTTCCTGCAAGGCTAGCGGGTACACATTCACAAACTACGGCATGAATTGGGTGCGGCAAGCCCCTGGACAGGGGTTGGAATGGATGGGATGGATTAACACTTACACCGGCGAGACTACTTATGCTGATGACTTTAAGGGCAGATTTGTTTTCAGTCTGGATACCTCCGTATCAACCGCCTATCTGCAGATCTCATCTCTCAAGGCAGAAGACACCGCGGTGTACTATTGTGAGAGGGAGGGCGGGGTCAATAACTGGGGTCAGGGAACACTCGTGACGGTGAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQVTQSPSSLSASVGDRVTITCITSTDIDDDMNWYQQKPGKVPKLLISGGNTLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLQSDSLPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQVTQSPSSLSASVGDRVTITCITSTDIDDDMNWYQQKPGKVPKLLISGGNTLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLQSDSLPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGGTCACACAAAGCCCCAGTAGCCTGAGCGCTTCAGTGGGCGACAGGGTCACCATTACCTGCATAACTTCCACCGATATCGACGATGATATGAATTGGTATCAGCAAAAGCCAGGTAAAGTACCAAAACTCCTTATCTCCGGAGGTAACACTCTGAGACCTGGAGTGCCGAGCCGCTTTTCTGGCTCCGGGAGTGGGACGGACTTCACACTGACCATTTCATCTTTGCAGCCTGAGGATGTGGCCACATACTATTGTCTGCAGTCCGACTCTCTCCCCTACACATTCGGCCAGGGGACTAAGGTTGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQVTQSPSSLSASVGDRVTITCITS--TDID------DDMNWYQQKPGKVPKLLISG--------GNTLRPGVPSRFSGSGSG--TDFTLTISSLQPEDVATYYCLQSDS-----------------------LPYTFGQGTKVEIK-,EVQLVQS-GPELKKPGASVKVSCKASG-YTFTN-----YGMNWVRQAPGQGLEWMGWINTY---TGETTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREGG------------------------VNNWGQGTLVTVSS
-GDPa1-120,lanadelumab,352.37,98.85499999999999,98.225,2.755,2.615,4.585,0.0,0.05,4.87,25.125,,,,IgG1,Kappa,Approved,NFD,EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGTTGGAATCCGGGGGCGGACTGGTCCAACCAGGCGGGTCTCTCAGACTGAGCTGTGCCGCCTCTGGTTTCACTTTTTCCCACTACATCATGATGTGGGTGAGGCAGGCACCTGGCAAAGGGCTTGAGTGGGTGTCTGGCATCTATTCAAGCGGAGGAATAACTGTTTACGCTGACTCAGTCAAGGGACGATTTACCATTAGTCGGGACAACAGTAAGAACACATTGTATCTGCAGATGAATTCCCTCAGAGCTGAGGATACGGCCGTATACTATTGCGCGTACCGGCGCATTGGCGTTCCCAGGCGCGACGAATTCGATATCTGGGGCCAGGGTACCATGGTGACAGTGAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACTCAGAGCCCCTCTACTCTGAGCGCTTCTGTGGGCGACAGAGTGACCATAACCTGCAGGGCTTCTCAGTCAATCAGTTCCTGGCTCGCGTGGTACCAACAGAAACCAGGAAAGGCACCCAAACTCTTGATTTATAAAGCCTCAACCCTGGAGAGCGGAGTCCCTTCCCGCTTCAGTGGTTCCGGGTCAGGCACTGAGTTTACACTTACAATCAGCTCCCTGCAACCGGATGACTTCGCCACGTACTACTGTCAGCAGTATAACACCTATTGGACATTTGGGCAGGGCACAAAGGTTGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,DIQMTQSPSTLSASVGDRVTITCRAS--QSIS------SWLAWYQQKPGKAPKLLIYK--------ASTLESGVPSRFSGSGSG--TEFTLTISSLQPDDFATYYCQQYNT------------------------YWTFGQGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSH-----YIMMWVRQAPGKGLEWVSGIYSS---GGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVP-----------------RRDEFDIWGQGTMVTVSS
-GDPa1-121,landogrozumab,285.99,99.295,97.89500000000001,2.6950000000000003,2.5,4.32,0.1,0.1,5.37,27.625,62.67,73.355,86.77000000000001,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGLTFSRYPMSWVRQAPGKGLVWVSAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARLPDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGLTFSRYPMSWVRQAPGKGLVWVSAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARLPDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTGTTGAGAGTGGAGGGGGTCTCGTTCAGCCGGGCGGATCACTGCGCCTGAGTTGCGCCGCCAGCGGCCTGACATTTTCTCGGTACCCCATGTCTTGGGTGAGACAAGCGCCAGGCAAAGGCTTGGTATGGGTGTCAGCTATCACTAGCTCCGGCGGGTCCACCTATTACAGCGATACCGTGAAGGGGAGGTTCACTATTTCCCGAGACAACGCAAAGAATACACTGTACCTCCAGATGAACTCTCTGAGGGCAGAAGATACGGCTGTCTATTATTGTGCCCGGCTTCCTGACTACTGGGGACAGGGTACCTTGGTCACAGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASSSVSSSYLHWYQQKPGQAPRLLIYSTSNLVAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHHSGYHFTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASSSVSSSYLHWYQQKPGQAPRLLIYSTSNLVAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHHSGYHFTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATCGTGTTGACCCAGAGCCCTGGAACTCTGTCACTTTCTCCGGGGGAGCGCGCTACCCTGTCCTGTAGAGCAAGTTCTTCTGTGAGCTCATCCTATCTTCATTGGTACCAACAGAAACCCGGACAGGCGCCTCGGCTGCTCATTTATAGTACTAGTAACCTCGTAGCCGGTATCCCCGATCGATTCAGCGGTTCCGGCAGCGGCACCGACTTTACACTGACAATTTCCAGGTTGGAACCAGAGGACTTCGCCGTCTACTATTGCCAGCACCACTCAGGGTACCATTTCACGTTTGGCGGGGGAACAAAGGTTGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,3,2,EIVLTQSPGTLSLSPGERATLSCRAS--SSVSS-----SYLHWYQQKPGQAPRLLIYS--------TSNLVAGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQHHSG-----------------------YHFTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-LTFSR-----YPMSWVRQAPGKGLVWVSAITSS---GGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARLP--------------------------DYWGQGTLVTVSS
-GDPa1-122,lebrikizumab,57.13,100.0,89.83500000000001,3.425,3.4850000000000003,,,,0.25,0.375,59.45,72.05,,IgG4,Kappa,Approved,Active,QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS,MRAWIFFLLCLAGRALAQVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGACTTTGCGGGAGAGCGGTCCAGCGCTGGTAAAACCAACCCAGACCCTTACGCTTACATGTACAGTCTCCGGATTCTCTCTGTCCGCCTACTCCGTGAATTGGATCAGACAGCCCCCTGGCAAAGCACTCGAATGGCTGGCCATGATCTGGGGCGACGGGAAAATAGTCTACAACAGCGCTTTGAAGAGTAGGCTGACCATTTCAAAGGACACCAGTAAGAACCAGGTGGTTCTCACAATGACAAACATGGATCCTGTTGATACCGCCACTTATTATTGCGCTGGTGATGGATATTACCCCTACGCAATGGACAATTGGGGGCAAGGCTCACTGGTGACTGTGAGCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTGTAATGACCCAGTCACCAGATTCCCTCAGTGTGTCCTTGGGCGAGAGGGCTACAATCAACTGTCGGGCCAGCAAGTCTGTGGACTCCTACGGTAATTCTTTCATGCACTGGTACCAGCAAAAGCCAGGACAGCCTCCCAAGCTGCTTATTTATCTGGCAAGTAACCTGGAAAGCGGCGTCCCTGACCGCTTTTCCGGGTCAGGGAGCGGCACAGATTTTACTCTCACGATCAGCTCTCTGCAAGCCGAAGACGTTGCGGTGTACTATTGCCAGCAGAATAACGAGGATCCCAGAACTTTCGGTGGAGGGACCAAAGTCGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,2,DIVMTQSPDSLSVSLGERATINCRAS--KSVDSY--GNSFMHWYQQKPGQPPKLLIYL--------ASNLESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQQNNE-----------------------DPRTFGGGTKVEIK-,QVTLRES-GPALVKPTQTLTLTCTVSG-FSLSA-----YSVNWIRQPPGKALEWLAMIWG----DGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYP--------------------YAMDNWGQGSLVTVSS
-GDPa1-123,lenzilumab,124.07,99.52000000000001,100.0,2.77,2.435,6.529999999999999,0.35,0.14,4.87,22.625,60.82,71.315,80.52,IgG1,Kappa,Preregistration,Active,QVQLVQSGAEVKKPGASVKVSCKASGYSFTNYYIHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRFPYYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYSFTNYYIHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRFPYYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTTGTGCAGTCTGGGGCGGAAGTCAAAAAGCCCGGTGCAAGTGTTAAGGTGTCCTGCAAGGCCTCAGGTTATTCATTCACCAACTACTACATACACTGGGTGAGACAGGCCCCTGGGCAGAGGTTGGAGTGGATGGGGTGGATCAATGCCGGCAACGGAAATACAAAATACTCCCAGAAATTCCAGGGAAGAGTAACCATTACTCGAGATACAAGCGCTTCTACGGCATATATGGAACTGAGCAGTCTGCGGAGCGAGGACACAGCTGTGTACTATTGTGTTCGGAGGCAGCGCTTTCCATATTACTTTGACTACTGGGGCCAAGGCACTCTCGTCACCGTCTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSVSPGERATLSCRASQSVGTNVAWYQQKPGQAPRVLIYSTSSRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFNKSPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSVSPGERATLSCRASQSVGTNVAWYQQKPGQAPRVLIYSTSSRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFNKSPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTCCTCACACAGTCTCCAGCTACCCTGTCTGTGAGTCCCGGTGAACGAGCAACCTTGTCTTGTAGGGCCTCCCAGTCCGTTGGGACTAATGTGGCGTGGTATCAACAAAAACCTGGACAGGCCCCAAGGGTGCTTATCTATAGCACCTCATCAAGAGCCACTGGGATCACAGACCGCTTCAGTGGCTCCGGAAGCGGGACAGATTTTACACTGACCATATCACGGCTCGAGCCTGAAGACTTCGCTGTCTACTACTGCCAGCAGTTTAACAAGAGCCCCCTGACGTTCGGCGGTGGCACTAAAGTAGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,1,3,EIVLTQSPATLSVSPGERATLSCRAS--QSVG------TNVAWYQQKPGQAPRVLIYS--------TSSRATGITDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQFNK-----------------------SPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YSFTN-----YYIHWVRQAPGQRLEWMGWINAG---NGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRFP--------------------YYFDYWGQGTLVTVSS
-GDPa1-124,lexatumumab,52.18,99.12,96.44,2.72,2.5,,,,2.25,13.375,60.87,68.63,82.51,IgG1,Lambda,Phase-I,Discontinued,EVQLVQSGGGVERPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDLWGKGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGGGVERPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDLWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAACTTGTCCAGAGCGGAGGGGGAGTGGAGAGGCCCGGTGGATCCCTGAGACTCTCATGCGCCGCTAGTGGCTTCACGTTCGACGACTACGGTATGTCTTGGGTCCGGCAGGCTCCTGGCAAAGGACTTGAGTGGGTGTCTGGAATTAACTGGAATGGCGGCAGCACTGGGTATGCCGATTCAGTCAAGGGCCGAGTGACCATCTCTAGGGATAACGCCAAAAACTCCTTGTACCTCCAGATGAATAGTCTGCGCGCAGAAGACACTGCGGTATATTATTGTGCAAAGATACTGGGGGCCGGGAGAGGCTGGTACTTTGATCTGTGGGGTAAGGGGACCACAGTTACAGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,MRAWIFFLLCLAGRALASSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCTCAAGTGAGTTGACCCAGGACCCCGCCGTCTCTGTGGCACTGGGGCAGACAGTGCGAATCACGTGCCAGGGAGATTCTCTGCGCAGCTACTATGCTAGTTGGTATCAGCAAAAACCTGGTCAAGCACCCGTACTCGTGATTTACGGTAAGAACAACCGGCCATCAGGCATCCCGGACAGGTTTAGCGGGTCTAGCTCCGGCAACACAGCTTCCCTGACCATAACTGGAGCCCAGGCCGAAGATGAGGCGGACTATTACTGTAATAGCAGAGATTCCTCCGGCAATCACGTTGTGTTCGGGGGCGGAACCAAGCTTACTGTCCTCGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,1,4,SSELTQD-PAVSVALGQTVRITCQGD---SLRS-----YYASWYQQKPGQAPVLVIYG--------KNNRPSGIPDRFSGSSSG--NTASLTITGAQAEDEADYYCNSRDSS---------------------GNHVVFGGGTKLTVL-,EVQLVQS-GGGVERPGGSLRLSCAASG-FTFDD-----YGMSWVRQAPGKGLEWVSGINWN---GGSTGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGR------------------GWYFDLWGKGTTVTVSS
-GDPa1-125,ligelizumab,132.11,99.15,97.49,3.0599999999999996,3.725,1.8199999999999998,0.87,0.1,1.0,8.875,66.97,74.46,75.01,IgG1,Kappa,Phase-III,Active,QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTTCAGTCCGGGGCCGAGGTGATGAAACCAGGGTCTTCAGTCAAGGTGAGCTGTAAGGCGAGCGGTTACACTTTTTCCTGGTATTGGCTGGAGTGGGTGAGACAAGCTCCTGGTCATGGGCTTGAATGGATGGGAGAGATCGACCCCGGCACATTTACTACTAACTACAACGAAAAATTCAAGGCACGCGTGACCTTCACCGCAGATACGTCTACAAGTACAGCCTACATGGAGTTGAGCAGTCTCCGGAGCGAAGACACCGCTGTTTATTATTGCGCCAGGTTCTCACACTTTTCCGGATCTAATTACGATTATTTCGACTACTGGGGCCAGGGCACCCTGGTCACAGTATCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTGATGACGCAGTCCCCAGCGACCCTCTCCGTCAGTCCTGGCGAGAGGGCCACTCTGTCATGCCGCGCCAGTCAGAGCATTGGCACAAACATTCACTGGTACCAGCAGAAGCCCGGGCAAGCCCCTAGACTGTTGATCTACTATGCTTCCGAATCCATCTCAGGAATTCCAGCTCGGTTCTCTGGATCAGGCAGCGGGACCGAGTTCACCCTTACAATCAGTTCTCTGCAATCTGAAGACTTTGCAGTTTACTATTGTCAGCAGAGCTGGAGCTGGCCCACTACCTTTGGCGGTGGTACAAAAGTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,3,EIVMTQSPATLSVSPGERATLSCRAS--QSIG------TNIHWYQQKPGQAPRLLIYY--------ASESISGIPARFSGSGSG--TEFTLTISSLQSEDFAVYYCQQSWS-----------------------WPTTFGGGTKVEIK-,QVQLVQS-GAEVMKPGSSVKVSCKASG-YTFSW-----YWLEWVRQAPGHGLEWMGEIDPG---TFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGS----------------NYDYFDYWGQGTLVTVSS
-GDPa1-126,lintuzumab,352.37,99.325,97.375,2.8099999999999996,3.0549999999999997,,0.15,0.0,3.0,0.0,61.605000000000004,69.89,80.68,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTCCAGAGTGGTGCCGAAGTGAAGAAGCCAGGCTCCTCCGTGAAAGTATCATGCAAAGCTAGCGGGTATACATTCACAGATTATAACATGCACTGGGTGAGGCAGGCACCCGGTCAGGGGCTCGAATGGATCGGCTATATTTACCCGTACAACGGCGGAACAGGGTATAATCAAAAGTTTAAATCCAAGGCGACCATAACCGCCGACGAGAGTACCAATACTGCCTACATGGAGCTGTCAAGCCTTCGGTCTGAGGATACTGCAGTGTACTACTGTGCCAGAGGACGCCCTGCTATGGACTACTGGGGACAGGGCACCTTGGTTACGGTTTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAAATGACACAGAGCCCCTCATCTCTTTCTGCGTCAGTTGGCGACAGGGTAACAATTACTTGTAGAGCTTCAGAGAGCGTGGATAACTACGGGATCAGCTTTATGAACTGGTTTCAGCAGAAACCAGGGAAGGCTCCTAAGCTGCTGATATACGCCGCATCCAATCAGGGGTCCGGCGTCCCCTCTCGGTTCAGTGGAAGTGGTAGTGGTACTGACTTCACGTTGACCATCAGCTCCCTCCAACCTGATGACTTTGCCACCTATTATTGCCAGCAGTCCAAGGAGGTGCCATGGACATTCGGCCAGGGAACCAAAGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,1,DIQMTQSPSSLSASVGDRVTITCRAS--ESVDNY--GISFMNWFQQKPGKAPKLLIYA--------ASNQGSGVPSRFSGSGSG--TDFTLTISSLQPDDFATYYCQQSKE-----------------------VPWTFGQGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFTD-----YNMHWVRQAPGQGLEWIGYIYPY---NGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRP-----------------------AMDYWGQGTLVTVSS
-GDPa1-127,lirilumab,148.22,99.565,96.64500000000001,10.0,4.5,1.47,0.82,0.1,15.0,11.625,57.510000000000005,70.475,,IgG4,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSFYAISWVRQAPGQGLEWMGGFIPIFGAANYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYCARIPSGSYYYDYDMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSFYAISWVRQAPGQGLEWMGGFIPIFGAANYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYCARIPSGSYYYDYDMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTGGTGCAGTCAGGAGCCGAGGTTAAGAAACCCGGCTCATCCGTTAAGGTATCATGCAAGGCTAGCGGCGGGACCTTCAGTTTCTACGCAATTTCTTGGGTGCGCCAGGCCCCTGGTCAGGGCCTGGAATGGATGGGTGGCTTTATCCCAATTTTTGGGGCGGCCAACTACGCTCAAAAATTCCAAGGGAGGGTCACAATCACAGCAGACGAATCTACTAGCACTGCATATATGGAGCTCAGTAGCCTTCGGTCCGACGATACGGCTGTGTACTACTGTGCCAGAATACCGTCCGGATCTTATTATTACGATTATGATATGGACGTGTGGGGCCAGGGAACCACCGTCACAGTGAGCTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWMYTFGQGTKLEIK,MRAWIFFLLCLAGRALAEIVLTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWMYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTGCTGACTCAGTCTCCAGTGACATTGAGTCTCTCACCCGGCGAAAGAGCAACCCTTAGCTGTCGCGCTTCACAGTCTGTTTCCAGCTACCTCGCTTGGTATCAACAGAAGCCTGGTCAGGCCCCTAGACTTCTGATCTACGACGCGTCCAACAGGGCCACAGGAATACCAGCCCGGTTCTCCGGGAGCGGATCCGGCACGGATTTTACTCTGACCATCAGCTCTTTGGAACCCGAGGACTTTGCAGTCTACTATTGCCAGCAGCGAAGTAATTGGATGTATACATTCGGCCAAGGGACCAAACTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,3,EIVLTQSPVTLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSN-----------------------WMYTFGQGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSF-----YAISWVRQAPGQGLEWMGGFIPI---FGAANYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYCARIPSGSYY----------------YDYDMDVWGQGTTVTVSS
-GDPa1-128,loncastuximab,224.95,98.47,98.28,2.7199999999999998,2.5149999999999997,,0.0,0.0,0.0,2.0,61.245,70.02000000000001,84.84,IgG1,Kappa,Approved,Active,QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS,MRAWIFFLLCLAGRALAQVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTGCAGCCTGGCGCCGAAGTAGTCAAGCCCGGAGCATCTGTGAAGCTTTCCTGCAAAACATCCGGGTACACCTTTACGAGTAATTGGATGCACTGGGTCAAGCAGGCCCCCGGTCAAGGGCTCGAATGGATTGGCGAGATCGATCCGAGCGACTCATACACCAATTATAACCAGAACTTCCAAGGCAAAGCCAAATTGACTGTTGACAAGAGTACTTCTACAGCGTACATGGAGGTTTCTTCCCTGAGGAGCGATGATACAGCTGTGTATTACTGTGCAAGAGGGTCCAACCCATATTATTACGCTATGGACTACTGGGGTCAGGGAACCAGCGTCACCGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK,MRAWIFFLLCLAGRALAEIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGCTGACCCAGTCACCCGCTATAATGAGCGCGTCACCAGGTGAGCGGGTTACCATGACATGCAGTGCTTCCTCTGGGGTGAACTATATGCATTGGTATCAGCAGAAGCCCGGCACATCCCCACGACGCTGGATTTACGATACGTCTAAACTGGCCTCAGGGGTCCCTGCAAGGTTCAGCGGTAGTGGATCCGGAACAAGTTACAGCCTTACCATCTCTAGCATGGAACCTGAGGACGCCGCCACTTATTACTGTCACCAAAGAGGCTCCTACACCTTTGGCGGGGGAACTAAGCTCGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,2,EIVLTQSPAIMSASPGERVTMTCSAS--SGVN-------YMHWYQQKPGTSPRRWIYD--------TSKLASGVPARFSGSGSG--TSYSLTISSMEPEDAATYYCHQRG-------------------------SYTFGGGTKLEIK-,QVQLVQP-GAEVVKPGASVKLSCKTSG-YTFTS-----NWMHWVKQAPGQGLEWIGEIDPS---DSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPY-------------------YYAMDYWGQGTSVTVSS
-GDPa1-129,lorvotuzumab,154.15,99.39500000000001,96.92500000000001,2.7350000000000003,2.5549999999999997,5.37,0.28,0.14,1.5,11.625,60.65,73.825,80.09,IgG1,Kappa,Phase-II,Discontinued,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGGTGGAGTCCGGCGGTGGCGTAGTTCAGCCCGGAAGATCCCTGCGCCTGAGCTGCGCCGCTTCTGGATTCACTTTTAGCAGCTTCGGGATGCACTGGGTCAGGCAAGCACCTGGTAAAGGGCTCGAGTGGGTGGCCTATATCTCCTCAGGCAGTTTCACAATTTATTACGCCGACTCTGTCAAGGGCCGGTTTACGATATCACGAGATAACAGTAAGAACACCCTCTATCTTCAGATGAATAGCCTGCGGGCCGAAGACACAGCTGTCTACTACTGTGCAAGGATGAGAAAAGGGTACGCGATGGATTATTGGGGACAGGGCACCTTGGTTACTGTGTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTTGTTATGACCCAGTCCCCTCTGAGCCTGCCCGTGACTCTGGGTCAGCCAGCTAGCATTTCTTGTCGGTCCTCTCAGATTATTATACACAGTGACGGCAATACATATTTGGAGTGGTTCCAACAGAGGCCAGGGCAAAGTCCGAGGCGGCTTATCTACAAGGTGAGCAACCGATTCTCAGGGGTCCCTGACAGATTTTCTGGAAGCGGCTCCGGAACGGACTTTACCCTCAAAATCTCACGCGTGGAAGCCGAGGATGTGGGCGTATATTACTGCTTCCAGGGTTCCCATGTGCCCCACACTTTTGGGCAGGGAACAAAGGTCGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,1,DVVMTQSPLSLPVTLGQPASISCRSS--QIIIHSD-GNTYLEWFQQRPGQSPRRLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCFQGSH-----------------------VPHTFGQGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----FGMHWVRQAPGKGLEWVAYISSG---SFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKG---------------------YAMDYWGQGTLVTVSS
-GDPa1-130,lucatumumab,240.58,87.75,98.64500000000001,2.875,2.9850000000000003,3.74,0.0,0.01,0.0,-0.375,62.89,71.215,83.495,IgG1,Kappa,Phase-I,Discontinued,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTCGTGGAGAGCGGAGGCGGGGTGGTACAGCCCGGTCGGTCCCTCCGACTGTCTTGTGCTGCCTCTGGTTTCACATTTTCCAGTTACGGAATGCACTGGGTTCGGCAGGCACCGGGCAAAGGACTTGAGTGGGTCGCCGTCATATCATATGAAGAGTCAAACCGCTATCATGCAGATAGTGTTAAGGGGAGGTTCACGATCAGCAGGGACAATTCCAAGATTACCTTGTACCTGCAAATGAACAGCCTGAGAACTGAAGACACCGCTGTGTACTATTGCGCCAGAGACGGGGGCATCGCGGCCCCAGGACCTGATTACTGGGGCCAGGGCACTCTGGTGACAGTAAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR,MRAWIFFLLCLAGRALADIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTGTCATGACACAGAGTCCTCTGTCCCTGACCGTGACTCCTGGTGAGCCCGCCAGCATCAGCTGCCGCTCTTCTCAATCACTCCTCTATTCCAATGGGTACAACTATCTTGATTGGTATCTGCAGAAGCCAGGGCAGAGCCCCCAGGTCCTTATCTCTCTGGGATCCAACCGGGCATCAGGGGTTCCGGATCGATTCTCAGGCTCCGGAAGTGGCACCGACTTCACCTTGAAGATTAGCAGAGTGGAGGCTGAAGACGTGGGCGTGTACTACTGTATGCAGGCCAGGCAAACGCCCTTTACTTTTGGTCCAGGAACAAAAGTAGATATAAGGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,1,DIVMTQSPLSLTVTPGEPASISCRSS--QSLLYSN-GYNYLDWYLQKPGQSPQVLISL--------GSNRASGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCMQARQ-----------------------TPFTFGPGTKVDIR-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YGMHWVRQAPGKGLEWVAVISYE---ESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIA-------------------APGPDYWGQGTLVTVSS
-GDPa1-131,lumiliximab,140.25,97.5,96.32,2.7300000000000004,2.6900000000000004,3.71,,,1.12,2.125,54.31,68.82,,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCGTCGAGAGCGGCGGCGGCTTGGCAAAACCTGGCGGCTCCCTTAGACTGTCTTGTGCCGCGTCAGGATTTAGGTTCACGTTTAACAATTATTACATGGACTGGGTCCGGCAGGCTCCCGGTCAGGGGTTGGAGTGGGTTTCCAGGATCAGTTCTAGCGGTGATCCAACCTGGTACGCTGATAGTGTGAAGGGGCGATTCACCATTTCACGCGAAAACGCCAATAATACACTTTTCCTGCAAATGAACAGCCTGAGAGCCGAGGACACTGCCGTGTATTACTGCGCATCCCTCACTACAGGATCCGACAGCTGGGGGCAGGGAGTACTGGTTACCGTGTCATCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACCCAGTCTCCCAGCTCTCTGTCCGCCAGTGTGGGCGACAGGGTAACAATCACATGCCGGGCTAGCCAGGATATCAGATATTACCTTAACTGGTATCAGCAGAAACCAGGCAAAGCGCCCAAGTTGCTGATTTACGTCGCATCTAGCCTCCAATCCGGAGTCCCATCCCGATTTAGTGGCTCAGGATCAGGGACCGAATTCACTCTGACCGTGTCATCCCTCCAACCTGAGGATTTCGCCACTTATTACTGTCTGCAGGTTTACAGCACGCCTCGCACCTTTGGTCAGGGGACAAAGGTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQMTQSPSSLSASVGDRVTITCRAS--QDIR------YYLNWYQQKPGKAPKLLIYV--------ASSLQSGVPSRFSGSGSG--TEFTLTVSSLQPEDFATYYCLQVYS-----------------------TPRTFGQGTKVEIK-,EVQLVES-GGGLAKPGGSLRLSCAASG-FRFTFN---NYYMDWVRQAPGQGLEWVSRISSS---GDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTT-----------------------GSDSWGQGVLVTVSS
-GDPa1-132,lumretuzumab,301.96,99.64,98.62,3.035,2.96,,0.32,0.73,2.37,13.875,62.05,71.88499999999999,85.285,IgG1,Kappa,Phase-I,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFRSSYISWVRQAPGQGLEWMGWIYAGTGSPSYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARHRDYYSNSLTYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFRSSYISWVRQAPGQGLEWMGWIYAGTGSPSYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARHRDYYSNSLTYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTCGTCCAGAGCGGTGCTGAGGTGAAAAAGCCCGGCGCAAGTGTGAAAGTTTCCTGTAAGGCCTCTGGCTATACTTTCCGCTCCAGTTACATTTCCTGGGTTCGGCAAGCCCCTGGGCAGGGGCTGGAATGGATGGGATGGATCTATGCAGGTACAGGATCACCAAGTTACAATCAGAAGTTGCAGGGAAGAGTAACGATGACCACCGACACATCAACCAGCACAGCGTATATGGAGCTGAGGTCCCTTAGGTCTGATGACACTGCTGTGTACTACTGCGCCCGACACAGAGATTACTACAGCAACAGCCTGACTTATTGGGGGCAGGGCACCCTCGTCACAGTGTCTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAVSLGERATINCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQSDYSYPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQSDYSYPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGTTATGACACAGAGCCCAGACAGCCTCGCTGTAAGTCTGGGCGAAAGAGCAACAATAAATTGTAAATCTTCCCAGTCCGTGCTGAACTCCGGAAATCAGAAGAACTATCTGACCTGGTACCAGCAAAAGCCCGGCCAACCCCCTAAGTTGTTGATTTATTGGGCCAGTACCCGGGAATCTGGTGTGCCTGATAGGTTCAGCGGCTCTGGGTCAGGAACAGACTTTACTCTCACTATCTCCTCACTTCAGGCCGAGGATGTGGCGGTCTACTATTGCCAGTCAGACTACAGCTACCCATATACGTTCGGGCAGGGTACCAAACTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DIVMTQSPDSLAVSLGERATINCKSS--QSVLNSGNQKNYLTWYQQKPGQPPKLLIYW--------ASTRESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQSDYS-----------------------YPYTFGQGTKLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFRS-----SYISWVRQAPGQGLEWMGWIYAG---TGSPSYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARHRDYY-------------------SNSLTYWGQGTLVTVSS
-GDPa1-133,margetuximab,116.1,98.85499999999999,95.80000000000001,2.7350000000000003,2.715,,,,1.0,0.375,61.57,71.475,81.755,IgG1,Kappa,Approved,Active,QVQLQQSGPELVKPGASLKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYDPKFQDKATITADTSSNTAYLQVSRLTSEDTAVYYCSRWGGDGFYAMDYWGQGASVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGPELVKPGASLKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYDPKFQDKATITADTSSNTAYLQVSRLTSEDTAVYYCSRWGGDGFYAMDYWGQGASVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGCAGCAGAGCGGTCCTGAACTGGTCAAGCCCGGAGCTTCACTCAAACTGAGTTGCACAGCCTCAGGGTTTAACATAAAGGACACCTATATCCACTGGGTTAAACAGCGGCCGGAACAGGGCTTGGAGTGGATTGGTAGGATTTACCCAACGAATGGGTATACAAGATACGATCCCAAATTCCAAGACAAGGCGACTATCACCGCAGACACATCCTCCAACACTGCCTACCTCCAGGTCAGTCGCCTTACTTCCGAGGATACCGCTGTGTATTACTGTTCTCGATGGGGCGGAGATGGATTCTATGCCATGGACTACTGGGGGCAGGGCGCAAGCGTAACCGTGAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRYTGVPDRFTGSRSGTDFTFTISSVQAEDLAVYYCQQHYTTPPTFGGGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRYTGVPDRFTGSRSGTDFTFTISSVQAEDLAVYYCQQHYTTPPTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGATGACTCAGTCTCATAAGTTTATGTCAACATCAGTGGGAGATAGGGTCAGCATTACTTGTAAGGCGTCCCAAGATGTTAACACCGCAGTGGCCTGGTACCAGCAGAAACCTGGGCACAGTCCCAAATTGCTGATTTACTCCGCTTCCTTCCGCTATACCGGCGTACCAGATAGATTTACAGGAAGTCGGAGCGGGACAGACTTCACCTTTACGATATCTAGCGTCCAGGCCGAGGACCTCGCTGTGTACTATTGCCAACAGCACTATACCACCCCGCCCACATTCGGCGGTGGCACTAAGGTTGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,2,2,DIVMTQSHKFMSTSVGDRVSITCKAS--QDVN------TAVAWYQQKPGHSPKLLIYS--------ASFRYTGVPDRFTGSRSG--TDFTFTISSVQAEDLAVYYCQQHYT-----------------------TPPTFGGGTKVEIK-,QVQLQQS-GPELVKPGASLKLSCTASG-FNIKD-----TYIHWVKQRPEQGLEWIGRIYPT---NGYTRYDPKFQDKATITADTSSNTAYLQVSRLTSEDTAVYYCSRWGGDG-------------------FYAMDYWGQGASVTVSS
-GDPa1-134,matuzumab,291.17,99.84,98.07,2.74,2.6900000000000004,3.7300000000000004,0.0,0.0,0.0,0.125,63.65,69.25,,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTCGTTCAGTCCGGGGCCGAAGTCAAGAAACCTGGTGCTAGCGTGAAGGTGAGCTGTAAGGCCAGTGGATACACCTTTACATCACATTGGATGCACTGGGTAAGACAGGCGCCAGGCCAAGGCCTGGAGTGGATCGGCGAATTCAACCCCAGCAACGGTCGCACTAATTACAATGAGAAATTCAAGAGCAAAGCTACAATGACCGTGGATACGTCCACCAACACAGCCTACATGGAACTGTCAAGTCTTCGGTCTGAGGACACTGCAGTCTATTACTGCGCATCTAGGGACTATGATTATGATGGGCGATATTTTGACTACTGGGGGCAAGGAACTTTGGTTACCGTGTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACGCAGAGCCCCTCATCCCTCAGCGCCTCCGTTGGCGACAGGGTCACAATTACCTGTTCCGCGTCTAGTAGCGTAACTTATATGTACTGGTACCAACAAAAACCAGGAAAGGCACCGAAGCTTCTGATCTATGATACTTCTAACCTGGCTAGTGGGGTGCCTTCTAGATTCAGCGGAAGCGGCTCCGGTACTGACTACACCTTTACAATTTCATCTTTGCAGCCCGAAGACATTGCCACCTATTACTGCCAGCAGTGGAGTTCACACATCTTTACATTCGGCCAGGGGACCAAAGTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,1,DIQMTQSPSSLSASVGDRVTITCSAS--SSVT-------YMYWYQQKPGKAPKLLIYD--------TSNLASGVPSRFSGSGSG--TDYTFTISSLQPEDIATYYCQQWSS-----------------------HIFTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----HWMHWVRQAPGQGLEWIGEFNPS---NGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYD------------------GRYFDYWGQGTLVTVSS
-GDPa1-135,mavrilimumab,,99.89500000000001,90.07,2.685,2.925,1.01,0.315,0.1,3.25,1.625,57.98,67.88,85.93,IgG4,Lambda,Phase-II,Active,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAACTGGTCCAGTCCGGGGCTGAAGTGAAAAAGCCTGGTGCAAGTGTCAAGGTGTCCTGCAAGGTTAGTGGTTACACACTCACCGAACTGTCTATCCACTGGGTGCGCCAGGCGCCCGGCAAAGGACTTGAGTGGATGGGAGGGTTCGATCCGGAGGAGAACGAGATTGTGTACGCCCAGAGGTTTCAGGGGCGGGTGACTATGACGGAAGACACTAGCACCGATACAGCCTACATGGAATTGTCATCACTGAGAAGCGAGGACACAGCCGTGTATTATTGTGCTATAGTCGGCTCTTTCTCCCCACTGACCTTGGGCCTCTGGGGCCAAGGAACCATGGTAACTGTTAGCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCAGTCTTGACACAGCCCCCATCCGTGAGCGGAGCCCCTGGACAGAGGGTGACTATCAGTTGTACTGGGTCTGGGTCCAATATAGGCGCCCCCTACGACGTCAGCTGGTACCAGCAACTTCCAGGGACAGCGCCTAAGCTGCTCATCTATCACAACAACAAAAGACCGTCCGGCGTTCCCGATCGGTTCTCTGGGTCCAAGTCAGGTACGAGTGCAAGCCTGGCTATTACCGGATTGCAAGCAGAGGATGAGGCCGACTACTATTGCGCCACAGTGGAAGCTGGTCTGTCTGGCAGCGTGTTTGGCGGAGGCACCAAACTCACCGTACTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,2,QSVLTQP-PSVSGAPGQRVTISCTGSG-SNIGA----PYDVSWYQQLPGTAPKLLIYH--------NNKRPSGVPDRFSGSKSG--TSASLAITGLQAEDEADYYCATVEAG---------------------LSGSVFGGGTKLTVL-,QVQLVQS-GAEVKKPGASVKVSCKVSG-YTLTE-----LSIHWVRQAPGKGLEWMGGFDPE---ENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFS-------------------PLTLGLWGQGTMVTVSS
-GDPa1-136,mepolizumab,319.37,97.805,94.485,2.725,2.5700000000000003,,0.0,0.0,0.37000000000000005,-0.875,61.555,70.52000000000001,84.07,IgG1,Kappa,Phase-II,Discontinued,QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS,MRAWIFFLLCLAGRALAQVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCACACTCCGGGAGAGCGGACCAGCTCTTGTGAAGCCCACTCAGACCCTGACCTTGACTTGTACGGTGAGCGGGTTCTCACTGACAAGCTATTCAGTGCACTGGGTGCGACAACCTCCAGGCAAAGGACTTGAATGGCTGGGCGTCATTTGGGCCTCCGGCGGTACCGACTACAATTCTGCCCTCATGAGTCGCCTGAGTATCTCCAAGGACACATCAAGAAACCAGGTAGTGTTGACCATGACTAACATGGATCCCGTCGACACTGCGACCTACTATTGCGCAAGGGATCCGCCTTCTTCCCTGCTCAGACTGGATTACTGGGGCAGGGGGACACCCGTTACGGTTTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATAGTAATGACTCAGAGCCCTGATTCACTGGCGGTGAGCCTCGGAGAGAGAGCTACCATCAACTGTAAGAGCAGCCAATCCTTGCTCAACTCCGGTAATCAGAAAAACTATTTGGCTTGGTACCAACAGAAGCCCGGCCAGCCACCAAAACTGCTTATTTACGGAGCCTCCACTCGGGAATCCGGGGTGCCCGACAGGTTTTCTGGCTCTGGGTCAGGCACAGACTTTACACTGACCATCTCTAGTCTGCAGGCCGAGGACGTCGCAGTTTACTATTGCCAGAATGTGCACAGTTTCCCTTTCACCTTCGGGGGTGGAACGAAGCTTGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,3,DIVMTQSPDSLAVSLGERATINCKSS--QSLLNSGNQKNYLAWYQQKPGQPPKLLIYG--------ASTRESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQNVHS-----------------------FPFTFGGGTKLEIK-,QVTLRES-GPALVKPTQTLTLTCTVSG-FSLTS-----YSVHWVRQPPGKGLEWLGVIWA----SGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSS-------------------LLRLDYWGRGTPVTVSS
-GDPa1-137,milatuzumab,162.76,99.62,96.635,2.6900000000000004,2.49,,0.7,0.1,0.5,-0.5,62.58,69.91,82.93,IgG1,Kappa,Phase-I/II,Discontinued,QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGVNWIKQAPGQGLQWMGWINPNTGEPTFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCSRSRGKNEAWFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGSELKKPGASVKVSCKASGYTFTNYGVNWIKQAPGQGLQWMGWINPNTGEPTFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCSRSRGKNEAWFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAGTTGCAGCAGTCTGGAAGCGAACTGAAGAAACCAGGTGCGTCAGTCAAGGTCAGCTGTAAGGCATCAGGATATACGTTCACCAACTACGGGGTGAATTGGATAAAGCAGGCCCCGGGTCAAGGACTTCAATGGATGGGCTGGATCAATCCCAACACAGGCGAGCCTACCTTTGATGATGACTTTAAAGGCCGGTTCGCTTTCAGCCTCGACACCAGTGTGTCTACTGCTTACCTGCAGATTAGCTCTCTGAAAGCCGATGACACTGCCGTGTATTTCTGCTCCAGATCCAGGGGGAAGAACGAGGCATGGTTTGCCTACTGGGGCCAGGGGACACTCGTTACAGTGTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPLSLPVTLGQPASISCRSSQSLVHRNGNTYLHWFQQRPGQSPRLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCSQSSHVPPTFGAGTRLEIK,MRAWIFFLLCLAGRALADIQLTQSPLSLPVTLGQPASISCRSSQSLVHRNGNTYLHWFQQRPGQSPRLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCSQSSHVPPTFGAGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAGCTCACACAGTCTCCCCTGAGCCTTCCTGTGACACTGGGTCAACCTGCATCAATTTCATGCCGCTCCAGCCAATCTTTGGTGCACAGGAACGGAAACACCTATCTTCATTGGTTCCAGCAGAGACCCGGCCAGAGCCCCCGGCTGCTCATTTACACGGTCTCCAATAGATTTTCCGGTGTGCCGGACAGGTTTAGTGGAAGTGGGTCAGGGACTGATTTCACCCTGAAAATCAGTCGGGTAGAAGCCGAGGACGTGGGGGTCTACTTTTGTTCCCAGAGCTCTCACGTTCCACCAACTTTCGGCGCTGGCACCCGATTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,1,4,DIQLTQSPLSLPVTLGQPASISCRSS--QSLVHRN-GNTYLHWFQQRPGQSPRLLIYT--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYFCSQSSH-----------------------VPPTFGAGTRLEIK-,QVQLQQS-GSELKKPGASVKVSCKASG-YTFTN-----YGVNWIKQAPGQGLQWMGWINPN---TGEPTFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCSRSRGKN-------------------EAWFAYWGQGTLVTVSS
-GDPa1-138,mirikizumab,133.78,99.515,89.9,2.745,2.675,,,,5.37,20.375,55.53,68.845,78.36500000000001,IgG4,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYKFTRYVMHWVRQAPGQGLEWMGYINPYNDGTNYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNWDTGLWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYKFTRYVMHWVRQAPGQGLEWMGYINPYNDGTNYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNWDTGLWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAACTTGTTCAGAGTGGCGCCGAGGTGAAGAAACCTGGTAGCTCTGTGAAGGTAAGCTGTAAAGCTTCCGGGTACAAGTTCACCCGCTATGTGATGCACTGGGTGCGGCAGGCCCCCGGCCAGGGACTGGAATGGATGGGTTACATCAATCCATACAACGACGGAACGAACTATAATGAAAAGTTTAAAGGCCGAGTCACCATTACCGCGGATAAGTCCACATCAACTGCTTATATGGAGCTGTCTTCCTTGAGAAGCGAGGATACAGCCGTCTACTATTGCGCAAGGAACTGGGACACCGGGCTCTGGGGACAAGGGACTACAGTTACTGTGTCAAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCKASDHILKFLTWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQMYWSTPFTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASDHILKFLTWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQMYWSTPFTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACACAGTCCCCCTCTTCTCTGTCCGCGAGCGTGGGAGATAGAGTCACAATAACCTGTAAGGCATCAGACCACATCCTGAAATTCCTCACGTGGTATCAGCAGAAACCTGGGAAGGCCCCCAAGCTGCTTATCTACGGCGCCACTAGCTTGGAAACAGGCGTGCCAAGTAGGTTCTCAGGAAGCGGGTCCGGTACCGACTTTACCCTGACAATCAGTAGCCTCCAACCTGAGGATTTCGCTACTTACTACTGCCAAATGTATTGGTCTACTCCATTTACCTTTGGTGGGGGCACCAAGGTTGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,0,DIQMTQSPSSLSASVGDRVTITCKAS--DHIL------KFLTWYQQKPGKAPKLLIYG--------ATSLETGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQMYWS-----------------------TPFTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YKFTR-----YVMHWVRQAPGQGLEWMGYINPY---NDGTNYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNWD------------------------TGLWGQGTTVTVSS
-GDPa1-139,mirvetuximab,100.17,99.86500000000001,96.9,2.715,2.6500000000000004,,,,1.87,1.0,60.805,73.16,79.07,IgG1,Kappa,Approved,Active,QVQLVQSGAEVVKPGASVKISCKASGYTFTGYFMNWVKQSPGQSLEWIGRIHPYDGDTFYNQKFQGKATLTVDKSSNTAHMELLSLTSEDFAVYYCTRYDGSRAMDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVVKPGASVKISCKASGYTFTGYFMNWVKQSPGQSLEWIGRIHPYDGDTFYNQKFQGKATLTVDKSSNTAHMELLSLTSEDFAVYYCTRYDGSRAMDYWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTCGTCCAGAGCGGAGCTGAAGTTGTGAAGCCAGGAGCCTCCGTTAAGATTTCCTGCAAGGCTAGCGGCTACACATTCACCGGGTATTTCATGAACTGGGTGAAACAGAGCCCCGGCCAGAGTCTGGAGTGGATCGGGAGAATACACCCTTATGACGGTGACACATTTTACAATCAGAAATTTCAAGGGAAAGCGACTCTGACGGTAGACAAGTCCTCTAACACAGCACATATGGAGTTGCTGTCACTTACCTCTGAAGATTTCGCCGTCTACTACTGTACTAGGTATGATGGTTCACGGGCCATGGATTATTGGGGCCAGGGAACCACTGTGACCGTGAGTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVLTQSPLSLAVSLGQPAIISCKASQSVSFAGTSLMHWYHQKPGQQPRLLIYRASNLEAGVPDRFSGSGSKTDFTLTISPVEAEDAATYYCQQSREYPYTFGGGTKLEIK,MRAWIFFLLCLAGRALADIVLTQSPLSLAVSLGQPAIISCKASQSVSFAGTSLMHWYHQKPGQQPRLLIYRASNLEAGVPDRFSGSGSKTDFTLTISPVEAEDAATYYCQQSREYPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTCCTCACTCAGTCACCCCTTAGCCTCGCCGTGTCACTGGGTCAGCCTGCAATTATCAGTTGCAAAGCTTCTCAATCCGTTTCCTTCGCCGGCACCAGCCTTATGCATTGGTATCACCAGAAGCCTGGACAGCAACCCCGGTTGTTGATATACAGGGCAAGTAACCTGGAGGCCGGGGTACCAGATCGCTTCAGCGGCAGCGGGTCTAAGACTGATTTTACCCTGACGATCTCCCCAGTGGAAGCCGAAGACGCGGCTACATACTACTGTCAGCAGTCTAGAGAGTATCCCTATACCTTTGGAGGCGGTACAAAGCTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,4,DIVLTQSPLSLAVSLGQPAIISCKAS--QSVSFA--GTSLMHWYHQKPGQQPRLLIYR--------ASNLEAGVPDRFSGSGSK--TDFTLTISPVEAEDAATYYCQQSRE-----------------------YPYTFGGGTKLEIK-,QVQLVQS-GAEVVKPGASVKISCKASG-YTFTG-----YFMNWVKQSPGQSLEWIGRIHPY---DGDTFYNQKFQGKATLTVDKSSNTAHMELLSLTSEDFAVYYCTRYDGS---------------------RAMDYWGQGTTVTVSS
-GDPa1-140,mitazalimab,678.57,99.58,98.34,2.75,2.7350000000000003,4.109999999999999,0.68,0.45,22.5,20.625,63.105000000000004,69.25999999999999,81.95,IgG1,Lambda,Phase-II,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAACTGCTGGAGTCTGGCGGGGGCCTCGTCCAGCCTGGAGGTTCACTCCGACTGAGTTGCGCAGCTAGCGGCTTTACATTTTCCACCTACGGGATGCACTGGGTCCGGCAGGCCCCCGGAAAGGGTCTTGAATGGCTCTCCTACATTTCCGGGGGCTCCAGCTATATCTTCTACGCCGATTCAGTTCGGGGTCGCTTCACAATAAGTAGAGACAACAGCGAGAACGCGCTGTATCTGCAGATGAATTCTCTTAGGGCAGAGGACACGGCCGTATACTATTGTGCTAGAATCCTGAGGGGCGGCTCAGGGATGGATTTGTGGGGACAGGGAACCTTGGTGACTGTGAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGAGCGTGCTGACCCAACCTCCATCCGCCTCTGGCACACCCGGGCAGCGGGTTACGATCTCCTGTACCGGCTCTTCATCTAATATCGGTGCTGGGTACAACGTCTATTGGTACCAGCAGCTGCCCGGAACTGCGCCGAAACTCCTTATTTACGGAAATATAAACAGGCCAAGTGGCGTGCCTGATCGCTTTTCAGGCAGCAAGTCCGGAACCAGTGCATCCCTGGCTATTAGCGGGCTGAGAAGCGAGGACGAAGCCGATTATTATTGCGCAGCCTGGGACAAGAGTATCTCAGGTCTCGTGTTCGGGGGCGGAACAAAATTGACTGTACTTGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,2,4,QSVLTQP-PSASGTPGQRVTISCTGSS-SNIGA----GYNVYWYQQLPGTAPKLLIYG--------NINRPSGVPDRFSGSKSG--TSASLAISGLRSEDEADYYCAAWDKS---------------------ISGLVFGGGTKLTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFST-----YGMHWVRQAPGKGLEWLSYISGG---SSYIFYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYCARILRGG--------------------SGMDLWGQGTLVTVSS
-GDPa1-141,mogamulizumab,100.17,100.0,94.18,2.7300000000000004,2.705,,,,0.25,-0.125,61.56,71.26,85.05,IgG1,Kappa,Approved,Active,EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTACAACTCGTGGAGTCCGGGGGCGATCTTGTGCAGCCCGGCCGAAGCCTTCGCCTGTCATGTGCTGCCTCAGGCTTTATCTTCAGTAACTATGGAATGAGTTGGGTTAGGCAGGCACCTGGCAAGGGCTTGGAATGGGTGGCGACAATATCCAGTGCCAGCACGTACTCTTATTACCCAGACTCCGTCAAGGGTAGATTCACCATTTCTAGAGATAATGCCAAAAACAGCCTGTACCTCCAGATGAATTCCCTGAGGGTCGAGGACACCGCTTTGTATTACTGCGGGCGGCACTCTGACGGTAACTTTGCATTCGGATATTGGGGGCAGGGAACTCTGGTGACAGTTAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTGTTGATGACTCAGTCTCCCTTGAGCCTGCCTGTTACCCCAGGTGAACCCGCTTCCATATCATGCCGGAGTAGCCGAAATATCGTGCACATTAACGGTGACACATATCTGGAGTGGTATCTCCAGAAGCCTGGGCAGAGCCCCCAACTCCTGATCTACAAGGTATCAAACCGCTTCTCCGGAGTCCCAGATAGATTCAGTGGCTCTGGAAGCGGGACAGACTTTACTCTGAAGATCTCTAGGGTTGAGGCCGAAGACGTCGGGGTGTACTACTGTTTCCAGGGCTCCCTTCTTCCGTGGACGTTTGGACAAGGCACCAAAGTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,1,DVLMTQSPLSLPVTPGEPASISCRSS--RNIVHIN-GDTYLEWYLQKPGQSPQLLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCFQGSL-----------------------LPWTFGQGTKVEIK-,EVQLVES-GGDLVQPGRSLRLSCAASG-FIFSN-----YGMSWVRQAPGKGLEWVATISSA---STYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGN--------------------FAFGYWGQGTLVTVSS
-GDPa1-142,monalizumab,302.17,99.14,88.30000000000001,2.7699999999999996,2.8099999999999996,1.54,0.1,0.1,2.0,1.625,57.349999999999994,66.65,75.18,IgG4,Kappa,Phase-III,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTGCAGTCAGGGGCAGAAGTCAAAAAGCCAGGTGCCTCCGTGAAGGTCTCCTGCAAAGCTTCAGGATACACATTCACCAGCTATTGGATGAACTGGGTGCGGCAGGCACCCGGCCAGGGACTGGAATGGATGGGCAGGATCGATCCTTATGATAGTGAGACACACTACGCCCAGAAGCTTCAGGGCCGCGTGACAATGACAACGGATACCAGCACCTCTACTGCTTACATGGAGTTGAGAAGTCTGAGGTCCGACGACACGGCGGTATACTATTGTGCCCGAGGGGGCTATGACTTTGACGTCGGCACTCTCTACTGGTTTTTCGATGTGTGGGGGCAAGGAACTACCGTTACCGTTTCTAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGTPRTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGTPRTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACTCAGAGTCCCAGCAGTCTGTCTGCTTCCGTTGGCGACAGGGTCACGATTACCTGTAGAGCCTCAGAGAACATATACAGCTATCTCGCGTGGTACCAGCAAAAACCTGGCAAAGCACCAAAGTTGCTTATTTATAATGCCAAAACCCTGGCTGAAGGCGTGCCTTCCCGGTTTTCTGGGAGCGGGTCAGGTACCGATTTCACACTCACTATCTCTTCCCTGCAACCCGAAGATTTTGCCACCTATTACTGCCAGCATCACTACGGGACTCCACGCACATTCGGAGGTGGAACAAAGGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSLSASVGDRVTITCRAS--ENIY------SYLAWYQQKPGKAPKLLIYN--------AKTLAEGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQHHYG-----------------------TPRTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----YWMNWVRQAPGQGLEWMGRIDPY---DSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVG--------------TLYWFFDVWGQGTTVTVSS
-GDPa1-143,mosunetuzumab,244.68,99.88,97.63,2.685,2.45,4.27,0.68,0.24,4.87,18.625,60.83,70.2,82.33,IgG1,Kappa,Approved,Active,EVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVRQAPGQGLEWIGWIYPGDGNTKYNEKFKGRATLTADTSTSTAYLELSSLRSEDTAVYYCARDSYSNYYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVRQAPGQGLEWIGWIYPGDGNTKYNEKFKGRATLTADTSTSTAYLELSSLRSEDTAVYYCARDSYSNYYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGCTGGTTCAGAGCGGTGCCGAAGTAAAGAAGCCAGGAGCCTCTGTGAAAGTCAGTTGTAAGGCCTCTGGCTATACCTTCACAAATTACTACATACACTGGGTGCGCCAAGCGCCTGGACAGGGATTGGAGTGGATTGGGTGGATCTACCCCGGCGATGGCAACACCAAGTACAACGAAAAATTTAAAGGGAGAGCAACTCTTACGGCCGATACATCTACTAGCACCGCTTACCTGGAGCTCTCCTCCCTCCGGTCAGAGGACACAGCAGTGTACTATTGCGCTAGGGACTCCTATAGCAATTACTATTTCGACTATTGGGGTCAGGGGACCCTGGTGACTGTCAGTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRTRKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCTQSFILRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCKSSQSLLNSRTRKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCTQSFILRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATAGTTATGACTCAGTCTCCTGACTCCTTGGCCGTGAGTCTGGGCGAAAGGGCAACGATCAACTGCAAGAGCTCTCAGAGTTTGCTCAACTCTCGCACCCGAAAAAATTACCTCGCGTGGTACCAACAGAAGCCGGGACAACCCCCAAAACTGCTTATTTACTGGGCCTCCACCAGAGAGTCCGGCGTCCCCGATCGGTTTTCAGGAAGCGGCAGCGGGACAGATTTCACACTTACAATCTCAAGCCTGCAGGCTGAGGACGTAGCTGTGTATTATTGTACCCAGTCCTTCATTCTGAGGACTTTTGGGCAGGGTACCAAAGTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DIVMTQSPDSLAVSLGERATINCKSS--QSLLNSRTRKNYLAWYQQKPGQPPKLLIYW--------ASTRESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCTQSFI------------------------LRTFGQGTKVEIK-,EVQLVQS-GAEVKKPGASVKVSCKASG-YTFTN-----YYIHWVRQAPGQGLEWIGWIYPG---DGNTKYNEKFKGRATLTADTSTSTAYLELSSLRSEDTAVYYCARDSYSN--------------------YYFDYWGQGTLVTVSS
-GDPa1-144,motavizumab,383.43,98.84,97.825,2.75,2.6950000000000003,,0.57,0.32,0.0,2.125,62.93,70.38,83.82,IgG1,Kappa,Phase-III,Discontinued,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGACACTGAGGGAGTCAGGACCAGCCCTTGTCAAACCCACCCAGACATTGACCCTGACATGTACGTTCTCTGGTTTCAGTCTCTCAACGGCGGGGATGAGCGTTGGGTGGATCAGACAGCCCCCTGGAAAGGCTTTGGAATGGCTCGCCGACATTTGGTGGGATGATAAAAAGCACTATAACCCATCTCTGAAAGATCGCCTGACTATCAGTAAGGACACTTCCAAGAACCAAGTCGTACTTAAGGTGACTAATATGGACCCTGCAGATACCGCTACCTACTATTGCGCCCGGGACATGATATTTAATTTCTACTTTGACGTGTGGGGCCAGGGCACAACCGTTACTGTGAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACTCAATCACCTTCTACATTGTCAGCGAGTGTAGGCGATAGAGTCACCATCACCTGCTCCGCAAGCAGCCGCGTGGGATATATGCACTGGTACCAGCAGAAGCCAGGCAAAGCCCCAAAACTCCTGATTTATGACACCTCCAAGCTTGCCAGCGGGGTGCCCAGCAGGTTCTCCGGCTCCGGAAGTGGTACAGAGTTTACTCTGACTATTTCTTCTCTGCAACCCGATGACTTCGCTACCTATTACTGTTTTCAGGGGTCAGGCTACCCTTTTACGTTCGGGGGAGGTACAAAAGTTGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,3,DIQMTQSPSTLSASVGDRVTITCSAS--SRVG-------YMHWYQQKPGKAPKLLIYD--------TSKLASGVPSRFSGSGSG--TEFTLTISSLQPDDFATYYCFQGSG-----------------------YPFTFGGGTKVEIK-,QVTLRES-GPALVKPTQTLTLTCTFSG-FSLSTA---GMSVGWIRQPPGKALEWLADIWW----DDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFN--------------------FYFDVWGQGTTVTVSS
-GDPa1-145,muromonab,91.04,99.91499999999999,95.94,2.715,2.4699999999999998,4.515,,,4.25,12.125,59.58,70.85,80.0,IgG2,Kappa,Approved (withdrawn),Discontinued,QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS,MRAWIFFLLCLAGRALAQVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAGCTGCAGCAGTCCGGAGCCGAACTCGCTCGCCCCGGTGCAAGCGTGAAGATGAGTTGCAAAGCCAGCGGCTATACATTCACCCGATATACAATGCATTGGGTCAAGCAAAGACCAGGACAGGGGCTGGAGTGGATTGGTTACATCAATCCTAGTAGGGGCTACACCAACTATAACCAGAAGTTTAAAGACAAGGCAACCTTGACTACAGACAAATCTTCTTCCACCGCCTACATGCAACTTAGCTCTCTGACGAGCGAGGATTCAGCTGTGTACTACTGCGCGCGGTATTACGATGACCACTATTGTCTCGATTACTGGGGGCAGGGCACAACTCTGACTGTTTCCTCAGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIK,MRAWIFFLLCLAGRALAQIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATAGTGCTCACCCAGAGCCCAGCCATCATGTCAGCCTCTCCCGGCGAGAAGGTCACAATGACCTGCAGTGCTTCTTCCTCCGTGAGCTACATGAACTGGTATCAGCAGAAAAGCGGAACTTCCCCTAAAAGATGGATTTATGATACCAGCAAGCTGGCCAGTGGGGTTCCGGCGCACTTTAGGGGTAGCGGATCCGGGACGTCCTACTCTTTGACCATCTCTGGCATGGAGGCTGAAGACGCAGCAACATATTACTGTCAACAATGGAGTTCAAATCCCTTCACTTTCGGTTCAGGCACAAAACTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,4,QIVLTQSPAIMSASPGEKVTMTCSAS--SSVS-------YMNWYQQKSGTSPKRWIYD--------TSKLASGVPAHFRGSGSG--TSYSLTISGMEAEDAATYYCQQWSS-----------------------NPFTFGSGTKLEIK-,QVQLQQS-GAELARPGASVKMSCKASG-YTFTR-----YTMHWVKQRPGQGLEWIGYINPS---RGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDH--------------------YCLDYWGQGTTLTVSS
-GDPa1-146,natalizumab,294.08,97.93,90.065,2.77,2.75,,0.1,0.1,0.8700000000000001,2.5,55.01,68.29,81.36,IgG4,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTCGTGCAGTCCGGCGCAGAGGTTAAGAAACCTGGAGCTAGTGTCAAGGTATCATGCAAGGCATCTGGTTTCAATATCAAAGACACATATATTCACTGGGTCAGACAGGCCCCAGGTCAACGGTTGGAGTGGATGGGAAGGATAGATCCCGCCAACGGGTATACGAAATACGATCCGAAGTTTCAGGGGAGGGTGACTATCACCGCGGACACAAGCGCAAGCACCGCCTACATGGAGCTGAGTTCACTTCGAAGCGAAGACACTGCTGTGTATTACTGTGCTCGCGAAGGCTACTACGGCAACTACGGGGTGTATGCCATGGATTATTGGGGACAGGGCACCCTGGTGACAGTTTCTTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACTCAATCTCCATCAAGCCTCTCTGCCTCCGTCGGCGACAGAGTTACAATCACCTGCAAAACAAGCCAGGACATTAATAAGTACATGGCGTGGTACCAGCAGACTCCTGGGAAAGCCCCACGGCTGCTGATTCACTATACATCCGCACTGCAGCCCGGAATACCCAGTCGCTTCAGTGGAAGCGGGTCCGGTAGGGACTACACCTTCACTATTTCATCTCTTCAACCTGAGGATATCGCTACGTATTACTGTCTCCAGTATGATAACTTGTGGACCTTTGGCCAGGGCACCAAGGTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSLSASVGDRVTITCKTS--QDIN------KYMAWYQQTPGKAPRLLIHY--------TSALQPGIPSRFSGSGSG--RDYTFTISSLQPEDIATYYCLQYDN------------------------LWTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-FNIKD-----TYIHWVRQAPGQRLEWMGRIDPA---NGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNY----------------GVYAMDYWGQGTLVTVSS
-GDPa1-147,necitumumab,248.86,99.89500000000001,98.095,2.885,3.01,,0.49,0.0,0.25,2.125,60.5,70.59,83.78,IgG1,Kappa,Approved,Active,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGCAGGAGTCAGGCCCGGGTCTTGTGAAACCCAGCCAGACCCTGAGTCTGACCTGTACTGTAAGCGGCGGATCTATTAGCAGTGGAGACTACTATTGGAGCTGGATCAGACAACCTCCCGGCAAGGGTTTGGAATGGATAGGCTACATCTATTACTCCGGGTCAACCGATTATAATCCAAGCCTCAAGTCCCGGGTGACAATGTCCGTGGACACAAGTAAAAACCAGTTTTCTCTGAAGGTTAACTCCGTTACTGCCGCCGATACAGCTGTCTACTACTGCGCAAGGGTCTCTATTTTCGGCGTGGGGACCTTCGACTATTGGGGGCAGGGAACTCTCGTCACGGTGTCATCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK,MRAWIFFLLCLAGRALAEIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGATGACGCAGAGCCCCGCAACACTCAGCCTCTCCCCGGGAGAAAGAGCCACCCTGTCCTGTCGAGCTTCTCAGTCTGTTTCATCATATCTTGCTTGGTACCAGCAAAAACCCGGGCAAGCGCCACGCCTGTTGATCTATGACGCCAGTAACCGGGCCACCGGGATTCCTGCCAGGTTCAGCGGGAGTGGCTCCGGCACAGATTTTACCCTGACAATATCTTCCTTGGAACCTGAGGACTTTGCTGTCTACTACTGCCACCAGTATGGTAGCACCCCACTGACTTTCGGCGGAGGTACTAAGGCAGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,3,EIVMTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCHQYGS-----------------------TPLTFGGGTKAEIK-,QVQLQES-GPGLVKPSQTLSLTCTVSG-GSISSG---DYYWSWIRQPPGKGLEWIGYIYY----SGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFG-------------------VGTFDYWGQGTLVTVSS
-GDPa1-148,nesvacumab,154.15,99.875,97.52,2.75,2.755,,,,-0.5,-0.125,55.41,64.05,80.14,IgG1,Kappa,Phase-I,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDIHWVRQATGKGLEWVSAIGPAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGLITFGGLIAPFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDIHWVRQATGKGLEWVSAIGPAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGLITFGGLIAPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGTTGGTAGAAAGCGGCGGTGGCCTTGTGCAGCCTGGGGGTAGCCTGCGGCTCAGTTGTGCTGCGAGCGGATTTACTTTCAGTTCATACGACATCCACTGGGTGCGCCAGGCCACCGGGAAGGGACTGGAATGGGTTTCCGCCATTGGCCCAGCCGGGGATACGTACTATCCGGGCTCTGTTAAAGGCAGGTTTACCATATCTCGAGAGAATGCAAAGAACTCACTGTATCTGCAGATGAACTCCCTTAGGGCTGGGGATACAGCTGTGTACTACTGCGCAAGAGGACTCATTACCTTCGGGGGACTGATCGCCCCCTTCGACTATTGGGGCCAAGGTACATTGGTCACTGTGTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYDNSQTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYDNSQTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATAGTGCTTACCCAGTCCCCTGGAACTCTGTCCCTGAGTCCCGGGGAGCGAGCCACACTCAGCTGCCGCGCTAGCCAGTCTGTGAGCTCCACCTATCTCGCGTGGTACCAGCAAAAACCTGGTCAAGCACCAAGGCTTTTGATCTACGGCGCTAGCTCTCGGGCCACCGGAATCCCAGATAGGTTCAGTGGGTCAGGGTCCGGCACTGACTTTACACTGACCATTTCTAGACTGGAACCCGAGGACTTTGCCGTCTACTATTGTCAGCACTATGATAACTCACAGACATTCGGCCAGGGTACGAAGGTTGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----TYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQHYDN------------------------SQTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YDIHWVRQATGKGLEWVSAIGP----AGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGLITFGG----------------LIAPFDYWGQGTLVTVSS
-GDPa1-149,nimotuzumab,60.31,100.0,94.94,2.75,2.73,,,,1.25,-0.125,60.48,69.58,84.39,IgG1,Kappa,Approved,Active,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTNYYIYWVRQAPGQGLEWIGGINPTSGGSNFNEKFKTRVTITADESSTTAYMELSSLRSEDTAFYFCTRQGLWFDSDGRGFDFWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGAEVKKPGSSVKVSCKASGYTFTNYYIYWVRQAPGQGLEWIGGINPTSGGSNFNEKFKTRVTITADESSTTAYMELSSLRSEDTAFYFCTRQGLWFDSDGRGFDFWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGCAGCAGTCCGGTGCGGAGGTGAAGAAACCTGGTTCATCAGTCAAGGTGTCCTGCAAAGCCTCCGGCTATACGTTTACTAACTACTATATTTACTGGGTGCGGCAAGCTCCCGGGCAGGGGCTCGAGTGGATCGGCGGAATCAATCCAACCAGTGGAGGCTCTAACTTCAATGAAAAGTTTAAAACACGCGTCACCATAACAGCAGACGAGTCCTCTACTACCGCCTACATGGAATTGAGCAGTCTTAGGAGCGAAGATACTGCTTTCTATTTCTGTACAAGACAGGGGCTGTGGTTTGATAGCGACGGGCGAGGATTCGACTTTTGGGGCCAAGGCACAACCGTAACCGTTTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRSSQNIVHSNGNTYLDWYQQTPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFQYSHVPWTFGQGTKLQIT,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRSSQNIVHSNGNTYLDWYQQTPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFQYSHVPWTFGQGTKLQITRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAAATGACACAGAGTCCTTCATCCCTGTCTGCCAGCGTAGGCGACAGAGTTACAATTACCTGCCGATCCTCTCAGAATATTGTGCACTCAAACGGTAATACATATCTGGACTGGTATCAGCAGACGCCCGGCAAAGCACCAAAACTTTTGATCTACAAGGTCTCTAACAGGTTTAGCGGCGTGCCCAGCCGGTTCTCCGGAAGTGGTTCCGGAACCGACTTTACCTTCACCATATCAAGCCTCCAGCCTGAGGATATCGCTACTTATTACTGTTTTCAATACAGTCATGTGCCATGGACTTTCGGGCAGGGGACAAAGCTGCAGATCACTAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQMTQSPSSLSASVGDRVTITCRSS--QNIVHSN-GNTYLDWYQQTPGKAPKLLIYK--------VSNRFSGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCFQYSH-----------------------VPWTFGQGTKLQIT-,QVQLQQS-GAEVKKPGSSVKVSCKASG-YTFTN-----YYIYWVRQAPGQGLEWIGGINPT---SGGSNFNEKFKTRVTITADESSTTAYMELSSLRSEDTAFYFCTRQGLWFDS----------------DGRGFDFWGQGTTVTVSS
-GDPa1-150,nivolumab,,,,,,,,,,,,,,IgG4,Kappa,Approved,Active,QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTCGAATCTGGCGGCGGAGTCGTTCAACCCGGGCGGTCCTTGCGACTGGACTGCAAAGCTTCTGGGATTACTTTTAGTAACTCCGGGATGCACTGGGTAAGGCAGGCTCCTGGCAAAGGTCTGGAGTGGGTGGCCGTCATCTGGTATGATGGAAGCAAGCGCTATTACGCCGACTCCGTGAAGGGTAGATTCACCATATCAAGGGACAACAGTAAGAATACCCTCTTCCTGCAAATGAACTCACTCAGAGCAGAGGATACAGCCGTGTACTACTGTGCGACAAATGATGACTATTGGGGACAGGGCACGCTTGTGACTGTGAGCAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTGCTGACTCAATCCCCAGCCACCCTCTCACTGTCTCCAGGAGAGCGAGCCACCTTGTCTTGCAGAGCGAGTCAGAGCGTTTCAAGCTATCTGGCTTGGTACCAGCAGAAACCTGGGCAGGCCCCTAGGCTGCTCATTTACGACGCTTCAAACCGCGCAACGGGTATTCCCGCCCGGTTCTCCGGCAGCGGCTCCGGGACAGACTTCACTCTTACCATCTCTAGCCTTGAACCGGAGGATTTTGCAGTGTATTACTGTCAGCAGTCCAGTAATTGGCCCAGAACATTTGGACAAGGCACAAAGGTCGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,2,3,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQSSN-----------------------WPRTFGQGTKVEIK-,QVQLVES-GGGVVQPGRSLRLDCKASG-ITFSN-----SGMHWVRQAPGKGLEWVAVIWYD---GSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATND--------------------------DYWGQGTLVTVSS
-GDPa1-151,obexelimab,190.23,99.89,97.825,2.9000000000000004,2.8049999999999997,3.795,0.21,0.7,1.0,2.875,61.665,70.55000000000001,81.87,IgG1,Kappa,Phase-III,Active,EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAACTGGTGGAATCTGGTGGAGGGCTGGTGAAGCCAGGCGGATCCTTGAAACTGAGTTGTGCGGCTTCCGGATATACATTCACCTCTTACGTAATGCACTGGGTCAGACAGGCCCCTGGTAAAGGGCTCGAATGGATTGGGTATATCAACCCCTATAATGACGGCACTAAGTACAACGAGAAATTTCAGGGGCGAGTCACCATATCAAGCGACAAGAGTATCAGCACTGCTTACATGGAGCTCAGCTCCCTTCGCTCAGAGGATACAGCAATGTATTACTGCGCCCGGGGCACCTACTATTACGGAACGAGGGTTTTCGATTACTGGGGCCAGGGCACCCTGGTGACAGTTAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGTTATGACGCAGAGCCCCGCTACACTTTCTCTTTCACCGGGTGAGAGAGCCACACTCAGTTGTCGCTCCTCAAAATCCCTGCAAAACGTGAATGGCAACACCTATCTGTACTGGTTTCAGCAGAAGCCCGGCCAATCCCCACAGCTGCTGATCTATAGGATGAGCAATCTCAACTCCGGAGTCCCTGACCGGTTCAGCGGAAGTGGGTCTGGCACTGAATTCACACTCACCATATCTAGCTTGGAGCCAGAGGACTTCGCCGTGTACTATTGCATGCAGCACTTGGAATACCCTATTACTTTTGGTGCAGGGACCAAACTGGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DIVMTQSPATLSLSPGERATLSCRSS--KSLQNVN-GNTYLYWFQQKPGQSPQLLIYR--------MSNLNSGVPDRFSGSGSG--TEFTLTISSLEPEDFAVYYCMQHLE-----------------------YPITFGAGTKLEIK-,EVQLVES-GGGLVKPGGSLKLSCAASG-YTFTS-----YVMHWVRQAPGKGLEWIGYINPY---NDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYG------------------TRVFDYWGQGTLVTVSS
-GDPa1-152,obiltoxaximab,118.75,99.765,92.375,2.785,2.82,,,,1.0,4.125,59.95,69.63,85.745,IgG1,Kappa,Approved,NFD,QVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAGCTGCAGCAGTCTGGTCCTGAGCTGAAAAAACCAGGCGCCAGTGTGAAGGTGTCATGTAAAGACAGCGGCTACGCTTTTTCCTCCTCCTGGATGAACTGGGTGCGCCAAGCCCCCGGACAAGGACTGGAGTGGATAGGGCGGATTTATCCGGGCGATGGCGACACTAACTACAATGGGAAGTTCCAGGGTAGGGTGACGATCACAGCGGATAAGTCTTCAAGCACCGCTTATATGGAACTGAGCTCATTGAGATCCGAAGATACCGCAGTTTATTTCTGCGCAAGGAGTGGACTCCTTCGATACGCCATGGACTACTGGGGGCAGGGCACTCTCGTCACAGTCTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIR,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACACAGTCACCCAGTAGCCTGTCCGCATCTGTTGGGGACAGGGTGACCATAACATGTCGAGCCAGCCAGGATATCAGAAACTATCTCAATTGGTATCAGCAGAAACCTGGCAAGGCTGTAAAACTGCTGATTTACTATACTTCTCGCCTTCTGCCGGGTGTCCCATCACGGTTCAGTGGGAGCGGCAGCGGCACAGATTACTCTCTCACTATCTCCTCCCAAGAGCAGGAGGACATCGGAACGTACTTCTGCCAACAGGGGAACACCTTGCCCTGGACCTTTGGTCAAGGAACCAAGGTGGAAATTAGGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,1,DIQMTQSPSSLSASVGDRVTITCRAS--QDIR------NYLNWYQQKPGKAVKLLIYY--------TSRLLPGVPSRFSGSGSG--TDYSLTISSQEQEDIGTYFCQQGNT-----------------------LPWTFGQGTKVEIR-,QVQLQQS-GPELKKPGASVKVSCKDSG-YAFSS-----SWMNWVRQAPGQGLEWIGRIYPG---DGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLR--------------------YAMDYWGQGTLVTVSS
-GDPa1-153,obinutuzumab,190.23,99.31,98.755,2.775,2.9450000000000003,,0.54,0.1,1.87,1.125,59.894999999999996,70.27000000000001,83.995,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTTGTGCAGTCCGGCGCTGAAGTTAAGAAGCCCGGTTCAAGCGTGAAAGTGTCTTGTAAAGCCTCCGGCTACGCCTTTAGCTATTCATGGATTAACTGGGTGCGGCAAGCCCCAGGACAGGGTTTGGAGTGGATGGGGCGCATATTCCCTGGAGATGGCGACACTGACTATAATGGCAAGTTCAAGGGGAGGGTCACAATCACCGCTGACAAAAGTACCAGCACAGCATACATGGAACTGTCCAGCCTCCGAAGTGAGGATACGGCAGTCTATTATTGCGCGAGAAACGTATTTGATGGCTACTGGCTGGTCTACTGGGGACAAGGGACCCTGGTTACTGTGTCTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK,MRAWIFFLLCLAGRALADIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCGTTATGACTCAGACCCCACTGTCTCTTCCGGTGACCCCAGGCGAACCTGCTTCCATTTCTTGTCGGAGCTCTAAGAGTCTTCTGCACTCAAACGGGATCACCTATCTGTATTGGTACTTGCAGAAACCTGGGCAAAGCCCCCAGCTGTTGATCTACCAAATGAGCAATCTCGTGTCCGGGGTCCCCGACAGGTTCTCAGGTAGTGGAAGCGGCACGGATTTCACACTCAAGATATCCAGAGTGGAGGCAGAAGACGTAGGCGTCTACTATTGCGCCCAGAACCTGGAGCTCCCCTACACTTTTGGAGGTGGAACAAAGGTGGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,1,4,DIVMTQTPLSLPVTPGEPASISCRSS--KSLLHSN-GITYLYWYLQKPGQSPQLLIYQ--------MSNLVSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCAQNLE-----------------------LPYTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YAFSY-----SWINWVRQAPGQGLEWMGRIFPG---DGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDG--------------------YWLVYWGQGTLVTVSS
-GDPa1-154,ocrelizumab,420.17,100.0,99.61500000000001,2.75,2.8600000000000003,,0.0,0.0,3.62,11.625,59.25,74.97,,IgG1,Kappa,Approved,NFD,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAACTGGTGGAATCCGGCGGAGGACTTGTGCAGCCTGGCGGATCTTTGAGACTGAGCTGCGCTGCCTCAGGTTATACGTTTACATCCTACAATATGCACTGGGTGCGGCAGGCGCCAGGGAAAGGCCTGGAATGGGTGGGGGCCATTTACCCCGGGAATGGCGACACCAGCTATAACCAAAAATTTAAGGGTAGGTTCACAATCTCAGTGGACAAGAGCAAGAACACCCTGTATCTTCAGATGAATTCTCTCCGAGCAGAGGATACTGCTGTCTACTATTGTGCCCGCGTCGTGTACTATAGTAACTCTTACTGGTACTTCGATGTTTGGGGCCAGGGGACCCTCGTAACTGTTAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGTCCCCCTCCTCCTTGAGTGCAAGTGTCGGTGACAGAGTGACTATCACATGCAGGGCTAGCTCTTCTGTAAGCTACATGCACTGGTATCAGCAGAAGCCAGGAAAAGCGCCTAAACCACTTATTTACGCTCCTAGCAACCTGGCCAGCGGCGTGCCCTCCCGCTTCTCTGGCTCAGGGTCTGGCACCGACTTTACCCTGACTATATCATCACTCCAGCCCGAGGATTTTGCCACGTATTACTGTCAGCAATGGAGTTTCAATCCTCCGACATTCGGACAAGGGACCAAGGTTGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCRAS--SSVS-------YMHWYQQKPGKAPKPLIYA--------PSNLASGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQWSF-----------------------NPPTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YTFTS-----YNMHWVRQAPGKGLEWVGAIYPG---NGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSN-----------------SYWYFDVWGQGTLVTVSS
-GDPa1-155,ofatumumab,266.55,99.465,97.71000000000001,2.88,2.7350000000000003,,0.0,0.04,1.62,0.625,61.655,69.445,83.10499999999999,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTGGTCGAGAGCGGGGGAGGTTTGGTTCAACCTGGCCGATCTCTGCGGTTGAGTTGTGCAGCGTCAGGGTTCACCTTCAACGATTATGCCATGCACTGGGTCAGACAGGCTCCCGGTAAGGGCCTGGAGTGGGTTTCTACAATCTCCTGGAACTCTGGCAGCATTGGGTACGCTGACAGTGTAAAGGGGAGGTTTACTATCTCCAGGGACAACGCAAAAAAGTCACTCTACCTTCAAATGAATTCCCTCCGCGCCGAAGATACAGCCCTGTATTACTGCGCCAAAGACATACAGTATGGCAATTACTACTATGGAATGGATGTGTGGGGCCAGGGAACGACTGTGACCGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATCGTGTTGACACAGTCCCCGGCCACTCTGTCACTGAGCCCCGGCGAGAGGGCCACACTCAGCTGTCGAGCCTCACAATCTGTCTCTTCCTACCTGGCGTGGTATCAACAGAAACCTGGGCAGGCACCAAGACTCCTTATTTATGATGCTTCCAATCGCGCTACCGGGATTCCAGCCAGATTCAGCGGATCTGGCAGTGGAACAGACTTCACCCTGACTATCAGCAGTCTTGAGCCCGAAGACTTTGCAGTTTACTACTGCCAGCAGAGGTCCAACTGGCCTATCACGTTTGGTCAGGGCACCCGGTTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,4,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSN-----------------------WPITFGQGTRLEIK-,EVQLVES-GGGLVQPGRSLRLSCAASG-FTFND-----YAMHWVRQAPGKGLEWVSTISWN---SGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGN-----------------YYYGMDVWGQGTTVTVSS
-GDPa1-156,olaratumab,157.0,91.05000000000001,84.875,2.715,2.9299999999999997,,0.37,0.29,-0.5,0.625,61.735,70.10499999999999,84.14500000000001,IgG1,Kappa,Approved,Active,QLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSS,MRAWIFFLLCLAGRALAQLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGCTGCAGCTTCAGGAAAGCGGTCCAGGGCTGGTTAAGCCGTCAGAGACCCTGTCCCTTACCTGCACAGTGAGTGGGGGCAGCATAAATTCTTCATCATATTATTGGGGCTGGCTCAGACAGAGTCCTGGTAAAGGACTGGAGTGGATCGGAAGCTTTTTTTATACCGGGTCCACCTACTACAACCCCTCTCTCCGAAGTCGCTTGACAATTTCCGTCGACACTTCCAAGAATCAGTTCTCTCTCATGCTGTCTAGCGTGACGGCTGCCGATACTGCCGTCTACTATTGTGCAAGGCAATCCACATATTACTACGGCAGTGGCAACTACTACGGCTGGTTCGACCGGTGGGATCAAGGAACTTTGGTGACAGTATCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTGCTCACTCAGAGCCCCGCGACACTGTCCCTGAGCCCCGGTGAAAGAGCAACACTTAGTTGTCGAGCTAGCCAATCCGTTAGTTCATATCTGGCCTGGTATCAGCAGAAACCCGGACAGGCCCCTAGGCTTCTGATCTACGACGCTTCCAACCGCGCCACCGGGATTCCAGCTCGGTTCTCTGGGAGCGGATCTGGCACCGACTTTACGTTGACCATATCTTCCCTCGAGCCAGAAGATTTTGCAGTGTACTACTGCCAACAGAGGTCAAATTGGCCGCCTGCCTTCGGCCAGGGCACTAAGGTCGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSN-----------------------WPPAFGQGTKVEIK-,QLQLQES-GPGLVKPSETLSLTCTVSG-GSINSS---SYYWGWLRQSPGKGLEWIGSFFY----TGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGS-------------GNYYGWFDRWDQGTLVTVSS
-GDPa1-157,oleclumab,591.12,99.49000000000001,98.59,2.7800000000000002,2.955,4.21,0.12,0.1,4.87,22.875,62.44,72.695,77.24,IgG1,Lambda,Phase-III,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAYSWVRQAPGKGLEWVSAISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLGYGRVDEWGRGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAYSWVRQAPGKGLEWVSAISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLGYGRVDEWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAACTGCTTGAAAGCGGCGGGGGACTCGTGCAGCCTGGTGGGAGCCTGCGACTGTCATGCGCCGCTTCCGGCTTTACTTTCAGTAGCTATGCGTATTCCTGGGTCCGCCAGGCACCCGGCAAGGGTCTGGAGTGGGTCTCTGCCATTTCCGGATCAGGCGGACGCACTTACTACGCCGACAGCGTTAAGGGCCGGTTCACCATCTCCCGGGATAACTCAAAAAACACCCTCTACTTGCAGATGAATTCTTTGAGGGCCGAGGACACAGCTGTGTATTACTGTGCAAGGCTGGGGTATGGAAGAGTTGATGAGTGGGGGAGAGGCACGCTTGTAACAGTGAGTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QSVLTQPPSASGTPGQRVTISCSGSLSNIGRNPVNWYQQLPGTAPKLLIYLDNLRLSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSHPGWTFGGGTKLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSASGTPGQRVTISCSGSLSNIGRNPVNWYQQLPGTAPKLLIYLDNLRLSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSHPGWTFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGAGTGTGCTGACCCAGCCACCCAGCGCTTCTGGGACACCCGGACAAAGAGTTACCATTAGCTGTTCCGGTTCCCTGTCCAATATCGGCCGCAACCCGGTGAACTGGTATCAGCAGCTCCCCGGTACGGCACCTAAATTGCTTATATACCTGGATAATCTTCGGTTGTCTGGCGTCCCTGACAGGTTCAGTGGCTCTAAGTCAGGGACTTCCGCCAGCCTGGCCATCAGCGGCCTCCAATCAGAAGATGAGGCGGACTACTATTGCGCTACTTGGGATGACTCACACCCAGGCTGGACATTTGGGGGAGGAACAAAGCTGACCGTACTCGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,0,4,QSVLTQP-PSASGTPGQRVTISCSGSL-SNIGR-----NPVNWYQQLPGTAPKLLIYL--------DNLRLSGVPDRFSGSKSG--TSASLAISGLQSEDEADYYCATWDDS---------------------HPGWTFGGGTKLTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----YAYSWVRQAPGKGLEWVSAISGS---GGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLGYG----------------------RVDEWGRGTLVTVSS
-GDPa1-158,olokizumab,516.74,99.16499999999999,91.08,2.78,2.84,,0.1,0.1,3.5,1.625,59.725,68.785,,IgG4,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGCTGGTGGAGAGCGGGGGCGGCTTGGTACAGCCCGGTGGCTCCCTGAGGCTCTCTTGTGCAGCTTCAGGGTTCAACTTCAACGATTACTTCATGAATTGGGTGCGGCAAGCGCCTGGCAAAGGGCTTGAATGGGTTGCCCAGATGCGCAATAAGAACTATCAGTATGGTACATACTACGCCGAATCATTGGAAGGACGATTTACGATCTCTAGGGACGACAGCAAAAACTCCCTCTATCTTCAGATGAATAGCCTGAAGACCGAGGATACCGCCGTGTACTATTGCGCTAGAGAGTCTTACTACGGCTTTACTAGTTATTGGGGACAAGGAACACTGGTGACTGTCTCCAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACCCAGAGCCCCAGCAGCCTGTCTGCTTCCGTGGGGGATAGGGTTACAATTACCTGTCAAGCTTCACAGGATATTGGCATCTCCCTGTCTTGGTATCAGCAAAAGCCTGGTAAGGCCCCCAAACTCCTTATCTATAATGCCAACAACCTGGCAGACGGCGTCCCATCAAGATTTTCCGGCAGTGGATCCGGAACTGATTTCACACTGACTATCTCTAGTTTGCAGCCTGAGGACTTTGCCACGTACTACTGCCTTCAGCACAATAGCGCGCCATACACCTTCGGTCAGGGGACAAAGCTCGAAATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,1,DIQMTQSPSSLSASVGDRVTITCQAS--QDIG------ISLSWYQQKPGKAPKLLIYN--------ANNLADGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCLQHNS-----------------------APYTFGQGTKLEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FNFND-----YFMNWVRQAPGKGLEWVAQMRNKN-YQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYY---------------------GFTSYWGQGTLVTVSS
-GDPa1-159,omalizumab,224.95,99.5,98.19,2.7,2.6399999999999997,2.645,0.0,0.0,0.75,-0.125,,,,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCGTCGAGTCCGGGGGTGGACTGGTGCAACCCGGAGGATCCTTGAGGCTTAGCTGCGCAGTGTCCGGGTATAGTATTACGAGCGGATACTCTTGGAACTGGATACGACAGGCGCCTGGCAAGGGGCTCGAGTGGGTAGCCAGCATCACATACGATGGCTCTACAAATTATAATCCATCTCTGAAAGGCAGGATCACCATTTCACGCGACGATTCAAAGAACACTTTCTACCTGCAGATGAACTCCCTTAGAGCTGAAGACACCGCTGTCTACTATTGTGCCCGGGGGAGCCATTATTTCGGCCACTGGCACTTTGCCGTTTGGGGTCAGGGCACCCTGGTGACTGTTTCAAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGCTCACACAGTCCCCCAGCTCCCTGAGTGCCTCAGTCGGCGATAGAGTGACGATCACATGCCGGGCATCACAGTCCGTTGACTACGACGGCGATAGTTATATGAACTGGTATCAGCAAAAGCCAGGGAAAGCGCCCAAGCTCCTGATATATGCTGCTAGCTACTTGGAGTCTGGCGTGCCAAGCAGGTTCAGCGGGAGTGGATCCGGTACCGACTTTACCCTTACCATCTCATCTCTGCAGCCTGAAGATTTTGCCACTTATTACTGTCAGCAATCTCACGAGGACCCTTACACATTCGGTCAGGGAACTAAAGTAGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQLTQSPSSLSASVGDRVTITCRAS--QSVDYD--GDSYMNWYQQKPGKAPKLLIYA--------ASYLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSHE-----------------------DPYTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAVSG-YSITS----GYSWNWIRQAPGKGLEWVASITY----DGSTNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFG------------------HWHFAVWGQGTLVTVSS
-GDPa1-160,omburtamab,140.25,99.515,93.035,2.685,2.535,,0.1,0.07,0.37000000000000005,15.5,61.989999999999995,74.38499999999999,,IgG1,Kappa,Preregistration,Active,QVQLQQSGAELVKPGASVKLSCKASGYTFTNYDINWVRQRPEQGLEWIGWIFPGDGSTQYNEKFKGKATLTTDTSSSTAYMQLSRLTSEDSAVYFCARQTTATWFAYWGQGTLVTVSA,MRAWIFFLLCLAGRALAQVQLQQSGAELVKPGASVKLSCKASGYTFTNYDINWVRQRPEQGLEWIGWIFPGDGSTQYNEKFKGKATLTTDTSSSTAYMQLSRLTSEDSAVYFCARQTTATWFAYWGQGTLVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGTTGCAACAGTCCGGGGCTGAGCTCGTTAAACCAGGCGCCAGTGTCAAGCTTTCTTGTAAAGCCTCTGGATATACGTTCACAAATTACGACATCAACTGGGTGCGCCAGAGACCTGAACAGGGTCTGGAATGGATAGGCTGGATTTTCCCCGGAGATGGGTCAACACAATATAACGAGAAGTTTAAAGGGAAGGCAACACTGACTACCGATACTTCATCCAGCACCGCCTATATGCAACTGTCCAGGCTGACAAGCGAGGACAGCGCGGTGTACTTTTGCGCTCGGCAGACCACCGCTACGTGGTTCGCATACTGGGGTCAGGGCACCCTCGTAACTGTGAGTGCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPATLSVTPGDRVSLSCRASQSISDYLHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGSDFTLSINSVEPEDVGVYYCQNGHSFPLTFGAGTKLELK,MRAWIFFLLCLAGRALADIVMTQSPATLSVTPGDRVSLSCRASQSISDYLHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGSDFTLSINSVEPEDVGVYYCQNGHSFPLTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTGTCATGACACAGAGTCCTGCCACCTTGAGCGTGACCCCTGGCGACAGAGTTTCTTTGTCTTGCAGGGCTAGTCAATCCATATCCGACTACCTTCACTGGTACCAACAGAAATCCCACGAAAGCCCCCGCCTCCTGATCAAATATGCATCTCAGTCAATCTCCGGTATCCCCTCTCGGTTCAGCGGGAGTGGCTCAGGAAGCGATTTTACGCTGTCCATTAATAGCGTAGAGCCAGAAGATGTGGGTGTGTATTACTGTCAGAACGGGCATTCATTTCCACTGACATTCGGAGCCGGCACTAAGCTCGAGCTGAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,2,DIVMTQSPATLSVTPGDRVSLSCRAS--QSIS------DYLHWYQQKSHESPRLLIKY--------ASQSISGIPSRFSGSGSG--SDFTLSINSVEPEDVGVYYCQNGHS-----------------------FPLTFGAGTKLELK-,QVQLQQS-GAELVKPGASVKLSCKASG-YTFTN-----YDINWVRQRPEQGLEWIGWIFPG---DGSTQYNEKFKGKATLTTDTSSSTAYMQLSRLTSEDSAVYFCARQTTA---------------------TWFAYWGQGTLVTVSA
-GDPa1-161,onartuzumab,375.2,99.11500000000001,93.02000000000001,2.7350000000000003,2.76,,0.1,0.1,-0.13,-1.5,60.629999999999995,70.27,83.96,IgG1,Kappa,Phase-III,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAATTGGTCGAGAGTGGTGGAGGCCTGGTGCAGCCGGGCGGATCCCTCAGGCTTTCTTGTGCCGCAAGCGGGTACACCTTCACATCTTACTGGCTTCACTGGGTGAGACAGGCCCCCGGGAAGGGTTTGGAATGGGTCGGCATGATTGATCCTTCAAATTCCGACACCCGATTTAACCCCAACTTCAAAGACCGGTTTACTATCAGCGCGGATACGTCAAAGAATACAGCTTATCTGCAGATGAACAGTCTGCGCGCAGAAGACACCGCCGTTTATTACTGCGCTACCTATAGGTCCTACGTAACACCACTGGATTATTGGGGGCAGGGAACTCTCGTGACTGTTTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACCCAGTCCCCAAGTAGCCTCTCCGCTAGCGTGGGCGACAGAGTGACTATCACATGCAAGTCAAGCCAGTCCCTCCTGTACACCAGCTCACAGAAGAACTACCTTGCTTGGTATCAGCAAAAACCCGGCAAGGCCCCTAAACTGCTGATTTATTGGGCATCAACCAGGGAGTCTGGGGTCCCCAGTCGGTTCAGTGGCTCTGGTTCCGGAACAGATTTTACGTTGACCATATCTTCTCTGCAACCAGAAGACTTTGCCACTTATTACTGTCAGCAGTATTACGCGTACCCTTGGACATTCGGACAAGGGACTAAAGTTGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQMTQSPSSLSASVGDRVTITCKSS--QSLLYTSSQKNYLAWYQQKPGKAPKLLIYW--------ASTRESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYYA-----------------------YPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YTFTS-----YWLHWVRQAPGKGLEWVGMIDPS---NSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYV--------------------TPLDYWGQGTLVTVSS
-GDPa1-162,opicinumab,319.37,99.62,98.28,2.71,2.605,,0.1,0.0,0.37000000000000005,2.0,60.36,68.75,83.77,IgG1,Kappa,Phase-II,Discontinued,EVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGTTGCTGGAAAGCGGAGGCGGGCTGGTGCAACCTGGGGGCTCTCTTCGCCTCAGCTGCGCCGCCTCTGGATTCACATTTAGCGCCTACGAAATGAAATGGGTGCGACAGGCACCAGGAAAAGGGCTGGAGTGGGTATCCGTCATAGGTCCCTCCGGCGGGTTTACTTTCTATGCGGACTCAGTCAAGGGTAGATTTACTATCTCACGGGACAACTCTAAGAACACGCTTTATCTGCAGATGAATAGTCTCAGGGCCGAAGATACAGCTGTTTACTACTGTGCAACCGAGGGAGACAATGATGCTTTCGATATTTGGGGCCAGGGCACCACCGTGACCGTGTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACCCAGAGCCCCGCGACTCTGAGTCTTTCCCCTGGTGAAAGGGCTACACTCAGCTGCCGAGCCAGCCAGTCCGTGTCTAGTTATTTGGCCTGGTACCAGCAGAAGCCAGGCCAGGCACCCAGGCTGCTGATCTATGATGCCTCTAATCGGGCTACAGGCATTCCAGCCCGCTTCTCAGGAAGCGGATCTGGGACAGACTTTACTTTGACCATCTCCTCACTGGAGCCTGAAGACTTCGCAGTCTACTATTGTCAACAGAGATCCAACTGGCCGATGTACACCTTTGGCCAAGGGACGAAACTCGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,2,2,DIQMTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSNW----------------------PMYTFGQGTKLEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSA-----YEMKWVRQAPGKGLEWVSVIGPS---GGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDN---------------------DAFDIWGQGTTVTVSS
-GDPa1-163,orticumab,700.57,99.85,99.795,2.76,2.5199999999999996,,0.48,0.3,4.87,19.625,61.525,73.045,79.09,IgG2,Lambda,Phase-II,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSSISVGGHRTYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCARIRVGPSGGAFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSSISVGGHRTYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCARIRVGPSGGAFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCCTTGAGAGCGGGGGCGGCCTGGTTCAGCCCGGCGGTAGCCTTCGCTTGTCCTGTGCTGCCAGCGGTTTTACATTCTCAAACGCATGGATGAGTTGGGTTAGACAAGCACCTGGCAAGGGGCTGGAATGGGTGAGCTCTATTAGTGTCGGGGGCCACAGGACGTACTACGCGGACTCAGTAAAAGGCAGGAGTACTATCTCCCGGGATAACTCTAAGAATACACTGTATCTGCAGATGAATTCCCTCCGGGCCGAGGACACTGCTGTCTACTATTGCGCCCGAATAAGAGTGGGGCCATCTGGAGGAGCCTTCGATTATTGGGGACAGGGAACCTTGGTGACCGTGTCATCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,QSVLTQPPSASGTPGQRVTISCSGSNTNIGKNYVSWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCASWDASLNGWVFGGGTKLTVL,MRAWIFFLLCLAGRALAQSVLTQPPSASGTPGQRVTISCSGSNTNIGKNYVSWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCASWDASLNGWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGAGTGTACTGACTCAGCCACCCTCAGCAAGCGGCACGCCAGGACAGCGCGTGACTATTTCTTGTTCCGGCTCCAATACAAACATCGGGAAGAATTACGTCTCATGGTACCAACAGCTGCCGGGGACCGCCCCTAAACTGCTGATATATGCCAACAGTAACAGGCCCAGTGGGGTTCCTGATAGATTCTCTGGTTCTAAGTCCGGTACCAGCGCTTCCTTGGCGATCAGCGGACTTCGGTCTGAGGACGAAGCAGACTACTATTGCGCTTCATGGGATGCCAGCCTTAATGGCTGGGTGTTTGGCGGCGGAACCAAACTCACAGTGCTCGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,2,3,QSVLTQP-PSASGTPGQRVTISCSGSN-TNIGK-----NYVSWYQQLPGTAPKLLIYA--------NSNRPSGVPDRFSGSKSG--TSASLAISGLRSEDEADYYCASWDAS---------------------LNGWVFGGGTKLTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSN-----AWMSWVRQAPGKGLEWVSSISVG---GHRTYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCARIRVGPS------------------GGAFDYWGQGTLVTVSS
-GDPa1-164,osocimab,279.15,99.02,93.185,2.79,2.9,,0.1,0.09,2.62,1.625,56.42,69.325,80.59,IgG4,Kappa,Phase-II,Discontinued,EVQLLESGGGLVQPGGSLRLSCAASGFTFSQYGMDWVRQAPGKGLEWVSGIGPSGGSTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGGPYYYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSQYGMDWVRQAPGKGLEWVSGIGPSGGSTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGGPYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGTTGCTTGAAAGCGGGGGCGGATTGGTGCAGCCGGGTGGGTCTCTGCGCCTGTCATGTGCAGCTAGTGGATTCACCTTTAGCCAATACGGCATGGACTGGGTGCGACAGGCGCCTGGCAAAGGTCTGGAATGGGTGTCCGGCATCGGACCATCTGGCGGGAGTACTGTCTACGCCGACAGCGTAAAGGGGAGATTCACAATTTCACGGGATAACAGCAAGAATACACTCTATCTCCAAATGAACTCCCTGAGGGCTGAGGACACTGCCGTGTATTACTGCACGAGGGGTGGCCCCTATTATTACTACGGAATGGATGTGTGGGGGCAGGGAACCACAGTTACCGTCTCTTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQADSFPVTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQADSFPVTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACCCAGAGTCCTTCCAGCCTTTCCGCCTCAGTAGGTGACAGGGTGACAATCACCTGTCAGGCTTCCCAGGACATTAGCAATTACCTGAACTGGTATCAGCAAAAGCCTGGGAAAGCTCCAAAGCTCTTGATCTATGATGCAAGCAACCTGGAGACCGGAGTTCCCTCTCGGTTTTCTGGAAGCGGCTCTGGTACGGACTTCACTTTTACCATTAGTTCCCTGCAACCAGAAGATATAGCCACTTACTACTGCCAGCAGGCGGACTCATTCCCCGTGACATTCGGCGGGGGCACAAAGGTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,1,DIQMTQSPSSLSASVGDRVTITCQAS--QDIS------NYLNWYQQKPGKAPKLLIYD--------ASNLETGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCQQADS-----------------------FPVTFGGGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSQ-----YGMDWVRQAPGKGLEWVSGIGPS---GGSTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGGPYY-------------------YYGMDVWGQGTTVTVSS
-GDPa1-165,otelixizumab,338.81,99.83500000000001,97.305,2.7,2.505,,0.0,0.0,2.25,10.875,59.525000000000006,70.74000000000001,81.45,IgG1,Lambda,Phase-II,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFPMAWVRQAPGKGLEWVSTISTSGGRTYYRDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKFRQYSGGFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSFPMAWVRQAPGKGLEWVSTISTSGGRTYYRDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKFRQYSGGFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTACAATTGTTGGAATCCGGCGGCGGACTCGTTCAGCCCGGAGGGAGCCTGCGGCTCTCTTGCGCTGCATCAGGGTTTACATTCAGCTCATTTCCAATGGCCTGGGTGCGGCAGGCGCCTGGTAAGGGGCTGGAGTGGGTGAGCACAATTAGCACTTCCGGCGGCAGGACGTATTACAGAGACAGTGTCAAAGGGCGATTCACCATCTCTAGGGACAATTCCAAGAACACCCTTTATCTGCAGATGAACTCCCTGAGAGCCGAAGATACTGCTGTGTACTATTGTGCCAAATTTCGCCAATACTCTGGAGGTTTCGATTACTGGGGCCAGGGAACCCTTGTGACAGTCTCAAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQPNSVSTSLGSTVKLSCTLSSGNIENNYVHWYQLYEGRSPTTMIYDDDKRPDGVPDRFSGSIDRSSNSAFLTIHNVAIEDEAIYFCHSYVSSFNVFGGGTKLTVL,MRAWIFFLLCLAGRALADIQLTQPNSVSTSLGSTVKLSCTLSSGNIENNYVHWYQLYEGRSPTTMIYDDDKRPDGVPDRFSGSIDRSSNSAFLTIHNVAIEDEAIYFCHSYVSSFNVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAACTTACCCAGCCAAACTCAGTGAGCACATCTCTCGGGTCTACTGTGAAGCTGAGTTGTACTCTCTCCTCCGGTAACATTGAAAACAACTATGTGCACTGGTATCAGCTGTACGAAGGACGCTCCCCTACCACGATGATTTACGACGACGACAAAAGGCCCGATGGCGTCCCGGATCGGTTTTCTGGCTCAATTGATAGAAGCAGTAATTCAGCTTTCTTGACCATACATAATGTTGCAATCGAGGACGAGGCCATCTATTTTTGCCACAGCTACGTATCCAGCTTCAATGTGTTCGGGGGCGGAACAAAGCTGACAGTCCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,2,1,1,DIQLTQP-NSVSTSLGSTVKLSCTLSS-GNIEN-----NYVHWYQLYEGRSPTTMIYD--------DDKRPDGVPDRFSGSIDRSSNSAFLTIHNVAIEDEAIYFCHSYVS-----------------------SFNVFGGGTKLTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----FPMAWVRQAPGKGLEWVSTISTS---GGRTYYRDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKFRQYS--------------------GGFDYWGQGTLVTVSS
-GDPa1-166,otlertuzumab,66.54,100.0,93.99,3.12,3.08,,,,3.25,3.875,62.2,71.71000000000001,,IgG1,Kappa,Phase-II,Discontinued,EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGGTTCAGTCAGGAGCTGAGGTGAAGAAGCCCGGCGAATCCCTGAAGATCTCTTGTAAAGGAAGTGGATATTCCTTCACCGGGTATAATATGAACTGGGTGAGACAAATGCCAGGCAAGGGGCTGGAATGGATGGGTAACATTGACCCGTACTACGGGGGCACTACCTATAATAGGAAATTCAAGGGTCAGGTAACCATCTCAGCCGACAAATCCATAAGCACAGCTTACCTTCAGTGGTCTTCCCTCAAAGCCAGCGATACTGCGATGTACTATTGCGCACGGAGTGTCGGGCCTTTTGATAGCTGGGGCCAAGGCACATTGGTCACGGTGTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTTTTGACGCAGTCACCGGCAACCCTGTCCCTGAGTCCAGGGGAAAGAGCTACACTGTCTTGTCGGGCCTCCGAGAATGTGTATTCCTATCTCGCCTGGTACCAACAAAAACCAGGTCAGGCACCCCGCCTTCTCATCTACTTCGCCAAGACCCTTGCGGAGGGCATTCCCGCTAGGTTCTCAGGGTCTGGCAGTGGAACTGACTTTACATTGACTATCAGCAGCCTGGAGCCTGAAGACTTTGCCGTCTACTATTGCCAGCATCACAGCGATAACCCTTGGACATTCGGACAGGGCACCAAGGTGGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,1,3,EIVLTQSPATLSLSPGERATLSCRAS--ENVY------SYLAWYQQKPGQAPRLLIYF--------AKTLAEGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQHHSD-----------------------NPWTFGQGTKVEIK-,EVQLVQS-GAEVKKPGESLKISCKGSG-YSFTG-----YNMNWVRQMPGKGLEWMGNIDPY---YGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVG-----------------------PFDSWGQGTLVTVSS
-GDPa1-167,ozanezumab,331.91,99.5,99.08500000000001,2.7,2.8200000000000003,4.11,0.78,0.84,3.12,14.875,61.795,71.765,84.13,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTTCAAAGTGGCGCCGAGGTGAAGAAGCCAGGGGCTTCCGTTAAGGTAAGCTGTAAAGCTTCTGGATACACATTTACTAGCTACTGGATGCACTGGGTCAGGCAGGCCCCTGGGCAGGGGCTGGAATGGATCGGTAACATTAACCCCTCAAATGGCGGAACGAACTACAATGAGAAATTCAAATCCAAGGCGACAATGACCAGAGACACCTCCACCAGCACCGCATATATGGAGCTCTCTTCACTGCGGAGTGAAGATACTGCCGTGTACTATTGCGAACTTATGCAGGGCTATTGGGGTCAGGGAACATTGGTGACTGTGTCTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATAGTGATGACCCAATCCCCACTGAGTAACCCTGTTACACTTGGACAACCCGTCTCCATCTCATGCCGAAGCTCAAAATCTTTGCTCTACAAAGACGGGAAGACTTATCTGAATTGGTTTCTGCAGAGGCCAGGCCAGAGCCCCCAGCTTCTGATTTATCTGATGAGCACCCGCGCTAGTGGCGTACCGGACAGATTCTCTGGCGGGGGTTCCGGTACGGATTTTACTCTGAAGATCTCTCGGGTCGAGGCCGAAGACGTGGGGGTGTATTACTGTCAGCAGCTCGTGGAGTACCCTTTGACCTTCGGACAGGGCACAAAGCTCGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,4,DIVMTQSPLSNPVTLGQPVSISCRSS--KSLLYKD-GKTYLNWFLQRPGQSPQLLIYL--------MSTRASGVPDRFSGGGSG--TDFTLKISRVEAEDVGVYYCQQLVE-----------------------YPLTFGQGTKLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----YWMHWVRQAPGQGLEWIGNINPS---NGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQ--------------------------GYWGQGTLVTVSS
-GDPa1-168,palivizumab,367.3,98.65,97.84,2.7199999999999998,2.5700000000000003,4.04,0.12,0.0,-1.25,-1.375,62.129999999999995,70.50999999999999,85.22,IgG1,Kappa,Approved,NFD,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS,MRAWIFFLLCLAGRALAQVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTAACCCTCCGGGAATCTGGTCCAGCACTGGTGAAACCTACGCAAACCCTGACCTTGACCTGTACTTTCTCCGGGTTTAGTCTGTCTACAAGTGGAATGTCAGTCGGGTGGATAAGGCAGCCTCCCGGCAAAGCTCTCGAGTGGCTGGCCGATATTTGGTGGGACGATAAGAAGGACTACAATCCCTCATTGAAGTCTCGCCTTACAATCTCCAAGGACACTTCCAAGAATCAGGTGGTCCTTAAAGTGACGAACATGGATCCAGCCGATACTGCGACATATTATTGCGCCAGAAGCATGATCACTAACTGGTACTTCGACGTTTGGGGCGCTGGAACCACAGTGACCGTTAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACGCAGTCACCATCAACATTGTCTGCCTCCGTTGGGGACAGGGTGACTATCACCTGCAAATGCCAGCTGTCTGTCGGATATATGCACTGGTATCAGCAAAAACCCGGGAAGGCACCAAAGCTTCTGATTTACGACACTAGCAAACTGGCCAGCGGCGTGCCTAGTAGATTCAGCGGTTCCGGCTCTGGGACCGAGTTTACCCTCACCATCAGCTCCCTCCAACCTGATGATTTCGCTACTTACTACTGTTTCCAGGGCAGTGGATATCCCTTTACATTTGGTGGAGGCACAAAGCTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,3,DIQMTQSPSTLSASVGDRVTITCKCQ--LSVG-------YMHWYQQKPGKAPKLLIYD--------TSKLASGVPSRFSGSGSG--TEFTLTISSLQPDDFATYYCFQGSG-----------------------YPFTFGGGTKLEIK-,QVTLRES-GPALVKPTQTLTLTCTFSG-FSLSTS---GMSVGWIRQPPGKALEWLADIWW----DDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITN--------------------WYFDVWGAGTTVTVSS
-GDPa1-169,pamrevlumab,339.94,99.06,93.105,3.295,3.2,3.24,0.06,0.1,3.87,12.875,58.295,69.0,,IgG4,Kappa,Phase-III,Active,EGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSS,MRAWIFFLLCLAGRALAEGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGGCCAGCTGGTACAAAGCGGTGGCGGTCTGGTGCACCCCGGGGGATCTCTCAGACTTTCTTGTGCTGGCTCAGGGTTCACATTCAGTTCTTACGGAATGCATTGGGTCCGCCAGGCACCTGGTAAGGGATTGGAATGGGTTTCCGGCATCGGCACTGGCGGGGGCACATATAGCACCGACTCCGTGAAGGGGCGGTTTACGATTTCAAGGGACAATGCGAAAAACAGTCTCTACCTGCAGATGAACTCCCTGCGAGCCGAGGACATGGCCGTGTATTATTGCGCTCGGGGAGATTACTACGGGTCAGGTAGCTTCTTTGATTGCTGGGGCCAGGGAACCCTTGTCACTGTGAGCTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAAATGACACAGAGCCCTAGTTCACTGTCAGCGAGCGTCGGGGACAGGGTGACCATAACGTGCAGAGCCAGCCAGGGGATTTCTAGTTGGCTCGCTTGGTACCAGCAAAAACCCGAGAAAGCCCCAAAGTCCCTGATCTACGCAGCCTCATCTCTTCAGTCCGGCGTTCCCAGCCGGTTCTCTGGAAGTGGAAGCGGTACTGATTTTACCCTGACAATTTCCTCCTTGCAACCGGAAGATTTTGCTACTTATTATTGTCAGCAGTACAACTCTTATCCTCCAACCTTCGGCCAGGGCACAAAGCTCGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,1,DIQMTQSPSSLSASVGDRVTITCRAS--QGIS------SWLAWYQQKPEKAPKSLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYNS-----------------------YPPTFGQGTKLEIK-,EGQLVQS-GGGLVHPGGSLRLSCAGSG-FTFSS-----YGMHWVRQAPGKGLEWVSGIGT----GGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGS------------------GSFFDCWGQGTLVTVSS
-GDPa1-170,panitumumab,303.51,99.50999999999999,98.8,2.755,2.605,,0.0,0.07,0.37,-0.5,58.465,71.305,82.45,IgG2,Kappa,Approved,Active,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAGCTGCAGGAGTCTGGTCCCGGCCTGGTGAAACCTTCAGAGACACTTTCATTGACCTGCACAGTATCAGGAGGATCCGTGTCTAGCGGCGACTACTATTGGACCTGGATCAGGCAGAGCCCGGGGAAGGGCCTGGAATGGATTGGACACATTTACTACTCTGGCAACACCAATTATAACCCATCCCTCAAGTCCCGGTTGACCATCTCCATAGACACTTCTAAGACTCAGTTCAGTCTCAAACTGAGCAGTGTGACAGCCGCTGACACGGCCATTTATTACTGTGTCAGAGATCGCGTCACAGGGGCATTTGATATCTGGGGTCAAGGGACTATGGTGACCGTTAGTAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACTCAGAGCCCATCTTCTTTGAGCGCCAGTGTTGGCGACAGAGTGACGATTACATGTCAAGCTTCTCAGGACATCTCAAATTATCTCAACTGGTACCAACAGAAACCCGGTAAAGCACCCAAGCTTCTGATTTATGATGCTTCAAACCTGGAGACCGGAGTGCCAAGTAGGTTCTCCGGGTCCGGGTCCGGCACCGACTTTACCTTCACAATCAGCAGCCTCCAGCCTGAGGATATCGCGACTTACTTCTGCCAGCATTTTGACCACCTGCCTCTGGCCTTTGGCGGTGGAACAAAGGTCGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,1,DIQMTQSPSSLSASVGDRVTITCQAS--QDIS------NYLNWYQQKPGKAPKLLIYD--------ASNLETGVPSRFSGSGSG--TDFTFTISSLQPEDIATYFCQHFDH-----------------------LPLAFGGGTKVEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-GSVSSG---DYYWTWIRQSPGKGLEWIGHIYY----SGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVT---------------------GAFDIWGQGTMVTVSS
-GDPa1-171,panobacumab,154.15,63.980000000000004,94.995,2.74,2.74,,0.0,0.0,0.0,-1.0,62.14,70.55,83.72,IgG1,Kappa,Phase-II,Active,EEQVVESGGGFVQPGGSLRLSCAASGFTFSPYWMHWVRQAPGKGLVWVSRINSDGSTYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRYYGPEMWGQGTMVTVSS,MRAWIFFLLCLAGRALAEEQVVESGGGFVQPGGSLRLSCAASGFTFSPYWMHWVRQAPGKGLVWVSRINSDGSTYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRYYGPEMWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGAGCAGGTGGTGGAATCTGGCGGTGGCTTTGTTCAGCCCGGCGGGAGCCTGAGACTGAGTTGTGCCGCATCTGGATTCACTTTCAGCCCATACTGGATGCACTGGGTCCGCCAGGCCCCTGGCAAGGGTTTGGTGTGGGTGTCCCGGATTAATTCAGATGGATCAACATATTATGCTGACAGTGTGAAAGGAAGGTTTACCATCTCCCGGGACAATGCGCGCAACACTCTTTACCTCCAGATGAACTCTCTGCGAGCTGAGGACACCGCCGTTTACTACTGCGCAAGAGATAGGTATTATGGGCCGGAGATGTGGGGGCAAGGCACGATGGTAACAGTCTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTGGTCATGACGCAGTCACCCCTGTCACTTCCAGTCACTCTGGGGCAGCCCGCTAGCATTAGCTGCCGATCCTCTCAGAGTCTCGTGTACAGTGATGGCAACACCTACCTGAACTGGTTTCAGCAGAGGCCTGGTCAATCTCCGAGACGGCTCATCTATAAGGTGTCCAATAGAGACTCTGGTGTGCCAGATAGGTTCAGCGGGAGCGGCTCCGGAACAGATTTCACCTTGAAAATATCCCGCGTTGAGGCCGAGGACGTGGGAGTATACTATTGTATGCAAGGCACACACTGGCCTCTGACCTTTGGGGGAGGCACTAAGGTTGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,1,DVVMTQSPLSLPVTLGQPASISCRSS--QSLVYSD-GNTYLNWFQQRPGQSPRRLIYK--------VSNRDSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCMQGTH-----------------------WPLTFGGGTKVEIK-,EEQVVES-GGGFVQPGGSLRLSCAASG-FTFSP-----YWMHWVRQAPGKGLVWVSRINS----DGSTYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRYY----------------------GPEMWGQGTMVTVSS
-GDPa1-172,parsatuzumab,193.48,99.015,97.46000000000001,2.725,2.5599999999999996,,0.1,0.0,0.25,1.5,62.855000000000004,72.53999999999999,85.05,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAGCTGGTGGAGTCAGGGGGAGGACTGGTGCAACCCGGCGGGAGTTTGAGACTGTCTTGCGCTGCCTCAGGCTATACTTTTATAGATTACTACATGAACTGGGTGCGGCAAGCTCCTGGCAAGGGCCTCGAATGGGTCGGGGACATCAATCTGGACAATAGTGGTACCCACTATAACCAGAAATTCAAAGGTAGATTCACCATTAGCCGCGATAAGAGCAAGAATACAGCATACTTGCAGATGAACTCCCTCAGGGCAGAAGACACTGCCGTTTATTATTGTGCGCGAGAGGGAGTATACCATGACTACGATGATTACGCCATGGACTATTGGGGGCAGGGCACGCTTGTTACAGTGTCCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAGTCACCCAGCTCCCTTTCTGCTAGTGTGGGAGACCGGGTAACAATCACCTGCAGGACTTCACAATCCCTGGTTCACATCAACGCCATTACTTATCTGCACTGGTACCAGCAGAAACCTGGGAAGGCACCTAAACTCCTCATATACCGCGTGTCCAATAGATTTTCCGGTGTGCCAAGCCGATTCTCTGGCAGCGGGAGCGGTACAGATTTCACATTGACCATTTCTTCACTGCAGCCCGAAGATTTTGCCACTTACTATTGTGGACAGAGTACGCATGTCCCACTGACCTTCGGCCAAGGCACAAAGGTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,0,DIQMTQSPSSLSASVGDRVTITCRTS--QSLVHIN-AITYLHWYQQKPGKAPKLLIYR--------VSNRFSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCGQSTH-----------------------VPLTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YTFID-----YYMNWVRQAPGKGLEWVGDINLD---NSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDY----------------DDYAMDYWGQGTLVTVSS
-GDPa1-173,patritumab,66.54,99.0,94.47999999999999,2.855,2.8449999999999998,,,,4.5,9.875,60.05,72.11,81.36500000000001,IgG1,Kappa,Phase-III,Discontinued,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCARDKWTWYFDLWGRGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCARDKWTWYFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAATTGCAACAGTGGGGCGCCGGACTGCTGAAGCCTTCTGAAACTCTGAGTCTTACTTGTGCGGTATACGGGGGTTCATTTTCAGGATATTACTGGTCCTGGATCCGGCAGCCACCCGGAAAAGGGCTCGAGTGGATTGGTGAAATCAACCACAGTGGCTCTACAAACTATAATCCGAGCCTCAAGTCTCGCGTTACAATAAGCGTGGAGACCTCCAAGAATCAGTTCAGCTTGAAACTGTCCTCCGTGACCGCTGCAGACACGGCCGTGTATTACTGCGCTAGAGATAAATGGACCTGGTACTTCGACCTTTGGGGGAGGGGCACACTGGTGACCGTCAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIEMTQSPDSLAVSLGERATINCRSSQSVLYSSSNRNYLAWYQQNPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIEMTQSPDSLAVSLGERATINCRSSQSVLYSSSNRNYLAWYQQNPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATAGAAATGACCCAGTCTCCTGACTCCCTGGCCGTATCACTGGGGGAGCGCGCAACAATTAACTGTAGAAGCAGTCAGTCTGTGCTGTACAGCTCCTCCAACAGGAATTATTTGGCTTGGTATCAACAGAATCCCGGTCAGCCTCCAAAGCTTCTGATCTACTGGGCGTCTACCCGGGAGAGTGGGGTTCCCGATAGGTTCAGTGGCAGCGGAAGCGGAACTGACTTCACTCTCACAATTTCATCCCTCCAAGCCGAAGATGTGGCTGTCTATTACTGCCAGCAGTACTATTCAACACCACGAACGTTTGGCCAGGGCACCAAGGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,DIEMTQSPDSLAVSLGERATINCRSS--QSVLYSSSNRNYLAWYQQNPGQPPKLLIYW--------ASTRESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQQYYS-----------------------TPRTFGQGTKVEIK-,QVQLQQW-GAGLLKPSETLSLTCAVYG-GSFSG-----YYWSWIRQPPGKGLEWIGEINH----SGSTNYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCARDKWT---------------------WYFDLWGRGTLVTVSS
-GDPa1-174,pembrolizumab,,,,,,,,,,,,,,IgG4,Kappa,Approved,Active,QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTGGTCCAATCTGGTGTAGAGGTTAAAAAACCAGGGGCAAGTGTGAAGGTGAGCTGTAAAGCTAGTGGATATACATTTACCAATTACTACATGTATTGGGTGCGACAGGCTCCTGGGCAAGGCCTCGAGTGGATGGGAGGCATCAACCCCTCAAACGGTGGCACTAACTTCAATGAAAAGTTTAAGAATCGCGTCACACTGACCACAGATTCCTCAACTACCACAGCGTATATGGAACTTAAGAGCTTGCAGTTCGATGACACCGCCGTTTACTACTGCGCCAGAAGGGACTATCGGTTCGATATGGGATTTGACTACTGGGGCCAGGGGACTACGGTCACCGTGTCCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATAGTTCTTACTCAGAGCCCAGCTACACTCTCCCTTTCTCCCGGGGAACGGGCCACTCTCAGTTGTCGAGCCAGCAAGGGGGTATCAACAAGCGGGTATTCTTATCTCCACTGGTATCAGCAGAAGCCTGGACAAGCGCCGCGCCTGTTGATCTACCTGGCCAGCTACCTGGAGAGTGGCGTGCCAGCTAGGTTTAGTGGATCAGGTTCTGGAACCGACTTTACATTGACGATCTCCTCCCTGGAGCCCGAGGATTTCGCAGTCTACTACTGCCAGCATTCCAGAGACCTGCCTCTGACCTTCGGCGGCGGTACCAAAGTGGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,3,EIVLTQSPATLSLSPGERATLSCRAS--KGVSTS--GYSYLHWYQQKPGQAPRLLIYL--------ASYLESGVPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQHSRD-----------------------LPLTFGGGTKVEIK-,QVQLVQS-GVEVKKPGASVKVSCKASG-YTFTN-----YYMYWVRQAPGQGLEWMGGINPS---NGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRF-------------------DMGFDYWGQGTTVTVSS
-GDPa1-175,pertuzumab,296.49,99.685,97.78,2.755,2.815,,0.0,0.0,-0.13,-0.875,61.129999999999995,70.17,82.34,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGCTCGTGGAGAGTGGTGGAGGCCTGGTACAACCGGGCGGGTCCCTGCGCTTGAGCTGCGCTGCTTCTGGTTTTACCTTCACCGACTATACAATGGATTGGGTGAGACAGGCCCCCGGAAAGGGCCTCGAGTGGGTGGCGGATGTCAACCCTAATTCCGGCGGGAGTATCTACAATCAAAGATTCAAAGGCCGGTTTACGCTGAGCGTGGACAGGAGCAAGAATACTCTGTACCTTCAGATGAACTCACTTAGGGCCGAAGATACCGCAGTCTATTACTGTGCCCGAAACCTGGGGCCATCTTTCTATTTTGACTACTGGGGGCAGGGAACTTTGGTGACAGTTTCATCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAGTCTCCCAGCTCCCTGAGCGCCTCTGTGGGCGATAGGGTGACCATTACTTGCAAGGCCTCTCAAGACGTGTCAATCGGTGTCGCTTGGTACCAGCAGAAACCTGGAAAGGCTCCAAAATTGCTGATCTATAGTGCATCCTACAGATATACAGGGGTACCCAGCCGGTTCTCCGGGAGTGGATCAGGCACCGATTTTACTCTTACAATAAGCTCCCTCCAACCAGAAGACTTTGCGACGTACTACTGTCAGCAGTATTACATTTATCCTTACACCTTCGGCCAGGGTACAAAGGTTGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,DIQMTQSPSSLSASVGDRVTITCKAS--QDVS------IGVAWYQQKPGKAPKLLIYS--------ASYRYTGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYYI-----------------------YPYTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFTD-----YTMDWVRQAPGKGLEWVADVNPN---SGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPS--------------------FYFDYWGQGTLVTVSS
-GDPa1-176,pidilizumab,217.56,99.295,97.78,2.685,2.54,3.79,0.44,0.14,0.8700000000000001,1.5,62.61,71.755,83.235,IgG1,Kappa,Phase-II,Active,QVQLVQSGSELKKPGASVKISCKASGYTFTNYGMNWVRQAPGQGLQWMGWINTDSGESTYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFCVRVGYDALDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGSELKKPGASVKISCKASGYTFTNYGMNWVRQAPGQGLQWMGWINTDSGESTYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFCVRVGYDALDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAGCTGGTACAATCCGGCAGCGAGCTGAAAAAACCCGGGGCTAGCGTGAAGATCTCATGTAAGGCCAGTGGGTACACCTTCACAAATTATGGCATGAACTGGGTGAGACAGGCACCTGGACAGGGGCTGCAGTGGATGGGTTGGATTAACACTGATAGTGGAGAATCCACATACGCGGAGGAATTTAAGGGCAGGTTTGTTTTCTCTCTCGACACCTCAGTGAATACGGCTTACCTGCAGATAACAAGCTTGACTGCCGAGGATACCGGAATGTATTTCTGCGTGCGGGTGGGTTATGACGCCCTCGACTACTGGGGCCAGGGCACTCTTGTCACCGTTTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPSSLSASVGDRVTITCSARSSVSYMHWFQQKPGKAPKLWIYRTSNLASGVPSRFSGSGSGTSYCLTINSLQPEDFATYYCQQRSSFPLTFGGGTKLEIK,MRAWIFFLLCLAGRALAEIVLTQSPSSLSASVGDRVTITCSARSSVSYMHWFQQKPGKAPKLWIYRTSNLASGVPSRFSGSGSGTSYCLTINSLQPEDFATYYCQQRSSFPLTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTGACACAGAGCCCCTCCTCACTGTCTGCCAGCGTTGGCGACCGAGTCACCATCACGTGCAGTGCACGGAGCTCAGTATCCTATATGCACTGGTTCCAGCAGAAGCCTGGTAAGGCCCCAAAATTGTGGATCTATAGAACTTCTAACCTCGCTTCTGGTGTGCCATCTCGCTTCAGCGGGAGTGGAAGCGGCACTAGTTACTGTCTTACCATAAATTCCCTGCAACCCGAGGATTTCGCGACATACTACTGCCAACAGAGGTCCTCATTTCCTCTGACCTTTGGAGGGGGCACAAAGCTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,1,EIVLTQSPSSLSASVGDRVTITCSAR--SSVS-------YMHWFQQKPGKAPKLWIYR--------TSNLASGVPSRFSGSGSG--TSYCLTINSLQPEDFATYYCQQRSS-----------------------FPLTFGGGTKLEIK-,QVQLVQS-GSELKKPGASVKISCKASG-YTFTN-----YGMNWVRQAPGQGLQWMGWINTD---SGESTYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFCVRVGYD----------------------ALDYWGQGTLVTVSS
-GDPa1-177,pinatuzumab,213.95,99.75,93.845,2.725,2.565,3.7699999999999996,0.0,0.0,-0.13,-0.125,60.51,70.79,84.33,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTGGTCGAATCCGGCGGGGGTTTGGTCCAGCCAGGCGGGAGCCTGAGGCTGAGCTGTGCCGCATCCGGATATGAGTTCTCTAGGTCATGGATGAATTGGGTTAGACAAGCGCCCGGTAAAGGGCTCGAATGGGTAGGTCGAATCTACCCTGGCGATGGCGATACAAATTATAGTGGCAAGTTTAAAGGGCGCTTCACTATTAGCGCCGACACTTCTAAGAACACAGCCTATCTTCAGATGAACAGCCTCAGAGCAGAGGACACCGCTGTGTACTACTGCGCTCGGGATGGAAGTTCTTGGGACTGGTACTTTGACGTGTGGGGACAGGGAACCCTGGTGACGGTGTCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACGCAGTCTCCATCAAGTCTGTCCGCTAGTGTGGGCGACAGAGTTACAATCACTTGTAGGTCCTCTCAGAGCATCGTGCACAGCGTAGGCAACACTTTTCTCGAGTGGTACCAGCAGAAACCCGGAAAGGCACCCAAGTTGCTGATTTATAAGGTCAGCAATCGGTTTTCAGGCGTGCCTAGCCGCTTTTCCGGTTCTGGATCAGGGACCGATTTCACACTTACCATAAGTTCTCTGCAACCTGAGGATTTTGCCACCTACTATTGCTTCCAAGGCTCCCAGTTCCCATACACATTCGGGCAGGGTACCAAAGTCGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,0,DIQMTQSPSSLSASVGDRVTITCRSS--QSIVHSV-GNTFLEWYQQKPGKAPKLLIYK--------VSNRFSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCFQGSQ-----------------------FPYTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YEFSR-----SWMNWVRQAPGKGLEWVGRIYPG---DGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSW-------------------DWYFDVWGQGTLVTVSS
-GDPa1-178,plozalizumab,,99.27000000000001,89.67,2.705,2.55,4.12,0.11,0.1,0.0,0.0,56.28,68.14500000000001,75.4,IgG4,Kappa,Phase-II,Active,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYAMNWVRQAPGKGLEWVGRIRTKNNNYATYYADSVKDRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTFYGNGVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVKPGGSLRLSCAASGFTFSAYAMNWVRQAPGKGLEWVGRIRTKNNNYATYYADSVKDRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTFYGNGVWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTACAACTGGTGGAATCCGGCGGGGGTCTGGTGAAGCCCGGGGGTAGCTTGAGGCTCAGCTGCGCTGCATCTGGCTTCACTTTTTCCGCATATGCCATGAATTGGGTTCGACAGGCCCCTGGCAAAGGCCTGGAGTGGGTCGGACGGATCAGAACGAAGAACAACAATTATGCGACTTATTACGCCGACTCTGTCAAAGATCGCTTCACAATTAGTAGGGATGACTCAAAAAATACCCTCTATTTGCAGATGAACAGCCTTAAGACTGAGGACACCGCTGTGTACTACTGTACAACCTTTTACGGAAACGGGGTGTGGGGACAGGGCACCCTGGTGACAGTTTCAAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DVVMTQSPLSLPVTLGQPASISCKSSQSLLDSDGKTFLNWFQQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPYTFGQGTRLEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCKSSQSLLDSDGKTFLNWFQQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPYTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTGGTGATGACTCAGTCTCCACTGAGTCTTCCTGTGACGCTCGGTCAGCCCGCCTCCATCTCTTGTAAGAGCTCACAGAGCCTTCTGGATTCTGATGGAAAAACATTTCTGAACTGGTTTCAACAGAGACCTGGGCAGTCCCCGAGACGACTGATTTACTTGGTTAGCAAGCTCGATTCCGGGGTGCCCGACCGCTTCTCAGGCAGCGGCTCCGGCACCGACTTTACCTTGAAAATCAGTCGGGTCGAAGCTGAGGACGTAGGGGTCTACTATTGCTGGCAAGGAACACACTTCCCATATACCTTCGGACAGGGTACTAGGCTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,4,DVVMTQSPLSLPVTLGQPASISCKSS--QSLLDSD-GKTFLNWFQQRPGQSPRRLIYL--------VSKLDSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCWQGTH-----------------------FPYTFGQGTRLEIK-,EVQLVES-GGGLVKPGGSLRLSCAASG-FTFSA-----YAMNWVRQAPGKGLEWVGRIRTKN-NNYATYYADSVKDRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTFYG------------------------NGVWGQGTLVTVSS
-GDPa1-179,polatuzumab,266.55,99.505,96.61,2.685,2.4800000000000004,1.56,0.0,0.02,0.0,-0.875,60.43,70.86500000000001,82.27,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGCTGGTGGAGTCTGGTGGCGGGTTGGTACAGCCTGGAGGGTCATTGCGACTGAGTTGCGCCGCCAGCGGGTACACTTTCTCTTCATATTGGATAGAATGGGTGCGGCAGGCGCCGGGGAAAGGCCTTGAGTGGATTGGCGAAATTCTCCCAGGTGGCGGAGATACCAACTATAATGAGATCTTCAAGGGCAGGGCCACGTTTAGCGCTGACACTAGTAAGAATACAGCTTATCTCCAAATGAACAGCCTGAGAGCAGAGGATACCGCAGTGTACTACTGTACAAGAAGGGTCCCCATCCGCCTGGACTACTGGGGACAGGGAACACTTGTGACCGTCTCCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGCTCACTCAGTCTCCAAGTTCACTGAGCGCTTCCGTAGGAGATAGAGTTACAATCACCTGTAAAGCATCTCAAAGCGTCGACTATGAGGGCGACTCCTTCCTCAACTGGTACCAGCAGAAACCAGGCAAGGCCCCCAAACTTTTGATCTACGCGGCCAGTAACCTGGAGTCAGGCGTGCCTTCTAGGTTCAGCGGGTCCGGCAGTGGAACGGACTTTACACTGACCATTTCCAGCTTGCAACCCGAAGATTTTGCTACCTATTACTGCCAGCAGTCAAATGAAGATCCTCTGACTTTCGGGCAGGGTACAAAGGTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQLTQSPSSLSASVGDRVTITCKAS--QSVDYE--GDSFLNWYQQKPGKAPKLLIYA--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQSNE-----------------------DPLTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YTFSS-----YWIEWVRQAPGKGLEWIGEILPG---GGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPI----------------------RLDYWGQGTLVTVSS
-GDPa1-180,ponezumab,128.11,98.36,98.03999999999999,2.815,2.9000000000000004,1.655,,,0.6200000000000001,0.5,58.05500000000001,66.575,78.32,IgG2,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAGCTCGTTCAGAGCGGGGCGGAAGTGAAGAAACCAGGAGCATCCGTGAAGGTCTCTTGTAAGGCCTCTGGCTACTACACAGAGGCTTACTACATCCACTGGGTGCGCCAGGCCCCCGGTCAGGGACTCGAGTGGATGGGCAGAATTGATCCTGCCACAGGCAACACGAAATATGCTCCGAGGCTGCAAGACCGGGTGACTATGACCAGGGATACAAGTACCTCAACTGTGTATATGGAGCTTTCCTCACTGCGATCTGAAGACACCGCCGTGTATTACTGCGCAAGCTTGTACTCCCTGCCCGTTTATTGGGGTCAAGGGACAACTGTCACCGTCAGTAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTTGTGATGACCCAGTCACCGTTGTCTCTGCCCGTGACTCTGGGTCAGCCAGCCTCTATCAGTTGCAAGAGCTCCCAGTCACTCCTGTACAGCGACGCAAAGACGTATCTGAACTGGTTCCAGCAAAGACCCGGCCAGAGCCCCCGGAGGCTTATTTACCAAATATCTCGCTTGGATCCTGGGGTGCCTGATAGATTTAGTGGCAGCGGGTCCGGTACCGACTTTACACTGAAAATCTCCAGGGTCGAGGCTGAAGACGTGGGCGTCTATTACTGTCTCCAGGGGACACACTATCCAGTACTTTTCGGACAGGGAACTCGACTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DVVMTQSPLSLPVTLGQPASISCKSS--QSLLYSD-AKTYLNWFQQRPGQSPRRLIYQ--------ISRLDPGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCLQGTH-----------------------YPVLFGQGTRLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YYTEA-----YYIHWVRQAPGQGLEWMGRIDPA---TGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYS-----------------------LPVYWGQGTTVTVSS
-GDPa1-181,prasinezumab,210.41,99.83,99.28999999999999,2.725,2.6100000000000003,,0.3,0.12,8.5,19.625,60.64,70.315,84.86,IgG1,Kappa,Phase-II,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAACTGGTTGAGAGCGGTGGCGGGCTGGTCCAGCCTGGCGGGTCTCTCCGCTTGTCCTGTGCCGCGTCCGGGTTTACCTTCAGCAATTATGGGATGTCTTGGGTTAGGCAGGCCCCCGGAAAAGGCCTTGAATGGGTAGCAAGTATCAGTTCAGGCGGAGGCTCCACATACTATCCAGACAACGTGAAGGGGAGATTCACAATATCCCGGGACGACGCCAAGAATAGCTTGTACCTGCAGATGAACTCTCTCCGAGCCGAGGATACTGCTGTGTACTATTGCGCAAGGGGTGGCGCTGGAATTGATTACTGGGGTCAGGGAACCCTGGTGACGGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACTCAGTCCCCAAGCTCCCTGAGCGCCTCCGTGGGCGATAGAGTCACAATTACCTGCAAATCCATCCAGACACTGCTCTACTCTTCAAATCAGAAAAACTACCTGGCGTGGTTTCAGCAGAAGCCTGGAAAAGCTCCTAAGTTGCTGATATATTGGGCCAGTATTAGGAAGAGCGGTGTTCCCAGTCGGTTCAGTGGCTCTGGTTCAGGGACAGACTTCACGCTTACCATCTCAAGCCTGCAACCCGAGGATCTTGCAACCTATTACTGTCAACAGTATTATTCTTACCCATTGACTTTTGGGGGCGGAACCAAGCTCGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,DIQMTQSPSSLSASVGDRVTITCKSI--QTLLYSSNQKNYLAWFQQKPGKAPKLLIYW--------ASIRKSGVPSRFSGSGSG--TDFTLTISSLQPEDLATYYCQQYYS-----------------------YPLTFGGGTKLEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSN-----YGMSWVRQAPGKGLEWVASISSG---GGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGA-----------------------GIDYWGQGTLVTVSS
-GDPa1-182,prezalumab,165.68,99.58500000000001,97.94,3.005,3.0549999999999997,,0.0,0.01,0.8700000000000001,0.375,61.905,69.935,80.68,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGTTGGTAGAATCCGGGGGAGGCCTGGTTCAGCCAGGTGGCTCATTGCGGCTGTCTTGCGCTGCATCAGGCTTTACTTTCAGTTCTTATTGGATGAGCTGGGTGAGGCAGGCTCCCGGCAAAGGGCTGGAGTGGGTCGCATACATTAAGCAAGACGGAAACGAGAAGTACTATGTTGACTCCGTCAAGGGGAGGTTTACAATAAGCAGAGACAACGCGAAAAATAGCCTGTATCTTCAGATGAATTCTCTCCGCGCCGAAGATACAGCCGTGTACTACTGTGCCCGAGAAGGAATCCTTTGGTTCGGGGATCTGCCTACCTTCTGGGGTCAAGGCACGCTCGTGACCGTGAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAGATGACTCAGTCCCCAAGTTCACTGTCCGCCTCAGTTGGAGACAGAGTGACGATCACCTGCCGCGCCAGCCAGGGAATCTCTAACTGGCTGGCATGGTATCAACAGAAGCCCGAGAAGGCCCCTAAATCTCTCATTTATGCTGCGTCTAGTCTGCAAAGCGGGGTGCCTTCCCGGTTTAGTGGCTCAGGCTCTGGCACAGACTTCACATTGACCATTTCCAGCCTTCAACCCGAGGACTTCGCTACATACTACTGTCAGCAGTATGATAGCTACCCAAGGACCTTTGGTCAGGGGACTAAAGTCGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,DIQMTQSPSSLSASVGDRVTITCRAS--QGIS------NWLAWYQQKPEKAPKSLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYDS-----------------------YPRTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YWMSWVRQAPGKGLEWVAYIKQD---GNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWF------------------GDLPTFWGQGTLVTVSS
-GDPa1-183,prolgolimab,198.68,100.0,99.19999999999999,2.88,2.835,,0.0,0.0,2.87,2.875,62.13,72.93,85.54,IgG1,Lambda,Approved,Active,QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYWMYWVRQVPGKGLEWVSAIDTGGGRTYYADSVKGRFAISRVNAKNTMYLQMNSLRAEDTAVYYCARDEGGGTGWGVLKDWPYGLDAWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYWMYWVRQVPGKGLEWVSAIDTGGGRTYYADSVKGRFAISRVNAKNTMYLQMNSLRAEDTAVYYCARDEGGGTGWGVLKDWPYGLDAWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTTGTGCAGAGCGGAGGTGGTCTGGTGCAGCCTGGCGGGAGTCTCAGACTTTCCTGCGCTGCAAGCGGCTTCACCTTCTCATCATATTGGATGTATTGGGTCCGACAAGTGCCCGGAAAGGGGCTCGAGTGGGTTAGTGCCATTGACACCGGGGGCGGAAGAACATACTACGCTGATTCTGTCAAAGGAAGGTTTGCCATCTCCCGGGTGAACGCGAAGAACACGATGTACCTGCAAATGAATTCTCTGAGGGCTGAGGATACTGCCGTATACTATTGTGCACGCGATGAAGGTGGCGGCACTGGCTGGGGCGTGCTGAAAGACTGGCCATATGGGTTGGACGCCTGGGGACAGGGGACATTGGTTACCGTCAGCTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QPVLTQPLSVSVALGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVIYRDSNRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYCQVWDSSTAVFGTGTKLTVL,MRAWIFFLLCLAGRALAQPVLTQPLSVSVALGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVIYRDSNRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYCQVWDSSTAVFGTGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGCCCGTTCTCACACAGCCACTGAGTGTCTCCGTTGCCTTGGGACAGACCGCGCGGATTACCTGTGGCGGCAATAACATAGGTAGCAAAAATGTGCACTGGTATCAACAGAAGCCTGGGCAAGCTCCCGTGCTCGTAATCTACAGGGATTCAAACCGCCCTAGCGGTATTCCAGAGCGATTCTCCGGAAGCAATTCTGGAAACACGGCCACACTTACCATCAGTAGAGCACAGGCTGGGGATGAAGCCGACTACTATTGCCAGGTCTGGGACTCTTCAACTGCAGTGTTTGGCACAGGGACTAAGCTGACCGTGCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,1,4,QPVLTQP-LSVSVALGQTARITCGGN---NIGS-----KNVHWYQQKPGQAPVLVIYR--------DSNRPSGIPERFSGSNSG--NTATLTISRAQAGDEADYYCQVWDS-----------------------STAVFGTGTKLTVL-,QVQLVQS-GGGLVQPGGSLRLSCAASG-FTFSS-----YWMYWVRQVPGKGLEWVSAIDTG---GGRTYYADSVKGRFAISRVNAKNTMYLQMNSLRAEDTAVYYCARDEGGGTGWGV----------LKDWPYGLDAWGQGTLVTVSS
-GDPa1-184,quilizumab,249.63,99.72,98.475,2.865,2.91,,0.0,0.02,0.62,0.375,,,,IgG2,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGIAWVRQAPGKGLEWVAFISDLAYTIYYADTVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDNWDAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGIAWVRQAPGKGLEWVAFISDLAYTIYYADTVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDNWDAMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAATTGGTGGAAAGCGGAGGCGGACTGGTGCAGCCCGGCGGCTCTCTGAGGTTGAGCTGTGCTGCCTCCGGGTTCACTTTTAGCGACTACGGGATTGCATGGGTACGACAGGCGCCTGGTAAAGGGCTCGAGTGGGTGGCATTCATATCCGACCTTGCATATACCATCTACTATGCTGATACAGTTACGGGCCGGTTTACAATCTCTCGCGATAATTCAAAGAACACCCTGTACCTTCAGATGAACAGTCTCAGGGCCGAGGACACAGCTGTGTACTATTGCGCCAGAGATAATTGGGATGCCATGGACTATTGGGGACAGGGTACCCTGGTCACTGTCAGTTCAGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHNNANTYLHWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCSQNTLVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRSSQSLVHNNANTYLHWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCSQNTLVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACGCAGAGCCCCTCATCTTTGAGTGCCTCTGTCGGCGATAGGGTTACTATCACCTGCAGATCAAGTCAGTCCCTCGTACATAACAATGCTAACACATATCTGCACTGGTACCAGCAGAAACCAGGGAAAGCCCCTAAGCTGCTTATTTATAAGGTGTCCAATCGGTTCTCCGGCGTGCCTAGTCGCTTTTCAGGCAGCGGAAGCGGAACAGACTTCACCCTCACTATCTCTTCCCTGCAACCAGAGGATTTTGCAACCTACTACTGTAGCCAGAACACCCTGGTCCCCTGGACATTCGGGCAAGGTACTAAGGTGGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,2,DIQMTQSPSSLSASVGDRVTITCRSS--QSLVHNN-ANTYLHWYQQKPGKAPKLLIYK--------VSNRFSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCSQNTL-----------------------VPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSD-----YGIAWVRQAPGKGLEWVAFISDL---AYTIYYADTVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDNWD----------------------AMDYWGQGTLVTVSS
-GDPa1-185,racotumomab,183.88,98.555,97.095,2.685,2.5149999999999997,,0.14,0.03,-0.13,0.0,60.364999999999995,70.285,85.15,IgG1,Kappa,Approved,Active,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSS,MRAWIFFLLCLAGRALAQVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTCCAGCAGAGCGGAGCTGAATTGGTTAAACCAGGGGCCAGCGTAAAACTCTCCTGCAAGGCTTCAGGATACACCTTTACATCCTATGACATAAACTGGGTGAGGCAACGCCCTGAGCAGGGCCTTGAATGGATCGGGTGGATTTTCCCCGGGGACGGCTCCACTAAATACAATGAGAAGTTCAAGGGTAAGGCCACCCTGACGACCGATAAGTCCTCATCTACTGCGTACATGCAGCTGAGCAGACTGACAAGCGAGGATAGTGCCGTCTATTTTTGTGCACGGGAAGATTACTATGACAACAGTTATTACTTCGACTACTGGGGTCAGGGCACTACACTGACCGTGTCTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK,MRAWIFFLLCLAGRALADIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACTCAGACAACCAGCTCACTGTCCGCATCCTTGGGCGACAGGGTTACGATCTCCTGTCGGGCCTCTCAAGATATCAGTAATTATCTGAATTGGTACCAGCAGAAACCAGACGGAACCGTGAAGCTTCTCATTTATTACACCTCCAGACTTCACTCTGGGGTCCCCTCTCGCTTCAGTGGTAGCGGCAGCGGTACTGACTACTCACTGACAATTAGCAACTTGGAGCAGGAAGATATCGCTACATATTTTTGCCAGCAAGGCAACACTCTCCCTTGGACCTTCGGAGGGGGAACAAAGCTGGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,4,1,DIQMTQTTSSLSASLGDRVTISCRAS--QDIS------NYLNWYQQKPDGTVKLLIYY--------TSRLHSGVPSRFSGSGSG--TDYSLTISNLEQEDIATYFCQQGNT-----------------------LPWTFGGGTKLEIK-,QVQLQQS-GAELVKPGASVKLSCKASG-YTFTS-----YDINWVRQRPEQGLEWIGWIFPG---DGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDN------------------SYYFDYWGQGTTLTVSS
-GDPa1-186,radretumab,352.37,99.875,97.455,2.7199999999999998,2.675,3.9000000000000004,0.0,0.0,-0.13,12.875,59.965,70.56,83.08500000000001,IgG1,Kappa,Phase-II,Discontinued,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGTTGGAATCAGGCGGGGGTCTCGTGCAACCGGGCGGTAGTCTGAGGTTGAGCTGCGCCGCAAGTGGCTTCACCTTTTCTTCATTTTCCATGAGCTGGGTGAGACAGGCGCCTGGCAAAGGGCTTGAGTGGGTCTCTAGCATTTCAGGATCTTCCGGAACAACATATTACGCCGATAGCGTTAAGGGGCGATTTACTATCTCCCGGGATAACTCCAAAAACACGCTTTATCTGCAGATGAATAGTCTCCGCGCCGAAGACACTGCTGTGTACTACTGTGCTAAGCCATTCCCCTATTTCGACTACTGGGGACAGGGCACCCTGGTCACCGTAAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTGACACAGTCCCCTGGGACTCTTTCCCTCTCTCCCGGCGAAAGAGCTACGCTTTCATGTCGGGCATCCCAATCAGTGTCCAGCTCTTTCCTGGCCTGGTACCAACAGAAGCCAGGACAGGCGCCAAGGCTGTTGATCTATTACGCTAGCAGCCGAGCCACAGGCATCCCGGACAGGTTCAGTGGCAGTGGATCTGGTACTGATTTTACCCTGACCATAAGCAGACTCGAGCCCGAGGACTTCGCCGTTTATTACTGCCAGCAGACAGGGCGCATTCCTCCCACCTTTGGTCAGGGGACCAAAGTCGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,4,2,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----SFLAWYQQKPGQAPRLLIYY--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQTGR-----------------------IPPTFGQGTKVEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSS-----FSMSWVRQAPGKGLEWVSSISGS---SGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFP-----------------------YFDYWGQGTLVTVSS
-GDPa1-187,ramucirumab,174.63,99.33500000000001,97.7,2.715,2.635,,0.0,0.01,-0.5,-0.125,61.825,72.785,84.87,IgG1,Kappa,Approved,Active,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTCGTCCAGTCTGGAGGCGGTCTCGTGAAACCTGGGGGTTCCTTGCGACTGAGCTGTGCAGCCTCTGGCTTTACGTTTAGCTCCTACTCAATGAATTGGGTGAGGCAGGCTCCCGGCAAAGGACTGGAATGGGTTTCTTCAATCAGTAGCTCCAGTAGCTATATATATTATGCCGACAGTGTCAAGGGGAGATTCACCATCTCCCGCGATAACGCCAAGAATTCCCTGTACCTTCAGATGAACTCACTGAGGGCTGAGGATACTGCCGTGTACTACTGCGCGCGGGTGACAGACGCATTCGACATTTGGGGACAAGGGACAATGGTAACCGTTAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK,MRAWIFFLLCLAGRALADIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGTCACCAAGCTCCGTCAGTGCTTCCATTGGGGACCGGGTGACCATCACCTGCAGAGCGAGCCAAGGGATCGACAACTGGCTCGGGTGGTACCAGCAAAAACCAGGCAAGGCACCCAAGCTGCTGATCTATGACGCATCTAATCTGGACACTGGCGTGCCTTCTAGGTTCAGTGGAAGCGGTTCCGGCACTTACTTTACACTTACGATTTCTTCATTGCAGGCCGAGGATTTCGCCGTATATTTCTGTCAGCAGGCCAAAGCTTTTCCCCCTACCTTTGGTGGAGGAACAAAAGTTGATATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,0,DIQMTQSPSSVSASIGDRVTITCRAS--QGID------NWLGWYQQKPGKAPKLLIYD--------ASNLDTGVPSRFSGSGSG--TYFTLTISSLQAEDFAVYFCQQAKA-----------------------FPPTFGGGTKVDIK-,EVQLVQS-GGGLVKPGGSLRLSCAASG-FTFSS-----YSMNWVRQAPGKGLEWVSSISSS---SSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTD-----------------------AFDIWGQGTMVTVSS
-GDPa1-188,ranibizumab,118.75,99.89500000000001,96.86,3.895,3.365,3.72,0.16,0.13,2.5,6.0,63.375,73.465,86.625,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTACAGCTGGTCGAGTCTGGAGGCGGCCTGGTTCAGCCTGGCGGAAGTCTGCGCCTCTCCTGCGCCGCGTCAGGTTACGACTTCACCCATTATGGGATGAACTGGGTCCGACAGGCACCCGGAAAGGGACTGGAATGGGTGGGCTGGATCAATACATACACGGGGGAACCGACTTATGCCGCCGACTTTAAACGGAGGTTCACTTTCTCTTTGGATACTAGCAAGAGCACCGCATATCTTCAGATGAACAGTTTGAGAGCTGAGGATACCGCCGTGTATTACTGTGCTAAATACCCATATTACTACGGCACATCCCACTGGTACTTTGACGTGTGGGGGCAAGGTACCCTCGTTACAGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGCTTACTCAGAGTCCATCTTCACTCTCAGCATCTGTGGGCGACAGGGTGACTATCACCTGCTCCGCTTCTCAGGATATTAGTAACTATCTGAATTGGTACCAGCAGAAGCCCGGAAAGGCCCCTAAAGTGTTGATTTATTTTACTAGCTCACTGCACAGCGGGGTCCCCTCCCGGTTCTCCGGCAGCGGGTCTGGCACCGATTTCACACTGACAATAAGTTCCCTCCAACCTGAGGACTTTGCCACATACTACTGTCAACAGTATAGCACGGTTCCATGGACCTTCGGACAGGGTACCAAAGTAGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,DIQLTQSPSSLSASVGDRVTITCSAS--QDIS------NYLNWYQQKPGKAPKVLIYF--------TSSLHSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYST-----------------------VPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-YDFTH-----YGMNWVRQAPGKGLEWVGWINTY---TGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGT----------------SHWYFDVWGQGTLVTVSS
-GDPa1-189,relatlimab,302.17,99.47,89.91499999999999,2.7649999999999997,3.1550000000000002,,0.82,0.1,4.0,2.625,58.879999999999995,67.83500000000001,77.22,IgG4,Kappa,Approved,Active,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWNWIRQPPGKGLEWIGEINHRGSTNSNPSLKSRVTLSLDTSKNQFSLKLRSVTAADTAVYYCAFGYSDYEYNWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWNWIRQPPGKGLEWIGEINHRGSTNSNPSLKSRVTLSLDTSKNQFSLKLRSVTAADTAVYYCAFGYSDYEYNWFDPWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGCAGCAATGGGGAGCTGGACTTCTTAAGCCCAGCGAGACCCTGTCTCTGACCTGTGCTGTCTATGGCGGCTCATTTTCCGACTATTACTGGAATTGGATAAGGCAACCGCCTGGTAAGGGGCTGGAGTGGATTGGCGAAATCAACCACCGGGGGAGTACCAATTCCAACCCATCATTGAAAAGCAGAGTAACACTGTCTCTCGATACATCCAAGAATCAGTTCTCCCTCAAATTGCGCAGCGTGACTGCCGCGGACACGGCCGTGTATTACTGCGCATTCGGGTACTCTGATTACGAATATAACTGGTTTGACCCCTGGGGTCAGGGAACTCTCGTGACAGTCAGCAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASQSISSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGQGTNLEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSISSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGQGTNLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTGCTGACCCAAAGTCCTGCCACATTGTCCCTGTCCCCGGGAGAAAGGGCTACTTTGTCCTGCCGGGCCAGCCAGTCTATCTCAAGCTATCTGGCGTGGTACCAGCAGAAACCAGGCCAGGCACCCCGCCTTCTGATTTACGATGCCAGCAACCGAGCCACCGGCATCCCAGCTAGGTTCTCTGGTTCAGGATCCGGGACCGACTTTACACTCACTATCAGCAGTCTCGAGCCCGAAGACTTTGCAGTCTACTATTGTCAGCAAAGATCTAACTGGCCTCTTACGTTCGGGCAGGGCACAAATCTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,2,EIVLTQSPATLSLSPGERATLSCRAS--QSIS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSN-----------------------WPLTFGQGTNLEIK-,QVQLQQW-GAGLLKPSETLSLTCAVYG-GSFSD-----YYWNWIRQPPGKGLEWIGEINH----RGSTNSNPSLKSRVTLSLDTSKNQFSLKLRSVTAADTAVYYCAFGYSDYE------------------YNWFDPWGQGTLVTVSS
-GDPa1-190,reslizumab,191.93,98.24000000000001,88.655,2.77,2.8449999999999998,1.21,0.59,0.1,1.87,4.375,57.525,68.59,76.19,IgG4,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAACTTGTGGAATCTGGCGGGGGTCTCGTGCAGCCTGGCGGAAGCCTTCGCTTGTCTTGCGCAGTCTCCGGCCTCTCTCTGACGAGTAACTCCGTTAACTGGATCAGACAGGCTCCCGGAAAGGGGTTGGAGTGGGTAGGTCTGATTTGGTCAAATGGCGACACAGACTACAATAGTGCCATCAAAAGCAGGTTTACCATATCCAGGGATACCAGCAAGAGCACAGTTTACCTGCAGATGAACTCACTGCGAGCGGAGGACACTGCTGTGTATTACTGTGCCCGGGAATACTATGGATATTTCGATTATTGGGGGCAGGGCACCCTGGTGACTGTCTCCTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGTCCCCTTCCTCACTCTCCGCCTCAGTGGGAGATAGGGTGACCATTACTTGCCTGGCTTCTGAGGGAATAAGCAGCTATCTCGCCTGGTACCAGCAGAAACCAGGGAAAGCACCCAAGCTTCTGATCTATGGCGCTAACAGTCTGCAAACCGGCGTACCTAGCAGATTTTCTGGGTCAGGCAGCGCGACTGACTACACACTGACCATTAGTTCCTTGCAACCAGAGGACTTTGCCACGTACTACTGTCAGCAGTCTTATAAATTCCCCAATACATTCGGTCAGGGTACCAAGGTTGAAGTCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,1,DIQMTQSPSSLSASVGDRVTITCLAS--EGIS------SYLAWYQQKPGKAPKLLIYG--------ANSLQTGVPSRFSGSGSA--TDYTLTISSLQPEDFATYYCQQSYK-----------------------FPNTFGQGTKVEVK-,EVQLVES-GGGLVQPGGSLRLSCAVSG-LSLTS-----NSVNWIRQAPGKGLEWVGLIWS----NGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYG----------------------YFDYWGQGTLVTVSS
-GDPa1-191,rilotumumab,220.5,100.0,98.655,6.795,3.33,1.9249999999999998,0.32,0.1,2.5,1.625,61.135000000000005,69.97,82.77,IgG2,Kappa,Phase-II,Discontinued,QVQLQESGPGLVKPSETLSLTCTVSGGSISIYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDFWSGYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGGSISIYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDFWSGYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGCAAGAATCCGGACCCGGTCTCGTGAAGCCATCAGAGACATTGTCCCTTACATGTACAGTGTCAGGCGGGAGCATAAGTATTTATTATTGGTCATGGATTAGACAGCCGCCCGGAAAAGGCCTGGAGTGGATCGGTTACGTCTATTACAGTGGGTCTACCAACTACAACCCTAGCCTTAAGAGCAGGGTTACCATCTCTGTGGACACGAGTAAGAATCAATTTTCTCTCAAACTGAATAGCGTGACCGCCGCAGATACCGCTGTCTACTATTGCGCCCGGGGCGGGTACGATTTCTGGTCCGGCTATTTCGACTACTGGGGACAGGGCACTCTGGTAACTGTGTCTTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,EIVMTQSPATLSVSPGERATLSCRASQSVDSNLAWYRQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYINWPPITFGQGTRLEIK,MRAWIFFLLCLAGRALAEIVMTQSPATLSVSPGERATLSCRASQSVDSNLAWYRQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYINWPPITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGATGACCCAGTCTCCGGCCACCCTGTCAGTTTCTCCAGGTGAGAGAGCCACACTGAGCTGTCGCGCGTCCCAAAGTGTGGATAGCAATCTCGCCTGGTACAGGCAGAAGCCTGGGCAGGCCCCCAGATTGCTCATATACGGAGCTAGTACCCGAGCTACAGGTATCCCTGCACGGTTCAGCGGCAGCGGGTCCGGAACGGAGTTTACTCTTACTATCTCTTCACTGCAATCCGAGGACTTTGCAGTCTATTACTGCCAGCAGTATATTAACTGGCCACCCATTACATTCGGCCAGGGCACCAGGCTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,1,EIVMTQSPATLSVSPGERATLSCRAS--QSVD------SNLAWYRQKPGQAPRLLIYG--------ASTRATGIPARFSGSGSG--TEFTLTISSLQSEDFAVYYCQQYINW----------------------PPITFGQGTRLEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-GSISI-----YYWSWIRQPPGKGLEWIGYVYY----SGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDFW------------------SGYFDYWGQGTLVTVSS
-GDPa1-192,rinucumab,171.61,99.88,96.66,2.8200000000000003,2.6500000000000004,,0.49,0.85,2.37,20.375,59.38,72.89,81.36,IgG1,Kappa,Phase-II,Discontinued,QLQLQESGPGLVKPSETLSLTCTVSGGSITSSSYYWGWIRQPPGKGLEWIGSIYYRGSTNYNPSLKSRVTISVDSSKNQFYLKVSSVTAVDTAVYYCARQNGAARPSWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAQLQLQESGPGLVKPSETLSLTCTVSGGSITSSSYYWGWIRQPPGKGLEWIGSIYYRGSTNYNPSLKSRVTISVDSSKNQFYLKVSSVTAVDTAVYYCARQNGAARPSWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGCTGCAGCTCCAAGAGAGCGGCCCGGGACTTGTGAAGCCCAGCGAAACATTGTCTCTCACATGCACTGTGAGTGGAGGGTCTATTACGAGCTCCTCATACTATTGGGGCTGGATACGCCAGCCACCTGGCAAAGGCCTGGAGTGGATCGGCAGTATTTATTACAGGGGATCCACCAATTACAATCCATCTTTGAAATCACGAGTAACCATCAGCGTCGACAGTTCCAAGAACCAGTTTTATCTGAAGGTGTCATCCGTGACCGCAGTGGACACTGCCGTTTATTACTGTGCCCGGCAGAACGGGGCGGCTAGACCTTCCTGGTTCGATCCCTGGGGTCAAGGGACACTGGTTACCGTCAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPDTISLSPGERATLSCRASQSISSIYLAWYQQKPGQAPRLLIYGASSRVTGIPDRFSVSGSGTDFTLTISRLEPEDFAVYYCQHYGISPFTFGPGTKVDIR,MRAWIFFLLCLAGRALAEIVLTQSPDTISLSPGERATLSCRASQSISSIYLAWYQQKPGQAPRLLIYGASSRVTGIPDRFSVSGSGTDFTLTISRLEPEDFAVYYCQHYGISPFTFGPGTKVDIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTGCTCACTCAGTCACCAGATACAATTTCCCTGAGCCCCGGCGAAAGAGCAACGCTGAGTTGTAGGGCTAGCCAATCCATCTCTAGTATCTACCTGGCCTGGTATCAGCAGAAGCCCGGGCAGGCTCCTCGCCTCCTGATTTATGGAGCGTCTTCTCGAGTCACCGGGATACCGGATCGGTTCAGCGTTTCCGGATCAGGCACAGACTTTACCCTTACTATCAGCAGGTTGGAACCTGAGGACTTCGCCGTGTATTACTGCCAACACTACGGTATCTCCCCATTTACATTCGGTCCCGGCACCAAAGTAGACATTAGAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,0,3,EIVLTQSPDTISLSPGERATLSCRAS--QSISS-----IYLAWYQQKPGQAPRLLIYG--------ASSRVTGIPDRFSVSGSG--TDFTLTISRLEPEDFAVYYCQHYGI-----------------------SPFTFGPGTKVDIR-,QLQLQES-GPGLVKPSETLSLTCTVSG-GSITSS---SYYWGWIRQPPGKGLEWIGSIYY----RGSTNYNPSLKSRVTISVDSSKNQFYLKVSSVTAVDTAVYYCARQNGAAR------------------PSWFDPWGQGTLVTVSS
-GDPa1-193,risankizumab,210.41,99.53,97.28,2.79,2.8600000000000003,,0.42,0.4,2.0,7.125,61.005,70.39,84.87,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTGGTGCAGTCTGGGGCAGAGGTGAAAAAACCGGGCAGTTCCGTTAAGGTAAGCTGCAAAGCAAGCGGATACACCTTCACAGATCAGACAATCCACTGGATGCGCCAGGCTCCAGGCCAAGGGCTTGAGTGGATCGGTTACATCTACCCCAGAGACGATTCTCCCAAGTACAACGAAAATTTCAAGGGGAAGGTCACCATTACTGCCGATAAGTCTACGTCAACTGCTTATATGGAGTTGTCCTCACTCCGGTCCGAAGACACCGCCGTTTATTATTGTGCGATTCCTGACAGGAGCGGCTACGCCTGGTTTATATATTGGGGTCAAGGAACACTGGTGACCGTGAGCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACTCAGAGCCCCTCCTCCCTGAGCGCTAGCGTCGGTGATCGCGTAACTATAACCTGCAAAGCGTCCCGAGATGTGGCCATCGCAGTGGCTTGGTACCAGCAAAAGCCTGGAAAAGTGCCAAAGCTTCTGATTTATTGGGCCTCAACAAGGCATACCGGAGTCCCAAGCAGATTTTCTGGCTCAGGGAGTCGGACCGATTTCACACTGACGATTAGTTCTTTGCAACCCGAAGACGTTGCCGACTACTTTTGTCACCAGTACTCTTCATATCCTTTCACCTTCGGCTCCGGGACAAAGCTCGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,1,DIQMTQSPSSLSASVGDRVTITCKAS--RDVA------IAVAWYQQKPGKVPKLLIYW--------ASTRHTGVPSRFSGSGSR--TDFTLTISSLQPEDVADYFCHQYSS-----------------------YPFTFGSGTKLEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-YTFTD-----QTIHWMRQAPGQGLEWIGYIYPR---DDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSG-------------------YAWFIYWGQGTLVTVSS
-GDPa1-194,rituximab,183.88,99.505,96.55,2.79,3.05,,0.59,0.61,0.8700000000000001,3.375,62.995,70.44,84.045,IgG1,Kappa,Approved,Active,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA,MRAWIFFLLCLAGRALAQVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTGCAGCAACCGGGAGCTGAGTTGGTGAAGCCTGGCGCATCTGTGAAAATGTCTTGCAAGGCGTCCGGATATACTTTTACTAGTTACAACATGCACTGGGTGAAGCAGACCCCAGGTAGAGGGCTGGAGTGGATCGGGGCCATTTACCCCGGAAATGGGGATACATCATATAACCAGAAGTTCAAGGGCAAAGCTACTCTTACCGCTGACAAAAGCAGCAGCACAGCCTATATGCAACTGAGCTCCCTCACCAGTGAAGATTCAGCCGTTTACTACTGTGCAAGGTCTACCTATTACGGCGGTGACTGGTACTTCAATGTCTGGGGCGCAGGCACAACAGTAACGGTGTCCGCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK,MRAWIFFLLCLAGRALAQIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATCGTATTGTCTCAGTCTCCAGCTATCCTTAGCGCATCTCCCGGCGAGAAGGTGACCATGACCTGTCGGGCATCATCATCTGTGTCCTACATACACTGGTTCCAACAGAAACCCGGTTCCAGCCCTAAACCGTGGATTTACGCCACCAGCAACCTGGCCAGTGGCGTGCCTGTTAGGTTCAGCGGGAGTGGAAGCGGTACATCATATTCCCTGACAATCTCCAGAGTCGAAGCGGAGGACGCCGCTACTTACTATTGCCAACAGTGGACGAGTAATCCACCCACTTTTGGCGGGGGAACAAAGCTCGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,2,QIVLSQSPAILSASPGEKVTMTCRAS--SSVS-------YIHWFQQKPGSSPKPWIYA--------TSNLASGVPVRFSGSGSG--TSYSLTISRVEAEDAATYYCQQWTS-----------------------NPPTFGGGTKLEIK-,QVQLQQP-GAELVKPGASVKMSCKASG-YTFTS-----YNMHWVKQTPGRGLEWIGAIYPG---NGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGG------------------DWYFNVWGAGTTVTVSA
-GDPa1-195,robatumumab,221.22,98.77000000000001,97.71000000000001,2.88,2.67,4.4,0.1,0.1,4.87,28.375,60.99,70.91,82.78,IgG1,Kappa,Phase-II,Discontinued,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTGTACAAAGCGGAGGCGGTTTGGTTAAACCCGGGGGTTCCCTTAGGCTGAGCTGCGCGGCTTCTGGGTTCACCTTTAGCTCTTTCGCAATGCACTGGGTGAGACAGGCTCCTGGCAAGGGGCTCGAATGGATATCCGTGATCGATACCCGGGGAGCAACATACTATGCCGACTCTGTTAAGGGCCGATTTACCATTAGTAGGGATAACGCCAAAAATTCACTCTATCTGCAGATGAATTCACTGCGCGCTGAGGACACAGCCGTCTACTATTGTGCCAGACTGGGCAACTTCTACTACGGAATGGACGTGTGGGGCCAGGGGACTACTGTGACGGTCAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGCTGACGCAGAGTCCTGGCACCCTGAGTGTGTCTCCGGGGGAACGCGCCACCCTGAGCTGCAGGGCTTCCCAGTCCATCGGTTCCAGCCTCCACTGGTATCAGCAGAAACCAGGACAGGCGCCCAGATTGCTCATTAAGTACGCCTCTCAGAGTTTGTCAGGAATCCCAGATAGGTTCTCAGGCTCCGGGAGCGGGACTGACTTCACACTGACAATATCTCGACTTGAGCCCGAGGACTTTGCAGTCTATTACTGTCACCAAAGCTCACGGCTTCCTCATACCTTTGGCCAAGGTACTAAGGTTGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPGTLSVSPGERATLSCRAS--QSIG------SSLHWYQQKPGQAPRLLIKY--------ASQSLSGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCHQSSR-----------------------LPHTFGQGTKVEIK-,EVQLVQS-GGGLVKPGGSLRLSCAASG-FTFSS-----FAMHWVRQAPGKGLEWISVIDT----RGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFY--------------------YGMDVWGQGTTVTVSS
-GDPa1-196,romosozumab,393.92,99.68,98.36,2.705,2.565,,0.0,0.04,1.12,0.375,59.835,71.36,80.58500000000001,IgG2,Kappa,Approved,NFD,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAACTGGTGCAGAGCGGGGCAGAGGTCAAGAAACCAGGTGCCAGTGTGAAGGTGTCATGTAAAGCGAGCGGATACACATTTACCGACTACAATATGCACTGGGTACGACAGGCTCCCGGACAGGGCCTGGAATGGATGGGGGAGATTAACCCTAATTCTGGCGGGGCAGGCTATAACCAAAAATTCAAGGGCCGCGTGACAATGACCACCGATACATCAACATCCACCGCCTACATGGAACTTAGGTCTCTCCGGAGTGATGACACTGCTGTGTACTATTGCGCCAGATTGGGTTATGATGACATCTATGACGATTGGTACTTCGACGTTTGGGGACAGGGCACGACTGTCACTGTTAGCTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAAATGACACAGAGCCCATCCTCACTGTCTGCTTCCGTGGGGGATAGAGTGACCATAACCTGCAGGGCCAGCCAGGATATTAGCAATTATCTCAACTGGTACCAGCAGAAACCAGGGAAGGCACCTAAACTGCTGATCTATTATACATCTCGGCTTCTCAGTGGGGTTCCCAGTCGCTTCAGCGGCTCCGGCTCAGGAACTGACTTCACCTTGACGATCTCTTCCCTTCAACCTGAAGACTTTGCCACTTACTACTGTCAGCAGGGAGATACACTGCCCTACACCTTTGGTGGCGGTACTAAGGTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,0,DIQMTQSPSSLSASVGDRVTITCRAS--QDIS------NYLNWYQQKPGKAPKLLIYY--------TSRLLSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQGDT-----------------------LPYTFGGGTKVEIK-,EVQLVQS-GAEVKKPGASVKVSCKASG-YTFTD-----YNMHWVRQAPGQGLEWMGEINPN---SGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIY----------------DDWYFDVWGQGTTVTVSS
-GDPa1-197,rontalizumab,89.39,99.4,96.12,2.8,2.9850000000000003,,,,0.37,11.375,,,,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCATSGYTFTEYIIHWVRQAPGKGLEWVASINPDYDITNYNQRFKGRFTISLDKSKRTAYLQMNSLRAEDTAVYYCASWISDFFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCATSGYTFTEYIIHWVRQAPGKGLEWVASINPDYDITNYNQRFKGRFTISLDKSKRTAYLQMNSLRAEDTAVYYCASWISDFFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAACTCGTTGAATCTGGTGGAGGCCTTGTGCAGCCTGGAGGCTCCCTGAGGCTGTCTTGTGCCACATCCGGGTACACATTTACTGAGTACATTATTCACTGGGTGCGACAAGCTCCCGGGAAAGGATTGGAGTGGGTCGCCAGCATAAACCCAGATTACGACATCACCAATTATAACCAGAGATTCAAGGGTCGGTTCACAATCAGTTTGGACAAGAGCAAACGCACTGCATATCTGCAGATGAATTCACTCAGGGCCGAGGATACCGCGGTGTATTATTGCGCTAGTTGGATCTCCGACTTCTTTGATTACTGGGGCCAGGGGACGCTGGTGACCGTAAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKVLISYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWGIPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKVLISYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWGIPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGTCCCCTTCATCCCTGAGCGCTTCAGTGGGCGATAGGGTGACCATTACCTGCAGAGCAAGCCAGTCCGTGTCCACCTCTTCCTACTCTTATATGCACTGGTATCAACAGAAACCAGGTAAGGCCCCTAAGGTACTTATCAGTTACGCCTCTAACCTCGAGAGCGGTGTTCCCTCTCGATTCAGCGGCAGTGGATCAGGGACTGACTTCACACTGACGATTTCAAGCTTGCAACCAGAGGACTTTGCGACTTATTACTGTCAGCATAGTTGGGGGATCCCCCGGACATTTGGCCAGGGAACCAAGGTCGAAATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,DIQMTQSPSSLSASVGDRVTITCRAS--QSVSTS--SYSYMHWYQQKPGKAPKVLISY--------ASNLESGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQHSWG-----------------------IPRTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCATSG-YTFTE-----YIIHWVRQAPGKGLEWVASINPD---YDITNYNQRFKGRFTISLDKSKRTAYLQMNSLRAEDTAVYYCASWISD----------------------FFDYWGQGTLVTVSS
-GDPa1-198,rovalpituzumab,174.63,99.6,97.64500000000001,2.7350000000000003,2.62,,0.07,0.0,1.87,1.125,61.225,73.5,86.58,IgG1,Kappa,Phase-III,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAATTGGTTCAGTCCGGTGCGGAGGTGAAGAAGCCTGGCGCTTCAGTGAAGGTCTCCTGCAAAGCAAGTGGCTACACCTTCACTAACTATGGGATGAATTGGGTCAGACAGGCCCCCGGCCAGGGCCTTGAGTGGATGGGGTGGATCAACACATATACAGGAGAACCGACCTACGCCGACGACTTTAAAGGTCGAGTGACCATGACGACTGATACAAGCACATCAACCGCATATATGGAACTGAGGAGCCTGCGGAGCGATGACACTGCCGTGTACTATTGTGCTCGCATTGGAGATTCTTCTCCATCTGACTACTGGGGGCAAGGAACCCTCGTAACGGTGTCCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK,MRAWIFFLLCLAGRALAEIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGATGACACAATCCCCAGCAACGTTGTCAGTGTCTCCCGGGGAGAGAGCCACACTGAGCTGCAAGGCCAGCCAGTCTGTATCTAATGATGTCGTGTGGTACCAGCAGAAACCCGGCCAGGCGCCACGGCTGCTCATATACTATGCTTCAAACAGGTATACCGGGATTCCTGCCCGCTTTAGTGGAAGTGGCTCCGGTACTGAGTTCACCCTTACCATCTCCAGCCTCCAAAGCGAAGACTTTGCTGTTTATTACTGTCAGCAGGACTACACATCCCCTTGGACTTTCGGCCAGGGAACCAAACTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,0,3,EIVMTQSPATLSVSPGERATLSCKAS--QSVS------NDVVWYQQKPGQAPRLLIYY--------ASNRYTGIPARFSGSGSG--TEFTLTISSLQSEDFAVYYCQQDYT-----------------------SPWTFGQGTKLEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTN-----YGMNWVRQAPGQGLEWMGWINTY---TGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDS---------------------SPSDYWGQGTLVTVSS
-GDPa1-199,rozanolixizumab,125.49,98.03999999999999,87.58,2.715,2.575,,,,1.87,1.5,56.17,69.58500000000001,,IgG4,Kappa,Approved,Active,EVPLVESGGGLVQPGGSLRLSCAVSGFTFSNYGMVWVRQAPGKGLEWVAYIDSDGDNTYYRDSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCTTGIVRPFLYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVPLVESGGGLVQPGGSLRLSCAVSGFTFSNYGMVWVRQAPGKGLEWVAYIDSDGDNTYYRDSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCTTGIVRPFLYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCCGTTGGTGGAAAGTGGCGGAGGGCTTGTACAGCCCGGCGGATCACTGAGACTGTCTTGTGCTGTTAGCGGATTCACCTTTTCTAACTATGGTATGGTGTGGGTGAGGCAGGCGCCAGGCAAGGGGCTGGAGTGGGTCGCCTACATTGACTCAGACGGTGATAATACCTACTATCGGGATTCCGTTAAGGGCCGCTTTACGATCAGTCGAGACAACGCCAAATCCTCTCTTTATCTGCAAATGAATAGCTTGAGGGCAGAAGATACCGCTGTGTACTATTGCACTACTGGAATAGTCAGACCTTTCCTCTACTGGGGCCAGGGGACACTCGTGACAGTGAGCTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSLSASVGDRVTITCKSSQSLVGASGKTYLYWLFQKPGKAPKRLIYLVSTLDSGIPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQGTHFPHTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKSSQSLVGASGKTYLYWLFQKPGKAPKRLIYLVSTLDSGIPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQGTHFPHTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACCCAATCCCCCTCATCTCTTAGCGCCTCAGTGGGCGATAGGGTGACAATTACGTGTAAGTCCAGCCAGTCTCTTGTCGGAGCCAGTGGCAAGACATATCTGTACTGGCTGTTTCAGAAACCAGGAAAGGCACCCAAAAGACTCATATATTTGGTTAGCACTCTCGACTCAGGCATTCCTAGCCGATTCTCCGGTTCCGGGAGTGGAACCGAATTCACACTGACTATCAGTTCTCTGCAACCAGAGGATTTCGCTACCTACTACTGCTTGCAGGGGACCCACTTTCCTCATACTTTTGGGCAGGGTACAAAGCTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,1,DIQMTQSPSSLSASVGDRVTITCKSS--QSLVGAS-GKTYLYWLFQKPGKAPKRLIYL--------VSTLDSGIPSRFSGSGSG--TEFTLTISSLQPEDFATYYCLQGTH-----------------------FPHTFGQGTKLEIK-,EVPLVES-GGGLVQPGGSLRLSCAVSG-FTFSN-----YGMVWVRQAPGKGLEWVAYIDSD---GDNTYYRDSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCTTGIVR----------------------PFLYWGQGTLVTVSS
-GDPa1-200,sarilumab,285.99,99.08,97.965,2.7,2.495,,0.0,0.0,-0.13,0.5,61.08,68.35,83.905,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCGTCGAGAGCGGGGGAGGCCTGGTGCAGCCCGGACGATCTCTCCGCCTTAGTTGCGCAGCCTCAAGATTTACTTTTGACGACTACGCCATGCACTGGGTCAGACAGGCCCCTGGCAAGGGTCTTGAGTGGGTGTCCGGGATCTCTTGGAATTCCGGGCGCATCGGCTACGCCGATAGCGTGAAAGGTAGGTTCACGATATCCCGGGATAACGCTGAAAACAGCTTGTTCCTGCAGATGAATGGACTGCGGGCAGAGGACACCGCGCTGTATTATTGTGCTAAGGGCAGGGATTCTTTCGACATTTGGGGACAAGGCACCATGGTTACAGTAAGTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAGATGACACAGAGTCCATCTTCCGTGAGCGCGTCTGTTGGTGACAGGGTCACCATCACGTGCAGAGCCAGCCAGGGAATTAGTAGTTGGCTGGCATGGTATCAGCAGAAACCCGGGAAGGCTCCTAAACTGTTGATCTATGGCGCTTCCTCACTGGAGTCAGGCGTGCCTAGCCGGTTCTCAGGTTCCGGGAGCGGAACAGATTTTACCCTCACTATCTCCTCTCTTCAACCAGAAGACTTCGCCTCTTACTACTGTCAACAGGCCAACTCCTTCCCCTACACTTTTGGGCAGGGCACCAAGCTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,0,DIQMTQSPSSVSASVGDRVTITCRAS--QGIS------SWLAWYQQKPGKAPKLLIYG--------ASSLESGVPSRFSGSGSG--TDFTLTISSLQPEDFASYYCQQANS-----------------------FPYTFGQGTKLEIK-,EVQLVES-GGGLVQPGRSLRLSCAASR-FTFDD-----YAMHWVRQAPGKGLEWVSGISWN---SGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRD-----------------------SFDIWGQGTMVTVSS
-GDPa1-201,satralizumab,211.24,100.0,98.13,2.83,2.5700000000000003,1.495,0.0,0.03,5.37,12.0,58.980000000000004,71.16499999999999,82.80000000000001,IgG2,Kappa,Approved,NFD,QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGTTGCAGGAGTCCGGACCCGGGCTCGTGAAGCCCAGCGAGACACTCTCTTTGACCTGTGCCGTCTCAGGTCACAGTATTAGCCACGATCATGCTTGGTCCTGGGTTAGACAGCCGCCAGGGGAGGGACTGGAATGGATAGGCTTCATTTCCTACTCAGGGATCACGAACTACAATCCTAGCCTGCAAGGTAGGGTAACCATCTCTAGAGACAATTCAAAAAACACCCTTTATCTGCAAATGAACAGCCTTCGGGCGGAAGATACAGCAGTGTACTATTGCGCTCGCAGTCTGGCCCGAACTACAGCCATGGACTATTGGGGCGAAGGCACTCTGGTCACCGTGTCCTCTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIERTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAAATGACGCAGTCCCCCTCAAGCTTGTCCGCCAGCGTGGGAGATAGTGTCACTATTACATGCCAAGCGAGCACAGACATCTCTAGTCATCTGAACTGGTATCAGCAGAAGCCTGGTAAGGCCCCGGAGCTCCTGATTTACTACGGCTCCCACCTTCTGTCCGGGGTGCCATCAAGATTTTCAGGCTCTGGCAGTGGGACTGACTTCACCTTTACCATATCTAGCCTCGAAGCAGAGGATGCTGCTACCTATTACTGTGGGCAGGGTAATAGGCTGCCCTATACCTTCGGACAGGGAACAAAAGTTGAGATCGAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,1,DIQMTQSPSSLSASVGDSVTITCQAS--TDIS------SHLNWYQQKPGKAPELLIYY--------GSHLLSGVPSRFSGSGSG--TDFTFTISSLEAEDAATYYCGQGNR-----------------------LPYTFGQGTKVEIE-,QVQLQES-GPGLVKPSETLSLTCAVSG-HSISH----DHAWSWVRQPPGEGLEWIGFISY----SGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLART--------------------TAMDYWGEGTLVTVSS
-GDPa1-202,secukinumab,193.48,99.47,98.93,2.725,3.115,,0.0,0.01,0.37,0.0,60.795,70.00999999999999,82.07,IgG1,Kappa,Approved,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGCTGGTGGAGTCTGGTGGAGGCTTGGTCCAGCCTGGGGGCAGCCTGCGCCTGAGTTGCGCGGCATCAGGCTTCACGTTTTCCAACTACTGGATGAATTGGGTGAGGCAAGCTCCCGGCAAGGGACTTGAATGGGTTGCCGCCATAAACCAGGATGGCTCAGAGAAATACTATGTTGGTAGTGTCAAAGGACGATTTACCATTAGCCGGGACAATGCCAAGAATTCCCTTTACCTGCAGATGAACTCTCTCAGAGTGGAGGATACAGCTGTATACTATTGTGTGCGGGACTACTATGACATCCTGACTGACTATTACATCCACTATTGGTACTTCGATTTGTGGGGGAGGGGGACCCTCGTGACAGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATTGTGTTGACCCAAAGTCCTGGGACTCTCAGCCTGTCACCAGGAGAGAGAGCTACCTTGTCTTGCCGAGCCTCCCAGTCCGTTTCATCTTCCTACCTTGCCTGGTATCAACAGAAACCTGGCCAGGCGCCGAGGCTTCTGATATACGGAGCATCAAGTCGCGCTACAGGGATCCCAGACCGGTTTAGCGGTAGTGGCTCCGGCACTGATTTTACACTCACAATTAGCAGACTGGAACCCGAGGACTTCGCCGTCTACTATTGCCAGCAGTATGGATCTAGCCCCTGTACCTTCGGTCAGGGGACGAGGCTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,3,2,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----SYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------SPCTFGQGTRLEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSN-----YWMNWVRQAPGKGLEWVAAINQD---GSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDY------------YIHYWYFDLWGRGTLVTVSS
-GDPa1-203,selicrelumab,180.76,99.58,97.25,2.8200000000000003,2.745,,0.0,0.0,-0.38,-0.375,61.25,69.67,79.875,IgG1,Kappa,Phase-I,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPDSGGTNYAQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYYCARDQPLGYCTNGVCSYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPDSGGTNYAQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYYCARDQPLGYCTNGVCSYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGGTGCAGAGCGGCGCGGAGGTGAAGAAGCCAGGTGCCTCCGTAAAAGTCTCTTGCAAGGCCTCTGGATACACTTTTACCGGGTACTACATGCACTGGGTTCGGCAAGCCCCTGGCCAGGGCCTGGAATGGATGGGATGGATCAACCCCGACAGCGGCGGGACTAATTACGCTCAGAAATTCCAGGGTCGAGTTACCATGACAAGAGATACTTCAATTAGTACAGCATATATGGAGCTCAACAGGCTTCGCAGTGACGACACGGCAGTCTATTATTGTGCTAGAGATCAGCCGTTGGGATACTGCACAAATGGCGTCTGTTCATACTTCGATTATTGGGGGCAGGGGACCCTGGTGACCGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSVSASVGDRVTITCRASQGIYSWLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANIFPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSVSASVGDRVTITCRASQGIYSWLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANIFPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACCCAGTCTCCATCCAGCGTGAGCGCCTCCGTCGGTGACAGAGTTACTATTACTTGTAGGGCCTCCCAGGGCATTTACTCATGGCTCGCTTGGTATCAACAGAAACCCGGAAAAGCACCTAACTTGCTGATATATACTGCCTCTACGCTCCAGAGCGGCGTGCCTTCTCGGTTTAGTGGCTCAGGGTCCGGTACCGATTTCACCCTGACCATCAGTAGCCTTCAACCAGAAGACTTTGCGACATACTACTGCCAGCAGGCTAATATCTTCCCCCTGACATTCGGAGGGGGAACAAAGGTAGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,3,1,DIQMTQSPSSVSASVGDRVTITCRAS--QGIY------SWLAWYQQKPGKAPNLLIYT--------ASTLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQANI-----------------------FPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTG-----YYMHWVRQAPGQGLEWMGWINPD---SGGTNYAQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYYCARDQPLGYCT-------------NGVCSYFDYWGQGTLVTVSS
-GDPa1-204,seribantumab,416.5,87.33,97.835,2.8449999999999998,2.875,,0.11,0.11,5.37,17.625,59.16,73.27,,IgG2,Lambda,Phase-II,Discontinued,EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYVMAWVRQAPGKGLEWVSSISSSGGWTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMATIFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSHYVMAWVRQAPGKGLEWVSSISSSGGWTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMATIFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGCTCGAATCCGGCGGGGGATTGGTACAGCCTGGTGGCAGCCTTCGGTTGTCTTGTGCAGCCAGTGGTTTTACTTTCAGCCACTATGTCATGGCCTGGGTGAGACAAGCGCCCGGCAAGGGCCTGGAGTGGGTGTCTTCAATTTCAAGTAGCGGCGGATGGACCCTGTATGCAGACTCTGTCAAAGGGCGCTTTACAATCAGCAGGGACAACTCCAAAAACACTCTCTACCTCCAGATGAATTCCCTTCGAGCTGAAGATACCGCTGTGTACTATTGCACCAGGGGGCTGAAGATGGCCACAATATTCGATTACTGGGGGCAGGGAACGCTGGTTACAGTTTCATCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNVVSWYQQHPGKAPKLIIYEVSQRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCCSYAGSSIFVIFGGGTKVTVL,MRAWIFFLLCLAGRALAQSALTQPASVSGSPGQSITISCTGTSSDVGSYNVVSWYQQHPGKAPKLIIYEVSQRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCCSYAGSSIFVIFGGGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGTCCGCCCTCACCCAGCCAGCGTCCGTGTCAGGAAGCCCTGGCCAGTCCATTACAATTAGCTGTACAGGGACTAGTAGTGACGTAGGTTCCTACAATGTTGTGAGCTGGTATCAGCAACACCCCGGCAAGGCTCCGAAACTGATAATCTATGAGGTTAGCCAGAGACCCTCTGGAGTCTCTAACAGGTTTAGTGGGAGCAAGTCTGGCAACACCGCATCTCTGACTATCTCAGGCTTGCAAACGGAGGACGAAGCCGATTACTACTGCTGCTCATATGCTGGTTCCTCAATTTTCGTCATCTTCGGCGGAGGGACCAAAGTGACAGTGCTTGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,4,3,QSALTQP-ASVSGSPGQSITISCTGTS-SDVGS----YNVVSWYQQHPGKAPKLIIYE--------VSQRPSGVSNRFSGSKSG--NTASLTISGLQTEDEADYYCCSYAGS---------------------SIFVIFGGGTKVTVL-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSH-----YVMAWVRQAPGKGLEWVSSISSS---GGWTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMA--------------------TIFDYWGQGTLVTVSS
-GDPa1-205,setrusumab,265.83,85.775,94.83500000000001,2.725,2.84,,0.12,0.0,0.5,2.5,60.55,69.5,81.55,IgG1,Lambda,Phase-III,Active,QVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGGTGGAGTCTGGCGGGGGACTGGTTCAGCCTGGCGGGAGCCTTCGCCTTAGCTGTGCTGCCTCAGGCTTTACGTTTAGAAGCCACTGGTTGTCATGGGTTAGGCAGGCTCCCGGTAAAGGGCTCGAATGGGTGTCCAACATTAACTATGACGGTTCTTCCACTTACTACGCGGATTCTGTCAAGGGACGATTCACCATCTCCCGGGACAATAGTAAGAACACACTCTACCTGCAGATGAATTCCCTGAGAGCCGAGGATACCGCAGTGTATTATTGCGCCAGGGATACTTACTTGCATTTCGACTATTGGGGCCAAGGAACACTGGTAACCGTCAGTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVL,MRAWIFFLLCLAGRALADIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGCCCTGACCCAGCCGGCGTCCGTTTCCGGCTCTCCTGGACAGAGCATCACTATCTCCTGCACGGGGACAAGTTCCGACGTCGGCGACATAAACGACGTGTCTTGGTACCAACAGCACCCAGGCAAAGCTCCCAAACTCATGATCTATGATGTGAATAACAGGCCCAGCGGCGTCAGCAATAGATTTTCTGGATCTAAGAGCGGTAACACCGCAAGTTTGACCATTAGTGGCCTGCAAGCTGAGGATGAGGCCGACTACTATTGTCAGTCATACGCCGGGTCATATCTCTCAGAAGTATTCGGTGGAGGGACTAAGCTTACAGTGCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,4,4,DIALTQP-ASVSGSPGQSITISCTGTS-SDVGD----INDVSWYQQHPGKAPKLMIYD--------VNNRPSGVSNRFSGSKSG--NTASLTISGLQAEDEADYYCQSYAGS---------------------YLSEVFGGGTKLTVL-,QVQLVES-GGGLVQPGGSLRLSCAASG-FTFRS-----HWLSWVRQAPGKGLEWVSNINYD---GSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYL----------------------HFDYWGQGTLVTVSS
-GDPa1-206,sifalimumab,232.62,99.875,97.72,2.74,2.6100000000000003,,0.17,0.17,0.37,1.0,62.06,69.9,83.03,IgG1,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYSISWVRQAPGQGLEWMGWISVYNGNTNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPIAAGYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYSISWVRQAPGQGLEWMGWISVYNGNTNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPIAAGYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTTGTGCAGTCCGGTGCCGAGGTGAAGAAACCCGGCGCTTCCGTCAAAGTCAGCTGTAAGGCGAGCGGCTACACTTTCACATCTTATTCTATAAGTTGGGTCCGACAGGCTCCTGGACAGGGGCTCGAGTGGATGGGATGGATTTCAGTGTATAACGGGAATACTAACTACGCACAGAAGTTTCAAGGGCGCGTTACCATGACTACGGATACAAGTACCAGCACCGCCTACCTGGAATTGCGGAGCCTGAGGTCCGACGACACAGCTGTGTACTATTGCGCCAGAGATCCAATCGCAGCCGGCTATTGGGGTCAGGGAACCCTGGTAACAGTTTCTTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATAGTTCTGACACAGTCTCCAGGTACCCTCTCCCTGAGTCCCGGGGAGCGGGCCACACTCTCTTGTCGCGCCTCCCAGTCAGTCAGTTCAACCTATTTGGCTTGGTATCAGCAAAAGCCCGGACAAGCGCCTAGGCTGCTTATTTATGGCGCCTCCTCTCGCGCAACCGGCATCCCAGACAGATTTAGCGGGTCCGGCTCAGGGACAGATTTCACCCTTACTATCAGCCGGCTGGAACCTGAGGACTTTGCTGTGTACTACTGCCAGCAGTACGGAAGCAGCCCGCGAACTTTCGGACAGGGTACGAAAGTGGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,3,EIVLTQSPGTLSLSPGERATLSCRAS--QSVSS-----TYLAWYQQKPGQAPRLLIYG--------ASSRATGIPDRFSGSGSG--TDFTLTISRLEPEDFAVYYCQQYGS-----------------------SPRTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTS-----YSISWVRQAPGQGLEWMGWISVY---NGNTNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPI-----------------------AAGYWGQGTLVTVSS
-GDPa1-207,siltuximab,257.51,99.0,98.93,3.38,3.165,,0.46,0.09,4.87,6.5,61.64,69.81,82.85,IgG1,Kappa,Approved,Active,EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTACAATTGGTCGAGTCCGGAGGGAAACTGCTTAAGCCTGGAGGCTCCCTCAAACTGTCCTGCGCAGCATCAGGCTTTACTTTCAGTTCTTTTGCCATGTCTTGGTTCAGACAGAGCCCAGAAAAGCGACTTGAATGGGTTGCCGAGATCTCTAGCGGGGGCTCATATACATACTACCCCGACACAGTGACCGGTAGGTTCACAATTAGTCGCGACAATGCTAAGAACACCCTCTACCTGGAGATGTCATCTTTGAGGAGCGAGGATACTGCGATGTATTACTGTGCCCGGGGGCTGTGGGGATACTATGCTCTGGATTATTGGGGTCAGGGCACGAGTGTGACCGTGTCCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK,MRAWIFFLLCLAGRALAQIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATTGTACTGATCCAGAGTCCTGCGATTATGAGCGCCAGTCCAGGCGAAAAAGTGACCATGACTTGTAGCGCATCTTCATCTGTTTCCTATATGTATTGGTACCAACAGAAGCCAGGATCTTCACCCAGGCTGTTGATCTATGACACTTCAAACCTGGCCTCCGGGGTGCCTGTCAGATTCAGCGGGAGCGGTTCCGGTACGAGCTACTCTCTCACCATAAGTCGGATGGAAGCCGAGGATGCTGCTACCTACTACTGCCAACAGTGGTCCGGCTACCCCTATACATTTGGGGGAGGCACAAAGCTTGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,4,3,QIVLIQSPAIMSASPGEKVTMTCSAS--SSVS-------YMYWYQQKPGSSPRLLIYD--------TSNLASGVPVRFSGSGSG--TSYSLTISRMEAEDAATYYCQQWSG-----------------------YPYTFGGGTKLEIK-,EVQLVES-GGKLLKPGGSLKLSCAASG-FTFSS-----FAMSWFRQSPEKRLEWVAEISSG---GSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGY--------------------YALDYWGQGTSVTVSS
-GDPa1-208,simtuzumab,231.48,99.195,85.39,2.9050000000000002,2.965,,0.33,0.27,4.37,3.625,59.08,69.86,,IgG4,Kappa,Phase-II,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYAFTYYLIEWVRQAPGQGLEWIGVINPGSGGTNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCARNWMNFDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYAFTYYLIEWVRQAPGQGLEWIGVINPGSGGTNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCARNWMNFDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTCCAGTCCGGAGCTGAGGTGAAGAAACCTGGAGCCAGTGTAAAGGTTAGTTGTAAGGCTAGCGGGTATGCATTTACATATTACTTGATTGAATGGGTGAGGCAGGCCCCCGGACAGGGTCTTGAGTGGATCGGCGTGATAAACCCAGGCTCTGGCGGTACTAACTACAATGAAAAGTTTAAAGGGCGCGCTACCATCACGGCGGACAAATCAACAAGCACCGCCTATATGGAGCTGTCAAGCCTCCGGTCCGAAGATACCGCCGTCTACTTCTGCGCAAGAAACTGGATGAATTTCGACTACTGGGGCCAAGGGACTACAGTTACCGTGTCTTCCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQTPLSLSVTPGQPASISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQHLEYPYTFGGGTKVEIK,MRAWIFFLLCLAGRALADIVMTQTPLSLSVTPGQPASISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQHLEYPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTCATGACCCAGACCCCACTGTCACTGAGCGTGACTCCGGGGCAGCCTGCATCTATATCTTGTCGCAGTAGCAAGAGCCTCTTGCATTCCAACGGAAATACATATCTTTATTGGTTTCTTCAGAAGCCCGGCCAATCCCCTCAATTTCTGATTTACCGGATGTCCAACCTCGCTTCTGGCGTGCCAGATAGATTCAGTGGATCCGGCAGCGGGACGGACTTCACTTTGAAGATTTCAAGGGTCGAGGCCGAGGATGTAGGAGTTTACTACTGCATGCAGCACCTGGAATACCCCTATACATTCGGTGGTGGGACCAAAGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,4,DIVMTQTPLSLSVTPGQPASISCRSS--KSLLHSN-GNTYLYWFLQKPGQSPQFLIYR--------MSNLASGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCMQHLE-----------------------YPYTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YAFTY-----YLIEWVRQAPGQGLEWIGVINPG---SGGTNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCARNWM-----------------------NFDYWGQGTTVTVSS
-GDPa1-209,sintilimab,310.74,99.705,91.06,2.795,3.0599999999999996,1.49,0.23,0.1,4.37,2.125,57.5,68.26,78.25,IgG4,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGLIIPMFDTAGYAQKFQGRVAITVDESTSTAYMELSSLRSEDTAVYYCARAEHSSTGTFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGLIIPMFDTAGYAQKFQGRVAITVDESTSTAYMELSSLRSEDTAVYYCARAEHSSTGTFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGCTTGTTCAGAGCGGGGCCGAGGTGAAGAAGCCAGGCTCAAGCGTAAAAGTCAGCTGTAAGGCTAGCGGAGGGACCTTCTCATCCTACGCAATTTCATGGGTCAGGCAGGCCCCCGGCCAGGGACTGGAATGGATGGGACTGATAATCCCTATGTTTGACACTGCTGGCTACGCGCAAAAATTTCAGGGCCGCGTTGCAATCACCGTCGATGAGTCTACCTCCACAGCTTATATGGAACTCTCCAGTCTGCGGTCTGAGGACACTGCAGTGTATTATTGCGCCAGAGCCGAACACTCCAGTACGGGTACATTCGATTACTGGGGGCAAGGTACATTGGTGACCGTGAGTTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANHLPFTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANHLPFTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACTCAGTCCCCTAGCAGCGTTTCTGCCTCCGTCGGAGACAGAGTGACCATAACATGCAGGGCCTCACAGGGGATTTCATCTTGGCTGGCATGGTATCAGCAGAAGCCCGGTAAGGCTCCCAAACTGTTGATCAGTGCAGCTAGTAGCCTTCAGTCAGGGGTACCATCCCGGTTTAGCGGATCTGGGAGTGGCACAGACTTCACACTGACGATCTCTTCCCTCCAACCTGAAGATTTCGCCACCTACTACTGTCAGCAAGCGAACCACCTCCCATTTACCTTCGGCGGCGGTACTAAAGTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSVSASVGDRVTITCRAS--QGIS------SWLAWYQQKPGKAPKLLISA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQANH-----------------------LPFTFGGGTKVEIK-,QVQLVQS-GAEVKKPGSSVKVSCKASG-GTFSS-----YAISWVRQAPGQGLEWMGLIIPM---FDTAGYAQKFQGRVAITVDESTSTAYMELSSLRSEDTAVYYCARAEHSS-------------------TGTFDYWGQGTLVTVSS
-GDPa1-210,sirukumab,83.88,99.45,99.03999999999999,3.975,3.18,,,,18.5,26.625,61.62,73.8,83.825,IgG1,Kappa,Preregistration (w),Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTTCAGCTGGTAGAGAGCGGCGGAGGGCTGGTGCAACCCGGGGGATCCCTTCGGCTGTCTTGCGCTGCGTCCGGCTTCACCTTTAGTCCGTTTGCTATGTCTTGGGTGAGGCAGGCCCCTGGCAAGGGTCTTGAGTGGGTTGCCAAAATAAGTCCAGGAGGAAGCTGGACATACTACTCTGATACTGTGACTGGGCGATTCACAATCTCAAGAGACAATGCAAAGAACAGCCTGTATTTGCAGATGAACTCCTTGAGGGCCGAAGACACCGCTGTCTATTACTGTGCCCGCCAACTCTGGGGCTACTATGCACTCGATATTTGGGGCCAGGGTACAACCGTGACGGTCTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATCGTGCTGACGCAGAGTCCCGCCACACTGTCTCTCTCACCAGGCGAACGGGCGACCCTCAGTTGTTCCGCCAGCATCTCCGTTTCCTATATGTATTGGTATCAGCAGAAGCCTGGACAGGCTCCTAGGCTGCTGATCTACGATATGTCTAACTTGGCCTCTGGGATTCCGGCTAGATTTTCCGGGAGCGGATCAGGTACTGACTTCACATTGACCATTTCAAGCCTTGAACCCGAGGACTTTGCAGTGTACTATTGCATGCAATGGAGCGGGTACCCATACACTTTCGGTGGCGGCACCAAAGTCGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,1,2,EIVLTQSPATLSLSPGERATLSCSAS--ISVS-------YMYWYQQKPGQAPRLLIYD--------MSNLASGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCMQWSG-----------------------YPYTFGGGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSP-----FAMSWVRQAPGKGLEWVAKISPG---GSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGY--------------------YALDIWGQGTTVTVSS
-GDPa1-211,solanezumab,187.04,100.0,96.55,2.62,2.5300000000000002,,0.0,0.0,-1.0,-1.125,73.26,81.43,,IgG1,Kappa,Phase-III,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGTTGGTGGAGTCCGGCGGCGGCTTGGTACAACCTGGAGGTAGCCTCAGGCTGTCATGCGCCGCGAGCGGCTTTACATTCTCCCGGTATAGCATGAGCTGGGTGCGACAGGCTCCCGGCAAAGGGCTGGAGCTTGTTGCTCAGATCAATTCTGTCGGGAACTCAACCTACTACCCAGACACTGTTAAGGGAAGGTTCACGATTTCCAGAGATAATGCCAAGAACACACTGTATCTCCAGATGAACAGTCTTCGCGCAGAAGACACTGCCGTGTACTATTGTGCATCTGGAGATTACTGGGGTCAAGGGACCCTGGTGACCGTGAGTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTGGTGATGACGCAGTCCCCCTTGAGTCTCCCTGTTACATTGGGCCAGCCCGCTAGCATCAGTTGTCGCAGCTCTCAGTCTCTGATTTACTCCGATGGCAACGCATATCTGCACTGGTTCCTCCAGAAGCCAGGTCAATCCCCAAGACTTCTGATATATAAGGTATCCAATAGGTTCAGTGGTGTGCCTGACCGGTTCTCAGGGAGCGGATCAGGGACAGATTTTACCCTGAAAATTTCACGAGTCGAGGCCGAGGACGTCGGAGTGTACTACTGCAGCCAGTCTACCCATGTGCCGTGGACTTTTGGGCAAGGCACTAAGGTTGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,1,DVVMTQSPLSLPVTLGQPASISCRSS--QSLIYSD-GNAYLHWFLQKPGQSPRLLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCSQSTH-----------------------VPWTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSR-----YSMSWVRQAPGKGLELVAQINSV---GNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASG---------------------------DYWGQGTLVTVSS
-GDPa1-212,spartalizumab,170.36,99.66,90.78999999999999,2.72,2.62,,0.1,0.1,2.5,2.0,57.955,67.775,,IgG4,Kappa,Phase-II,Active,EVQLVQSGAEVKKPGESLRISCKGSGYTFTTYWMHWVRQATGQGLEWMGNIYPGTGGSNFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYCTRWTTGTGAYWGQGTTVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGESLRISCKGSGYTFTTYWMHWVRQATGQGLEWMGNIYPGTGGSNFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYCTRWTTGTGAYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAGCTCGTCCAGAGCGGAGCTGAGGTAAAAAAACCCGGTGAGAGTCTTAGAATTAGTTGTAAGGGTAGCGGCTACACCTTCACGACATACTGGATGCACTGGGTGCGGCAAGCGACCGGGCAGGGCCTGGAGTGGATGGGCAATATATACCCTGGAACCGGGGGCTCCAACTTTGATGAGAAGTTCAAGAACCGCGTTACAATCACCGCCGACAAATCTACTTCAACAGCTTATATGGAATTGTCCTCACTGCGATCCGAAGACACCGCAGTGTATTATTGCACTAGGTGGACCACTGGGACTGGAGCCTACTGGGGGCAGGGCACAACAGTGACGGTCTCTAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCKSSQSLLDSGNQKNFLTWYQQKPGQAPRLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCQNDYSYPYTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCKSSQSLLDSGNQKNFLTWYQQKPGQAPRLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCQNDYSYPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTGCTCACCCAGTCACCCGCCACTCTTAGTTTGAGCCCTGGTGAAAGGGCAACCCTCTCTTGTAAAAGTAGCCAGTCCCTGCTGGACTCCGGCAACCAAAAGAACTTTCTGACTTGGTATCAGCAAAAACCAGGCCAGGCCCCTAGACTTTTGATATACTGGGCCTCTACACGCGAATCAGGAGTTCCCTCTCGGTTTTCCGGCAGCGGATCCGGTACAGATTTCACCTTCACTATCTCAAGTCTGGAAGCTGAGGACGCGGCTACGTATTACTGCCAGAATGATTACAGCTATCCATACACATTCGGGCAGGGGACCAAGGTCGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,3,EIVLTQSPATLSLSPGERATLSCKSS--QSLLDSGNQKNFLTWYQQKPGQAPRLLIYW--------ASTRESGVPSRFSGSGSG--TDFTFTISSLEAEDAATYYCQNDYS-----------------------YPYTFGQGTKVEIK-,EVQLVQS-GAEVKKPGESLRISCKGSG-YTFTT-----YWMHWVRQATGQGLEWMGNIYPG---TGGSNFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYCTRWTTG----------------------TGAYWGQGTTVTVSS
-GDPa1-213,sutimlimab,142.34,99.47999999999999,84.86,2.7300000000000004,2.635,4.17,,,29.87,24.5,54.89,69.56,77.825,IgG4,Kappa,Approved,NFD,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTTGTGGAATCTGGTGGCGGCCTCGTGAAGCCTGGGGGCTCTTTGCGCCTCAGTTGTGCTGCCTCCGGGTTTACTTTCTCCAATTATGCAATGTCCTGGGTGAGGCAAGCCCCCGGGAAAGGTTTGGAGTGGGTCGCTACTATCTCCAGCGGGGGCAGCCACACATATTATCTGGATAGCGTCAAAGGAAGGTTCACGATTAGTCGGGACAATTCAAAGAACACACTTTACCTGCAGATGAACAGCCTGCGAGCCGAAGATACCGCCCTGTACTACTGCGCGAGACTGTTTACAGGCTACGCAATGGACTATTGGGGACAGGGAACCCTCGTAACCGTTTCTTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,QIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIK,MRAWIFFLLCLAGRALAQIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATTGTGCTTACCCAGTCACCAGCGACGCTGAGCTTGTCCCCTGGCGAGAGAGCCACAATGTCCTGTACAGCAAGTAGCTCTGTCAGTTCCTCATACCTGCACTGGTACCAGCAGAAACCTGGTAAGGCTCCCAAACTGTGGATCTACTCAACCAGCAACCTTGCCAGCGGAGTTCCCTCTCGGTTCAGTGGCTCTGGGTCCGGAACTGACTATACCCTGACAATTTCTAGCCTCCAACCAGAAGATTTCGCTACCTATTATTGCCATCAGTATTACAGGCTCCCGCCCATAACTTTTGGCCAAGGGACTAAGTTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,0,3,QIVLTQSPATLSLSPGERATMSCTAS--SSVSS-----SYLHWYQQKPGKAPKLWIYS--------TSNLASGVPSRFSGSGSG--TDYTLTISSLQPEDFATYYCHQYYRL----------------------PPITFGQGTKLEIK-,EVQLVES-GGGLVKPGGSLRLSCAASG-FTFSN-----YAMSWVRQAPGKGLEWVATISSG---GSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTG---------------------YAMDYWGQGTLVTVSS
-GDPa1-214,tabalumab,203.97,99.485,89.695,2.915,3.025,,0.54,0.1,1.87,1.625,58.155,67.0,,IgG4,Kappa,Phase-III,Discontinued,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTACAATTGCAGCAATGGGGAGCTGGGCTCCTCAAGCCGTCCGAAACCCTGAGCCTTACATGCGCCGTGTACGGCGGTTCTTTTAGTGGATACTACTGGTCCTGGATCAGACAGCCACCTGGTAAAGGCTTGGAGTGGATTGGCGAGATCAATCACTCAGGAAGTACCAATTATAACCCCAGCCTGAAATCCAGGGTCACAATATCAGTCGATACATCCAAGAACCAGTTCTCTCTGAAGCTGAGCAGCGTTACTGCGGCTGACACCGCCGTGTACTATTGTGCACGGGGCTATTATGATATTCTGACCGGCTACTACTACTATTTCGACTATTGGGGGCAGGGGACGCTTGTGACTGTGTCATCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATAGTGCTGACGCAGTCTCCCGCCACACTCAGTTTGTCTCCAGGCGAGAGAGCCACCTTGTCATGCAGAGCGTCCCAATCCGTGTCACGGTACCTGGCTTGGTATCAACAGAAACCAGGACAGGCACCTCGGCTGCTTATCTACGATGCTTCTAACCGCGCCACCGGGATTCCCGCCAGGTTCTCCGGAAGCGGGAGCGGTACAGACTCCACTCTGACAATCAGCAGCCTCGAACCGGAGGACTTCGCAGTCTATTACTGTCAGCAGAGGAGTAATTGGCCTCGAACTTTTGGCCAGGGCACCAAGGTTGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------RYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDSTLTISSLEPEDFAVYYCQQRSN-----------------------WPRTFGQGTKVEIK-,QVQLQQW-GAGLLKPSETLSLTCAVYG-GSFSG-----YYWSWIRQPPGKGLEWIGEINH----SGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILT---------------GYYYYFDYWGQGTLVTVSS
-GDPa1-215,tanezumab,202.18,99.67500000000001,97.44999999999999,3.16,3.0599999999999996,,0.59,0.04,0.37000000000000005,4.0,59.105000000000004,71.00999999999999,80.875,IgG2,Kappa,Phase-III,Discontinued,QVQLQESGPGLVKPSETLSLTCTVSGFSLIGYDLNWIRQPPGKGLEWIGIIWGDGTTDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYATSYYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGFSLIGYDLNWIRQPPGKGLEWIGIIWGDGTTDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYATSYYFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAACTGCAGGAGTCTGGGCCAGGCTTGGTGAAACCCTCTGAAACCCTGAGCCTCACATGCACTGTTAGCGGATTTTCCCTCATCGGGTACGATCTGAATTGGATAAGACAGCCTCCGGGCAAAGGCCTGGAGTGGATTGGGATTATCTGGGGAGATGGAACAACCGATTATAACTCCGCCGTCAAGTCAAGGGTGACCATCAGCAAGGACACCAGCAAGAACCAGTTCAGTCTTAAATTGAGTTCAGTGACTGCCGCAGACACGGCTGTTTACTACTGTGCGCGGGGCGGCTACTGGTATGCTACTTCTTATTATTTCGACTACTGGGGTCAAGGTACACTTGTCACAGTATCCTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCRASQSISNNLNWYQQKPGKAPKLLIYYTSRFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQEHTLPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQSISNNLNWYQQKPGKAPKLLIYYTSRFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQEHTLPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACACAGAGCCCTAGTTCTCTCTCCGCTTCTGTGGGCGATAGAGTTACGATCACCTGTCGCGCATCCCAGAGCATCAGCAACAATCTGAACTGGTACCAACAGAAACCAGGCAAGGCCCCCAAACTTCTGATTTACTATACTTCAAGGTTCCACAGTGGTGTCCCTTCTCGGTTTTCCGGCTCCGGGTCAGGAACCGATTTCACTTTTACCATCTCAAGCCTGCAGCCCGAGGACATAGCCACCTATTACTGCCAGCAAGAACATACATTGCCATATACTTTCGGACAGGGGACAAAGCTCGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,1,DIQMTQSPSSLSASVGDRVTITCRAS--QSIS------NNLNWYQQKPGKAPKLLIYY--------TSRFHSGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCQQEHT-----------------------LPYTFGQGTKLEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-FSLIG-----YDLNWIRQPPGKGLEWIGIIWG----DGTTDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYA-----------------TSYYFDYWGQGTLVTVSS
-GDPa1-216,tarextumab,352.64,99.535,99.685,2.7199999999999998,2.46,4.295,0.25,0.19,8.5,22.875,63.545,74.135,,IgG2,Kappa,Phase-II,Active,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTGGTGGAGTCCGGGGGAGGGCTCGTCCAGCCTGGCGGATCTCTCCGGCTTAGTTGCGCCGCTTCCGGCTTCACATTTAGTTCTTCCGGCATGAGCTGGGTGAGACAGGCCCCCGGCAAGGGTCTGGAATGGGTGTCTGTAATTGCGAGCAGCGGTTCTAATACTTATTACGCTGACAGTGTTAAAGGCCGATTCACCATCTCACGCGATAATTCCAAGAACACGTTGTACCTGCAGATGAACTCCCTTAGGGCCGAAGACACAGCAGTTTATTACTGTGCAAGGTCAATATTTTATACCACATGGGGACAAGGGACTCTGGTCACCGTGTCAAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIK,MRAWIFFLLCLAGRALADIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGCTCACACAGTCCCCGGCAACGCTGTCCCTCAGTCCCGGCGAAAGGGCCACCCTGTCTTGTCGAGCTAGCCAAAGCGTCAGAAGTAACTATCTGGCATGGTACCAGCAGAAGCCCGGCCAGGCCCCTAGGTTGCTGATTTATGGGGCTTCTTCCCGGGCGACCGGTGTGCCTGCCCGCTTTTCAGGATCAGGGTCCGGAACCGATTTCACACTTACTATCAGCAGCTTGGAACCAGAGGACTTTGCCGTTTACTACTGCCAACAGTATTCTAATTTCCCAATTACATTCGGTCAGGGCACTAAAGTAGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,3,4,DIVLTQSPATLSLSPGERATLSCRAS--QSVRS-----NYLAWYQQKPGQAPRLLIYG--------ASSRATGVPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQYSN-----------------------FPITFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----SGMSWVRQAPGKGLEWVSVIASS---GSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIF------------------------YTTWGQGTLVTVSS
-GDPa1-217,tavolimab,108.15,99.535,95.095,2.955,2.9850000000000003,3.795,,,1.75,2.5,59.31,70.44,79.85,IgG1,Kappa,Phase-II,Discontinued,QVQLQESGPGLVKPSQTLSLTCAVYGGSFSSGYWNWIRKHPGKGLEYIGYISYNGITYHNPSLKSRITINRDTSKNQYSLQLNSVTPEDTAVYYCARYKYDYDGGHAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSQTLSLTCAVYGGSFSSGYWNWIRKHPGKGLEYIGYISYNGITYHNPSLKSRITINRDTSKNQYSLQLNSVTPEDTAVYYCARYKYDYDGGHAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTACAGCTGCAGGAGTCCGGCCCCGGACTGGTCAAGCCTTCACAAACTCTCAGCTTGACCTGTGCTGTGTACGGTGGAAGCTTCTCCTCCGGTTATTGGAACTGGATCCGCAAACACCCGGGCAAAGGACTGGAGTATATCGGCTACATTAGCTATAACGGGATCACCTACCACAATCCCTCTCTTAAGTCCAGAATTACAATAAATAGGGACACAAGTAAGAACCAGTACTCACTTCAGCTCAATTCTGTGACACCAGAAGACACGGCAGTCTATTATTGCGCCCGGTACAAATACGACTACGATGGCGGGCATGCCATGGATTATTGGGGCCAGGGGACCCTGGTGACTGTTAGTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQGSALPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQGSALPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACACAGAGCCCATCAAGTCTGTCCGCGAGCGTCGGAGATAGAGTTACGATTACCTGCAGGGCTAGCCAGGACATTTCTAATTACCTGAACTGGTACCAGCAAAAGCCTGGCAAGGCCCCTAAACTTTTGATCTATTACACCTCTAAACTCCACTCCGGCGTGCCATCCCGGTTTAGCGGGAGTGGGTCAGGTACAGATTATACCCTCACCATCTCCTCTCTGCAACCCGAAGACTTCGCCACTTACTATTGTCAGCAGGGATCAGCACTGCCCTGGACATTCGGTCAGGGCACTAAGGTGGAGATAAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,3,DIQMTQSPSSLSASVGDRVTITCRAS--QDIS------NYLNWYQQKPGKAPKLLIYY--------TSKLHSGVPSRFSGSGSG--TDYTLTISSLQPEDFATYYCQQGSA-----------------------LPWTFGQGTKVEIK-,QVQLQES-GPGLVKPSQTLSLTCAVYG-GSFSS-----GYWNWIRKHPGKGLEYIGYISY----NGITYHNPSLKSRITINRDTSKNQYSLQLNSVTPEDTAVYYCARYKYDYD-----------------GGHAMDYWGQGTLVTVSS
-GDPa1-218,telisotuzumab,261.98,99.61,98.52000000000001,2.8200000000000003,2.685,,0.0,0.0,0.0,-0.5,60.76,70.64500000000001,81.56,IgG1,Kappa,Phase-I,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYIFTAYTMHWVRQAPGQGLEWMGWIKPNNGLANYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSEITTEFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYIFTAYTMHWVRQAPGQGLEWMGWIKPNNGLANYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSEITTEFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTGCAGAGCGGTGCAGAGGTGAAAAAGCCAGGGGCGAGTGTCAAGGTGTCCTGTAAAGCTTCAGGGTATATATTCACTGCTTATACCATGCACTGGGTGCGCCAGGCCCCCGGACAGGGACTTGAGTGGATGGGTTGGATTAAGCCTAATAACGGCCTGGCTAACTACGCCCAAAAATTCCAGGGCCGGGTTACCATGACACGAGACACCTCCATCAGTACTGCCTACATGGAACTCTCTAGATTGAGGAGCGATGATACAGCAGTCTACTACTGCGCCAGGAGCGAGATCACGACTGAATTTGACTATTGGGGGCAAGGCACACTGGTAACCGTGTCATCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAVSLGERATINCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEDPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEDPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGATGACCCAGTCCCCAGACAGCCTGGCGGTATCACTGGGGGAACGCGCTACCATTAATTGCAAGTCATCCGAGAGTGTCGATAGCTATGCCAACAGTTTCCTGCACTGGTACCAACAGAAGCCAGGCCAGCCCCCTAAGCTCTTGATATACCGGGCCTCTACCAGAGAGTCCGGCGTCCCTGACAGGTTCTCTGGGTCTGGATCAGGCACAGACTTTACACTTACTATTAGCAGCCTCCAAGCTGAAGATGTGGCAGTTTACTATTGTCAGCAGTCCAAAGAGGATCCCCTGACGTTTGGTGGAGGTACTAAAGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,4,DIVMTQSPDSLAVSLGERATINCKSS--ESVDSY--ANSFLHWYQQKPGQPPKLLIYR--------ASTRESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQQSKE-----------------------DPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YIFTA-----YTMHWVRQAPGQGLEWMGWIKPN---NGLANYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSEIT---------------------TEFDYWGQGTLVTVSS
-GDPa1-219,teplizumab,190.23,95.19,97.715,2.725,2.465,,0.41,0.3,3.87,16.625,60.83,69.51,84.02,IgG1,Kappa,Approved,NFD,QVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKGLEWIGYINPSRGYTNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYCLDYWGQGTPVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKGLEWIGYINPSRGYTNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYCLDYWGQGTPVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTGCAGAGTGGGGGAGGCGTAGTGCAGCCGGGTCGCTCCCTGCGGCTTTCTTGCAAGGCTTCTGGATATACATTCACCCGATACACGATGCACTGGGTGAGACAAGCACCCGGCAAGGGTTTGGAATGGATAGGCTACATTAACCCATCACGGGGGTATACCAACTACAACCAGAAAGTCAAAGACCGCTTTACAATCTCCAGGGATAATAGTAAGAATACTGCCTTTCTCCAAATGGACAGCCTGAGACCTGAGGATACAGGGGTTTACTTCTGTGCCAGGTACTACGATGACCATTATTGCCTCGACTATTGGGGCCAGGGAACCCCCGTCACTGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSNPFTFGQGTKLQIT,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSNPFTFGQGTKLQITRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACTCAGAGTCCATCTAGCCTTTCCGCCAGCGTCGGGGATAGGGTTACAATCACCTGCTCAGCCTCTAGTAGCGTGTCTTATATGAATTGGTATCAGCAGACCCCCGGAAAAGCACCTAAGAGATGGATATATGACACTTCCAAGCTGGCGTCCGGGGTGCCATCTCGGTTCTCAGGCTCAGGCAGCGGAACAGACTACACATTCACCATCAGCAGTCTCCAACCCGAGGATATTGCTACTTACTACTGTCAGCAGTGGTCCTCCAACCCTTTTACGTTTGGCCAGGGTACAAAACTGCAAATCACCAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,1,DIQMTQSPSSLSASVGDRVTITCSAS--SSVS-------YMNWYQQTPGKAPKRWIYD--------TSKLASGVPSRFSGSGSG--TDYTFTISSLQPEDIATYYCQQWSS-----------------------NPFTFGQGTKLQIT-,QVQLVQS-GGGVVQPGRSLRLSCKASG-YTFTR-----YTMHWVRQAPGKGLEWIGYINPS---RGYTNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDH--------------------YCLDYWGQGTPVTVSS
-GDPa1-220,teprotumumab,240.58,97.82499999999999,99.62,2.7350000000000003,2.575,,0.22,0.13,5.0,25.125,62.01,71.19,84.65,IgG1,Kappa,Approved,Active,QVELVESGGGVVQPGRSQRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAIIWFDGSSTYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARELGRRYFDLWGRGTLVSVSS,MRAWIFFLLCLAGRALAQVELVESGGGVVQPGRSQRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAIIWFDGSSTYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARELGRRYFDLWGRGTLVSVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGGAACTGGTCGAGTCAGGGGGTGGAGTGGTTCAACCCGGCCGCTCCCAGAGGCTCAGCTGTGCAGCTTCTGGATTTACCTTTTCTTCTTACGGTATGCACTGGGTTAGACAGGCCCCTGGCAAGGGACTTGAGTGGGTGGCCATAATCTGGTTCGACGGCTCCTCCACTTATTACGCTGATAGCGTCAGGGGGAGATTCACCATTAGCCGAGATAACAGTAAAAATACACTCTACCTGCAGATGAACTCACTGCGCGCAGAAGACACGGCGGTGTATTTCTGCGCCCGGGAGCTTGGCAGGCGGTATTTTGACTTGTGGGGGAGAGGCACACTGGTATCCGTGAGCAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSKWPPWTFGQGTKVESK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSKWPPWTFGQGTKVESKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAATAGTTCTTACTCAGTCTCCCGCCACCCTCTCCTTGTCCCCGGGTGAAAGGGCCACGCTGAGCTGCCGGGCGAGCCAGAGCGTGTCTTCCTACCTCGCCTGGTACCAACAGAAACCAGGCCAGGCTCCAAGGTTGCTGATTTATGATGCCTCTAAGCGAGCAACAGGGATCCCCGCTAGATTCTCAGGCTCAGGATCCGGAACTGACTTCACACTGACAATCAGCAGTCTGGAGCCTGAGGACTTTGCAGTGTACTATTGTCAGCAACGCAGTAAGTGGCCTCCCTGGACCTTTGGGCAGGGCACCAAAGTCGAGTCAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,3,3,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASKRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSKW----------------------PPWTFGQGTKVESK-,QVELVES-GGGVVQPGRSQRLSCAASG-FTFSS-----YGMHWVRQAPGKGLEWVAIIWFD---GSSTYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARELGR---------------------RYFDLWGRGTLVSVSS
-GDPa1-221,tezepelumab,327.68,100.0,98.75,2.705,2.7800000000000002,,0.0,0.03,2.37,0.625,58.715,67.63,77.78,IgG2,Lambda,Approved,Active,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS,MRAWIFFLLCLAGRALAQMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGATGCAGCTCGTCGAATCCGGCGGCGGAGTAGTCCAACCAGGAAGATCTCTGCGGTTGTCTTGTGCGGCTAGCGGCTTTACATTCCGCACCTACGGAATGCACTGGGTGCGACAAGCTCCTGGCAAAGGTCTGGAGTGGGTGGCAGTGATTTGGTACGACGGGTCAAATAAGCATTATGCCGACAGTGTTAAGGGTAGATTTACTATCACCCGGGATAACAGCAAAAACACCCTGAATCTGCAGATGAACTCACTCAGGGCCGAAGACACAGCTGTGTACTATTGCGCCAGGGCACCCCAGTGGGAGCTTGTTCACGAGGCCTTCGATATATGGGGGCAGGGGACGATGGTGACTGTCTCCAGTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,MRAWIFFLLCLAGRALASYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCTCTTACGTGCTGACCCAACCCCCGAGCGTGAGTGTCGCCCCAGGGCAGACGGCCCGCATAACATGCGGCGGTAATAATTTGGGTAGCAAATCTGTGCACTGGTACCAGCAAAAGCCCGGGCAGGCACCAGTGCTGGTCGTTTATGATGACTCTGATCGGCCTTCCTGGATCCCTGAGAGGTTTTCCGGATCAAACTCAGGAAACACTGCGACTCTTACAATTAGCAGAGGCGAAGCTGGCGACGAGGCTGATTATTACTGTCAGGTTTGGGACAGTTCCAGCGACCATGTCGTGTTCGGAGGGGGCACCAAGCTCACCGTACTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,0,3,SYVLTQP-PSVSVAPGQTARITCGGN---NLGS-----KSVHWYQQKPGQAPVLVVYD--------DSDRPSWIPERFSGSNSG--NTATLTISRGEAGDEADYYCQVWDSS---------------------SDHVVFGGGTKLTVL-,QMQLVES-GGGVVQPGRSLRLSCAASG-FTFRT-----YGMHWVRQAPGKGLEWVAVIWYD---GSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWEL-----------------VHEAFDIWGQGTMVTVSS
-GDPa1-222,tigatuzumab,121.41,98.88499999999999,98.93,2.74,2.885,,,,4.0,11.125,61.335,74.52000000000001,87.965,IgG1,Kappa,Phase-II,Discontinued,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTCCAGCTGGTGGAATCAGGGGGAGGGCTGGTTCAGCCTGGAGGCAGCCTGCGGCTCAGCTGCGCTGCCTCCGGTTTTACCTTCAGCTCATACGTTATGTCTTGGGTGCGACAGGCACCCGGTAAAGGCTTGGAGTGGGTCGCCACCATCAGCTCCGGCGGGAGTTATACATATTATCCAGACTCTGTCAAGGGACGCTTCACCATAAGTAGAGATAACGCTAAGAACACACTTTATTTGCAAATGAATTCCCTGAGGGCGGAGGATACAGCCGTGTACTACTGTGCAAGAAGGGGCGACTCTATGATTACGACTGACTACTGGGGACAGGGCACCCTCGTAACTGTGTCCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGAGTCCCTCCTCTCTGTCTGCCAGCGTCGGCGACCGGGTGACAATAACTTGTAAGGCCTCCCAGGACGTAGGTACTGCCGTGGCTTGGTATCAACAGAAGCCTGGCAAAGCACCGAAGCTCCTTATCTACTGGGCGTCCACCAGGCACACAGGAGTGCCCAGCCGCTTCTCCGGCAGCGGTTCAGGGACGGATTTCACTTTGACCATCTCTAGCCTGCAACCAGAGGACTTTGCTACATATTACTGCCAGCAGTACAGTTCATATAGAACCTTTGGACAGGGGACCAAAGTTGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCKAS--QDVG------TAVAWYQQKPGKAPKLLIYW--------ASTRHTGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYSS------------------------YRTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FTFSS-----YVMSWVRQAPGKGLEWVATISSG---GSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSM--------------------ITTDYWGQGTLVTVSS
-GDPa1-223,tildrakizumab,187.04,99.57,99.06,2.8899999999999997,3.0999999999999996,,0.09,0.1,1.12,2.0,60.8,70.57,82.66499999999999,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTGGTGCAATCAGGCGCCGAAGTGAAGAAACCTGGCGCCTCCGTGAAGGTATCTTGCAAGGCCAGCGGTTATATCTTCATAACTTATTGGATGACCTGGGTCAGGCAGGCACCCGGGCAAGGGCTTGAGTGGATGGGTCAGATTTTTCCAGCGTCTGGGAGTGCCGACTACAACGAGAAATTCGAAGGAAGAGTGACAATGACCACAGACACTTCCACCAGCACAGCATACATGGAGTTGCGATCCCTGCGGTCAGATGATACCGCTGTTTACTACTGTGCTCGCGGCGGAGGAGGCTTTGCTTATTGGGGGCAGGGCACGCTCGTGACTGTCAGTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGATGACACAGAGCCCTAGTTCACTTAGCGCCTCTGTCGGTGACAGAGTTACGATTACATGTAGGACTAGCGAGAATATTTATTCTTACCTCGCTTGGTACCAGCAGAAGCCTGGCAAGGCTCCCAAACTGCTGATATATAACGCGAAAACTCTCGCCGAGGGTGTGCCCTCCCGGTTTTCCGGATCCGGCTCAGGGACTGATTTCACATTGACCATTAGTTCTCTGCAACCAGAAGACTTCGCAACCTATTACTGCCAGCACCATTACGGAATCCCATTCACCTTTGGGCAAGGCACCAAGGTGGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,1,DIQMTQSPSSLSASVGDRVTITCRTS--ENIY------SYLAWYQQKPGKAPKLLIYN--------AKTLAEGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQHHYG-----------------------IPFTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YIFIT-----YWMTWVRQAPGQGLEWMGQIFPA---SGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGG-----------------------GFAYWGQGTLVTVSS
-GDPa1-224,tislelizumab,226.51,99.39500000000001,90.08,3.0599999999999996,3.085,1.0550000000000002,0.32,0.1,4.87,11.5,57.230000000000004,67.905,84.565,IgG4,Kappa,Approved,Active,QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTCCAAGAGTCAGGTCCAGGACTTGTTAAACCGTCCGAAACCCTCTCCTTGACTTGCACCGTGTCAGGCTTCTCACTGACAAGCTATGGGGTCCACTGGATCAGACAGCCCCCTGGCAAAGGTTTGGAGTGGATCGGCGTGATATATGCGGACGGGTCCACCAATTACAACCCCAGTCTGAAGAGCCGGGTGACGATTAGCAAAGACACTTCTAAGAATCAGGTGAGCCTGAAGCTGTCTTCCGTGACAGCTGCTGATACAGCCGTATACTATTGTGCAAGGGCCTACGGCAACTACTGGTATATTGATGTTTGGGGACAAGGGACCACTGTGACAGTCTCTAGTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCGTTATGACACAGTCCCCTGACTCCCTGGCCGTGAGTCTCGGCGAGAGGGCAACTATTAACTGTAAGTCAAGCGAATCTGTATCTAATGATGTGGCTTGGTACCAGCAGAAACCAGGCCAACCACCCAAGCTTCTCATCAACTATGCGTTTCATCGGTTCACCGGTGTCCCCGACAGATTTAGTGGGAGCGGATACGGCACGGACTTCACACTGACTATAAGCTCATTGCAGGCCGAGGATGTGGCTGTCTATTATTGCCACCAAGCCTACTCTTCCCCTTACACCTTCGGACAGGGGACCAAGCTGGAAATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,3,2,DIVMTQSPDSLAVSLGERATINCKSS--ESVS------NDVAWYQQKPGQPPKLLINY--------AFHRFTGVPDRFSGSGYG--TDFTLTISSLQAEDVAVYYCHQAYS-----------------------SPYTFGQGTKLEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-FSLTS-----YGVHWIRQPPGKGLEWIGVIYA----DGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNY--------------------WYIDVWGQGTTVTVSS
-GDPa1-225,tisotumab,186.82,99.85,97.305,2.74,2.625,,0.0,0.0,2.5,2.125,59.99,70.535,84.89500000000001,IgG1,Kappa,Approved,Active,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSSISGSGDYTYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPWGYYLDSWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSSISGSGDYTYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPWGYYLDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGTGCAACTGCTCGAGTCCGGCGGGGGCCTTGTTCAGCCAGGAGGCAGCTTGCGGCTGTCCTGCGCGGCCAGTGGGTTCACTTTCTCTAATTATGCCATGTCATGGGTGAGGCAGGCTCCTGGCAAGGGACTTGAGTGGGTATCTTCCATTTCAGGTTCCGGCGATTATACCTACTACACAGACTCTGTCAAAGGTCGATTTACGATCAGTAGGGATAACTCTAAGAATACCTTGTATCTGCAGATGAACAGTCTGAGAGCTGAAGACACCGCAGTGTACTACTGTGCCCGCAGCCCCTGGGGGTACTATCTCGACTCATGGGGACAGGGAACACTGGTGACTGTCAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPPSLSASAGDRVTITCRASQGISSRLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPPSLSASAGDRVTITCRASQGISSRLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATTCAGATGACACAGTCTCCTCCATCCCTGAGCGCATCAGCTGGGGATAGAGTGACTATCACCTGCAGGGCTTCCCAGGGCATATCCTCCCGGCTCGCCTGGTACCAACAGAAACCTGAGAAAGCCCCAAAGTCACTGATCTACGCCGCGTCTTCATTGCAGAGTGGTGTCCCCAGTCGCTTCAGCGGAAGCGGCTCTGGCACCGATTTTACACTTACTATCAGCAGTCTGCAACCGGAGGACTTCGCAACATATTACTGTCAGCAGTATAACTCTTATCCCTACACGTTTGGACAAGGGACCAAGCTCGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,3,0,DIQMTQSPPSLSASAGDRVTITCRAS--QGIS------SRLAWYQQKPEKAPKSLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYNS-----------------------YPYTFGQGTKLEIK-,EVQLLES-GGGLVQPGGSLRLSCAASG-FTFSN-----YAMSWVRQAPGKGLEWVSSISGS---GDYTYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPWG---------------------YYLDSWGQGTLVTVSS
-GDPa1-226,tocilizumab,124.07,99.435,94.85,2.7300000000000004,2.545,4.125,0.17,0.13,2.0,1.625,60.53,70.125,84.42500000000001,IgG1,Kappa,Approved,Active,QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGTTGCAAGAATCTGGGCCGGGCCTTGTTCGGCCCTCTCAGACACTCAGCCTGACCTGTACGGTATCCGGATATAGTATTACATCTGACCACGCCTGGAGTTGGGTCCGGCAACCTCCCGGCCGAGGTCTTGAGTGGATCGGTTACATCTCATACTCCGGAATAACCACTTATAACCCAAGCCTGAAAAGCCGCGTGACAATGTTGAGAGATACCAGCAAGAATCAGTTCTCCCTGAGGCTGTCTTCAGTTACCGCAGCCGACACCGCGGTCTATTACTGCGCTAGATCCCTGGCCAGGACAACTGCTATGGATTACTGGGGCCAGGGGTCACTCGTGACTGTGAGTAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACCCAGTCTCCTAGCTCACTGTCCGCCAGTGTCGGTGACCGCGTGACAATCACTTGTAGGGCTTCTCAAGACATCTCCTCCTACCTGAATTGGTACCAGCAGAAGCCCGGCAAAGCACCAAAACTCCTCATATATTATACCTCTAGACTTCACAGTGGTGTTCCTAGCCGGTTCTCAGGATCAGGCAGCGGAACTGACTTCACTTTTACAATCTCCAGCTTGCAGCCAGAAGATATTGCCACCTATTACTGCCAACAGGGGAACACACTGCCCTACACGTTTGGCCAGGGGACCAAGGTGGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,3,DIQMTQSPSSLSASVGDRVTITCRAS--QDIS------SYLNWYQQKPGKAPKLLIYY--------TSRLHSGVPSRFSGSGSG--TDFTFTISSLQPEDIATYYCQQGNT-----------------------LPYTFGQGTKVEIK-,QVQLQES-GPGLVRPSQTLSLTCTVSG-YSITS----DHAWSWVRQPPGRGLEWIGYISY----SGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLART--------------------TAMDYWGQGSLVTVSS
-GDPa1-227,toripalimab,142.34,99.29,90.495,2.715,2.665,,0.37,0.1,1.5,0.625,59.66,67.06,,IgG4,Kappa,Approved,Active,QGQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPIHGLEWIGVIESETGGTAYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGITTVATTYYWYFDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQGQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPIHGLEWIGVIESETGGTAYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGITTVATTYYWYFDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGGCCAGCTGGTGCAATCTGGTGCTGAGGTGAAAAAGCCCGGAGCCAGTGTGAAGGTCTCTTGTAAAGCTAGCGGGTATACATTCACTGATTACGAGATGCATTGGGTCAGGCAGGCCCCTATTCACGGCCTTGAGTGGATCGGAGTCATAGAATCAGAAACTGGAGGCACCGCTTATAACCAGAAATTCAAGGGGCGCGTTACAATCACCGCGGACAAGAGTACGTCCACTGCATACATGGAACTGTCCAGCCTCAGATCAGAGGACACCGCCGTATACTATTGCGCACGGGAGGGTATTACAACAGTGGCCACCACCTACTACTGGTATTTTGATGTTTGGGGGCAGGGCACTACGGTGACCGTGTCCAGCGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,DVVMTQSPLSLPVTLGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPLTFGQGTKLEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTLGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPLTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATGTAGTGATGACTCAGTCTCCTCTCTCATTGCCCGTGACCTTGGGCCAGCCGGCTTCCATTTCTTGCCGCTCTTCCCAAAGCATCGTTCATAGTAATGGGAACACCTATCTTGAGTGGTACCTGCAGAAGCCTGGCCAGAGTCCACAGCTGCTGATATACAAGGTCAGCAACCGGTTCAGCGGGGTGCCAGACAGGTTTTCCGGTAGCGGATCAGGAACAGATTTCACACTCAAAATTTCAAGAGTCGAAGCCGAAGACGTGGGGGTTTATTACTGTTTTCAAGGCTCCCACGTGCCCCTTACTTTCGGTCAGGGAACGAAGCTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,4,DVVMTQSPLSLPVTLGQPASISCRSS--QSIVHSN-GNTYLEWYLQKPGQSPQLLIYK--------VSNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCFQGSH-----------------------VPLTFGQGTKLEIK-,QGQLVQS-GAEVKKPGASVKVSCKASG-YTFTD-----YEMHWVRQAPIHGLEWIGVIESE---TGGTAYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGITTVAT--------------TYYWYFDVWGQGTTVTVSS
-GDPa1-228,tovetumab,491.52,99.64,87.91,2.7350000000000003,2.5,3.88,0.1,0.1,2.5,2.625,63.335,75.175,,IgG2,Kappa,Phase-II,Discontinued,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTTGTGGAATCCGGCGGCGGGCTGGTGAAGCCCGGTGGATCACTCCGACTGAGCTGTGCAGCCAGTGGCTTCACATTCTCAGATTACTATATGAATTGGATCCGCCAGGCCCCTGGCAAAGGATTGGAGTGGGTAAGTTACATTAGCTCTTCCGGATCCATCATCTACTATGCGGACTCAGTCAAAGGGAGGTTTACCATATCTCGGGACAACGCAAAGAATTCCCTGTACCTCCAAATGAACAGCCTGCGGGCTGAGGACACGGCTGTCTATTATTGCGCCAGAGAAGGTAGAATTGCCGCTAGGGGCATGGATGTGTGGGGGCAGGGGACAACCGTGACTGTCAGCTCTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATACAAATGACTCAGAGTCCTTCTTCACTTTCCGCATCCGTCGGAGATAGAGTGAGCATTACTTGCAGGCCTAGTCAGTCTTTTAGCCGGTATATCAACTGGTACCAGCAGAAGCCCGGCAAAGCCCCCAAGCTCCTGATCCACGCTGCGTCATCTTTGGTTGGTGGGGTGCCGTCCCGATTCTCCGGGAGCGGAAGTGGTACCGACTTTACGCTGACCATTAGCTCTCTGCAACCAGAGGACTTCGCCACATACTATTGTCAGCAGACATACTCAAATCCCCCAATCACCTTCGGCCAGGGCACACGCCTCGAAATGAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,2,DIQMTQSPSSLSASVGDRVSITCRPS--QSFS------RYINWYQQKPGKAPKLLIHA--------ASSLVGGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQTYSN----------------------PPITFGQGTRLEMK-,QVQLVES-GGGLVKPGGSLRLSCAASG-FTFSD-----YYMNWIRQAPGKGLEWVSYISSS---GSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIA-------------------ARGMDVWGQGTTVTVSS
-GDPa1-229,tralokinumab,287.68,99.95,92.625,2.76,2.87,,0.85,0.1,4.87,11.125,58.14,67.83000000000001,,IgG4,Lambda,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAACTGGTGCAGAGCGGGGCCGAGGTCAAGAAGCCTGGCGCTTCTGTGAAAGTGAGCTGCAAAGCTAGCGGCTACACTTTTACAAACTATGGATTGTCCTGGGTCCGCCAGGCACCCGGTCAAGGACTGGAATGGATGGGATGGATCAGCGCGAATAATGGGGACACCAACTACGGGCAGGAATTTCAGGGCAGAGTGACTATGACCACCGACACGTCCACATCAACTGCCTATATGGAGCTCAGGTCTCTTAGGTCAGATGATACAGCAGTATATTACTGTGCCAGAGATTCCAGTAGTTCCTGGGCCCGGTGGTTCTTCGACCTCTGGGGTCGAGGCACCCTGGTTACAGTGTCTTCAGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,SYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVL,MRAWIFFLLCLAGRALASYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCTCATACGTGCTGACCCAGCCCCCGAGTGTTTCAGTCGCTCCTGGTAAAACGGCGCGGATCACATGCGGCGGAAATATAATCGGATCTAAGCTGGTACACTGGTACCAGCAGAAGCCCGGACAGGCCCCTGTCCTGGTGATCTATGATGACGGCGATAGACCCTCTGGGATTCCAGAGCGCTTTAGTGGCTCCAACTCCGGGAACACTGCCACCTTGACTATTAGCAGGGTGGAGGCCGGCGACGAAGCAGACTATTACTGTCAAGTCTGGGATACCGGGAGCGACCCAGTGGTGTTCGGGGGTGGCACAAAACTTACAGTTCTCGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,3,2,SYVLTQP-PSVSVAPGKTARITCGGN---IIGS-----KLVHWYQQKPGQAPVLVIYD--------DGDRPSGIPERFSGSNSG--NTATLTISRVEAGDEADYYCQVWDTG---------------------SDPVVFGGGTKLTVL-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTN-----YGLSWVRQAPGQGLEWMGWISAN---NGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSW-----------------ARWFFDLWGRGTLVTVSS
-GDPa1-230,trastuzumab,352.37,99.35,97.695,2.725,2.675,4.015,0.0,0.0,0.8700000000000001,1.125,62.46,70.68,82.745,IgG1,Kappa,Approved,NFD,EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTGCAGCTCGTGGAAAGTGGGGGTGGCTTGGTACAGCCAGGCGGCAGCCTGCGCCTTAGCTGCGCCGCCTCAGGGTTTAACATCAAAGACACCTATATACACTGGGTCCGACAAGCTCCTGGTAAGGGCCTGGAATGGGTTGCAAGGATCTACCCCACCAATGGATACACCAGATACGCCGATAGCGTCAAAGGACGGTTCACAATTTCCGCCGACACATCAAAGAATACGGCTTATCTGCAGATGAACTCCCTCAGAGCTGAGGATACAGCAGTGTATTATTGTAGTAGGTGGGGCGGGGACGGATTCTACGCGATGGATTACTGGGGACAGGGGACTCTGGTGACTGTTTCTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAAATGACCCAGTCTCCTAGCTCCCTGAGCGCTAGTGTGGGTGACAGAGTAACAATCACTTGTCGCGCCTCCCAGGATGTGAACACCGCGGTCGCCTGGTACCAGCAGAAACCTGGCAAGGCCCCCAAACTGCTGATTTATAGCGCATCATTCTTGTACTCCGGCGTGCCGTCTCGGTTCAGTGGGTCAAGGAGCGGAACAGACTTCACCCTCACGATTTCTTCCCTTCAACCAGAGGATTTTGCTACCTACTATTGCCAGCAGCACTATACTACACCCCCAACTTTTGGGCAGGGAACAAAGGTTGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,1,0,DIQMTQSPSSLSASVGDRVTITCRAS--QDVN------TAVAWYQQKPGKAPKLLIYS--------ASFLYSGVPSRFSGSRSG--TDFTLTISSLQPEDFATYYCQQHYT-----------------------TPPTFGQGTKVEIK-,EVQLVES-GGGLVQPGGSLRLSCAASG-FNIKD-----TYIHWVRQAPGKGLEWVARIYPT---NGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDG-------------------FYAMDYWGQGTLVTVSS
-GDPa1-231,tregalizumab,85.5,99.82,95.84,2.83,2.9800000000000004,3.665,,,1.0,0.875,58.64,73.54499999999999,,IgG1,Kappa,Phase-II,Discontinued,EEQLVESGGGLVKPGGSLRLSCAASGFSFSDCRMYWLRQAPGKGLEWIGVISVKSENYGANYAESVRGRFTISRDDSKNTVYLQMNSLKTEDTAVYYCSASYYRYDVGAWFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEEQLVESGGGLVKPGGSLRLSCAASGFSFSDCRMYWLRQAPGKGLEWIGVISVKSENYGANYAESVRGRFTISRDDSKNTVYLQMNSLKTEDTAVYYCSASYYRYDVGAWFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAAGAGCAGCTCGTTGAGAGCGGGGGAGGGCTGGTCAAGCCCGGCGGAAGTCTGAGACTTTCATGCGCGGCCTCCGGCTTTAGCTTTTCTGACTGCAGGATGTACTGGCTGAGACAAGCCCCTGGCAAGGGCCTCGAATGGATAGGGGTGATTTCAGTAAAATCCGAAAACTACGGTGCAAATTACGCTGAGAGCGTGAGGGGGCGATTCACTATCTCCCGCGACGACAGCAAAAACACAGTCTATTTGCAGATGAATTCCCTGAAGACCGAGGATACAGCAGTTTATTATTGTTCTGCCTCTTACTACCGGTACGATGTGGGAGCTTGGTTCGCCTATTGGGGCCAGGGTACGCTTGTGACCGTGTCAAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQHSRELPWTFGQGTKVEIK,MRAWIFFLLCLAGRALADIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQHSRELPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTGTAATGACACAGTCCCCAGACTCCCTGGCGGTTAGCCTCGGCGAAAGGGCTACCATTAACTGCCGCGCTTCAAAGTCCGTGTCCACAAGCGGCTATTCTTATATATACTGGTACCAGCAGAAGCCTGGGCAACCACCCAAACTTTTGATTTACCTGGCATCTATCCTGGAGTCAGGGGTGCCTGATCGGTTCTCTGGCAGCGGAAGTGGTACCGACTTCACTTTGACTATCTCAAGCCTCCAAGCCGAGGACGTGGCCGTCTATTACTGTCAGCACAGTAGAGAACTGCCCTGGACGTTTGGACAGGGTACCAAGGTCGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,2,DIVMTQSPDSLAVSLGERATINCRAS--KSVSTS--GYSYIYWYQQKPGQPPKLLIYL--------ASILESGVPDRFSGSGSG--TDFTLTISSLQAEDVAVYYCQHSRE-----------------------LPWTFGQGTKVEIK-,EEQLVES-GGGLVKPGGSLRLSCAASG-FSFSD-----CRMYWLRQAPGKGLEWIGVISVKS-ENYGANYAESVRGRFTISRDDSKNTVYLQMNSLKTEDTAVYYCSASYYRYD-----------------VGAWFAYWGQGTLVTVSS
-GDPa1-232,tremelimumab,339.78,99.52000000000001,99.86500000000001,4.779999999999999,3.0700000000000003,3.755,0.0,0.0,8.0,9.625,60.32,72.92500000000001,78.32,IgG2,Kappa,Approved,Active,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAGCTCGTGGAGAGCGGGGGAGGGGTAGTGCAGCCTGGACGGTCTCTGCGCCTGTCCTGCGCTGCATCCGGCTTCACATTCAGCTCTTACGGCATGCACTGGGTCAGGCAAGCTCCCGGTAAGGGGCTGGAATGGGTCGCCGTGATCTGGTATGATGGATCTAACAAGTATTATGCGGACAGCGTGAAAGGCAGATTTACTATTTCCAGAGACAATAGTAAAAACACGCTTTACTTGCAAATGAATTCACTGCGGGCCGAGGACACTGCCGTTTACTACTGTGCCCGAGATCCAAGGGGCGCAACCCTCTATTACTATTACTACGGAATGGATGTGTGGGGCCAGGGTACAACCGTCACCGTGTCAAGTGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAGATGACACAGTCTCCGAGCTCACTCAGTGCTTCTGTTGGCGACAGAGTCACCATCACATGCAGGGCTTCACAGTCCATAAACAGCTATTTGGATTGGTACCAGCAGAAGCCTGGTAAGGCCCCAAAGCTGCTGATCTACGCCGCAAGCAGTCTGCAATCTGGCGTGCCTAGTCGGTTCTCCGGGAGCGGGTCAGGAACCGACTTTACTCTTACCATTTCTTCCCTCCAACCCGAAGACTTCGCGACATATTACTGTCAGCAGTATTACTCCACTCCATTTACGTTCGGCCCCGGAACCAAAGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,4,2,DIQMTQSPSSLSASVGDRVTITCRAS--QSIN------SYLDWYQQKPGKAPKLLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYYS-----------------------TPFTFGPGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YGMHWVRQAPGKGLEWVAVIWYD---GSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLY--------------YYYYGMDVWGQGTTVTVSS
-GDPa1-233,ublituximab,46.59,100.0,95.02,2.87,3.14,,,,3.75,6.375,58.5,67.18,81.78,IgG1,Kappa,Approved,Active,QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSS,MRAWIFFLLCLAGRALAQAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGCCTACTTGCAGCAGTCTGGAGCTGAGCTGGTTCGGCCAGGGGCGAGTGTGAAGATGTCCTGCAAAGCCAGCGGCTACACCTTCACTTCATACAATATGCACTGGGTCAAACAGACCCCTAGGCAAGGTCTCGAGTGGATTGGCGGTATCTATCCCGGAAACGGGGACACATCCTATAATCAGAAGTTCAAGGGAAAAGCTACGCTGACAGTAGGGAAGTCCAGTTCAACTGCATACATGCAGCTGAGCTCTCTTACATCCGAAGATTCTGCCGTGTATTTTTGTGCAAGATATGACTACAACTATGCCATGGATTACTGGGGCCAGGGCACCAGCGTGACCGTCAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIK,MRAWIFFLLCLAGRALAQIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAATTGTGCTCAGTCAGAGCCCCGCCATTCTGTCAGCAAGCCCAGGTGAGAAGGTCACTATGACGTGCAGAGCTTCAAGCTCTGTAAGTTACATGCACTGGTACCAACAGAAACCGGGAAGCTCTCCCAAACCCTGGATATATGCGACTTCAAACCTGGCCTCTGGAGTTCCAGCCCGGTTTTCTGGGTCCGGGTCCGGCACCAGTTATTCCTTCACAATCTCCAGGGTGGAAGCTGAAGACGCAGCCACCTACTATTGTCAGCAGTGGACATTTAATCCTCCTACATTCGGTGGCGGCACCCGCTTGGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,2,QIVLSQSPAILSASPGEKVTMTCRAS--SSVS-------YMHWYQQKPGSSPKPWIYA--------TSNLASGVPARFSGSGSG--TSYSFTISRVEAEDAATYYCQQWTF-----------------------NPPTFGGGTRLEIK-,QAYLQQS-GAELVRPGASVKMSCKASG-YTFTS-----YNMHWVKQTPRQGLEWIGGIYPG---NGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYN---------------------YAMDYWGQGTSVTVSS
-GDPa1-234,urelumab,180.78,98.495,94.445,3.535,3.105,1.065,0.1,0.1,3.5,13.5,57.985,69.985,,IgG4,Kappa,Phase-II,Active,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAGCTTCAGCAGTGGGGCGCCGGGCTGCTGAAACCGAGCGAGACTTTGTCTCTGACATGCGCTGTCTATGGTGGCAGCTTTAGCGGGTATTACTGGAGTTGGATTAGACAATCCCCCGAGAAAGGACTTGAGTGGATAGGTGAAATCAACCACGGCGGGTACGTGACATACAACCCATCACTGGAATCACGCGTCACCATCAGTGTTGACACATCCAAGAATCAGTTCTCCCTGAAGTTGAGCTCTGTGACTGCTGCGGATACCGCCGTGTACTACTGTGCACGGGACTATGGACCTGGCAATTACGATTGGTATTTCGACCTCTGGGGCAGGGGAACGCTCGTGACCGTATCCTCTGCCTCGACCAAGGGCCCCTCTGTCTTCCCGTTGGCACCTTGTTCTAGGTCTACTTCTGAAAGCACTGCTGCCCTGGGCTGCCTGGTGAAAGATTACTTCCCTGAGCCCGTCACCGTAAGCTGGAATTCAGGCGCGCTCACCAGTGGGGTTCACACTTTTCCTGCCGTGCTGCAGAGCTCAGGACTTTACTCTTTATCATCTGTGGTTACAGTCCCGTCTTCGAGCCTGGGTACAAAGACATATACATGTAACGTGGATCATAAACCCTCCAACACTAAAGTGGATAAGCGAGTTGAATCGAAGTATGGCCCCCCTTGTCCACCATGTCCTGCTCCAGAATTTCTTGGGGGGCCTAGCGTCTTCTTGTTTCCACCTAAGCCCAAGGACACTCTGATGATCTCTCGGACCCCAGAGGTGACCTGCGTTGTGGTAGATGTGTCGCAGGAAGATCCCGAGGTCCAGTTTAATTGGTACGTTGATGGCGTGGAAGTGCATAACGCCAAAACAAAGCCCAGAGAAGAGCAATTCAACAGCACATATAGAGTAGTGAGTGTCCTCACCGTATTACATCAGGACTGGCTGAACGGGAAGGAATACAAATGTAAGGTGTCAAATAAAGGTCTGCCTAGCTCTATTGAAAAAACTATTTCTAAGGCTAAGGGACAACCTCGAGAACCCCAGGTCTACACACTTCCCCCCTCGCAGGAAGAAATGACTAAAAATCAGGTGAGCCTTACCTGCTTGGTCAAGGGCTTTTACCCTTCAGACATCGCGGTGGAGTGGGAATCAAACGGCCAGCCTGAGAACAATTATAAGACTACCCCCCCAGTGCTTGACAGCGATGGGTCATTTTTCCTGTATAGCAGGCTGACGGTAGACAAAAGCCGGTGGCAGGAAGGGAACGTGTTCTCATGTAGCGTTATGCACGAGGCGTTGCATAATCATTATACCCAGAAATCCCTGTCCTTGAGCCTGGGTTAG,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK,MRAWIFFLLCLAGRALAEIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGATTGTTCTGACGCAGTCACCCGCCACATTGTCCCTTAGTCCCGGCGAGAGAGCCACACTGTCCTGTCGAGCTTCTCAAAGCGTGAGCTCATACCTGGCCTGGTATCAGCAGAAGCCTGGCCAAGCTCCACGCCTTTTGATCTATGACGCAAGCAACAGAGCGACCGGTATACCCGCAAGGTTTTCTGGCAGCGGGTCCGGTACTGATTTCACACTCACCATTAGTTCCCTCGAGCCTGAAGACTTCGCCGTGTACTACTGCCAGCAGCGGTCTAATTGGCCGCCAGCTCTGACCTTTGGAGGAGGGACTAAGGTCGAAATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,1,2,EIVLTQSPATLSLSPGERATLSCRAS--QSVS------SYLAWYQQKPGQAPRLLIYD--------ASNRATGIPARFSGSGSG--TDFTLTISSLEPEDFAVYYCQQRSNW---------------------PPALTFGGGTKVEIK-,QVQLQQW-GAGLLKPSETLSLTCAVYG-GSFSG-----YYWSWIRQSPEKGLEWIGEINH----GGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGN-----------------YDWYFDLWGRGTLVTVSS
-GDPa1-235,ustekinumab,168.63,99.32,98.0,2.6900000000000004,2.45,4.125,0.17,0.12,0.8700000000000001,0.0,62.715,71.475,84.465,IgG1,Kappa,Approved,Active,EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTTCAGCTGGTGCAGTCCGGAGCTGAAGTCAAGAAACCGGGCGAGAGTCTTAAAATCTCATGCAAGGGCTCTGGTTACTCTTTCACGACATACTGGTTGGGGTGGGTGCGACAGATGCCCGGAAAAGGCCTGGACTGGATTGGCATTATGTCTCCCGTCGATAGCGACATCCGCTATTCCCCTTCCTTCCAAGGTCAGGTGACAATGAGCGTTGATAAGAGTATAACCACCGCGTATCTGCAGTGGAACTCCCTCAAGGCCAGCGATACTGCCATGTACTATTGTGCAAGACGGAGGCCAGGACAAGGGTACTTTGACTTTTGGGGGCAGGGCACCCTCGTAACTGTGTCAAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATTCAAATGACCCAGTCCCCCTCATCTTTGAGTGCCTCCGTTGGCGACAGAGTGACAATCACTTGCAGGGCCTCCCAGGGGATCAGCTCTTGGCTCGCATGGTATCAGCAGAAGCCTGAAAAAGCTCCCAAAAGTCTCATATACGCTGCCTCATCCCTGCAATCTGGAGTCCCAAGCCGGTTCTCAGGGAGTGGCAGCGGTACAGATTTTACTCTGACAATTTCTAGCCTGCAACCTGAGGACTTTGCGACGTACTATTGTCAGCAGTACAACATCTACCCATATACCTTCGGCCAGGGAACCAAGCTTGAGATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,3,3,DIQMTQSPSSLSASVGDRVTITCRAS--QGIS------SWLAWYQQKPEKAPKSLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYNI-----------------------YPYTFGQGTKLEIK-,EVQLVQS-GAEVKKPGESLKISCKGSG-YSFTT-----YWLGWVRQMPGKGLDWIGIMSPV---DSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQ--------------------GYFDFWGQGTLVTVSS
-GDPa1-236,utomilumab,438.38,94.00999999999999,99.845,2.83,3.035,,0.75,0.17,16.37,26.625,62.285,71.28999999999999,,IgG2,Lambda,Phase-II,Active,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAEVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGAGGTCCAACTGGTCCAGAGCGGAGCTGAGGTGAAAAAGCCTGGGGAATCTTTGCGGATCTCTTGTAAGGGATCAGGGTACTCCTTCAGCACATATTGGATTTCCTGGGTAAGGCAGATGCCAGGCAAAGGCCTCGAATGGATGGGTAAGATCTATCCCGGTGATAGTTACACAAACTACTCCCCGAGCTTTCAAGGCCAGGTGACCATAAGTGCGGACAAATCAATCTCTACTGCCTACCTGCAGTGGAGTTCACTGAAGGCAAGCGACACGGCTATGTACTACTGCGCCAGAGGGTATGGCATTTTCGATTATTGGGGACAGGGCACCCTTGTGACTGTTTCTTCCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,MRAWIFFLLCLAGRALASYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCTCCTACGAGTTGACTCAGCCTCCCAGTGTAAGTGTCAGCCCAGGCCAGACCGCCTCCATAACCTGTTCTGGGGACAACATCGGTGACCAGTACGCGCACTGGTATCAGCAGAAGCCTGGACAAAGCCCGGTGCTGGTTATCTACCAGGACAAAAACAGACCCTCAGGCATTCCAGAGAGGTTCAGCGGCTCCAATTCTGGGAATACCGCCACTCTGACCATTTCTGGGACGCAAGCAATGGATGAAGCTGATTATTATTGCGCTACATACACAGGTTTTGGATCACTGGCCGTGTTCGGCGGAGGCACTAAGCTCACAGTGCTTGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,3,2,3,SYELTQP-PSVSVSPGQTASITCSGD---NIGD-----QYAHWYQQKPGQSPVLVIYQ--------DKNRPSGIPERFSGSNSG--NTATLTISGTQAMDEADYYCATYTGF---------------------GSLAVFGGGTKLTVL-,EVQLVQS-GAEVKKPGESLRISCKGSG-YSFST-----YWISWVRQMPGKGLEWMGKIYPG---DSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYG-----------------------IFDYWGQGTLVTVSS
-GDPa1-237,vadastuximab,261.98,99.9,98.36000000000001,2.705,2.58,,0.16,0.0,1.12,0.0,60.665,70.28,86.03999999999999,IgG1,Kappa,Phase-III,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQAPGQGLEWIGWIYPGDGSTKYNEKFKAKATLTADTSTSTAYMELRSLRSDDTAVYYCASGYEDAMDYWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQAPGQGLEWIGWIYPGDGSTKYNEKFKAKATLTADTSTSTAYMELRSLRSDDTAVYYCASGYEDAMDYWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTCCAACTCGTTCAGTCAGGTGCGGAAGTGAAGAAGCCAGGCGCCTCCGTGAAGGTGTCTTGCAAAGCAAGTGGCTACACATTCACGAACTACGACATTAACTGGGTGAGACAGGCACCCGGGCAGGGGCTGGAGTGGATCGGATGGATATACCCTGGCGATGGAAGCACTAAATATAATGAGAAGTTTAAGGCCAAAGCTACCCTTACAGCCGACACTAGCACCAGCACCGCATACATGGAACTGCGGTCATTGAGGTCCGATGACACAGCTGTTTACTATTGTGCTTCTGGGTATGAGGATGCCATGGACTATTGGGGTCAGGGAACTACAGTAACCGTCAGTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTINCKASQDINSYLSWFQQKPGKAPKTLIYRANRLVDGVPSRFSGSGSGQDYTLTISSLQPEDFATYYCLQYDEFPLTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTINCKASQDINSYLSWFQQKPGKAPKTLIYRANRLVDGVPSRFSGSGSGQDYTLTISSLQPEDFATYYCLQYDEFPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACACAGTCTCCTTCCTCACTTTCTGCGTCCGTCGGAGATAGGGTGACCATAAATTGCAAGGCCAGCCAGGACATCAACTCCTATCTGTCTTGGTTCCAGCAGAAGCCAGGTAAAGCTCCTAAAACGCTGATTTACAGAGCAAACCGGCTGGTGGACGGCGTTCCCTCACGCTTCAGCGGGAGCGGGAGTGGACAGGACTACACCCTCACCATCTCAAGTCTCCAACCAGAGGATTTTGCCACATATTATTGTTTGCAATACGATGAATTTCCCCTGACTTTCGGTGGCGGCACTAAGGTAGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,0,1,DIQMTQSPSSLSASVGDRVTINCKAS--QDIN------SYLSWFQQKPGKAPKTLIYR--------ANRLVDGVPSRFSGSGSG--QDYTLTISSLQPEDFATYYCLQYDE-----------------------FPLTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFTN-----YDINWVRQAPGQGLEWIGWIYPG---DGSTKYNEKFKAKATLTADTSTSTAYMELRSLRSDDTAVYYCASGYED----------------------AMDYWGQGTTVTVSS
-GDPa1-238,varlilumab,261.98,99.60499999999999,97.375,2.7300000000000004,2.585,4.12,0.12,0.1,1.5,15.375,61.425,70.72,83.405,IgG1,Kappa,Phase-II,Active,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTGCAGCTGGTGGAATCTGGCGGTGGAGTTGTACAACCCGGGCGCAGCCTGAGACTCTCCTGCGCCGCTTCTGGATTCACTTTTAGCTCCTACGATATGCACTGGGTCCGGCAGGCCCCTGGTAAGGGCTTGGAGTGGGTGGCAGTGATCTGGTACGACGGGTCAAACAAGTATTACGCTGACAGCGTCAAAGGAAGATTCACCATTTCAAGGGATAATTCTAAAAACACACTGTATCTCCAGATGAACAGCCTTAGGGCAGAGGACACAGCGGTTTATTACTGTGCCCGAGGCTCCGGGAATTGGGGGTTTTTCGATTATTGGGGCCAGGGCACGCTGGTCACCGTGAGTAGTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAAATGACACAGAGCCCTAGTTCCCTGAGCGCGTCTGTGGGCGACAGGGTGACTATCACCTGTCGGGCTAGCCAGGGCATTAGTCGCTGGCTCGCCTGGTACCAGCAGAAGCCAGAGAAGGCCCCAAAATCCCTGATTTACGCCGCTTCTTCCCTTCAATCTGGCGTTCCTAGTCGATTTAGCGGGTCAGGATCAGGGACAGACTTCACGCTGACCATATCATCCTTGCAACCCGAGGATTTTGCAACATACTATTGCCAGCAGTATAACACTTATCCCAGAACCTTCGGACAGGGTACCAAAGTCGAAATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,2,0,DIQMTQSPSSLSASVGDRVTITCRAS--QGIS------RWLAWYQQKPEKAPKSLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQYNT-----------------------YPRTFGQGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFSS-----YDMHWVRQAPGKGLEWVAVIWYD---GSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNW--------------------GFFDYWGQGTLVTVSS
-GDPa1-239,vatelizumab,202.74,98.8,86.11,2.9050000000000002,2.775,3.68,0.02,0.1,2.0,0.375,61.239999999999995,71.57,85.13499999999999,IgG1,Kappa,Phase-II/III,Discontinued,QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAATTGCAAGAGTCCGGACCCGGCCTGGTCAAACCTAGCGAAACTCTTTCTCTGACTTGCACAGTTTCAGGCTTTAGCCTTACCAACTACGGGATTCACTGGATCAGACAGCCGCCAGGCAAAGGTTTGGAGTGGCTCGGGGTGATCTGGGCAAGGGGATTCACCAATTATAATTCAGCTCTCATGTCTCGCCTGACCATATCCAAGGACAACTCTAAGAACCAGGTCAGTCTGAAGCTCAGTTCCGTGACCGCTGCGGACACGGCCGTCTACTATTGTGCACGGGCCAATGATGGGGTTTATTACGCCATGGATTACTGGGGACAGGGTACACTGGTGACAGTAAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK,MRAWIFFLLCLAGRALADFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATTTTGTGATGACTCAGAGCCCTGCCTTTCTGTCAGTTACCCCAGGCGAAAAGGTCACCATAACATGCAGCGCTCAGAGCTCTGTGAACTACATCCACTGGTACCAGCAGAAGCCTGACCAGGCCCCAAAGAAACTTATCTACGACACAAGTAAACTGGCGTCTGGGGTGCCCTCTAGGTTCTCCGGATCAGGCTCCGGTACCGATTATACTTTCACAATTAGTTCCCTCGAGGCCGAGGACGCAGCTACATATTATTGTCAGCAATGGACGACCAATCCCTTGACCTTCGGGCAAGGAACTAAAGTAGAAATTAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,4,3,DFVMTQSPAFLSVTPGEKVTITCSAQ--SSVN-------YIHWYQQKPDQAPKKLIYD--------TSKLASGVPSRFSGSGSG--TDYTFTISSLEAEDAATYYCQQWTT-----------------------NPLTFGQGTKVEIK-,QVQLQES-GPGLVKPSETLSLTCTVSG-FSLTN-----YGIHWIRQPPGKGLEWLGVIWA----RGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGV-------------------YYAMDYWGQGTLVTVSS
-GDPa1-240,vedolizumab,307.59,98.485,98.76,3.215,3.0949999999999998,,0.1,0.04,0.0,0.375,60.955,70.31,84.535,IgG1,Kappa,Approved,Active,QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGTTGGTTCAGAGCGGGGCGGAGGTCAAGAAGCCTGGGGCCTCTGTGAAAGTGAGTTGTAAAGGCAGCGGATATACCTTTACTTCCTACTGGATGCACTGGGTGCGCCAGGCCCCCGGTCAACGGCTGGAGTGGATAGGTGAAATCGATCCAAGCGAGTCCAACACTAATTACAACCAAAAGTTCAAAGGGAGGGTTACCCTGACCGTAGACATCAGTGCCTCTACAGCTTACATGGAACTCAGCTCTCTTCGATCAGAAGATACAGCAGTGTACTACTGCGCTAGAGGCGGCTATGACGGATGGGATTATGCAATTGACTATTGGGGACAGGGCACGCTGGTGACAGTCTCATCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK,MRAWIFFLLCLAGRALADVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACGTGGTAATGACCCAATCACCATTGTCTCTTCCCGTCACTCCAGGCGAGCCTGCCTCCATTTCCTGTCGCTCTTCACAATCTCTGGCAAAAAGCTACGGGAATACATATCTTTCCTGGTATCTCCAGAAGCCTGGGCAGAGTCCCCAGCTGCTCATTTACGGTATCAGTAACCGGTTTAGCGGCGTTCCGGATAGGTTCAGCGGAAGCGGCTCCGGTACTGATTTTACCCTGAAAATCTCAAGAGTGGAAGCTGAGGACGTCGGAGTGTACTATTGCCTGCAGGGCACCCACCAGCCCTACACGTTCGGACAGGGGACAAAGGTGGAAATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,2,4,DVVMTQSPLSLPVTPGEPASISCRSS--QSLAKSY-GNTYLSWYLQKPGQSPQLLIYG--------ISNRFSGVPDRFSGSGSG--TDFTLKISRVEAEDVGVYYCLQGTH-----------------------QPYTFGQGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKGSG-YTFTS-----YWMHWVRQAPGQRLEWIGEIDPS---ESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGW------------------DYAIDYWGQGTLVTVSS
-GDPa1-241,veltuzumab,221.22,87.42,98.38499999999999,2.8499999999999996,3.16,,0.0,0.09,1.0,0.125,68.85499999999999,69.4,81.855,IgG1,Kappa,Phase-II,Discontinued,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS,MRAWIFFLLCLAGRALAQVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGCAGTTGCAGCAGTCCGGTGCTGAAGTGAAAAAGCCAGGGTCCTCAGTGAAGGTCTCTTGCAAGGCCTCCGGATATACTTTCACCAGTTACAATATGCACTGGGTGAAGCAGGCACCCGGCCAAGGCCTGGAGTGGATCGGTGCCATTTACCCTGGAATGGGAGACACCTCTTACAACCAGAAATTCAAAGGCAAGGCAACTCTCACGGCTGATGAGTCAACAAACACCGCCTATATGGAACTGAGCAGTCTTAGAAGCGAGGATACAGCGTTTTATTATTGTGCCAGGAGCACCTACTACGGCGGGGACTGGTACTTTGACGTTTGGGGGCAAGGCACAACTGTCACAGTAAGCTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK,MRAWIFFLLCLAGRALADIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGATATCCAGCTCACGCAGTCACCAAGCTCTTTGAGTGCTTCAGTGGGCGATAGGGTAACTATGACCTGTCGGGCTAGCAGCTCCGTGTCCTATATCCACTGGTTTCAACAGAAGCCTGGCAAGGCCCCCAAACCCTGGATTTATGCAACCTCCAATCTTGCCTCTGGGGTTCCCGTCAGATTCAGCGGATCCGGGTCAGGAACCGACTACACTTTCACAATCAGTAGTCTGCAACCGGAAGACATTGCGACATACTACTGCCAGCAGTGGACTTCTAACCCTCCAACCTTTGGTGGTGGCACAAAACTGGAGATAAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,2,1,DIQLTQSPSSLSASVGDRVTMTCRAS--SSVS-------YIHWFQQKPGKAPKPWIYA--------TSNLASGVPVRFSGSGSG--TDYTFTISSLQPEDIATYYCQQWTS-----------------------NPPTFGGGTKLEIK-,QVQLQQS-GAEVKKPGSSVKVSCKASG-YTFTS-----YNMHWVKQAPGQGLEWIGAIYPG---MGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGG------------------DWYFDVWGQGTTVTVSS
-GDPa1-242,visilizumab,303.51,94.69999999999999,98.11,2.745,2.495,4.27,0.38,0.42,3.37,19.625,59.945,73.035,,IgG2,Kappa,Phase-III,Discontinued,QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTTCAACTGGTCCAGTCCGGGGCGGAAGTGAAGAAACCAGGCGCTAGCGTGAAGGTCAGCTGCAAAGCATCCGGGTACACCTTCATCTCCTACACCATGCACTGGGTTCGGCAGGCCCCTGGCCAGGGACTGGAGTGGATGGGCTATATTAATCCCAGAAGCGGTTACACACATTACAACCAAAAGCTCAAAGATAAGGCAACCCTTACGGCCGACAAGTCTGCCTCTACAGCCTATATGGAACTCAGTAGTCTGCGCTCTGAGGACACTGCAGTGTATTATTGTGCTAGGTCAGCTTACTACGACTATGATGGGTTTGCCTACTGGGGTCAGGGAACATTGGTAACTGTGTCAAGCGCTTCAACAAAGGGCCCCAGCGTTTTCCCATTGGCACCATGCAGCAGATCCACTAGCGAATCTACTGCCGCCTTGGGCTGCCTGGTCAAGGACTATTTCCCCGAACCTGTGACAGTGTCTTGGAACAGTGGCGCTCTCACCTCAGGTGTGCACACATTCCCCGCCGTGCTCCAGTCAAGTGGTCTCTATTCGCTGTCGTCCGTCGTGACAGTCCCCAGCTCGAACTTCGGAACGCAGACTTATACCTGTAATGTAGATCACAAACCATCAAACACGAAAGTAGACAAGACAGTAGAAAGAAAATGCTGCGTTGAGTGTCCCCCCTGCCCTGCGCCACCTGTGGCTGGCCCTAGCGTTTTCTTGTTCCCCCCCAAGCCCAAGGACACTTTAATGATTTCTAGGACACCCGAGGTCACATGCGTTGTAGTGGATGTATCCCACGAAGATCCGGAGGTGCAGTTCAATTGGTATGTGGACGGAGTAGAGGTGCATAACGCAAAGACTAAGCCTCGGGAGGAACAGTTCAATTCCACTTTTAGAGTCGTCTCCGTGTTGACCGTCGTGCATCAGGACTGGCTGAATGGGAAGGAGTATAAATGTAAAGTTAGCAACAAGGGCCTACCTGCCCCTATAGAAAAAACTATCTCAAAAACTAAAGGGCAGCCCCGAGAACCCCAAGTCTATACTCTGCCACCCAGCAGAGAGGAGATGACCAAGAACCAAGTTTCTCTGACCTGCTTAGTGAAAGGCTTCTACCCGAGCGACATCGCTGTCGAGTGGGAGTCTAATGGACAACCCGAAAACAATTATAAAACAACACCACCAATGCTTGACTCTGACGGCAGCTTCTTCCTCTATTCTAAGTTGACTGTTGATAAGAGCCGCTGGCAGCAGGGTAACGTCTTTAGCTGTTCCGTGATGCACGAGGCTTTGCACAACCACTACACTCAGAAGAGCCTGAGCCTGTCTCCCGGATAG,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIK,MRAWIFFLLCLAGRALADIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCCAGATGACTCAGAGCCCTTCCAGCCTTTCCGCAAGTGTTGGCGATAGGGTCACAATTACATGTTCTGCTAGCAGTTCCGTGTCCTATATGAACTGGTATCAGCAGAAGCCAGGTAAGGCCCCCAAACGGCTGATTTACGACACCAGTAAGCTGGCCTCTGGAGTACCAAGCAGATTTTCAGGGTCAGGCTCTGGCACCGACTTCACGTTGACTATATCCTCTCTCCAACCCGAAGATTTCGCGACATACTACTGCCAACAGTGGAGCTCAAATCCGCCTACCTTTGGTGGGGGAACCAAAGTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,1,1,0,DIQMTQSPSSLSASVGDRVTITCSAS--SSVS-------YMNWYQQKPGKAPKRLIYD--------TSKLASGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQWSS-----------------------NPPTFGGGTKVEIK-,QVQLVQS-GAEVKKPGASVKVSCKASG-YTFIS-----YTMHWVRQAPGQGLEWMGYINPR---SGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYD-------------------YDGFAYWGQGTLVTVSS
-GDPa1-243,xentuzumab,281.21,98.97,99.875,10.0,4.5,,0.18,0.12,26.87,25.625,,,,IgG1,Lambda,Phase-II,Active,QVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTGGAGCTTGTAGAATCCGGCGGTGGGCTGGTCCAGCCTGGAGGATCCCTCCGACTTAGTTGCGCCGCGTCAGGGTTTACCTTCACCTCATATTGGATGTCTTGGGTTCGCCAGGCCCCCGGCAAAGGGTTGGAACTGGTGTCAAGCATCACCAGTTACGGTAGCTTCACTTACTACGCTGATTCTGTCAAGGGCAGGTTCACCATTAGTAGGGACAATTCCAAGAACACATTGTATCTGCAAATGAACAGCCTGCGGGCTGAGGATACAGCAGTGTACTATTGTGCCAGAAATATGTATACTCACTTTGACAGCTGGGGCCAGGGAACACTCGTTACGGTGTCTTCCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVL,MRAWIFFLLCLAGRALADIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTCCTCACACAGCCACCGTCTGTGAGTGGTGCGCCCGGGCAGCGCGTGACCATTTCATGTAGCGGAAGCTCTTCCAACATTGGCAGCAATTCAGTCAGCTGGTACCAGCAACTTCCAGGCACCGCCCCTAAATTGCTGATCTATGATAACAGTAAACGGCCTAGTGGAGTTCCCGATAGATTTTCCGGCAGCAAGTCTGGCACCTCCGCCTCTCTCGCAATAACTGGGCTGCAATCCGAAGACGAGGCTGATTATTACTGCCAGTCAAGGGACACTTATGGCTACTACTGGGTATTCGGGGGTGGAACGAAGCTGACAGTGCTGGGCCAGCCCAAGGCAGCCCCATCCGTTACCCTGTTTCCCCCATCCTCCGAAGAATTGCAGGCAAATAAAGCTACCCTGGTGTGCCTTATCTCCGATTTTTACCCCGGGGCCGTGACTGTGGCATGGAAGGCAGATTCTTCGCCTGTGAAGGCTGGTGTTGAAACAACCACACCCTCCAAGCAAAGCAACAACAAGTACGCAGCCAGCTCCTATCTGTCCCTGACCCCGGAACAATGGAAGTCTCATAGGTCCTACAGCTGTCAGGTCACACATGAGGGCTCCACAGTGGAGAAAACAGTGGCTCCAACAGAGTGTAGTTAG,4,4,4,DIVLTQP-PSVSGAPGQRVTISCSGSS-SNIGS-----NSVSWYQQLPGTAPKLLIYD--------NSKRPSGVPDRFSGSKSG--TSASLAITGLQSEDEADYYCQSRDTY---------------------GYYWVFGGGTKLTVL-,QVELVES-GGGLVQPGGSLRLSCAASG-FTFTS-----YWMSWVRQAPGKGLELVSSITSY---GSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYT----------------------HFDSWGQGTLVTVSS
-GDPa1-244,zalutumumab,266.55,89.43,98.065,2.705,2.59,3.76,0.0,0.03,-1.13,-1.375,61.31,69.59,78.73,IgG1,Kappa,Phase-II,Discontinued,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAGCTTGTGGAATCTGGCGGGGGAGTAGTCCAACCTGGCAGATCCCTCCGACTCTCCTGCGCTGCAAGTGGTTTTACCTTCTCAACATACGGAATGCACTGGGTGCGCCAAGCTCCCGGAAAGGGATTGGAGTGGGTTGCCGTCATATGGGATGACGGGAGTTATAAATACTATGGTGATTCCGTTAAAGGCAGGTTCACTATCAGCCGGGACAATTCTAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCGGAGGACACTGCCGTGTATTATTGTGCCAGGGATGGCATTACCATGGTGAGAGGGGTGATGAAGGATTACTTTGACTACTGGGGGCAGGGCACGCTGGTAACAGTGAGCTCAGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,MRAWIFFLLCLAGRALAAIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGCCATTCAGTTGACGCAGAGTCCCTCATCTCTGAGCGCCAGCGTCGGGGACAGAGTTACAATTACTTGTAGGGCAAGCCAGGACATCTCCTCCGCGCTCGTGTGGTATCAGCAGAAACCCGGAAAGGCTCCTAAGCTGCTCATATACGATGCTTCCTCTTTGGAGTCTGGCGTGCCTAGTCGGTTCAGCGGTTCAGAATCCGGAACAGACTTTACCCTGACTATCTCAAGTCTGCAACCAGAAGATTTTGCCACCTACTATTGCCAACAGTTCAACTCTTACCCGCTTACCTTCGGCGGCGGGACAAAAGTAGAGATCAAGAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,0,0,0,AIQLTQSPSSLSASVGDRVTITCRAS--QDIS------SALVWYQQKPGKAPKLLIYD--------ASSLESGVPSRFSGSESG--TDFTLTISSLQPEDFATYYCQQFNS-----------------------YPLTFGGGTKVEIK-,QVQLVES-GGGVVQPGRSLRLSCAASG-FTFST-----YGMHWVRQAPGKGLEWVAVIWDD---GSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRG--------------VMKDYFDYWGQGTLVTVSS
-GDPa1-245,zanolimumab,301.96,99.11500000000001,97.78,2.725,2.66,3.7300000000000004,0.72,0.1,1.87,1.0,62.86,70.485,86.18,IgG1,Kappa,Phase-III,Discontinued,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVINWFDPWGQGTLVTVSS,MRAWIFFLLCLAGRALAQVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVINWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAGGTCCAATTGCAGCAGTGGGGCGCTGGACTGCTCAAGCCGAGCGAAACACTTAGCTTGACTTGTGCCGTGTACGGGGGATCATTTTCCGGTTACTACTGGTCATGGATAAGGCAGCCACCCGGCAAAGGACTCGAGTGGATCGGCGAGATTAATCACTCTGGGTCCACTAACTATAACCCCAGTCTTAAGTCCAGAGTGACCATCAGTGTGGACACCTCAAAGAACCAGTTCTCCCTGAAACTGAGCAGCGTCACAGCAGCTGACACGGCCGTATATTATTGCGCGCGGGTTATTAATTGGTTCGATCCTTGGGGTCAAGGCACACTGGTTACCGTGTCTTCTGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPYTFGQGTKLEIK,MRAWIFFLLCLAGRALADIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATACAGATGACCCAGTCTCCCTCATCCGTGAGTGCAAGCGTTGGAGACCGGGTCACAATCACTTGCAGAGCAAGTCAGGACATTTCATCCTGGCTGGCCTGGTACCAGCACAAGCCAGGTAAGGCTCCTAAGCTCCTTATCTATGCGGCTTCTTCTCTGCAAAGCGGAGTGCCAAGCAGGTTCAGTGGGTCCGGCAGCGGGACAGATTTCACCTTGACAATTTCCTCTCTCCAACCTGAAGATTTCGCCACGTACTATTGTCAGCAGGCCAACTCATTTCCCTACACCTTTGGCCAGGGCACTAAACTGGAGATCAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,2,2,3,DIQMTQSPSSVSASVGDRVTITCRAS--QDIS------SWLAWYQHKPGKAPKLLIYA--------ASSLQSGVPSRFSGSGSG--TDFTLTISSLQPEDFATYYCQQANS-----------------------FPYTFGQGTKLEIK-,QVQLQQW-GAGLLKPSETLSLTCAVYG-GSFSG-----YYWSWIRQPPGKGLEWIGEINH----SGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVIN-----------------------WFDPWGQGTLVTVSS
-GDPa1-246,zolbetuximab,375.2,100.0,99.465,2.6799999999999997,2.5300000000000002,,0.13,0.1,31.12,29.875,59.875,69.95500000000001,84.89500000000001,IgG1,Kappa,Approved,Active,QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS,MRAWIFFLLCLAGRALAQVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCCAAGTTCAGCTGCAGCAGCCTGGTGCGGAATTGGTACGGCCGGGCGCCTCTGTCAAACTGAGTTGTAAAGCTTCAGGATATACATTCACCTCTTACTGGATCAATTGGGTGAAACAGAGACCCGGTCAGGGGCTTGAGTGGATTGGGAACATATATCCATCCGACAGTTACACCAACTACAACCAAAAGTTCAAGGATAAGGCCACGCTCACTGTCGACAAGTCCAGTTCTACCGCATACATGCAGCTGAGCTCACCCACCTCCGAGGACAGCGCTGTGTACTATTGCACTAGGTCATGGCGCGGAAATTCCTTTGATTATTGGGGCCAGGGCACAACACTCACTGTGAGCAGCGCTTCCACCAAGGGCCCCTCTGTTTTCCCATTGGCTCCTTCATCAAAGTCTACAAGCGGCGGCACCGCTGCTCTAGGATGTCTCGTCAAAGACTACTTCCCTGAACCTGTTACAGTGAGCTGGAACAGTGGCGCGCTAACGTCTGGAGTGCACACATTCCCAGCTGTGCTGCAGAGTTCTGGCCTGTATTCTCTGTCTAGCGTGGTGACAGTGCCTTCCAGTTCCCTCGGTACGCAGACTTACATTTGCAACGTAAACCACAAACCCTCAAACACAAAAGTGGATAAGAAGGTTGAGCCTAAATCTTGCGATAAGACACACACATGCCCCCCATGCCCAGCTCCTGAGCTGCTAGGGGGGCCATCCGTCTTTCTGTTTCCTCCTAAACCAAAAGACACACTCATGATCTCCCGGACCCCAGAGGTAACTTGCGTGGTGGTGGACGTGTCTCATGAAGACCCAGAGGTGAAGTTCAACTGGTATGTCGATGGAGTCGAGGTACATAACGCAAAGACTAAACCCAGGGAAGAGCAGTACAACAGCACCTACCGTGTTGTGTCTGTGCTGACTGTGCTCCACCAGGACTGGCTCAACGGCAAGGAATATAAATGCAAAGTCTCCAATAAGGCACTACCCGCGCCCATTGAGAAAACCATCTCTAAGGCAAAAGGGCAACCACGCGAGCCTCAGGTTTACACTCTGCCCCCCAGCAGGGAAGAGATGACTAAGAATCAGGTTTCCCTGACATGTCTCGTGAAGGGCTTTTACCCATCGGATATTGCCGTCGAATGGGAGAGTAACGGACAGCCCGAGAATAATTACAAGACTACACCCCCCGTACTCGACTCCGATGGAAGCTTTTTCCTGTACTCCAAGCTGACCGTTGACAAGAGCCGCTGGCAACAAGGCAATGTGTTCTCTTGCAGTGTAATGCACGAGGCCCTCCATAATCACTACACCCAGAAGTCACTGAGTTTATCCCCCGGGTAG,DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK,MRAWIFFLLCLAGRALADIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,GCCGCCACCATGAGAGCCTGGATCTTTTTCCTGCTGTGCCTGGCTGGGCGCGCCCTGGCCGACATCGTGATGACACAGTCACCCTCTAGCCTGACTGTTACCGCCGGCGAAAAGGTCACAATGAGCTGCAAGAGCAGTCAGTCACTTCTGAACTCTGGGAACCAGAAGAATTACCTGACTTGGTACCAACAGAAGCCTGGTCAACCCCCAAAACTTCTGATCTATTGGGCCTCCACCAGAGAGAGTGGCGTGCCAGATAGGTTCACAGGATCCGGTAGCGGGACAGATTTTACGTTGACCATATCATCCGTGCAGGCTGAAGACCTCGCAGTATATTACTGTCAGAATGACTATTCCTACCCTTTCACCTTTGGCTCTGGAACTAAACTCGAGATTAAAAGGACAGTTGCCGCCCCTAGTGTGTTCATCTTTCCGCCTTCAGACGAGCAGCTGAAGTCCGGTACAGCTTCCGTGGTGTGCCTTCTAAATAATTTCTATCCGAGGGAAGCGAAGGTGCAGTGGAAGGTCGATAATGCACTGCAAAGCGGCAACAGTCAGGAGTCCGTCACAGAACAGGATAGCAAAGACTCCACTTATAGTCTGTCCTCGACCCTTACACTATCCAAGGCCGACTACGAAAAACACAAAGTCTACGCTTGCGAGGTGACCCACCAGGGTCTGAGCTCCCCTGTAACAAAGTCTTTCAACCGCGGAGAGTGCTAG,4,4,4,DIVMTQSPSSLTVTAGEKVTMSCKSS--QSLLNSGNQKNYLTWYQQKPGQPPKLLIYW--------ASTRESGVPDRFTGSGSG--TDFTLTISSVQAEDLAVYYCQNDYS-----------------------YPFTFGSGTKLEIK-,QVQLQQP-GAELVRPGASVKLSCKASG-YTFTS-----YWINWVKQRPGQGLEWIGNIYPS---DSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRG---------------------NSFDYWGQGTTLTVSS
+antibody_name,vh_protein_sequence,vl_protein_sequence,hierarchical_cluster_IgG_isotype_stratified_fold,Tm2
+abagovomab,QVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSS,DIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIK,2,-0.6869
+abituzumab,QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIK,0,-0.5555
+abrezekimab,QVTLKESGPVLVKPTETLTLTCTVSGFSLTNYHVQWIRQPPGKALEWLGVMWSDGDTSFNSVLKSRLTISRDTSKSQVVLTMTNMDPVDTATYYCARDGTIAAMDYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCLASEDISNYLAWYQQKPGKAPKLLIYHTSRLQDGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYRFPLTFGGGTKVEIK,2,-0.606
+abrilumab,QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIK,0,-0.3819
+adalimumab,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK,0,-0.3916
+aducanumab,QVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,0,-0.3331
+alemtuzumab,QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK,3,-0.5924
+alirocumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK,2,-0.5128
+amatuximab,QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSS,DIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIK,2,-0.6317
+andecaliximab,QVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIK,3,-0.5775
+anetumab,QVELVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSS,DIALTQPASVSGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYDIESATPVFGGGTKLTVL,4,-0.6126
+anifrolumab,EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK,3,-0.4305
+anrukinzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFISYAMSWVRQAPGKGLEWVASISSGGNTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLDGYYFGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASESVDNYGKSLMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPWTFGGGTKVEIK,0,-0.3952
+atezolizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK,0,-0.2465
+avelumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,4,-0.4467
+bapineuzumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASIRSGGGRTYYSDNVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHYSGSSDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCKSSQSLLDSDGKTYLNWLLQKPGQSPQRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGQGTKVEIK,1,-0.4162
+basiliximab,QVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS,QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK,2,-0.5039
+bavituximab,EVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSS,DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELK,2,-0.4605
+belantamab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYWMHWVRQAPGQGLEWMGATYRGHSDTYYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGAIYDGYDVLDNWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKLLIYYTSNLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYRKLPWTFGQGTKLEIK,1,-0.5859
+belimumab,QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSS,SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVL,4,-0.5729
+bemarituzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYIFTTYNVHWVRQAPGQGLEWIGSIYPDNGDTSYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYCARGDFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQGVSNDVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHSTTPYTFGQGTKLEIK,1,-0.5135
+benralizumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK,1,-0.7917
+bevacizumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK,0,-0.4232
+bezlotoxumab,EVQLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIFYPGDSSTRYSPSFQGQVTISADKSVNTAYLQWSSLKASDTAMYYCARRRNWGNAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSTWTFGQGTKVEIK,3,-0.261
+bimagrumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSSYINWVRQAPGQGLEWMGTINPVSGSTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGWFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVNWYQQHPGKAPKLMIYGVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCGTFAGGSYYGVFGGGTKLTVL,4,-0.3222
+bimekizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMAWVRQAPGKGLEWVATITYEGRNTYYRDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGSIYRLWFAHWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK,0,-0.8582
+bleselumab,QLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIK,2,-0.5707
+blosozumab,QVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIK,0,-0.7168
+bococizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK,0,-0.5661
+brazikumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL,4,-0.3232
+brentuximab,QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSA,DIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIK,4,-0.4561
+briakinumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIRYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHGSHDNWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCSGSRSNIGSNTVKWYQQLPGTAPKLLIYYNDQRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDRYTHPALLFGTGTKVTVL,4,-0.4652
+brodalumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK,2,-0.2976
+brontictuzumab,QVQLVQSGAEVKKPGASVKISCKVSGYTLRGYWIEWVRQAPGKGLEWIGQILPGTGRTNYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYCARFDGNYGYYAMDYWGQGTTVTVSS,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWFQQKPGQAPRTLIGGTNNRAPGVPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNHWVFGGGTKLTVL,4,-0.6063
+budigalimab,EIQLVQSGAEVKKPGSSVKVSCKASGYTFTHYGMNWVRQAPGQGLEWVGWVNTYTGEPTYADDFKGRLTFTLDTSTSTAYMELSSLRSEDTAVYYCTREGEGLGFGDWGQGTTVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSIVHSHGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHIPVTFGQGTKLEIK,4,-0.6081
+burosumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIK,1,-0.4443
+cabiralizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDNYMIWVRQAPGQGLEWMGDINPYNGGTTFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARESPYFSNLYVMDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCKASQSVDYDGDNYMNWYQQKPGQAPRLLIYAASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHLSNEDLSTFGGGTKVEIK,3,-0.5299
+camidanlumab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYIINWVRQAPGQGLEWMGRIIPILGVENYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARKDWFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,3,-0.335
+camrelizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYMMSWVRQAPGKGLEWVATISGGGANTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLYYFDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCLASQTIGTWLTWYQQKPGKAPKLLIYTATSLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQVYSIPWTFGGGTKVEIK,1,-0.4328
+carlumab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGIYGELDFWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSDAYLAWYQQKPGQAPRLLIYDASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYIQLHSFTFGQGTKVEIK,3,-0.389
+cemiplimab,EVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFR,1,-0.6422
+certolizumab,EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK,0,-0.4283
+cetrelimab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARPGLAAAYDTGSLDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNYWPLTFGQGTKVEIK,3,-0.3418
+cetuximab,QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA,DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK,1,-0.4187
+cixutumumab,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWSTQDHYYYYYMDVWGKGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYATWYQQKPGQAPILVIYGENKRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCKSRDGSGQHLVFGGGTKLTVL,4,-0.4752
+clazakizumab,EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS,AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK,0,-0.8216
+codrituzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPGQGLEWMGALDPKTGDTAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCTRFYSYTYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSNRNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQNTHVPPTFGQGTKLEIK,4,-0.4749
+coltuximab,QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS,EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK,2,-0.6531
+concizumab,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIK,4,-0.5749
+crenezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK,4,-0.2956
+crizanlizumab,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK,0,-0.5038
+cusatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSVYYMNWVRQAPGKGLEWVSDINNEGGTTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYCARDAGYSNHVPIFDSWGQGTLVTVSS,QAVVTQEPSLTVSPGGTVTLTCGLKSGSVTSDNFPTWYQQTPGQAPRLLIYNTNTRHSGVPDRFSGSILGNKAALTITGAQADDEAEYFCALFISNPSVEFGGGTQLTVL,4,-0.85
+dacetuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK,0,-0.6604
+daclizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK,1,-0.474
+dalotuzumab,QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK,3,-0.4673
+daratumumab,EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK,2,-0.3822
+denosumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIK,4,-0.3034
+depatuxizumab,QVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSS,DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK,3,-0.7391
+dinutuximab,EVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSS,EIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK,4,-0.7035
+domagrozumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK,0,-0.3051
+dostarlimab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSTISGGGSYTYYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASPYYAMDYWGQGTTVTVSS,DIQLTQSPSFLSAYVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTLHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHYSSYPWTFGQGTKLEIK,1,-0.4664
+duligotuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIK,0,-0.5221
+dupilumab,EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIK,4,-0.4308
+durvalumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFGELAFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIK,2,-0.313
+eculizumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,0,-0.5248
+efalizumab,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK,0,-0.3772
+eldelumab,QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK,2,-0.348
+elezanumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSHGISWVRQAPGQGLDWMGWISPYSGNTNYAQKLQGRVTMTTDTSTSTAYMELSSLRSEDTAVYYCARVGSGPYYYMDVWGQGTLVTVSS,QSALTQPRSVSGSPGQSVTISCTGTSSSVGDSIYVSWYQQHPGKAPKLMLYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGTDTLFGGGTKVTVL,4,-0.5913
+elotuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK,0,-0.4099
+emactuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGVIWTDGGTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQRLYFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASEDVNTYVSWYQQKPGKAPKLLIYAASNRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSYPTFGQGTKLEIK,1,-0.4999
+emapalumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSS,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVL,4,-0.3016
+emibetuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK,0,-0.5429
+enavatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIK,0,-0.2763
+enokizumab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK,1,-0.6215
+epratuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIK,1,-0.5157
+eptinezumab,EVQLVESGGGLVQPGGSLRLSCAVSGIDLSGYYMNWVRQAPGKGLEWVGVIGINGATYYASWAKGRFTISRDNSKTTVYLQMNSLRAEDTAVYFCARGDIWGQGTLVTVSS,QVLTQSPSSLSASVGDRVTINCQASQSVYHNTYLAWYQQKPGKVPKQLIYDASTLASGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLGSYDCTNGDCFVFGGGTKVEIK,0,-0.7842
+erenumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSS,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL,3,-0.4194
+etaracizumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK,2,-0.6292
+etrolizumab,EVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIK,0,-0.4999
+evinacumab,EVQLVESGGGVIQPGGSLRLSCAASGFTFDDYAMNWVRQGPGKGLEWVSAISGDGGSTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAFFYCAKDLRNTIFGVVIPDAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK,1,-0.4587
+evolocumab,EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS,ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL,3,-0.5175
+farletuzumab,EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS,DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK,1,-0.6441
+fasinumab,QVQLVQSGAEVKKPGASVKVSCKVSGFTLTELSIHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCSTIFGVVTNFDNWGQGTLVTVSS,DIQMTQSPSSLSASAGDRVTITCRASQAIRNDLGWYQQKPGKAPKRLIYAAFNLQSGVPSRFSGSGSGTEFTLTISSLQPEDLASYYCQQYNRYPWTFGQGTKVEIK,0,-0.5393
+fezakinumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWVGWINPYTGSAFYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREPEKFDSDDSDVWGRGTLVTVSS,QAVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGDSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDNSLSGYVFGGGTQLTVL,4,-0.5323
+ficlatuzumab,QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS,DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK,4,-0.6872
+figitumumab,EVQLLESGGGLVQPGGSLRLSCTASGFTFSSYAMNWVRQAPGKGLEWVSAISGSGGTTFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSYYYYYGMDVWGQGTTVTVSS,DIQMTQFPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASRLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPCSFGQGTKLEIK,2,-0.4647
+fletikumab,QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,0,-0.4892
+foralumab,QVQLVESGGGVVQPGRSLRLSCAASGFKFSGYGMHWVRQAPGKGLEWVAVIWYDGSKKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGYWHFDLWGRGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPLTFGGGTKVEIK,2,-0.2493
+fremanezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK,4,-0.9131
+fresolimumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFSSNVISWVRQAPGQGLEWMGGVIPIVDIANYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLVLDAMDYWGQGTLVTVSS,ETVLTQSPGTLSLSPGERATLSCRASQSLGSSYLAWYQQKPGQAPRLLIYGASSRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYADSPITFGQGTRLEIK,3,-0.6078
+fulranumab,EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,2,-0.4767
+galcanezumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK,0,-0.7124
+galiximab,QVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSS,ESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVL,4,-0.8473
+ganitumab,QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGRTDAFDIWGQGTMVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGQGTKVEIK,3,-0.2896
+gantenerumab,QVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSS,DIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIK,2,-0.6789
+gatipotuzumab,EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS,DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK,1,-0.5297
+gemtuzumab,EVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSS,DIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVK,0,-0.7711
+gevokizumab,QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS,DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK,1,-0.5178
+gimsilumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMHWLRQVPGKGPVWVSRINGAGTSITYADSVRGRFTISRDNANNTLFLQMNSLRADDTALYFCARANSVWFRGLFDYWGQGTPVTVSS,EIVLTQSPVTLSVSPGERVTLSCRASQSVSTNLAWYQQKLGQGPRLLIYGASTRATDIPARFSGSGSETEFTLTISSLQSEDFAVYYCQQYDKWPDTFGQGTKLEIK,2,-0.7963
+girentuximab,DVKLVESGGGLVKLGGSLKLSCAASGFTFSNYYMSWVRQTPEKRLELVAAINSDGGITYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSGYFSMDYWGQGTSVTVSS,DIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIK,3,-0.5408
+glembatumumab,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK,1,-0.3958
+golimumab,QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,2,-0.368
+guselkumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL,4,-0.5369
+ianalumab,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWGWIRQSPGRGLEWLGRIYYRSKWYNSYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARYQWVPKIGVFDSWGQGTLVTVSS,DIVLTQSPATLSLSPGERATLSCRASQFILPEYLSWYQQKPGQAPRLLIYGSSSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQFYSSPLTFGQGTKVEIK,3,-0.6635
+ibalizumab,QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK,4,-0.4465
+icrucumab,QAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,2,-0.4417
+imgatuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGFTFTDYKIHWVRQAPGQGLEWMGYFNPNSGYSTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGGYYVMDAWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGINNYLNWYQQKPGKAPKRLIYNTNNLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSFPTFGQGTKLEIK,1,-0.5117
+inclacumab,EVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,3,-0.4618
+inebilizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSWMNWVRQAPGKGLEWVGRIYPGDGDTNYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITTVRDFDYWGQGTLVTVSS,EIVLTQSPDFQSVTPKEKVTITCRASESVDTFGISFMNWFQQKPDQSPKLLIHEASNQGSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQSKEVPFTFGGGTKVEIK,3,-0.583
+infliximab,EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS,DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK,1,0
+inotuzumab,EVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSS,DVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIK,0,-0.7383
+intetumumab,QVQLVESGGGVVQPGRSRRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAVISFDGSNKYYVDSVKGRFTISRDNSENTLYLQVNILRAEDTAVYYCAREARGSYAFDIWGQGTMVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,2,-0.397
+ipilimumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,2,-0.258
+isatuximab,QVQLVQSGAEVAKPGTSVKLSCKASGYTFTDYWMQWVKQRPGQGLEWIGTIYPGDGDTGYAQKFQGKATLTADKSSKTVYMHLSSLASEDSAVYYCARGDYYGSNSLDYWGQGTSVTVSS,DIVMTQSHLSMSTSLGDPVSITCKASQDVSTVVAWYQQKPGQSPRRLIYSASYRYIGVPDRFTGSGAGTDFTFTISSVQAEDLAVYYCQQHYSPPYTFGGGTKLEIK,2,-0.7586
+iscalimab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS,DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR,1,-0.5988
+itolizumab,EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK,3,-0.6986
+ixekizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS,DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK,4,-0.5765
+ladiratuzumab,QVQLVQSGAEVKKPGASVKVSCKASGLTIEDYYMHWVRQAPGQGLEWMGWIDPENGDTEYGPKFQGRVTMTRDTSINTAYMELSRLRSDDTAVYYCAVHNAHYGTWFAYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLLHSSGNTYLEWYQQRPGQSPRPLIYKISTRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPYTFGGGTKVEIK,4,-0.7068
+lampalizumab,EVQLVQSGPELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREGGVNNWGQGTLVTVSS,DIQVTQSPSSLSASVGDRVTITCITSTDIDDDMNWYQQKPGKVPKLLISGGNTLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLQSDSLPYTFGQGTKVEIK,1,-0.6211
+lanadelumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIK,0,-0.4353
+landogrozumab,EVQLVESGGGLVQPGGSLRLSCAASGLTFSRYPMSWVRQAPGKGLVWVSAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARLPDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASSSVSSSYLHWYQQKPGQAPRLLIYSTSNLVAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHHSGYHFTFGGGTKVEIK,2,-0.6072
+lebrikizumab,QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS,DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK,2,-0.6012
+lenzilumab,QVQLVQSGAEVKKPGASVKVSCKASGYSFTNYYIHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRFPYYFDYWGQGTLVTVSS,EIVLTQSPATLSVSPGERATLSCRASQSVGTNVAWYQQKPGQAPRVLIYSTSSRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFNKSPLTFGGGTKVEIK,3,-0.4989
+lexatumumab,EVQLVQSGGGVERPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDLWGKGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,4,-0.4052
+ligelizumab,QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK,3,-0.697
+lintuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK,1,-0.3741
+lirilumab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSFYAISWVRQAPGQGLEWMGGFIPIFGAANYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYCARIPSGSYYYDYDMDVWGQGTTVTVSS,EIVLTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWMYTFGQGTKLEIK,3,-0.37
+loncastuximab,QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS,EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK,2,-0.6089
+lorvotuzumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIK,1,-0.3998
+lucatumumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS,DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR,1,-0.587
+lumiliximab,EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK,0,-0.7035
+lumretuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFRSSYISWVRQAPGQGLEWMGWIYAGTGSPSYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARHRDYYSNSLTYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQSDYSYPYTFGQGTKLEIK,4,-0.4671
+margetuximab,QVQLQQSGPELVKPGASLKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYDPKFQDKATITADTSSNTAYLQVSRLTSEDTAVYYCSRWGGDGFYAMDYWGQGASVTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRYTGVPDRFTGSRSGTDFTFTISSVQAEDLAVYYCQQHYTTPPTFGGGTKVEIK,2,-0.5174
+matuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK,1,-0.4542
+mavrilimumab,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL,2,-0.7507
+mepolizumab,QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK,3,-0.5578
+milatuzumab,QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGVNWIKQAPGQGLQWMGWINPNTGEPTFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCSRSRGKNEAWFAYWGQGTLVTVSS,DIQLTQSPLSLPVTLGQPASISCRSSQSLVHRNGNTYLHWFQQRPGQSPRLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCSQSSHVPPTFGAGTRLEIK,4,-0.7928
+mirikizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYKFTRYVMHWVRQAPGQGLEWMGYINPYNDGTNYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNWDTGLWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASDHILKFLTWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQMYWSTPFTFGGGTKVEIK,0,-0.5624
+mirvetuximab,QVQLVQSGAEVVKPGASVKISCKASGYTFTGYFMNWVKQSPGQSLEWIGRIHPYDGDTFYNQKFQGKATLTVDKSSNTAHMELLSLTSEDFAVYYCTRYDGSRAMDYWGQGTTVTVSS,DIVLTQSPLSLAVSLGQPAIISCKASQSVSFAGTSLMHWYHQKPGQQPRLLIYRASNLEAGVPDRFSGSGSKTDFTLTISPVEAEDAATYYCQQSREYPYTFGGGTKLEIK,4,-0.9527
+mitazalimab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVL,4,-0.5823
+mogamulizumab,EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS,DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK,1,-0.6398
+monalizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGTPRTFGGGTKVEIK,0,-0.4418
+mosunetuzumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVRQAPGQGLEWIGWIYPGDGNTKYNEKFKGRATLTADTSTSTAYLELSSLRSEDTAVYYCARDSYSNYYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRTRKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCTQSFILRTFGQGTKVEIK,4,-0.378
+motavizumab,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK,3,-0.4143
+muromonab,QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIK,4,-0.3904
+natalizumab,QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK,0,-0.4136
+necitumumab,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK,3,-0.3228
+nesvacumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDIHWVRQATGKGLEWVSAIGPAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGLITFGGLIAPFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYDNSQTFGQGTKVEIK,2,-0.4769
+nimotuzumab,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTNYYIYWVRQAPGQGLEWIGGINPTSGGSNFNEKFKTRVTITADESSTTAYMELSSLRSEDTAFYFCTRQGLWFDSDGRGFDFWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQNIVHSNGNTYLDWYQQTPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFQYSHVPWTFGQGTKLQIT,1,-0.7467
+nivolumab,QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK,3,-0.3307
+obexelimab,EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS,DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK,4,-0.7938
+obiltoxaximab,QVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIR,1,-0.556
+obinutuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS,DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK,4,-0.4646
+ocrelizumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIK,0,-0.4689
+ofatumumab,EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK,2,-0.307
+olaratumab,QLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIK,3,-0.496
+oleclumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAYSWVRQAPGKGLEWVSAISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLGYGRVDEWGRGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSLSNIGRNPVNWYQQLPGTAPKLLIYLDNLRLSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSHPGWTFGGGTKLTVL,4,-0.6487
+olokizumab,EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK,1,-0.57
+omalizumab,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK,0,-0.2452
+omburtamab,QVQLQQSGAELVKPGASVKLSCKASGYTFTNYDINWVRQRPEQGLEWIGWIFPGDGSTQYNEKFKGKATLTTDTSSSTAYMQLSRLTSEDSAVYFCARQTTATWFAYWGQGTLVTVSA,DIVMTQSPATLSVTPGDRVSLSCRASQSISDYLHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGSDFTLSINSVEPEDVGVYYCQNGHSFPLTFGAGTKLELK,2,-0.4533
+onartuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK,0,-0.3719
+opicinumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSS,DIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIK,2,-0.3881
+orticumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSSISVGGHRTYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCARIRVGPSGGAFDYWGQGTLVTVSS,QSVLTQPPSASGTPGQRVTISCSGSNTNIGKNYVSWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCASWDASLNGWVFGGGTKLTVL,3,-0.5256
+osocimab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSQYGMDWVRQAPGKGLEWVSGIGPSGGSTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGGPYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQADSFPVTFGGGTKVEIK,1,-0.3102
+otelixizumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFPMAWVRQAPGKGLEWVSTISTSGGRTYYRDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKFRQYSGGFDYWGQGTLVTVSS,DIQLTQPNSVSTSLGSTVKLSCTLSSGNIENNYVHWYQLYEGRSPTTMIYDDDKRPDGVPDRFSGSIDRSSNSAFLTIHNVAIEDEAIYFCHSYVSSFNVFGGGTKLTVL,1,-0.9565
+otlertuzumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK,3,-0.5806
+ozanezumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS,DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK,4,-0.5646
+palivizumab,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK,3,-0.5386
+pamrevlumab,EGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIK,1,-0.6149
+panitumumab,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK,1,-0.3812
+panobacumab,EEQVVESGGGFVQPGGSLRLSCAASGFTFSPYWMHWVRQAPGKGLVWVSRINSDGSTYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRYYGPEMWGQGTMVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIK,1,-0.4659
+parsatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK,0,-0.5737
+patritumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCARDKWTWYFDLWGRGTLVTVSS,DIEMTQSPDSLAVSLGERATINCRSSQSVLYSSSNRNYLAWYQQNPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK,3,-0.3164
+pembrolizumab,QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK,3,0
+pertuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK,0,-0.4473
+pidilizumab,QVQLVQSGSELKKPGASVKISCKASGYTFTNYGMNWVRQAPGQGLQWMGWINTDSGESTYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFCVRVGYDALDYWGQGTLVTVSS,EIVLTQSPSSLSASVGDRVTITCSARSSVSYMHWFQQKPGKAPKLWIYRTSNLASGVPSRFSGSGSGTSYCLTINSLQPEDFATYYCQQRSSFPLTFGGGTKLEIK,1,-0.6508
+pinatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK,0,-0.4276
+plozalizumab,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYAMNWVRQAPGKGLEWVGRIRTKNNNYATYYADSVKDRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTFYGNGVWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCKSSQSLLDSDGKTFLNWFQQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPYTFGQGTRLEIK,4,-0.4158
+polatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK,0,-0.4111
+ponezumab,QVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIK,4,-0.8136
+prasinezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK,0,-0.5026
+prezalumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK,0,-0.4122
+prolgolimab,QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYWMYWVRQVPGKGLEWVSAIDTGGGRTYYADSVKGRFAISRVNAKNTMYLQMNSLRAEDTAVYYCARDEGGGTGWGVLKDWPYGLDAWGQGTLVTVSS,QPVLTQPLSVSVALGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVIYRDSNRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYCQVWDSSTAVFGTGTKLTVL,4,-0.7815
+quilizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGIAWVRQAPGKGLEWVAFISDLAYTIYYADTVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDNWDAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHNNANTYLHWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCSQNTLVPWTFGQGTKVEIK,2,-0.5339
+racotumomab,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK,1,-0.3198
+radretumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK,2,-0.3793
+ramucirumab,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS,DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK,0,-0.5007
+ranibizumab,EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK,0,-0.4677
+relatlimab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWNWIRQPPGKGLEWIGEINHRGSTNSNPSLKSRVTLSLDTSKNQFSLKLRSVTAADTAVYYCAFGYSDYEYNWFDPWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSISSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGQGTNLEIK,2,-0.4428
+reslizumab,EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK,1,-0.5403
+rilotumumab,QVQLQESGPGLVKPSETLSLTCTVSGGSISIYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDFWSGYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVDSNLAWYRQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYINWPPITFGQGTRLEIK,1,-0.3799
+rinucumab,QLQLQESGPGLVKPSETLSLTCTVSGGSITSSSYYWGWIRQPPGKGLEWIGSIYYRGSTNYNPSLKSRVTISVDSSKNQFYLKVSSVTAVDTAVYYCARQNGAARPSWFDPWGQGTLVTVSS,EIVLTQSPDTISLSPGERATLSCRASQSISSIYLAWYQQKPGQAPRLLIYGASSRVTGIPDRFSVSGSGTDFTLTISRLEPEDFAVYYCQHYGISPFTFGPGTKVDIR,3,-0.7331
+risankizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK,1,-0.8021
+rituximab,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA,QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK,2,-0.4116
+robatumumab,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK,2,-0.5435
+romosozumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK,0,-0.3994
+rontalizumab,EVQLVESGGGLVQPGGSLRLSCATSGYTFTEYIIHWVRQAPGKGLEWVASINPDYDITNYNQRFKGRFTISLDKSKRTAYLQMNSLRAEDTAVYYCASWISDFFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKVLISYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWGIPRTFGQGTKVEIK,0,-0.4472
+rovalpituzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK,3,-0.4548
+rozanolixizumab,EVPLVESGGGLVQPGGSLRLSCAVSGFTFSNYGMVWVRQAPGKGLEWVAYIDSDGDNTYYRDSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCTTGIVRPFLYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSSQSLVGASGKTYLYWLFQKPGKAPKRLIYLVSTLDSGIPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQGTHFPHTFGQGTKLEIK,1,-0.7772
+sarilumab,EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK,0,-0.3551
+satralizumab,QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS,DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE,1,-0.9377
+secukinumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK,2,-0.3276
+selicrelumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPDSGGTNYAQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYYCARDQPLGYCTNGVCSYFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGIYSWLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANIFPLTFGGGTKVEIK,1,-0.4613
+seribantumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYVMAWVRQAPGKGLEWVSSISSSGGWTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMATIFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNVVSWYQQHPGKAPKLIIYEVSQRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCCSYAGSSIFVIFGGGTKVTVL,3,-0.5369
+setrusumab,QVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSS,DIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVL,4,-0.5237
+sifalimumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYSISWVRQAPGQGLEWMGWISVYNGNTNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPIAAGYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,3,-0.2522
+siltuximab,EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS,QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK,3,-0.5003
+simtuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYAFTYYLIEWVRQAPGQGLEWIGVINPGSGGTNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCARNWMNFDYWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQHLEYPYTFGGGTKVEIK,4,-0.4507
+sintilimab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGLIIPMFDTAGYAQKFQGRVAITVDESTSTAYMELSSLRSEDTAVYYCARAEHSSTGTFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANHLPFTFGGGTKVEIK,0,-0.5297
+sirukumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK,2,-0.5793
+solanezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK,1,-0.4986
+spartalizumab,EVQLVQSGAEVKKPGESLRISCKGSGYTFTTYWMHWVRQATGQGLEWMGNIYPGTGGSNFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYCTRWTTGTGAYWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCKSSQSLLDSGNQKNFLTWYQQKPGQAPRLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCQNDYSYPYTFGQGTKVEIK,3,-0.7153
+sutimlimab,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSS,QIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIK,3,-0.6479
+tabalumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK,2,-0.2721
+tanezumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLIGYDLNWIRQPPGKGLEWIGIIWGDGTTDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYATSYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNNLNWYQQKPGKAPKLLIYYTSRFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQEHTLPYTFGQGTKLEIK,1,-0.5061
+tarextumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSS,DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIK,4,-0.482
+tavolimab,QVQLQESGPGLVKPSQTLSLTCAVYGGSFSSGYWNWIRKHPGKGLEYIGYISYNGITYHNPSLKSRITINRDTSKNQYSLQLNSVTPEDTAVYYCARYKYDYDGGHAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQGSALPWTFGQGTKVEIK,3,-0.5901
+telisotuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFTAYTMHWVRQAPGQGLEWMGWIKPNNGLANYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSEITTEFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEDPLTFGGGTKVEIK,4,-0.5401
+teplizumab,QVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKGLEWIGYINPSRGYTNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYCLDYWGQGTPVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSNPFTFGQGTKLQIT,1,-0.705
+teprotumumab,QVELVESGGGVVQPGRSQRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAIIWFDGSSTYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARELGRRYFDLWGRGTLVSVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSKWPPWTFGQGTKVESK,2,-0.439
+tezepelumab,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,3,-0.4592
+tigatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK,0,-0.3206
+tildrakizumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK,1,-0.5034
+tislelizumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIK,2,-0.6019
+tisotumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSSISGSGDYTYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPWGYYLDSWGQGTLVTVSS,DIQMTQSPPSLSASAGDRVTITCRASQGISSRLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIK,0,-0.4653
+tocilizumab,QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK,3,-0.4773
+toripalimab,QGQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPIHGLEWIGVIESETGGTAYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGITTVATTYYWYFDVWGQGTTVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPLTFGQGTKLEIK,4,-0.4838
+tovetumab,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK,2,-0.5433
+tralokinumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSS,SYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVL,2,-0.5084
+trastuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK,0,-0.2536
+tregalizumab,EEQLVESGGGLVKPGGSLRLSCAASGFSFSDCRMYWLRQAPGKGLEWIGVISVKSENYGANYAESVRGRFTISRDDSKNTVYLQMNSLKTEDTAVYYCSASYYRYDVGAWFAYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQHSRELPWTFGQGTKVEIK,2,-0.6992
+tremelimumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK,2,-0.3008
+ublituximab,QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSS,QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIK,2,-0.5653
+urelumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK,2,-0.3484
+ustekinumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIK,3,-0.6199
+utomilumab,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,3,-0.3202
+vadastuximab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQAPGQGLEWIGWIYPGDGSTKYNEKFKAKATLTADTSTSTAYMELRSLRSDDTAVYYCASGYEDAMDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTINCKASQDINSYLSWFQQKPGKAPKTLIYRANRLVDGVPSRFSGSGSGQDYTLTISSLQPEDFATYYCLQYDEFPLTFGGGTKVEIK,1,-0.3856
+varlilumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIK,0,-0.359
+vatelizumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS,DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK,3,-0.8239
+vedolizumab,QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK,4,-0.5884
+veltuzumab,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK,1,-0.5567
+visilizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIK,0,-0.4
+xentuzumab,QVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSS,DIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVL,4,-0.6543
+zalutumumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,0,-0.5345
+zanolimumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVINWFDPWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPYTFGQGTKLEIK,3,-0.2446
+zolbetuximab,QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS,DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK,4,-0.3497
\ No newline at end of file